country,term,count
AR,CONDITION AGGRAVATED,1
AR,EPISTAXIS,1
AR,EXPIRED PRODUCT ADMINISTERED,1
AR,FALL,1
AR,GANGRENE,1
AR,GASTRITIS,1
AR,HAEMORRHOIDAL HAEMORRHAGE,1
AR,HEART RATE DECREASED,1
AR,HUMERUS FRACTURE,1
AR,HYPERTENSION,1
AR,HYPONATRAEMIA,1
AR,HYPOTENSION,1
AR,MALAISE,1
AR,MYOSCLEROSIS,1
AR,RHEUMATOID ARTHRITIS,1
AR,UPPER LIMB FRACTURE,1
AU,DYSPNOEA,37
AU,CEREBROVASCULAR ACCIDENT,33
AU,FALL,32
AU,NAUSEA,29
AU,DIARRHOEA,22
AU,ARTHRALGIA,21
AU,MYOCARDIAL INFARCTION,21
AU,VOMITING,21
AU,PNEUMONIA,20
AU,MALAISE,19
AU,ANAEMIA,18
AU,MYALGIA,18
AU,DIZZINESS,17
AU,HYPERTENSION,17
AU,WEIGHT DECREASED,17
AU,ATRIAL FIBRILLATION,16
AU,CONFUSIONAL STATE,16
AU,PAIN IN EXTREMITY,15
AU,RENAL IMPAIRMENT,15
AU,BLOOD CREATININE INCREASED,14
AU,BLOOD GLUCOSE INCREASED,14
AU,DEATH,14
AU,DEHYDRATION,14
AU,RENAL FAILURE ACUTE,14
AU,FATIGUE,13
AU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,13
AU,MUSCLE SPASMS,13
AU,PAIN,13
AU,RHABDOMYOLYSIS,13
AU,ASTHENIA,12
AU,DRUG INEFFECTIVE,12
AU,GAIT DISTURBANCE,12
AU,HYPERHIDROSIS,12
AU,HYPOTENSION,12
AU,URINARY TRACT INFECTION,12
AU,CARDIAC FAILURE CONGESTIVE,11
AU,GLOMERULAR FILTRATION RATE DECREASED,11
AU,CARDIAC FAILURE,10
AU,CHEST DISCOMFORT,10
AU,CHEST PAIN,10
AU,HAEMOGLOBIN DECREASED,10
AU,IMMUNE-MEDIATED NECROTISING MYOPATHY,10
AU,LOSS OF CONSCIOUSNESS,10
AU,MYOSITIS,10
AU,PRURITUS,10
AU,SYNCOPE,10
AU,CARDIAC DISORDER,9
AU,DRUG-INDUCED LIVER INJURY,9
AU,HEADACHE,9
AU,LETHARGY,9
AU,LOWER RESPIRATORY TRACT INFECTION,9
AU,SEPSIS,9
AU,ABDOMINAL PAIN,8
AU,ALOPECIA,8
AU,APHASIA,8
AU,ARTHRITIS,8
AU,BLOOD ALKALINE PHOSPHATASE INCREASED,8
AU,BLOOD PRESSURE INCREASED,8
AU,CONSTIPATION,8
AU,DEPRESSION,8
AU,DYSPHAGIA,8
AU,FEELING ABNORMAL,8
AU,NEUTROPENIA,8
AU,OEDEMA PERIPHERAL,8
AU,PLEURAL EFFUSION,8
AU,RENAL FAILURE,8
AU,ACUTE MYOCARDIAL INFARCTION,7
AU,ANGINA PECTORIS,7
AU,ANXIETY,7
AU,BACK PAIN,7
AU,DECREASED APPETITE,7
AU,EPISTAXIS,7
AU,MUSCULAR WEAKNESS,7
AU,MUSCULOSKELETAL PAIN,7
AU,PANCREATITIS,7
AU,PARAESTHESIA,7
AU,PULMONARY EMBOLISM,7
AU,PYREXIA,7
AU,RASH,7
AU,RECTAL HAEMORRHAGE,7
AU,SKIN CANCER,7
AU,TREMOR,7
AU,VISION BLURRED,7
AU,BASAL CELL CARCINOMA,6
AU,CELLULITIS,6
AU,DELIRIUM,6
AU,GASTROOESOPHAGEAL REFLUX DISEASE,6
AU,GLYCOSYLATED HAEMOGLOBIN INCREASED,6
AU,HAEMORRHAGE INTRACRANIAL,6
AU,LIVER FUNCTION TEST ABNORMAL,6
AU,MELAENA,6
AU,MEMORY IMPAIRMENT,6
AU,OSTEOARTHRITIS,6
AU,PALPITATIONS,6
AU,SQUAMOUS CELL CARCINOMA OF SKIN,6
AU,ACTINIC KERATOSIS,5
AU,ANGIOEDEMA,5
AU,AORTIC STENOSIS,5
AU,ASTHMA,5
AU,BLINDNESS,5
AU,BLOOD BICARBONATE INCREASED,5
AU,BLOOD IRON DECREASED,5
AU,BLOOD PRESSURE DECREASED,5
AU,CARDIOMYOPATHY,5
AU,COUGH,5
AU,DIVERTICULUM,5
AU,DYSPEPSIA,5
AU,FEBRILE NEUTROPENIA,5
AU,GENERAL PHYSICAL HEALTH DETERIORATION,5
AU,HEART RATE INCREASED,5
AU,HYPERKALAEMIA,5
AU,HYPOGLYCAEMIA,5
AU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
AU,LEFT VENTRICULAR DYSFUNCTION,5
AU,MYOCARDIAL ISCHAEMIA,5
AU,OSTEOPOROSIS,5
AU,SUICIDAL IDEATION,5
AU,TRANSIENT ISCHAEMIC ATTACK,5
AU,ABDOMINAL PAIN UPPER,4
AU,ACUTE PULMONARY OEDEMA,4
AU,AGITATION,4
AU,AMNESIA,4
AU,ATAXIA,4
AU,ATRIAL FLUTTER,4
AU,BALANCE DISORDER,4
AU,BLOOD SODIUM DECREASED,4
AU,BLOOD UREA INCREASED,4
AU,BOWEN^S DISEASE,4
AU,CARDIAC ARREST,4
AU,CATARACT,4
AU,CHOKING,4
AU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
AU,DEMENTIA,4
AU,DIABETES MELLITUS,4
AU,DISORIENTATION,4
AU,DRUG DOSE OMISSION,4
AU,DYSARTHRIA,4
AU,ERYTHEMA,4
AU,FLUID OVERLOAD,4
AU,GASTROINTESTINAL DISORDER,4
AU,HEAD INJURY,4
AU,HEMIPARESIS,4
AU,HEPATIC ENZYME INCREASED,4
AU,HOT FLUSH,4
AU,HYPERCALCAEMIA,4
AU,HYPERSENSITIVITY,4
AU,HYPOAESTHESIA,4
AU,HYPONATRAEMIA,4
AU,INFECTION,4
AU,INFLUENZA LIKE ILLNESS,4
AU,INJECTION SITE BRUISING,4
AU,IRON DEFICIENCY,4
AU,IRON DEFICIENCY ANAEMIA,4
AU,ISCHAEMIC STROKE,4
AU,LIP SWELLING,4
AU,MITRAL VALVE INCOMPETENCE,4
AU,MOBILITY DECREASED,4
AU,MULTI-ORGAN FAILURE,4
AU,MYOPATHY,4
AU,OSTEONECROSIS OF JAW,4
AU,PALLOR,4
AU,PRODUCT QUALITY ISSUE,4
AU,PULMONARY OEDEMA,4
AU,RASH PRURITIC,4
AU,RED BLOOD CELL COUNT DECREASED,4
AU,RESPIRATORY FAILURE,4
AU,SOMNOLENCE,4
AU,UNRESPONSIVE TO STIMULI,4
AU,URINARY INCONTINENCE,4
AU,URINARY RETENTION,4
AU,WEIGHT INCREASED,4
AU,WHEEZING,4
AU,ABDOMINAL DISCOMFORT,3
AU,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,3
AU,ACUTE KIDNEY INJURY,3
AU,ALANINE AMINOTRANSFERASE INCREASED,3
AU,ANION GAP INCREASED,3
AU,ARTHROPATHY,3
AU,BLOOD ALBUMIN DECREASED,3
AU,BLOOD BILIRUBIN INCREASED,3
AU,BLOOD CHOLESTEROL INCREASED,3
AU,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
AU,BLOOD LACTATE DEHYDROGENASE INCREASED,3
AU,BLOOD PHOSPHORUS DECREASED,3
AU,BLOOD POTASSIUM INCREASED,3
AU,BLOOD THYROID STIMULATING HORMONE INCREASED,3
AU,BLOOD URIC ACID INCREASED,3
AU,BLOOD URINE PRESENT,3
AU,BONE DENSITY DECREASED,3
AU,BREAST CANCER,3
AU,CARDIAC MURMUR,3
AU,CIRCULATORY COLLAPSE,3
AU,COLITIS ISCHAEMIC,3
AU,COLON CANCER,3
AU,CONVULSION,3
AU,DIVERTICULITIS,3
AU,DRUG EFFECT INCOMPLETE,3
AU,EJECTION FRACTION DECREASED,3
AU,EMPHYSEMA,3
AU,FLUID RETENTION,3
AU,GASTRIC HAEMORRHAGE,3
AU,GASTRIC ULCER,3
AU,GASTROINTESTINAL HAEMORRHAGE,3
AU,HAEMATOCRIT DECREASED,3
AU,HAEMATURIA,3
AU,HAEMORRHAGE,3
AU,HALLUCINATION,3
AU,HEMIPLEGIA,3
AU,HEPATIC FAILURE,3
AU,HYPERCHOLESTEROLAEMIA,3
AU,INSOMNIA,3
AU,INTERNATIONAL NORMALISED RATIO INCREASED,3
AU,INTERSTITIAL LUNG DISEASE,3
AU,INTERVERTEBRAL DISC PROTRUSION,3
AU,JOINT DISLOCATION,3
AU,LEG AMPUTATION,3
AU,LIVER DISORDER,3
AU,LOW DENSITY LIPOPROTEIN INCREASED,3
AU,LUNG NEOPLASM MALIGNANT,3
AU,MALIGNANT NEOPLASM PROGRESSION,3
AU,MOUTH ULCERATION,3
AU,MOVEMENT DISORDER,3
AU,NASOPHARYNGITIS,3
AU,NEUTROPHIL COUNT INCREASED,3
AU,OEDEMA,3
AU,OVERDOSE,3
AU,PERIPHERAL SWELLING,3
AU,PRODUCT USE ISSUE,3
AU,PROSTATE CANCER METASTATIC,3
AU,RADIUS FRACTURE,3
AU,RASH GENERALISED,3
AU,RED CELL DISTRIBUTION WIDTH INCREASED,3
AU,RENAL FAILURE CHRONIC,3
AU,RETCHING,3
AU,RHEUMATOID ARTHRITIS,3
AU,RIB FRACTURE,3
AU,SCHIZOPHRENIA,3
AU,SEDATION,3
AU,SKIN LESION,3
AU,SKIN ULCER,3
AU,SPINAL COMPRESSION FRACTURE,3
AU,SQUAMOUS CELL CARCINOMA,3
AU,STAPHYLOCOCCAL INFECTION,3
AU,STRESS,3
AU,SUBDURAL HAEMORRHAGE,3
AU,SWELLING FACE,3
AU,TOOTH DISORDER,3
AU,URTICARIA,3
AU,VASCULAR DEMENTIA,3
AU,VERTIGO,3
AU,VIITH NERVE PARALYSIS,3
AU,VISUAL ACUITY REDUCED,3
AU,VULVOVAGINAL CANDIDIASIS,3
AU,WHITE BLOOD CELL COUNT INCREASED,3
AU,ABASIA,2
AU,ABDOMINAL DISTENSION,2
AU,ACTIVITIES OF DAILY LIVING IMPAIRED,2
AU,ACUTE CORONARY SYNDROME,2
AU,ADENOMA BENIGN,2
AU,ADVERSE DRUG REACTION,2
AU,AGE-RELATED MACULAR DEGENERATION,2
AU,AGGRESSION,2
AU,ANGER,2
AU,ASPARTATE AMINOTRANSFERASE INCREASED,2
AU,AUTOIMMUNE HEPATITIS,2
AU,BASAL GANGLIA HAEMORRHAGE,2
AU,BLISTER,2
AU,BLOOD CALCIUM DECREASED,2
AU,BLOOD CHLORIDE DECREASED,2
AU,BLOOD GLUCOSE DECREASED,2
AU,BRADYCARDIA,2
AU,CALCINOSIS,2
AU,CAROTID ARTERY STENOSIS,2
AU,CEREBRAL INFARCTION,2
AU,CEREBRAL ISCHAEMIA,2
AU,CHILLS,2
AU,CHOLECYSTITIS,2
AU,CHROMATURIA,2
AU,COLD SWEAT,2
AU,COLITIS,2
AU,COMA SCALE ABNORMAL,2
AU,CONDITION AGGRAVATED,2
AU,CONTUSION,2
AU,CORONARY ARTERY DISEASE,2
AU,CUSHINGOID,2
AU,DERMATITIS BULLOUS,2
AU,DIABETES MELLITUS INADEQUATE CONTROL,2
AU,DIABETIC KETOACIDOSIS,2
AU,DIASTOLIC DYSFUNCTION,2
AU,DILATATION VENTRICULAR,2
AU,DISEASE PROGRESSION,2
AU,DISEASE RECURRENCE,2
AU,DISSEMINATED INTRAVASCULAR COAGULATION,2
AU,DIVERTICULUM INTESTINAL HAEMORRHAGIC,2
AU,DRUG ADMINISTRATION ERROR,2
AU,DRUG HYPERSENSITIVITY,2
AU,DRUG INTOLERANCE,2
AU,DRY MOUTH,2
AU,DRY SKIN,2
AU,DYSGEUSIA,2
AU,DYSPHONIA,2
AU,ESCHERICHIA URINARY TRACT INFECTION,2
AU,EYE HAEMORRHAGE,2
AU,EYE PAIN,2
AU,EYE SWELLING,2
AU,FAECES DISCOLOURED,2
AU,GASTRIC CANCER,2
AU,GASTROINTESTINAL CARCINOMA,2
AU,GLAUCOMA,2
AU,HAEMATEMESIS,2
AU,HAEMATOCHEZIA,2
AU,HAEMATOMA,2
AU,HAEMORRHAGIC STROKE,2
AU,HALLUCINATION_ AUDITORY,2
AU,HEART RATE DECREASED,2
AU,HEPATITIS,2
AU,HERNIA,2
AU,HERPES SIMPLEX,2
AU,HERPES ZOSTER,2
AU,HIP SURGERY,2
AU,HYPERSOMNIA,2
AU,HYPOKINESIA,2
AU,HYPOMAGNESAEMIA,2
AU,HYPOPHAGIA,2
AU,HYPOXIA,2
AU,IMMUNE SYSTEM DISORDER,2
AU,INCORRECT PRODUCT STORAGE,2
AU,INTENTIONAL OVERDOSE,2
AU,INTESTINAL OBSTRUCTION,2
AU,INVASIVE DUCTAL BREAST CARCINOMA,2
AU,IRRITABILITY,2
AU,JOINT INJURY,2
AU,JOINT SWELLING,2
AU,LACERATION,2
AU,LACRIMATION INCREASED,2
AU,LEFT VENTRICULAR FAILURE,2
AU,LIGAMENT SPRAIN,2
AU,LIMB DISCOMFORT,2
AU,LIMB INJURY,2
AU,LOCAL SWELLING,2
AU,LUMBAR VERTEBRAL FRACTURE,2
AU,LUNG INFECTION,2
AU,LUNG NEOPLASM,2
AU,LYMPH NODE PAIN,2
AU,MAJOR DEPRESSION,2
AU,MEAN CELL VOLUME INCREASED,2
AU,MENTAL IMPAIRMENT,2
AU,METASTASES TO CENTRAL NERVOUS SYSTEM,2
AU,METASTATIC RENAL CELL CARCINOMA,2
AU,METRORRHAGIA,2
AU,MOTOR DYSFUNCTION,2
AU,MUCOUS STOOLS,2
AU,MUSCLE ATROPHY,2
AU,MUSCULOSKELETAL STIFFNESS,2
AU,MYOCLONUS,2
AU,NECK PAIN,2
AU,NEPHROLITHIASIS,2
AU,NEUROLOGIC NEGLECT SYNDROME,2
AU,NIGHTMARE,2
AU,NOCTURIA,2
AU,ORAL HERPES,2
AU,OROPHARYNGEAL PAIN,2
AU,OSTEOMYELITIS,2
AU,OSTEOPOROTIC FRACTURE,2
AU,PERICARDIAL EFFUSION,2
AU,PERIORBITAL OEDEMA,2
AU,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
AU,PERIPHERAL VASCULAR DISORDER,2
AU,PLASMA CELL MYELOMA,2
AU,PLATELET COUNT DECREASED,2
AU,PNEUMONIA ASPIRATION,2
AU,PNEUMONITIS,2
AU,POLLAKIURIA,2
AU,POST PROCEDURAL HAEMORRHAGE,2
AU,PRESYNCOPE,2
AU,PRODUCTIVE COUGH,2
AU,PROSTATE CANCER,2
AU,PSYCHOTIC DISORDER,2
AU,RASH MACULAR,2
AU,RENAL DISORDER,2
AU,RESPIRATORY TRACT OEDEMA,2
AU,SALIVARY HYPERSECRETION,2
AU,SERUM FERRITIN DECREASED,2
AU,SINUS BRADYCARDIA,2
AU,SINUS TACHYCARDIA,2
AU,SKIN DISORDER,2
AU,SKIN GRAFT,2
AU,SKIN NEOPLASM EXCISION,2
AU,SLEEP APNOEA SYNDROME,2
AU,SLEEP DISORDER,2
AU,SPEECH DISORDER,2
AU,SUDDEN DEATH,2
AU,SUICIDE ATTEMPT,2
AU,SWOLLEN TONGUE,2
AU,SYNOVITIS,2
AU,TACHYCARDIA,2
AU,TEMPERATURE INTOLERANCE,2
AU,TENDON RUPTURE,2
AU,THERAPEUTIC RESPONSE UNEXPECTED,2
AU,THIRST,2
AU,THORACIC VERTEBRAL FRACTURE,2
AU,TINNITUS,2
AU,TOE AMPUTATION,2
AU,TRANSFERRIN SATURATION DECREASED,2
AU,TRICUSPID VALVE INCOMPETENCE,2
AU,TROPONIN INCREASED,2
AU,TYPE 2 DIABETES MELLITUS,2
AU,UPPER LIMB FRACTURE,2
AU,URINE OUTPUT DECREASED,2
AU,UROSEPSIS,2
AU,VAGINAL HAEMORRHAGE,2
AU,VASODILATATION,2
AU,VENTRICULAR HYPOKINESIA,2
AU,VIRAL INFECTION,2
AU,VITAMIN D DECREASED,2
AU,VITAMIN D DEFICIENCY,2
AU,WHITE BLOOD CELL COUNT DECREASED,2
AU,WRIST FRACTURE,2
AU,ABDOMINAL TENDERNESS,1
AU,ABNORMAL BEHAVIOUR,1
AU,ABNORMAL DREAMS,1
AU,ABNORMAL LOSS OF WEIGHT,1
AU,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
AU,ACETABULUM FRACTURE,1
AU,ACIDOSIS,1
AU,ACUTE LEFT VENTRICULAR FAILURE,1
AU,ACUTE PRERENAL FAILURE,1
AU,ACUTE RESPIRATORY DISTRESS SYNDROME,1
AU,ADVERSE EVENT,1
AU,ALBUMIN URINE PRESENT,1
AU,ALCOHOLISM,1
AU,ALTERED STATE OF CONSCIOUSNESS,1
AU,ANAPHYLACTIC REACTION,1
AU,ANASTOMOTIC LEAK,1
AU,ANGINA UNSTABLE,1
AU,ANGIOMYOLIPOMA,1
AU,ANKLE FRACTURE,1
AU,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,1
AU,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,1
AU,AORTIC ANEURYSM,1
AU,AORTIC DISSECTION,1
AU,AORTIC DISSECTION RUPTURE,1
AU,APLASIA PURE RED CELL,1
AU,APPLICATION SITE ERYTHEMA,1
AU,APPLICATION SITE IRRITATION,1
AU,ARRHYTHMIA,1
AU,ARTERIAL THROMBOSIS,1
AU,ARTERIOSCLEROSIS,1
AU,ASCITES,1
AU,ASPIRATION,1
AU,ATELECTASIS,1
AU,ATRIOVENTRICULAR BLOCK COMPLETE,1
AU,ATROPHIC VULVOVAGINITIS,1
AU,ATYPICAL FEMUR FRACTURE,1
AU,AUTOANTIBODY POSITIVE,1
AU,AVULSION FRACTURE,1
AU,BASAL GANGLIA STROKE,1
AU,BILE DUCT STONE,1
AU,BILIRUBIN CONJUGATED INCREASED,1
AU,BLADDER CANCER,1
AU,BLADDER DILATATION,1
AU,BLADDER DISORDER,1
AU,BLEEDING TIME PROLONGED,1
AU,BLINDNESS UNILATERAL,1
AU,BLOOD ALKALINE PHOSPHATASE ABNORMAL,1
AU,BLOOD ALKALINE PHOSPHATASE DECREASED,1
AU,BLOOD CALCIUM INCREASED,1
AU,BLOOD CHLORIDE INCREASED,1
AU,BLOOD CREATININE DECREASED,1
AU,BLOOD GLUCOSE FLUCTUATION,1
AU,BLOOD IRON INCREASED,1
AU,BLOOD MAGNESIUM DECREASED,1
AU,BLOOD MAGNESIUM INCREASED,1
AU,BLOOD PARATHYROID HORMONE INCREASED,1
AU,BLOOD PHOSPHORUS INCREASED,1
AU,BLOOD POTASSIUM DECREASED,1
AU,BLOOD PRESSURE FLUCTUATION,1
AU,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
AU,BLOOD PRESSURE SYSTOLIC DECREASED,1
AU,BLOOD TRIGLYCERIDES INCREASED,1
AU,BLOOD UREA DECREASED,1
AU,BLOOD UREA NITROGEN/CREATININE RATIO DECREASED,1
AU,BLOOD UREA NITROGEN/CREATININE RATIO INCREASED,1
AU,BLOODY DISCHARGE,1
AU,BODY TEMPERATURE INCREASED,1
AU,BONE LOSS,1
AU,BONE PAIN,1
AU,BOWEL MOVEMENT IRREGULARITY,1
AU,BRAIN INJURY,1
AU,BRAIN OEDEMA,1
AU,BREAST MASS,1
AU,BRONCHIAL CARCINOMA,1
AU,BRONCHOPNEUMONIA,1
AU,BRONCHOPULMONARY ASPERGILLOSIS,1
AU,BUNDLE BRANCH BLOCK LEFT,1
AU,BURNING SENSATION,1
AU,C-REACTIVE PROTEIN INCREASED,1
AU,CACHEXIA,1
AU,CANDIDA INFECTION,1
AU,CARDIAC ANEURYSM,1
AU,CARDIAC FAILURE ACUTE,1
AU,CARDIAC OUTPUT DECREASED,1
AU,CARDIAC PACEMAKER INSERTION,1
AU,CARDIAC VALVE DISEASE,1
AU,CARDIO-RESPIRATORY ARREST,1
AU,CARDIOGENIC SHOCK,1
AU,CARDIOVASCULAR DISORDER,1
AU,CAROTID ARTERIOSCLEROSIS,1
AU,CAROTID ARTERY OCCLUSION,1
AU,CARPAL TUNNEL SYNDROME,1
AU,CENTRAL OBESITY,1
AU,CEREBELLAR TUMOUR,1
AU,CEREBRAL HAEMORRHAGE,1
AU,CHEST INJURY,1
AU,CHOLECYSTECTOMY,1
AU,CHOLELITHIASIS,1
AU,CHOLESTATIC LIVER INJURY,1
AU,CHOROIDAL INFARCTION,1
AU,CHRONIC FATIGUE SYNDROME,1
AU,CHRONIC KIDNEY DISEASE,1
AU,CHRONIC MYELOID LEUKAEMIA (IN REMISSION),1
AU,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
AU,CLAUSTROPHOBIA,1
AU,CLUSTER HEADACHE,1
AU,COELIAC DISEASE,1
AU,COGNITIVE DISORDER,1
AU,COLON ADENOMA,1
AU,COLON CANCER STAGE III,1
AU,COLONOSCOPY,1
AU,CONCOMITANT DISEASE AGGRAVATED,1
AU,CONGESTIVE CARDIOMYOPATHY,1
AU,CONJUNCTIVAL DISORDER,1
AU,CONJUNCTIVAL HAEMORRHAGE,1
AU,CONTRAINDICATED PRODUCT ADMINISTERED,1
AU,CORNEAL PIGMENTATION,1
AU,CORONARY ANGIOPLASTY,1
AU,CORONARY ARTERY BYPASS,1
AU,CORONARY ARTERY DILATATION,1
AU,CORONARY ARTERY OCCLUSION,1
AU,CORONARY ARTERY STENOSIS,1
AU,CREATININE RENAL CLEARANCE ABNORMAL,1
AU,CREATININE RENAL CLEARANCE DECREASED,1
AU,CYANOSIS,1
AU,CYSTITIS,1
AU,DEAFNESS,1
AU,DECREASED ACTIVITY,1
AU,DECUBITUS ULCER,1
AU,DEEP VEIN THROMBOSIS,1
AU,DEMENTIA ALZHEIMER^S TYPE,1
AU,DEPENDENCE,1
AU,DEPRESSED LEVEL OF CONSCIOUSNESS,1
AU,DEPRESSED MOOD,1
AU,DEVICE BREAKAGE,1
AU,DEVICE DISLOCATION,1
AU,DEVICE LEAKAGE,1
AU,DEVICE RELATED INFECTION,1
AU,DIFFUSE LARGE B-CELL LYMPHOMA,1
AU,DILATATION ATRIAL,1
AU,DISCOMFORT,1
AU,DISSOCIATIVE FUGUE,1
AU,DISTURBANCE IN ATTENTION,1
AU,DROOLING,1
AU,DRUG DISPENSING ERROR,1
AU,DRUG WITHDRAWAL MAINTENANCE THERAPY,1
AU,DRUG WITHDRAWAL SYNDROME,1
AU,DRY EYE,1
AU,DUODENAL VASCULAR ECTASIA,1
AU,DUODENITIS,1
AU,DYSPNOEA AT REST,1
AU,DYSPNOEA EXERTIONAL,1
AU,DYSSTASIA,1
AU,EATING DISORDER,1
AU,ECCHYMOSIS,1
AU,ECZEMA,1
AU,ELECTROCARDIOGRAM PR PROLONGATION,1
AU,ELECTROCARDIOGRAM QT PROLONGED,1
AU,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
AU,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
AU,ELECTROCARDIOGRAM ST-T CHANGE,1
AU,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,1
AU,ELECTROCARDIOGRAM T WAVE INVERSION,1
AU,ENCOPRESIS,1
AU,ENDOSCOPY UPPER GASTROINTESTINAL TRACT,1
AU,EOSINOPHIL COUNT DECREASED,1
AU,EPIGLOTTITIS,1
AU,EPILEPSY,1
AU,ERECTILE DYSFUNCTION,1
AU,ERUCTATION,1
AU,EXCORIATION,1
AU,EXFOLIATIVE RASH,1
AU,EXPOSED BONE IN JAW,1
AU,EXTRAPYRAMIDAL DISORDER,1
AU,EYE INFECTION SYPHILITIC,1
AU,EYE PRURITUS,1
AU,FACE OEDEMA,1
AU,FACIAL BONES FRACTURE,1
AU,FACIAL PARESIS,1
AU,FAECAL INCONTINENCE,1
AU,FAECES HARD,1
AU,FAECES PALE,1
AU,FEEDING DISORDER,1
AU,FEELING COLD,1
AU,FEELING HOT,1
AU,FEMORAL NECK FRACTURE,1
AU,FEMUR FRACTURE,1
AU,FIBULA FRACTURE,1
AU,FLANK PAIN,1
AU,FLUSHING,1
AU,FOLATE DEFICIENCY,1
AU,FOOT FRACTURE,1
AU,FRACTURE,1
AU,FULL BLOOD COUNT INCREASED,1
AU,FUNGAL INFECTION,1
AU,GANGRENE,1
AU,GASTRIC ULCER HAEMORRHAGE,1
AU,GASTROENTERITIS,1
AU,GASTROENTERITIS VIRAL,1
AU,GASTROINTESTINAL TUBE INSERTION,1
AU,GASTROINTESTINAL ULCER,1
AU,GAZE PALSY,1
AU,GINGIVAL ABSCESS,1
AU,GINGIVAL DISORDER,1
AU,GINGIVAL INFECTION,1
AU,GLIOSIS,1
AU,GOUT,1
AU,GRIP STRENGTH DECREASED,1
AU,HAEMOCHROMATOSIS,1
AU,HAEMOPHILIA,1
AU,HAEMOPTYSIS,1
AU,HAEMORRHAGE URINARY TRACT,1
AU,HAEMORRHAGIC INFARCTION,1
AU,HAEMORRHOID OPERATION,1
AU,HAEMORRHOIDS,1
AU,HAEMOTHORAX,1
AU,HAIR TEXTURE ABNORMAL,1
AU,HALLUCINATION_ GUSTATORY,1
AU,HAND FRACTURE,1
AU,HEMIANOPIA,1
AU,HEPATIC CYST,1
AU,HEPATOCELLULAR INJURY,1
AU,HIP FRACTURE,1
AU,HISTIOCYTOSIS HAEMATOPHAGIC,1
AU,HOMELESS,1
AU,HUMERUS FRACTURE,1
AU,HYDRONEPHROSIS,1
AU,HYPERAMMONAEMIC ENCEPHALOPATHY,1
AU,HYPERLACTACIDAEMIA,1
AU,HYPERPARATHYROIDISM SECONDARY,1
AU,HYPERSENSITIVITY VASCULITIS,1
AU,HYPERTROPHIC CARDIOMYOPATHY,1
AU,HYPERVENTILATION,1
AU,HYPOCHONDRIASIS,1
AU,HYPOKALAEMIA,1
AU,HYPOPITUITARISM,1
AU,HYPOTHYROIDISM,1
AU,HYPOVOLAEMIA,1
AU,HYPOVOLAEMIC SHOCK,1
AU,IDIOPATHIC PULMONARY FIBROSIS,1
AU,ILEECTOMY,1
AU,IMMUNE THROMBOCYTOPENIC PURPURA,1
AU,IMPAIRED HEALING,1
AU,IMPAIRED WORK ABILITY,1
AU,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
AU,INCONTINENCE,1
AU,INCREASED TENDENCY TO BRUISE,1
AU,INFECTIOUS PLEURAL EFFUSION,1
AU,INFERIOR VENA CAVA DILATATION,1
AU,INFLAMMATION,1
AU,INFLUENZA,1
AU,INFUSION,1
AU,INGROWN HAIR,1
AU,INGUINAL HERNIA,1
AU,INJECTION SITE ABSCESS,1
AU,INJECTION SITE HAEMORRHAGE,1
AU,INJECTION SITE INFECTION,1
AU,INJECTION SITE MASS,1
AU,INJECTION SITE PAIN,1
AU,INJURY,1
AU,INSULIN-LIKE GROWTH FACTOR INCREASED,1
AU,INTENTIONAL PRODUCT USE ISSUE,1
AU,INTERNAL HAEMORRHAGE,1
AU,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
AU,INTERVERTEBRAL DISC DEGENERATION,1
AU,INTERVERTEBRAL DISC DISORDER,1
AU,INTESTINAL OPERATION,1
AU,INTRACARDIAC THROMBUS,1
AU,INTRACRANIAL ANEURYSM,1
AU,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
AU,INTRAOCULAR PRESSURE INCREASED,1
AU,ISCHAEMIA,1
AU,JAUNDICE,1
AU,JAW DISORDER,1
AU,JAW FRACTURE,1
AU,JOINT INSTABILITY,1
AU,JOINT RANGE OF MOTION DECREASED,1
AU,JOINT STIFFNESS,1
AU,KETOACIDOSIS,1
AU,KNEE ARTHROPLASTY,1
AU,LEFT ATRIAL HYPERTROPHY,1
AU,LEFT VENTRICULAR HYPERTROPHY,1
AU,LESION EXCISION,1
AU,LEUKOPENIA,1
AU,LOOSE TOOTH,1
AU,LOSS OF LIBIDO,1
AU,LOWER LIMB FRACTURE,1
AU,LUNG INFILTRATION,1
AU,LYMPHADENOPATHY,1
AU,LYMPHOPENIA,1
AU,MACULAR PIGMENTATION,1
AU,MAGNESIUM DEFICIENCY,1
AU,MALIGNANT MELANOMA,1
AU,MALNUTRITION,1
AU,MANIA,1
AU,MEAN CELL HAEMOGLOBIN DECREASED,1
AU,MEAN CELL VOLUME ABNORMAL,1
AU,MEAN CELL VOLUME DECREASED,1
AU,MEDICATION ERROR,1
AU,MELANOSIS COLI,1
AU,MENINGIOMA,1
AU,MENTAL DISORDER,1
AU,METASTASES TO BONE,1
AU,METASTASES TO LIVER,1
AU,METASTASES TO LYMPH NODES,1
AU,METASTASES TO SPINE,1
AU,METASTATIC MALIGNANT MELANOMA,1
AU,MICROALBUMINURIA,1
AU,MONOCYTE COUNT INCREASED,1
AU,MOOD ALTERED,1
AU,MUCOSAL INFLAMMATION,1
AU,MULTIPLE FRACTURES,1
AU,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
AU,MUSCLE FATIGUE,1
AU,MUSCLE INJURY,1
AU,MUSCLE RUPTURE,1
AU,MUSCULOSKELETAL CHEST PAIN,1
AU,MUTISM,1
AU,MYASTHENIA GRAVIS,1
AU,MYOCARDITIS,1
AU,NAIL DISORDER,1
AU,NAIL RIDGING,1
AU,NASAL DISCOMFORT,1
AU,NEPHROPATHY,1
AU,NERVOUS SYSTEM DISORDER,1
AU,NERVOUSNESS,1
AU,NEUROENDOCRINE TUMOUR,1
AU,NEUROPATHY PERIPHERAL,1
AU,NEUTROPHIL COUNT DECREASED,1
AU,NIGHT SWEATS,1
AU,NO ADVERSE EVENT,1
AU,NO THERAPEUTIC RESPONSE,1
AU,OBSESSIVE-COMPULSIVE DISORDER,1
AU,OBSTRUCTIVE AIRWAYS DISORDER,1
AU,OCCULT BLOOD POSITIVE,1
AU,OCULAR DISCOMFORT,1
AU,OCULAR ICTERUS,1
AU,OESOPHAGEAL ADENOCARCINOMA,1
AU,OLIGODENDROGLIOMA,1
AU,ONYCHOMYCOSIS,1
AU,OPTIC ISCHAEMIC NEUROPATHY,1
AU,ORAL CAVITY FISTULA,1
AU,ORAL INFECTION,1
AU,ORAL PAIN,1
AU,ORTHOPNOEA,1
AU,ORTHOSTATIC HYPOTENSION,1
AU,OSTEITIS DEFORMANS,1
AU,PAIN IN JAW,1
AU,PANCREATIC CARCINOMA,1
AU,PANCREATITIS NECROTISING,1
AU,PANIC DISORDER,1
AU,PARANOIA,1
AU,PARAPLEGIA,1
AU,PARKINSONISM,1
AU,PARKINSON^S DISEASE,1
AU,PEPTIC ULCER HAEMORRHAGE,1
AU,PERIARTHRITIS,1
AU,PERIPHERAL COLDNESS,1
AU,PERIPHERAL SENSORY NEUROPATHY,1
AU,PETIT MAL EPILEPSY,1
AU,PHARYNGEAL ULCERATION,1
AU,PHARYNGITIS,1
AU,PHOTOPHOBIA,1
AU,PHYSICAL ASSAULT,1
AU,PLATELET COUNT INCREASED,1
AU,PLEURAL FIBROSIS,1
AU,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
AU,PNEUMONIA CRYPTOCOCCAL,1
AU,PNEUMONIA PSEUDOMONAL,1
AU,PNEUMOTHORAX,1
AU,POISONING DELIBERATE,1
AU,POOR PERIPHERAL CIRCULATION,1
AU,POOR QUALITY SLEEP,1
AU,POST PROCEDURAL INFECTION,1
AU,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
AU,POSTOPERATIVE WOUND INFECTION,1
AU,PRODUCT SHAPE ISSUE,1
AU,PRODUCT SIZE ISSUE,1
AU,PRODUCT SUBSTITUTION ISSUE,1
AU,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
AU,PROTEIN TOTAL DECREASED,1
AU,PROTEIN TOTAL INCREASED,1
AU,PROTEINURIA,1
AU,PROTHROMBIN TIME PROLONGED,1
AU,PRURIGO,1
AU,PSORIASIS,1
AU,PSYCHOMOTOR RETARDATION,1
AU,PSYCHOTIC SYMPTOM,1
AU,PULMONARY ARTERIAL HYPERTENSION,1
AU,PULMONARY CONGESTION,1
AU,PULMONARY FIBROSIS,1
AU,PULMONARY MASS,1
AU,PULMONARY THROMBOSIS,1
AU,PULMONARY VALVE INCOMPETENCE,1
AU,PULMONARY VASCULAR DISORDER,1
AU,PULSE ABSENT,1
AU,PURULENCE,1
AU,QUADRIPLEGIA,1
AU,QUALITY OF LIFE DECREASED,1
AU,RADIATION INJURY,1
AU,RALES,1
AU,RASH ERYTHEMATOUS,1
AU,RASH MACULO-PAPULAR,1
AU,RASH PAPULAR,1
AU,REBOUND EFFECT,1
AU,RECTAL ADENOCARCINOMA,1
AU,RECTOSIGMOID CANCER,1
AU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
AU,RED MAN SYNDROME,1
AU,RENAL INJURY,1
AU,RENAL ISCHAEMIA,1
AU,RENAL PAIN,1
AU,RENAL SURGERY,1
AU,RENAL TUBULAR NECROSIS,1
AU,RESPIRATORY ARREST,1
AU,RESPIRATORY RATE INCREASED,1
AU,RESPIRATORY TRACT INFECTION VIRAL,1
AU,RESTLESS LEGS SYNDROME,1
AU,RESTLESSNESS,1
AU,RETINAL ARTERY OCCLUSION,1
AU,RETINAL DISORDER,1
AU,RETINAL PIGMENTATION,1
AU,RETINAL VASCULAR THROMBOSIS,1
AU,RHINORRHOEA,1
AU,RIGHT ATRIAL DILATATION,1
AU,ROAD TRAFFIC ACCIDENT,1
AU,ROTATOR CUFF SYNDROME,1
AU,RUPTURED CEREBRAL ANEURYSM,1
AU,SCAB,1
AU,SCAR,1
AU,SCOLIOSIS,1
AU,SEASONAL ALLERGY,1
AU,SEBORRHOEA,1
AU,SEIZURE,1
AU,SEMINOMA,1
AU,SENSORY LOSS,1
AU,SEROTONIN SYNDROME,1
AU,SHOULDER ARTHROPLASTY,1
AU,SHOULDER DEFORMITY,1
AU,SINUS NODE DYSFUNCTION,1
AU,SKIN ATROPHY,1
AU,SKIN DISCOLOURATION,1
AU,SKIN EXFOLIATION,1
AU,SKIN INDURATION,1
AU,SKIN STRIAE,1
AU,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,1
AU,SOCIAL PROBLEM,1
AU,SOFT TISSUE INJURY,1
AU,SPIDER NAEVUS,1
AU,SPINAL COLUMN STENOSIS,1
AU,SPINAL CORD COMPRESSION,1
AU,SPINAL CORD DISORDER,1
AU,SPINAL CORD HAEMORRHAGE,1
AU,SPINAL OPERATION,1
AU,SPLENIC CYST,1
AU,SPLENIC LESION,1
AU,SPLENOMEGALY,1
AU,SQUAMOUS CELL CARCINOMA OF THE VULVA,1
AU,STARING,1
AU,STATUS EPILEPTICUS,1
AU,STERNAL FRACTURE,1
AU,STREPTOCOCCAL SEPSIS,1
AU,STRIDOR,1
AU,SUBACUTE ENDOCARDITIS,1
AU,SUBARACHNOID HAEMORRHAGE,1
AU,SUDDEN CARDIAC DEATH,1
AU,SUICIDAL BEHAVIOUR,1
AU,SUPRAVENTRICULAR EXTRASYSTOLES,1
AU,SURGERY,1
AU,SWELLING,1
AU,SYNOVIAL CYST,1
AU,T-CELL LYMPHOMA,1
AU,TACHYARRHYTHMIA,1
AU,TACHYPNOEA,1
AU,TEARFULNESS,1
AU,TEETH BRITTLE,1
AU,TEMPORAL ARTERITIS,1
AU,TENDON OPERATION,1
AU,TENSION,1
AU,THERAPY CHANGE,1
AU,THORACIC CAVITY DRAINAGE,1
AU,THROAT IRRITATION,1
AU,THROMBOSIS,1
AU,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
AU,THYROID CANCER,1
AU,THYROID DISORDER,1
AU,TONIC CONVULSION,1
AU,TONSILLITIS,1
AU,TOOTH ABSCESS,1
AU,TOOTH LOSS,1
AU,TRANSFERRIN SATURATION INCREASED,1
AU,TRANSFUSION,1
AU,TRANSIENT GLOBAL AMNESIA,1
AU,TRAUMATIC HAEMATOMA,1
AU,TROPONIN NORMAL,1
AU,TUBULOINTERSTITIAL NEPHRITIS,1
AU,UNDERDOSE,1
AU,UNEVALUABLE EVENT,1
AU,UPPER GASTROINTESTINAL HAEMORRHAGE,1
AU,UPPER RESPIRATORY TRACT INFECTION,1
AU,URETERIC OBSTRUCTION,1
AU,URINARY TRACT INFECTION ENTEROCOCCAL,1
AU,URINE FLOW DECREASED,1
AU,URINE OUTPUT INCREASED,1
AU,VARICELLA,1
AU,VARICOSE VEIN,1
AU,VASCULAR ACCESS SITE HAEMORRHAGE,1
AU,VASCULAR NEOPLASM,1
AU,VASCULITIS,1
AU,VENOUS PRESSURE INCREASED,1
AU,VENTRICULAR FIBRILLATION,1
AU,VERTIGO POSITIONAL,1
AU,VESTIBULAR NEURONITIS,1
AU,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
AU,VITAMIN B12 DEFICIENCY,1
AU,VITILIGO,1
AU,VITREOUS HAEMORRHAGE,1
AU,WAIST CIRCUMFERENCE INCREASED,1
AU,WEIGHT ABNORMAL,1
AU,WEIGHT BEARING DIFFICULTY,1
AU,WOUND,1
AU,WOUND SECRETION,1
AU,WRIST DEFORMITY,1
AU,WRONG DRUG ADMINISTERED,1
AU,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
AU,YELLOW SKIN,1
AT,ABDOMINAL PAIN UPPER,1
AT,ANAEMIA,1
AT,ATRIAL FIBRILLATION,1
AT,DECREASED APPETITE,1
AT,DEHYDRATION,1
AT,DRUG ERUPTION,1
AT,GASTRITIS,1
AT,GASTRITIS HAEMORRHAGIC,1
AT,GENERAL PHYSICAL HEALTH DETERIORATION,1
AT,HAEMATOMA,1
AT,HEADACHE,1
AT,NAUSEA,1
AT,PERICARDIAL HAEMORRHAGE,1
AT,RENAL FAILURE,1
AT,RENAL FAILURE ACUTE,1
BS,DIABETES MELLITUS,1
BS,MITRAL VALVE INCOMPETENCE,1
BY,DRY MOUTH,1
BY,INSOMNIA,1
BY,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
BY,THIRST,1
BY,URINARY RETENTION,1
BE,FATIGUE,14
BE,DECREASED APPETITE,10
BE,DYSPNOEA,10
BE,ANAEMIA,9
BE,GAIT DISTURBANCE,9
BE,MALAISE,9
BE,MYALGIA,9
BE,PYREXIA,9
BE,DIARRHOEA,8
BE,GENERAL PHYSICAL HEALTH DETERIORATION,8
BE,RENAL FAILURE ACUTE,8
BE,WEIGHT DECREASED,8
BE,ABDOMINAL PAIN,7
BE,PNEUMONIA,7
BE,PRURITUS,7
BE,RENAL FAILURE,7
BE,CEREBROVASCULAR ACCIDENT,6
BE,DEATH,6
BE,HYPOTENSION,6
BE,MYOCARDIAL INFARCTION,6
BE,OEDEMA PERIPHERAL,6
BE,ASTHENIA,5
BE,BLOOD CREATININE INCREASED,5
BE,C-REACTIVE PROTEIN INCREASED,5
BE,CONFUSIONAL STATE,5
BE,DRUG INEFFECTIVE,5
BE,JOINT SWELLING,5
BE,LEUKOPENIA,5
BE,NAUSEA,5
BE,ABDOMINAL DISTENSION,4
BE,AMNESIA,4
BE,ANGINA PECTORIS,4
BE,ASCITES,4
BE,CARDIAC FAILURE,4
BE,CHILLS,4
BE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
BE,DYSGEUSIA,4
BE,DYSPHONIA,4
BE,EPISTAXIS,4
BE,HAEMOGLOBIN DECREASED,4
BE,NEUTROPENIA,4
BE,OSTEONECROSIS OF JAW,4
BE,PANCYTOPENIA,4
BE,SEPTIC SHOCK,4
BE,SYNCOPE,4
BE,VOMITING,4
BE,ALOPECIA,3
BE,ARTHRALGIA,3
BE,ATRIAL FIBRILLATION,3
BE,BACK PAIN,3
BE,CONSTIPATION,3
BE,CYTOMEGALOVIRUS INFECTION,3
BE,DEHYDRATION,3
BE,DIABETES MELLITUS,3
BE,DYSPEPSIA,3
BE,ERYTHEMA,3
BE,FALL,3
BE,FEBRILE NEUTROPENIA,3
BE,HEADACHE,3
BE,HYPERGLYCAEMIA,3
BE,HYPOCALCAEMIA,3
BE,IMMUNE-MEDIATED NECROTISING MYOPATHY,3
BE,INSOMNIA,3
BE,MITRAL VALVE INCOMPETENCE,3
BE,MUSCLE HAEMORRHAGE,3
BE,MUSCLE SPASMS,3
BE,MUSCULAR WEAKNESS,3
BE,NASOPHARYNGITIS,3
BE,PARAESTHESIA,3
BE,PNEUMONIA ASPIRATION,3
BE,RESPIRATORY TRACT INFECTION,3
BE,TENOSYNOVITIS,3
BE,THROMBOCYTOPENIA,3
BE,TOXICITY TO VARIOUS AGENTS,3
BE,TRICUSPID VALVE INCOMPETENCE,3
BE,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,2
BE,ANGIOEDEMA,2
BE,ARRHYTHMIA,2
BE,BLOOD ALBUMIN DECREASED,2
BE,BRAIN OEDEMA,2
BE,CACHEXIA,2
BE,CARDIAC ARREST,2
BE,CARDIAC MURMUR,2
BE,CARDIO-RESPIRATORY ARREST,2
BE,CHEST DISCOMFORT,2
BE,CHOLESTASIS,2
BE,COMPLETED SUICIDE,2
BE,COUGH,2
BE,DEPRESSION,2
BE,DRUG INTOLERANCE,2
BE,DRY SKIN,2
BE,DYSPHAGIA,2
BE,DYSPNOEA EXERTIONAL,2
BE,EPILEPSY,2
BE,ERYSIPELAS,2
BE,EWING^S SARCOMA,2
BE,EYELID OEDEMA,2
BE,GUILLAIN-BARRE SYNDROME,2
BE,HAEMATEMESIS,2
BE,HAEMORRHAGIC STROKE,2
BE,HEPATITIS,2
BE,HERPES ZOSTER,2
BE,HYPERTENSION,2
BE,HYPERTHYROIDISM,2
BE,HYPONATRAEMIA,2
BE,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
BE,INTERSTITIAL LUNG DISEASE,2
BE,LENTIGO MALIGNA,2
BE,LIPASE INCREASED,2
BE,LOSS OF CONSCIOUSNESS,2
BE,NEUROPATHY PERIPHERAL,2
BE,OSTEOARTHRITIS,2
BE,OSTEONECROSIS,2
BE,OXYGEN SATURATION DECREASED,2
BE,PAIN IN EXTREMITY,2
BE,PALPITATIONS,2
BE,PERIPHERAL VENOUS DISEASE,2
BE,PLASMA CELL MYELOMA,2
BE,PLEURAL EFFUSION,2
BE,POLYNEUROPATHY,2
BE,PRERENAL FAILURE,2
BE,PULMONARY EMBOLISM,2
BE,RASH,2
BE,RESTLESS LEGS SYNDROME,2
BE,RETINAL DISORDER,2
BE,RHINORRHOEA,2
BE,SEASONAL ALLERGY,2
BE,SEDATION,2
BE,SOMNOLENCE,2
BE,SPEECH DISORDER,2
BE,SUPERINFECTION,2
BE,THROAT TIGHTNESS,2
BE,TRANSIENT ISCHAEMIC ATTACK,2
BE,URINARY TRACT INFECTION,2
BE,VENTRICULAR TACHYCARDIA,2
BE,ABASIA,1
BE,ABDOMINAL DISCOMFORT,1
BE,ABDOMINAL PAIN UPPER,1
BE,ABDOMINAL WALL HAEMATOMA,1
BE,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
BE,ACTIVITIES OF DAILY LIVING IMPAIRED,1
BE,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
BE,ACUTE KIDNEY INJURY,1
BE,ACUTE MYELOID LEUKAEMIA,1
BE,ACUTE MYOCARDIAL INFARCTION,1
BE,ACUTE PULMONARY OEDEMA,1
BE,ADRENAL INSUFFICIENCY,1
BE,AGITATION,1
BE,ALANINE AMINOTRANSFERASE INCREASED,1
BE,ALTERED STATE OF CONSCIOUSNESS,1
BE,AMAUROSIS FUGAX,1
BE,AMYLASE INCREASED,1
BE,AMYOTROPHY,1
BE,ANAL SQUAMOUS CELL CARCINOMA,1
BE,ANGER,1
BE,ANOGENITAL WARTS,1
BE,ANOSMIA,1
BE,AORTIC VALVE STENOSIS,1
BE,APATHY,1
BE,APHASIA,1
BE,APHTHOUS STOMATITIS,1
BE,ARTERIOSCLEROSIS CORONARY ARTERY,1
BE,ARTHRITIS,1
BE,ASPARTATE AMINOTRANSFERASE INCREASED,1
BE,ASTHMA,1
BE,BACTERIAL DIARRHOEA,1
BE,BLOOD ALKALINE PHOSPHATASE INCREASED,1
BE,BLOOD CALCIUM DECREASED,1
BE,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
BE,BLOOD CREATININE DECREASED,1
BE,BLOOD GLUCOSE ABNORMAL,1
BE,BLOOD GLUCOSE INCREASED,1
BE,BLOOD PHOSPHORUS DECREASED,1
BE,BLOOD PRESSURE DECREASED,1
BE,BLOOD PRESSURE FLUCTUATION,1
BE,BLOOD PRESSURE INCREASED,1
BE,BODY TEMPERATURE DECREASED,1
BE,BODY TEMPERATURE INCREASED,1
BE,BONE MARROW FAILURE,1
BE,BURNING SENSATION,1
BE,CARDIAC DEATH,1
BE,CARDIAC FAILURE CHRONIC,1
BE,CAROTID ARTERY STENOSIS,1
BE,CATARACT,1
BE,CEREBRAL HAEMORRHAGE,1
BE,CERVICAL SPINAL STENOSIS,1
BE,CHOLECYSTITIS,1
BE,CHOLECYSTITIS ACUTE,1
BE,CHOLELITHIASIS,1
BE,CHROMATURIA,1
BE,CHRONIC KIDNEY DISEASE,1
BE,COGNITIVE DISORDER,1
BE,COLITIS,1
BE,COMA,1
BE,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
BE,CONCOMITANT DISEASE AGGRAVATED,1
BE,CONCOMITANT DISEASE PROGRESSION,1
BE,CONJUNCTIVAL HYPERAEMIA,1
BE,CRUSH SYNDROME,1
BE,CUSHINGOID,1
BE,CUSHING^S SYNDROME,1
BE,CYANOSIS,1
BE,DECUBITUS ULCER,1
BE,DEEP VEIN THROMBOSIS,1
BE,DEPRESSED LEVEL OF CONSCIOUSNESS,1
BE,DERMATITIS,1
BE,DEVICE ALARM ISSUE,1
BE,DEVICE ISSUE,1
BE,DISEASE PROGRESSION,1
BE,DISORIENTATION,1
BE,DISTURBANCE IN ATTENTION,1
BE,DIVERTICULITIS,1
BE,DIVERTICULITIS INTESTINAL HAEMORRHAGIC,1
BE,DRUG ADMINISTRATION ERROR,1
BE,DRUG HYPERSENSITIVITY,1
BE,DRUG LEVEL INCREASED,1
BE,DRUG-INDUCED LIVER INJURY,1
BE,DUODENAL ULCER HAEMORRHAGE,1
BE,DUPUYTREN^S CONTRACTURE,1
BE,DYSARTHRIA,1
BE,DYSKINESIA,1
BE,DYSSTASIA,1
BE,ECCHYMOSIS,1
BE,EJECTION FRACTION DECREASED,1
BE,EMBOLISM,1
BE,ENDOTHELIAL DYSFUNCTION,1
BE,EOSINOPHIL COUNT DECREASED,1
BE,EOSINOPHILIC PNEUMONIA,1
BE,ERUCTATION,1
BE,ERYTHEMA MULTIFORME,1
BE,EXPIRATORY RESERVE VOLUME DECREASED,1
BE,EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE),1
BE,EYE DISCHARGE,1
BE,EYE DISORDER,1
BE,EYE HAEMORRHAGE,1
BE,EYE INFECTION,1
BE,EYE PAIN,1
BE,FACIAL PARESIS,1
BE,FAECALITH,1
BE,FEELING ABNORMAL,1
BE,FEMUR FRACTURE,1
BE,FIBULA FRACTURE,1
BE,FISTULA,1
BE,FLUSHING,1
BE,FOOT FRACTURE,1
BE,FREEZING PHENOMENON,1
BE,FRUSTRATION TOLERANCE DECREASED,1
BE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
BE,GASTRIC HAEMORRHAGE,1
BE,GASTRODUODENAL ULCER,1
BE,GASTROINTESTINAL DISORDER,1
BE,GASTROINTESTINAL MUCOSAL DISORDER,1
BE,GASTROINTESTINAL STROMAL TUMOUR,1
BE,GENITAL LESION,1
BE,GLAUCOMA,1
BE,GLUCOSE TOLERANCE IMPAIRED,1
BE,HAEMARTHROSIS,1
BE,HAEMATOCRIT DECREASED,1
BE,HAEMATOMA,1
BE,HAEMATURIA,1
BE,HAEMOPHILUS INFECTION,1
BE,HAEMORRHAGE,1
BE,HAEMORRHAGE INTRACRANIAL,1
BE,HAEMORRHAGIC TRANSFORMATION STROKE,1
BE,HALLUCINATION,1
BE,HEMIANOPIA,1
BE,HEMIPLEGIA,1
BE,HEPATIC FAILURE,1
BE,HEPATIC STEATOSIS,1
BE,HEPATITIS TOXIC,1
BE,HEPATOSPLENIC T-CELL LYMPHOMA,1
BE,HEPATOTOXICITY,1
BE,HYPERCAPNIA,1
BE,HYPERHIDROSIS,1
BE,HYPERKALAEMIA,1
BE,HYPERSENSITIVITY,1
BE,HYPERVENTILATION,1
BE,HYPOAESTHESIA,1
BE,HYPOALBUMINAEMIA,1
BE,HYPOCHROMIC ANAEMIA,1
BE,HYPOGLYCAEMIA,1
BE,HYPOKALAEMIA,1
BE,HYPOPHAGIA,1
BE,HYPOPROTEINAEMIA,1
BE,HYPOXIA,1
BE,ILEAL ULCER,1
BE,ILEUS PARALYTIC,1
BE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
BE,INFARCTION,1
BE,INFECTION,1
BE,INFLUENZA LIKE ILLNESS,1
BE,INJECTION SITE NECROSIS,1
BE,INTESTINAL OBSTRUCTION,1
BE,INVASIVE DUCTAL BREAST CARCINOMA,1
BE,IRON DEFICIENCY ANAEMIA,1
BE,IRRITABILITY,1
BE,ISCHAEMIC CARDIOMYOPATHY,1
BE,ISCHAEMIC STROKE,1
BE,JAUNDICE,1
BE,KETOACIDOSIS,1
BE,KIDNEY TRANSPLANT REJECTION,1
BE,KNEE DEFORMITY,1
BE,LACRIMATION INCREASED,1
BE,LETHARGY,1
BE,LIPOHYPERTROPHY,1
BE,LIPOMA,1
BE,LIVER DISORDER,1
BE,LIVER FUNCTION TEST ABNORMAL,1
BE,LIVER FUNCTION TEST INCREASED,1
BE,LOBAR PNEUMONIA,1
BE,LUNG ADENOCARCINOMA,1
BE,LUNG NEOPLASM MALIGNANT,1
BE,LYMPHADENOPATHY,1
BE,LYMPHOCYTE COUNT DECREASED,1
BE,LYMPHOPENIA,1
BE,MACULAR DEGENERATION,1
BE,MALIGNANT MELANOMA,1
BE,MALIGNANT NEOPLASM PROGRESSION,1
BE,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,1
BE,MEDULLARY THYROID CANCER,1
BE,MELAENA,1
BE,MEMORY IMPAIRMENT,1
BE,METABOLIC ALKALOSIS,1
BE,METAMORPHOPSIA,1
BE,METASTASIS,1
BE,MICROCYTIC ANAEMIA,1
BE,MICTURITION FREQUENCY DECREASED,1
BE,MONOCYTOPENIA,1
BE,MORAXELLA INFECTION,1
BE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
BE,MULTIPLE SCLEROSIS,1
BE,MUSCLE ATROPHY,1
BE,MYELITIS,1
BE,MYELODYSPLASTIC SYNDROME,1
BE,NECK PAIN,1
BE,NEOPLASM MALIGNANT,1
BE,NEURALGIA,1
BE,NEUTROPENIC SEPSIS,1
BE,NEUTROPHIL PERCENTAGE INCREASED,1
BE,NIGHT SWEATS,1
BE,NOCTURIA,1
BE,NON-HODGKIN^S LYMPHOMA,1
BE,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
BE,OBSTRUCTION GASTRIC,1
BE,OBSTRUCTIVE UROPATHY,1
BE,OCULAR HYPERAEMIA,1
BE,OEDEMA MOUTH,1
BE,OPTIC NEURITIS,1
BE,ORTHOPNOEA,1
BE,OSTEOMYELITIS,1
BE,OSTEOPENIA,1
BE,PALLOR,1
BE,PANCREATIC CARCINOMA,1
BE,PANCREATIC CARCINOMA METASTATIC,1
BE,PANCREATIC NEOPLASM,1
BE,PANCREATITIS,1
BE,PAROTID GLAND ENLARGEMENT,1
BE,PATHOLOGICAL FRACTURE,1
BE,PEMPHIGUS,1
BE,PENILE SWELLING,1
BE,PERICARDIAL EFFUSION,1
BE,PERIPHERAL COLDNESS,1
BE,PERIPHERAL SWELLING,1
BE,PERIRENAL HAEMATOMA,1
BE,PERITONEAL HAEMORRHAGE,1
BE,PHLEBITIS SUPERFICIAL,1
BE,PLANTAR FASCIAL FIBROMATOSIS,1
BE,PLEUROPERICARDITIS,1
BE,PNEUMONIA PSEUDOMONAL,1
BE,PNEUMOTHORAX,1
BE,POLIOMYELITIS,1
BE,PORPHYRIA,1
BE,POST PROCEDURAL HAEMORRHAGE,1
BE,POST-INJECTION DELIRIUM SEDATION SYNDROME,1
BE,PRESCRIBED OVERDOSE,1
BE,PROSTATE CANCER,1
BE,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
BE,PROTEIN TOTAL DECREASED,1
BE,PSORIASIS,1
BE,PYELONEPHRITIS,1
BE,QUADRIPARESIS,1
BE,RADIATION SKIN INJURY,1
BE,RALES,1
BE,RASH MACULAR,1
BE,RASH MACULO-PAPULAR,1
BE,RECTAL HAEMORRHAGE,1
BE,RED BLOOD CELL COUNT DECREASED,1
BE,RED CELL DISTRIBUTION WIDTH INCREASED,1
BE,RENAL CYST,1
BE,RENAL IMPAIRMENT,1
BE,RESPIRATORY DISORDER,1
BE,RETINAL DEGENERATION,1
BE,RETINAL DETACHMENT,1
BE,RETINAL HAEMORRHAGE,1
BE,RETINAL NEOVASCULARISATION,1
BE,RETINAL PIGMENT EPITHELIOPATHY,1
BE,RETINAL TEAR,1
BE,RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED,1
BE,SCLEROSING ENCAPSULATING PERITONITIS,1
BE,SCROTAL SWELLING,1
BE,SEIZURE CLUSTER,1
BE,SENSORY LOSS,1
BE,SEPSIS,1
BE,SINUS ARREST,1
BE,SINUS BRADYCARDIA,1
BE,SKIN ATROPHY,1
BE,SKIN FISSURES,1
BE,SKIN TOXICITY,1
BE,SLEEP DISORDER,1
BE,SPINAL COMPRESSION FRACTURE,1
BE,STAPHYLOCOCCAL INFECTION,1
BE,STATUS EPILEPTICUS,1
BE,STEVENS-JOHNSON SYNDROME,1
BE,STOMA SITE DISCHARGE,1
BE,STOMA SITE ERYTHEMA,1
BE,STOMA SITE HYPERGRANULATION,1
BE,STOMA SITE PAIN,1
BE,STRESS,1
BE,STRESS FRACTURE,1
BE,SUBRETINAL FLUID,1
BE,SUDDEN DEATH,1
BE,SUICIDE ATTEMPT,1
BE,SUPRAVENTRICULAR TACHYCARDIA,1
BE,SUTURE INSERTION,1
BE,SYNOVITIS,1
BE,SYSTEMIC LUPUS ERYTHEMATOSUS RASH,1
BE,TACHYCARDIA,1
BE,TACHYPNOEA,1
BE,TENDERNESS,1
BE,TERMINAL STATE,1
BE,THERAPY NON-RESPONDER,1
BE,THROMBOSIS,1
BE,THROMBOSIS IN DEVICE,1
BE,THYMOMA,1
BE,TOXIC EPIDERMAL NECROLYSIS,1
BE,TRANSAMINASES INCREASED,1
BE,TRANSIENT GLOBAL AMNESIA,1
BE,TREMOR,1
BE,TYPE 2 DIABETES MELLITUS,1
BE,UPPER GASTROINTESTINAL HAEMORRHAGE,1
BE,URETERIC OBSTRUCTION,1
BE,URINARY TRACT DISORDER,1
BE,URTICARIA,1
BE,VASCULAR STENT THROMBOSIS,1
BE,VERTIGO,1
BE,VISUAL ACUITY REDUCED,1
BE,VISUAL FIELD DEFECT,1
BE,VISUAL IMPAIRMENT,1
BE,VITAMIN D DEFICIENCY,1
BE,VITREOUS HAEMORRHAGE,1
BE,VON WILLEBRAND^S FACTOR ANTIGEN INCREASED,1
BE,WALKING AID USER,1
BE,WHEEZING,1
BE,WHITE BLOOD CELL COUNT INCREASED,1
BE,WOUND,1
BE,WOUND SECRETION,1
BE,YELLOW SKIN,1
BO,CARTILAGE ATROPHY,1
BO,DEATH,1
BO,LIVER DISORDER,1
BA,THROMBOCYTOPENIA,1
BR,INFARCTION,122
BR,CARDIAC DISORDER,105
BR,CEREBROVASCULAR ACCIDENT,95
BR,DRUG INEFFECTIVE,90
BR,PAIN,73
BR,HYPERTENSION,66
BR,FALL,60
BR,MALAISE,59
BR,PAIN IN EXTREMITY,59
BR,PNEUMONIA,53
BR,DIABETES MELLITUS,51
BR,ARRHYTHMIA,47
BR,BLOOD PRESSURE INCREASED,47
BR,HEADACHE,45
BR,FATIGUE,44
BR,MYOCARDIAL INFARCTION,43
BR,WEIGHT DECREASED,43
BR,ASTHENIA,41
BR,DIZZINESS,41
BR,DYSPNOEA,40
BR,CORONARY ARTERY OCCLUSION,39
BR,CATARACT,37
BR,DEATH,37
BR,ARTHRALGIA,36
BR,FEELING ABNORMAL,36
BR,DEPRESSION,35
BR,NAUSEA,35
BR,URINARY TRACT INFECTION,35
BR,GAIT DISTURBANCE,34
BR,VENOUS OCCLUSION,33
BR,INTENTIONAL PRODUCT MISUSE,31
BR,ARTERIAL OCCLUSIVE DISEASE,30
BR,MEMORY IMPAIRMENT,30
BR,BLOOD CHOLESTEROL INCREASED,29
BR,DIARRHOEA,28
BR,ANGIOPATHY,26
BR,CHEST PAIN,26
BR,INSOMNIA,26
BR,VOMITING,26
BR,GLAUCOMA,25
BR,OSTEOARTHRITIS,25
BR,FEMUR FRACTURE,24
BR,ANAEMIA,23
BR,HYPERSENSITIVITY,23
BR,MYALGIA,23
BR,PRODUCT USE ISSUE,22
BR,THROMBOSIS,22
BR,WEIGHT INCREASED,22
BR,ANXIETY,21
BR,BACK PAIN,21
BR,BLOOD GLUCOSE INCREASED,21
BR,CONDITION AGGRAVATED,21
BR,SPINAL DISORDER,21
BR,CORONARY ARTERY DISEASE,20
BR,PRURITUS,20
BR,DEMENTIA ALZHEIMER^S TYPE,19
BR,DECREASED APPETITE,18
BR,INTERVERTEBRAL DISC PROTRUSION,18
BR,PYREXIA,18
BR,RENAL DISORDER,18
BR,VISUAL IMPAIRMENT,18
BR,PERIPHERAL SWELLING,17
BR,SYNCOPE,17
BR,CARDIAC ARREST,16
BR,CAROTID ARTERY OCCLUSION,16
BR,INFLUENZA,16
BR,ANGINA PECTORIS,15
BR,BALANCE DISORDER,15
BR,CARDIOVASCULAR DISORDER,15
BR,HYPOTENSION,15
BR,SOMNOLENCE,15
BR,ABASIA,14
BR,COUGH,14
BR,GASTRITIS,14
BR,HAEMORRHAGE,14
BR,LABYRINTHITIS,14
BR,SPEECH DISORDER,14
BR,BLOOD PRESSURE DECREASED,13
BR,DENGUE FEVER,13
BR,HYPERGLYCAEMIA,13
BR,MUSCLE SPASMS,13
BR,TREMOR,13
BR,ABDOMINAL PAIN UPPER,12
BR,BREAST CANCER,12
BR,DRUG DOSE OMISSION,12
BR,EATING DISORDER,12
BR,LUNG DISORDER,12
BR,MUSCULAR WEAKNESS,12
BR,SWELLING,12
BR,ABDOMINAL PAIN,11
BR,EYE DISORDER,11
BR,HYPOAESTHESIA,11
BR,ISCHAEMIA,11
BR,RETCHING,11
BR,SKIN DISCOLOURATION,11
BR,STRESS,11
BR,VISION BLURRED,11
BR,AMNESIA,10
BR,ARTHRITIS,10
BR,ARTHROPATHY,10
BR,BLOOD CHOLESTEROL ABNORMAL,10
BR,BLOOD PRESSURE FLUCTUATION,10
BR,DRUG HYPERSENSITIVITY,10
BR,DYSPHAGIA,10
BR,DYSSTASIA,10
BR,ERYTHEMA,10
BR,FLATULENCE,10
BR,HAEMATOMA,10
BR,LUNG NEOPLASM MALIGNANT,10
BR,NEOPLASM MALIGNANT,10
BR,OSTEOPOROSIS,10
BR,THYROID DISORDER,10
BR,AGITATION,9
BR,ATRIAL FIBRILLATION,9
BR,BEDRIDDEN,9
BR,BLINDNESS,9
BR,BLOOD TRIGLYCERIDES INCREASED,9
BR,BODY HEIGHT DECREASED,9
BR,FIBROMYALGIA,9
BR,HAEMATOCHEZIA,9
BR,HERNIA,9
BR,ISCHAEMIC STROKE,9
BR,MULTI-ORGAN FAILURE,9
BR,NERVOUSNESS,9
BR,SPINAL PAIN,9
BR,TENDON RUPTURE,9
BR,VARICOSE VEIN,9
BR,ALOPECIA,8
BR,BLOOD GLUCOSE DECREASED,8
BR,BLOOD PRESSURE ABNORMAL,8
BR,BLOOD PRESSURE INADEQUATELY CONTROLLED,8
BR,CARDIAC FAILURE,8
BR,DEAFNESS,8
BR,DISEASE PROGRESSION,8
BR,DYSPHONIA,8
BR,HALLUCINATION,8
BR,LIVER DISORDER,8
BR,NEPHROLITHIASIS,8
BR,OEDEMA PERIPHERAL,8
BR,RENAL FAILURE,8
BR,TACHYCARDIA,8
BR,ABDOMINAL DISCOMFORT,7
BR,ACTIVITIES OF DAILY LIVING IMPAIRED,7
BR,CHOLELITHIASIS,7
BR,DIABETES MELLITUS INADEQUATE CONTROL,7
BR,GASTROINTESTINAL DISORDER,7
BR,INCORRECT DOSE ADMINISTERED,7
BR,INFECTION,7
BR,INTESTINAL HAEMORRHAGE,7
BR,MOBILITY DECREASED,7
BR,MUSCULOSKELETAL STIFFNESS,7
BR,NOSOCOMIAL INFECTION,7
BR,PARAESTHESIA,7
BR,PULMONARY OEDEMA,7
BR,RENAL IMPAIRMENT,7
BR,SURGERY,7
BR,ACUTE MYOCARDIAL INFARCTION,6
BR,APHASIA,6
BR,ASTHMA,6
BR,BONE PAIN,6
BR,CARDIOMEGALY,6
BR,COLON CANCER,6
BR,CONFUSIONAL STATE,6
BR,CONSTIPATION,6
BR,DEHYDRATION,6
BR,DEPRESSED MOOD,6
BR,DIVERTICULITIS,6
BR,DRUG EFFECT INCOMPLETE,6
BR,FEAR,6
BR,GALLBLADDER DISORDER,6
BR,GASTROINTESTINAL HAEMORRHAGE,6
BR,HEMIPLEGIA,6
BR,HEPATIC STEATOSIS,6
BR,HERPES ZOSTER,6
BR,HYPERHIDROSIS,6
BR,HYPERTENSIVE CRISIS,6
BR,HYPOGLYCAEMIA,6
BR,HYPOTHYROIDISM,6
BR,INTRAOCULAR PRESSURE INCREASED,6
BR,JOINT SWELLING,6
BR,MOVEMENT DISORDER,6
BR,PULMONARY EMBOLISM,6
BR,RHEUMATOID ARTHRITIS,6
BR,RIB FRACTURE,6
BR,ROAD TRAFFIC ACCIDENT,6
BR,SEIZURE,6
BR,SHOCK,6
BR,URINARY INCONTINENCE,6
BR,URTICARIA,6
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,6
BR,ABDOMINAL DISTENSION,5
BR,ACCIDENT,5
BR,ANKLE FRACTURE,5
BR,AORTIC ANEURYSM,5
BR,BLOOD GLUCOSE ABNORMAL,5
BR,BONE DISORDER,5
BR,CARDIAC VALVE DISEASE,5
BR,CHEST DISCOMFORT,5
BR,CHILLS,5
BR,CHONDROPATHY,5
BR,COMA,5
BR,CRYING,5
BR,CYST,5
BR,DRY MOUTH,5
BR,FORMICATION,5
BR,GASTRIC ULCER,5
BR,GASTROINTESTINAL CARCINOMA,5
BR,GROIN PAIN,5
BR,HEAD DISCOMFORT,5
BR,HEAD INJURY,5
BR,HIATUS HERNIA,5
BR,HYPOACUSIS,5
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
BR,INJECTION SITE ERYTHEMA,5
BR,INJECTION SITE PAIN,5
BR,INTRACRANIAL ANEURYSM,5
BR,JOINT INJURY,5
BR,LIMB INJURY,5
BR,LOCAL SWELLING,5
BR,MOOD ALTERED,5
BR,OESOPHAGITIS,5
BR,OSTEOPENIA,5
BR,PARKINSON^S DISEASE,5
BR,PLATELET COUNT DECREASED,5
BR,PROSTATE CANCER,5
BR,PROSTATIC DISORDER,5
BR,RHINITIS,5
BR,SKIN CANCER,5
BR,SKIN EXFOLIATION,5
BR,SPINAL COLUMN INJURY,5
BR,TENDONITIS,5
BR,TRANSIENT ISCHAEMIC ATTACK,5
BR,UPPER LIMB FRACTURE,5
BR,VASCULAR OCCLUSION,5
BR,VISUAL ACUITY REDUCED,5
BR,WALKING DISABILITY,5
BR,ABDOMINAL HERNIA,4
BR,ANGINA UNSTABLE,4
BR,APNOEA,4
BR,ARTERIOSCLEROSIS,4
BR,BLOOD CREATINE PHOSPHOKINASE INCREASED,4
BR,BLOOD CREATININE ABNORMAL,4
BR,BLOOD CREATININE INCREASED,4
BR,BLOOD IRON DECREASED,4
BR,BLOOD URINE PRESENT,4
BR,BRADYCARDIA,4
BR,BREAST MASS,4
BR,CAROTID ARTERIOSCLEROSIS,4
BR,CAROTID ARTERY DISEASE,4
BR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
BR,DISORIENTATION,4
BR,DRUG ADMINISTRATION ERROR,4
BR,DRY SKIN,4
BR,DYSGEUSIA,4
BR,DYSKINESIA,4
BR,DYSLIPIDAEMIA,4
BR,DYSPEPSIA,4
BR,EMOTIONAL DISORDER,4
BR,FAECES DISCOLOURED,4
BR,FEELING HOT,4
BR,GASTROINTESTINAL NEOPLASM,4
BR,GASTROOESOPHAGEAL REFLUX DISEASE,4
BR,HEARING IMPAIRED,4
BR,HEART RATE DECREASED,4
BR,HEART RATE IRREGULAR,4
BR,HERPES VIRUS INFECTION,4
BR,HYPOKINESIA,4
BR,IMMUNODEFICIENCY,4
BR,INJECTION SITE BRUISING,4
BR,INJURY,4
BR,IRRITABILITY,4
BR,LUMBAR VERTEBRAL FRACTURE,4
BR,LYMPHOMA,4
BR,MUSCULOSKELETAL DISORDER,4
BR,NASOPHARYNGITIS,4
BR,NERVOUS SYSTEM DISORDER,4
BR,NEUROPATHY PERIPHERAL,4
BR,NODULE,4
BR,OVERDOSE,4
BR,PLEURAL EFFUSION,4
BR,POLLAKIURIA,4
BR,POLYNEUROPATHY,4
BR,RENAL CANCER,4
BR,RESPIRATORY FAILURE,4
BR,RHEUMATIC DISORDER,4
BR,SENSORY LOSS,4
BR,SEPSIS,4
BR,SKIN DISORDER,4
BR,SPINAL FRACTURE,4
BR,ULCER,4
BR,VEIN DISORDER,4
BR,AGGRESSION,3
BR,ANEURYSM,3
BR,ANGER,3
BR,AORTIC DISORDER,3
BR,ARTERIAL DISORDER,3
BR,ASPIRATION,3
BR,ASPIRATION BRONCHIAL,3
BR,BACTERIAL INFECTION,3
BR,BIPOLAR DISORDER,3
BR,BLISTER,3
BR,BLOOD POTASSIUM INCREASED,3
BR,BRAIN HYPOXIA,3
BR,BREAST CANCER FEMALE,3
BR,BREAST CANCER METASTATIC,3
BR,BRONCHITIS,3
BR,CAPILLARY FRAGILITY,3
BR,CARDIAC FIBRILLATION,3
BR,CARDIAC PACEMAKER INSERTION,3
BR,CARDIO-RESPIRATORY ARREST,3
BR,CARPAL TUNNEL SYNDROME,3
BR,CEREBRAL HAEMORRHAGE,3
BR,COLD SWEAT,3
BR,CORONARY ARTERY BYPASS,3
BR,DEMENTIA,3
BR,DIABETIC NEUROPATHY,3
BR,DRUG DEPENDENCE,3
BR,DRUG PRESCRIBING ERROR,3
BR,DRUG-INDUCED LIVER INJURY,3
BR,DYSARTHRIA,3
BR,ECCHYMOSIS,3
BR,EPISTAXIS,3
BR,ERYSIPELAS,3
BR,EXOSTOSIS,3
BR,EXTRA DOSE ADMINISTERED,3
BR,EYE PAIN,3
BR,FACE INJURY,3
BR,FEEDING DISORDER,3
BR,FEELING COLD,3
BR,FOOT FRACTURE,3
BR,GASTROENTERITIS,3
BR,GASTROINTESTINAL INFECTION,3
BR,GENERALISED OEDEMA,3
BR,GINGIVAL BLEEDING,3
BR,HAEMOPTYSIS,3
BR,HEART RATE INCREASED,3
BR,ILL-DEFINED DISORDER,3
BR,INFLAMMATION,3
BR,INFUSION RELATED REACTION,3
BR,INJECTION SITE NODULE,3
BR,INTENTIONAL PRODUCT USE ISSUE,3
BR,LACRIMATION INCREASED,3
BR,LIMB DISCOMFORT,3
BR,LIVER INJURY,3
BR,LOCALISED INFECTION,3
BR,LOWER LIMB FRACTURE,3
BR,METASTASES TO LIVER,3
BR,MITRAL VALVE DISEASE,3
BR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
BR,MULTIPLE SCLEROSIS RELAPSE,3
BR,MUSCLE RIGIDITY,3
BR,MYOCARDIAL ISCHAEMIA,3
BR,NAIL DISORDER,3
BR,NEOPLASM,3
BR,NERVE COMPRESSION,3
BR,NEURALGIA,3
BR,NO ADVERSE EVENT,3
BR,ORAL DISORDER,3
BR,OROPHARYNGEAL PAIN,3
BR,OSTEOMYELITIS,3
BR,OVERWEIGHT,3
BR,PANCREATITIS,3
BR,PANIC DISORDER,3
BR,PHLEBITIS,3
BR,POST PROCEDURAL COMPLICATION,3
BR,PRODUCT USE IN UNAPPROVED INDICATION,3
BR,RASH MACULAR,3
BR,RENAL HAEMORRHAGE,3
BR,SINUSITIS,3
BR,SLEEP DISORDER,3
BR,SLUGGISHNESS,3
BR,SMALL INTESTINAL HAEMORRHAGE,3
BR,SPINAL OSTEOARTHRITIS,3
BR,SYSTEMIC LUPUS ERYTHEMATOSUS,3
BR,THYROID NEOPLASM,3
BR,TOOTH FRACTURE,3
BR,TYPE 2 DIABETES MELLITUS,3
BR,URINARY RETENTION,3
BR,VASCULAR CATHETERISATION,3
BR,WHEELCHAIR USER,3
BR,WHEEZING,3
BR,WHITE BLOOD CELL COUNT DECREASED,3
BR,ABDOMINAL MASS,2
BR,ABNORMAL BEHAVIOUR,2
BR,ABSCESS,2
BR,ACUTE CORONARY SYNDROME,2
BR,ACUTE RESPIRATORY DISTRESS SYNDROME,2
BR,ACUTE RESPIRATORY FAILURE,2
BR,ALANINE AMINOTRANSFERASE INCREASED,2
BR,ANGIOPLASTY,2
BR,AORTIC CALCIFICATION,2
BR,AORTIC OCCLUSION,2
BR,APPARENT DEATH,2
BR,APPLICATION SITE ERYTHEMA,2
BR,APPLICATION SITE HYPERSENSITIVITY,2
BR,ARTERIOSCLEROSIS CORONARY ARTERY,2
BR,BLOOD GLUCOSE FLUCTUATION,2
BR,BLOOD POTASSIUM DECREASED,2
BR,BLOOD SODIUM DECREASED,2
BR,BLOOD THYROID STIMULATING HORMONE DECREASED,2
BR,BLOOD TRIGLYCERIDES ABNORMAL,2
BR,BLOOD UREA ABNORMAL,2
BR,BLOOD URIC ACID INCREASED,2
BR,BLOOD URINE,2
BR,BONE DEFORMITY,2
BR,BONE DENSITY DECREASED,2
BR,BONE LOSS,2
BR,BRONCHOPNEUMONIA,2
BR,BURNING SENSATION MUCOSAL,2
BR,BURSITIS,2
BR,CARDIAC HYPERTROPHY,2
BR,CARDIAC MURMUR,2
BR,CAROTID ARTERY STENOSIS,2
BR,CARTILAGE INJURY,2
BR,CATARACT OPERATION,2
BR,CEREBELLAR ATAXIA,2
BR,CEREBRAL INFARCTION,2
BR,CHOKING,2
BR,CHOLESTASIS,2
BR,CHROMATURIA,2
BR,COAGULOPATHY,2
BR,CONCOMITANT DISEASE AGGRAVATED,2
BR,CONTUSION,2
BR,CONVULSION,2
BR,COORDINATION ABNORMAL,2
BR,CYSTITIS,2
BR,DECREASED IMMUNE RESPONSIVENESS,2
BR,DERMATITIS ALLERGIC,2
BR,DERMATOPHYTOSIS OF NAIL,2
BR,DEVICE OCCLUSION,2
BR,DISCOMFORT,2
BR,DRUG DISPENSING ERROR,2
BR,DRUG INTOLERANCE,2
BR,DRY EYE,2
BR,DYSENTERY,2
BR,DYSLALIA,2
BR,DYSURIA,2
BR,EAR DISCOMFORT,2
BR,EAR HAEMORRHAGE,2
BR,EAR INFECTION,2
BR,EFFUSION,2
BR,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
BR,EMPHYSEMA,2
BR,ENDOCARDITIS,2
BR,EPILEPSY,2
BR,EXPIRED DRUG ADMINISTERED,2
BR,EYE HAEMORRHAGE,2
BR,EYE IRRITATION,2
BR,FAECES SOFT,2
BR,FLUID RETENTION,2
BR,FOOT DEFORMITY,2
BR,FUNCTIONAL GASTROINTESTINAL DISORDER,2
BR,FURUNCLE,2
BR,GAIT INABILITY,2
BR,GASTRIC DISORDER,2
BR,GASTRIC HAEMORRHAGE,2
BR,GASTRIC INFECTION,2
BR,GASTROINTESTINAL PAIN,2
BR,GENERAL PHYSICAL HEALTH DETERIORATION,2
BR,GENERAL SYMPTOM,2
BR,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
BR,HAEMATEMESIS,2
BR,HAEMORRHAGIC STROKE,2
BR,HAEMORRHOIDS,2
BR,HEART DISEASE CONGENITAL,2
BR,HEMIPARESIS,2
BR,HEPATIC ENZYME ABNORMAL,2
BR,HEPATIC NEOPLASM,2
BR,HEPATIC PAIN,2
BR,HEPATITIS,2
BR,HIGH DENSITY LIPOPROTEIN DECREASED,2
BR,HYPERCHOLESTEROLAEMIA,2
BR,HYPERKERATOSIS,2
BR,HYPERPHAGIA,2
BR,HYPOAESTHESIA ORAL,2
BR,HYPONATRAEMIA,2
BR,HYPOPHAGIA,2
BR,IMMUNE SYSTEM DISORDER,2
BR,IMPAIRED HEALING,2
BR,INCORRECT PRODUCT STORAGE,2
BR,INCREASED BRONCHIAL SECRETION,2
BR,INFLUENZA LIKE ILLNESS,2
BR,INGUINAL HERNIA,2
BR,INJECTION SITE HAEMORRHAGE,2
BR,INJECTION SITE INDURATION,2
BR,INJECTION SITE PRURITUS,2
BR,INJECTION SITE SWELLING,2
BR,INTESTINAL ISCHAEMIA,2
BR,JOINT LOCK,2
BR,LEG AMPUTATION,2
BR,LEIOMYOMA,2
BR,LETHARGY,2
BR,LIVER FUNCTION TEST ABNORMAL,2
BR,LOW DENSITY LIPOPROTEIN DECREASED,2
BR,LOW DENSITY LIPOPROTEIN INCREASED,2
BR,LUMBAR SPINAL STENOSIS,2
BR,LUNG INFECTION,2
BR,MACULE,2
BR,MALNUTRITION,2
BR,MASS,2
BR,MEDICATION ERROR,2
BR,MENIERE^S DISEASE,2
BR,MENISCUS INJURY,2
BR,MENTAL DISORDER,2
BR,MENTAL IMPAIRMENT,2
BR,METASTASES TO BONE,2
BR,MIGRAINE,2
BR,MOTOR DYSFUNCTION,2
BR,MUSCLE ATROPHY,2
BR,MUSCULOSKELETAL CHEST PAIN,2
BR,MUSCULOSKELETAL PAIN,2
BR,MYOCARDIAL NECROSIS MARKER INCREASED,2
BR,NERVE INJURY,2
BR,NEURITIS,2
BR,OBESITY,2
BR,OCULAR DISCOMFORT,2
BR,OCULAR VASCULAR DISORDER,2
BR,OPTIC NERVE DISORDER,2
BR,OSCILLOPSIA,2
BR,PALPITATIONS,2
BR,PANCREATIC NEOPLASM,2
BR,PANCREATOLITHIASIS,2
BR,PARALYSIS,2
BR,PERIPHERAL COLDNESS,2
BR,PERIPHERAL VASCULAR DISORDER,2
BR,PHARYNGEAL DISORDER,2
BR,PLATELET DISORDER,2
BR,PNEUMONIA BACTERIAL,2
BR,POISONING,2
BR,POOR PERIPHERAL CIRCULATION,2
BR,PROCEDURAL COMPLICATION,2
BR,PROCEDURAL PAIN,2
BR,PRODUCT QUALITY ISSUE,2
BR,PRODUCT SIZE ISSUE,2
BR,PRODUCTIVE COUGH,2
BR,PROSTATITIS,2
BR,PRURITUS GENERALISED,2
BR,PSYCHIATRIC SYMPTOM,2
BR,PULMONARY MASS,2
BR,RASH,2
BR,RASH ERYTHEMATOUS,2
BR,RASH PUSTULAR,2
BR,RECTAL CANCER,2
BR,REPETITIVE SPEECH,2
BR,RESPIRATORY DISORDER,2
BR,RETINAL DETACHMENT,2
BR,RETINAL VASCULAR THROMBOSIS,2
BR,SCIATICA,2
BR,SCLERODERMA,2
BR,SCOLIOSIS,2
BR,SEDATION,2
BR,SENSORY DISTURBANCE,2
BR,SEPTIC SHOCK,2
BR,SKIN BURNING SENSATION,2
BR,SKIN HAEMORRHAGE,2
BR,SPINAL COLUMN STENOSIS,2
BR,SPINAL DEFORMITY,2
BR,SPONDYLOLISTHESIS,2
BR,STENT PLACEMENT,2
BR,SUFFOCATION FEELING,2
BR,THROAT TIGHTNESS,2
BR,THYROID CANCER,2
BR,THYROID MASS,2
BR,TINNITUS,2
BR,TOOTH DISORDER,2
BR,TOOTH EXTRACTION,2
BR,TRAUMATIC LUNG INJURY,2
BR,ULCER HAEMORRHAGE,2
BR,UNEVALUABLE EVENT,2
BR,VASCULAR CALCIFICATION,2
BR,VASCULAR GRAFT,2
BR,VERTIGO,2
BR,VIITH NERVE PARALYSIS,2
BR,VITAMIN D DECREASED,2
BR,VITAMIN D DEFICIENCY,2
BR,WEIGHT FLUCTUATION,2
BR,WOUND,2
BR,WRONG DRUG ADMINISTERED,2
BR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
BR,ABDOMINAL RIGIDITY,1
BR,ABNORMAL DREAMS,1
BR,ABNORMAL FAECES,1
BR,ABNORMAL SENSATION IN EYE,1
BR,ACCIDENT AT HOME,1
BR,ACCIDENT AT WORK,1
BR,ACIDOSIS,1
BR,ACNE,1
BR,ACUTE KIDNEY INJURY,1
BR,ACUTE SINUSITIS,1
BR,ADENOCARCINOMA PANCREAS,1
BR,ADENOMA BENIGN,1
BR,ADRENAL DISORDER,1
BR,ADVERSE EVENT,1
BR,ADVERSE REACTION,1
BR,AFFECTIVE DISORDER,1
BR,AGEUSIA,1
BR,ALLERGIC RESPIRATORY SYMPTOM,1
BR,AMERICAN TRYPANOSOMIASIS,1
BR,AMPUTATION,1
BR,ANAL FISSURE,1
BR,ANAL HAEMORRHAGE,1
BR,ANAPHYLACTIC SHOCK,1
BR,ANKLE OPERATION,1
BR,ANTHRAX,1
BR,ANURIA,1
BR,AORTIC DISSECTION RUPTURE,1
BR,AORTIC VALVE DISEASE,1
BR,APHONIA,1
BR,APHTHOUS ULCER,1
BR,APPENDICITIS,1
BR,APPLICATION SITE INJURY,1
BR,APPLICATION SITE PRURITUS,1
BR,APPLICATION SITE RASH,1
BR,ARTERIAL INJURY,1
BR,ARTHRITIS BACTERIAL,1
BR,ARTHRITIS INFECTIVE,1
BR,ASCITES,1
BR,ASPARTATE AMINOTRANSFERASE INCREASED,1
BR,ASPHYXIA,1
BR,ATRIAL FLUTTER,1
BR,ATROPHY,1
BR,AURAL POLYP,1
BR,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
BR,BACK DISORDER,1
BR,BARTHOLIN^S CYST,1
BR,BENIGN NEOPLASM OF THYROID GLAND,1
BR,BENIGN PANCREATIC NEOPLASM,1
BR,BLADDER CANCER,1
BR,BLADDER CYST,1
BR,BLADDER DISORDER,1
BR,BLEPHARAL PAPILLOMA,1
BR,BLOOD CALCIUM DECREASED,1
BR,BLOOD CALCIUM INCREASED,1
BR,BLOOD CHOLESTEROL DECREASED,1
BR,BLOOD CREATINE INCREASED,1
BR,BLOOD DISORDER,1
BR,BLOOD ELECTROLYTES INCREASED,1
BR,BLOOD PRESSURE SYSTOLIC INCREASED,1
BR,BLOOD UREA INCREASED,1
BR,BONE CANCER,1
BR,BONE DECALCIFICATION,1
BR,BONE EROSION,1
BR,BONE FISSURE,1
BR,BONE NEOPLASM,1
BR,BRAIN DEATH,1
BR,BRAIN HERNIATION,1
BR,BRAIN NEOPLASM,1
BR,BREAST DISCHARGE,1
BR,BREAST DISORDER,1
BR,BREAST DISORDER FEMALE,1
BR,BREAST DISORDER MALE,1
BR,BRONCHIECTASIS,1
BR,BRONCHITIS CHRONIC,1
BR,BRONCHOSPASM,1
BR,BRONCHOSTENOSIS,1
BR,BRUXISM,1
BR,BUNDLE BRANCH BLOCK BILATERAL,1
BR,BURN INFECTION,1
BR,BURNS THIRD DEGREE,1
BR,C-REACTIVE PROTEIN INCREASED,1
BR,CALCINOSIS,1
BR,CALCIUM DEFICIENCY,1
BR,CALCULUS BLADDER,1
BR,CANCER PAIN,1
BR,CANDIDA INFECTION,1
BR,CARDIAC ANEURYSM,1
BR,CARDIAC ENZYMES INCREASED,1
BR,CARDIAC FAILURE CHRONIC,1
BR,CARDIAC FAILURE CONGESTIVE,1
BR,CARDIAC OPERATION,1
BR,CARDIOMYOPATHY,1
BR,CARDIOPULMONARY FAILURE,1
BR,CAROTID ARTERY CALCIFICATION,1
BR,CAROTID ARTERY INSUFFICIENCY,1
BR,CARTILAGE ATROPHY,1
BR,CATATONIA,1
BR,CATHETER SITE HAEMORRHAGE,1
BR,CATHETERISATION CARDIAC,1
BR,CEREBRAL CALCIFICATION,1
BR,CEREBRAL DISORDER,1
BR,CEREBRAL HAEMATOMA,1
BR,CEREBRAL ISCHAEMIA,1
BR,CEREBRAL THROMBOSIS,1
BR,CEREBROVASCULAR DISORDER,1
BR,CERVICAL CORD COMPRESSION,1
BR,CERVICAL VERTEBRAL FRACTURE,1
BR,CHIKUNGUNYA VIRUS INFECTION,1
BR,CHOKING SENSATION,1
BR,CHOLANGIOCARCINOMA,1
BR,CHOLECYSTECTOMY,1
BR,CHOLECYSTITIS,1
BR,CHRONIC SINUSITIS,1
BR,CIRCULATORY COLLAPSE,1
BR,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
BR,COELIAC DISEASE,1
BR,COGNITIVE DISORDER,1
BR,COLON NEOPLASM,1
BR,COMPLICATION ASSOCIATED WITH DEVICE,1
BR,COMPULSIONS,1
BR,CONGENITAL HIATUS HERNIA,1
BR,CONJUNCTIVAL HAEMORRHAGE,1
BR,CONJUNCTIVITIS,1
BR,CONNECTIVE TISSUE DISORDER,1
BR,CONTRAINDICATED PRODUCT ADMINISTERED,1
BR,CORNEAL DISORDER,1
BR,CORONARY ANGIOPLASTY,1
BR,CORONARY ARTERY INSUFFICIENCY,1
BR,CORONARY ARTERY RESTENOSIS,1
BR,CORONARY ARTERY THROMBOSIS,1
BR,CORONARY REVASCULARISATION,1
BR,CREATININE URINE INCREASED,1
BR,CREPITATIONS,1
BR,CUSHING^S SYNDROME,1
BR,CUTIS LAXA,1
BR,CYTOMEGALOVIRUS INFECTION,1
BR,DAYDREAMING,1
BR,DECUBITUS ULCER,1
BR,DEFAECATION URGENCY,1
BR,DELIRIUM,1
BR,DEMENTIA WITH LEWY BODIES,1
BR,DEMYELINATING POLYNEUROPATHY,1
BR,DENTAL IMPLANTATION,1
BR,DEPENDENCE,1
BR,DERMAL CYST,1
BR,DEVELOPMENTAL DELAY,1
BR,DEVICE DISLOCATION,1
BR,DEVICE FAILURE,1
BR,DIABETIC COMPLICATION,1
BR,DIABETIC FOOT,1
BR,DIABETIC RETINOPATHY,1
BR,DIET REFUSAL,1
BR,DILATATION ATRIAL,1
BR,DIPLEGIA,1
BR,DISLOCATION OF VERTEBRA,1
BR,DISORGANISED SPEECH,1
BR,DISTURBANCE IN SOCIAL BEHAVIOUR,1
BR,DIVERTICULUM INTESTINAL,1
BR,DIZZINESS POSTURAL,1
BR,DRUG EFFECT DECREASED,1
BR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
BR,DRUG USE DISORDER,1
BR,DYSMENORRHOEA,1
BR,EAR CANAL STENOSIS,1
BR,EAR DISORDER,1
BR,EAR PAIN,1
BR,EAR PRURITUS,1
BR,EJECTION FRACTION ABNORMAL,1
BR,ELECTRIC SHOCK,1
BR,ELECTRICAL BURN,1
BR,ELECTROCARDIOGRAM AMBULATORY ABNORMAL,1
BR,EMOTIONAL DISTRESS,1
BR,ENDOTRACHEAL INTUBATION,1
BR,ESCHERICHIA INFECTION,1
BR,EXCESSIVE GRANULATION TISSUE,1
BR,EXERCISE TOLERANCE DECREASED,1
BR,EXPOSURE DURING PREGNANCY,1
BR,EYE CONTUSION,1
BR,EYE INFLAMMATION,1
BR,EYE OEDEMA,1
BR,EYE OPERATION,1
BR,EYE PRURITUS,1
BR,EYE SWELLING,1
BR,EYELID DISORDER,1
BR,FACIAL PAIN,1
BR,FAT TISSUE INCREASED,1
BR,FEAR OF DISEASE,1
BR,FEBRILE NEUTROPENIA,1
BR,FEELING DRUNK,1
BR,FEELING OF DESPAIR,1
BR,FEMALE SEX HORMONE LEVEL ABNORMAL,1
BR,FINGER DEFORMITY,1
BR,FINGERPRINT LOSS,1
BR,FLUID INTAKE REDUCED,1
BR,FLUSHING,1
BR,FOOD INTOLERANCE,1
BR,FOOT OPERATION,1
BR,FRACTURE,1
BR,FREQUENT BOWEL MOVEMENTS,1
BR,FUNGAL SKIN INFECTION,1
BR,GALACTOSTASIS,1
BR,GALLBLADDER INJURY,1
BR,GALLBLADDER OPERATION,1
BR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
BR,GASTRIC CANCER,1
BR,GASTRITIS BACTERIAL,1
BR,GASTRITIS EROSIVE,1
BR,GASTROINTESTINAL BACTERIAL INFECTION,1
BR,GASTROINTESTINAL INFLAMMATION,1
BR,GASTROINTESTINAL INJURY,1
BR,GASTROINTESTINAL TRACT ADENOMA,1
BR,GENITAL HERPES,1
BR,GINGIVITIS,1
BR,GLAUCOMA SURGERY,1
BR,GLUCOSE TOLERANCE IMPAIRED,1
BR,GOITRE,1
BR,GOUT,1
BR,GROWTH RETARDATION,1
BR,HAEMOLYSIS,1
BR,HAEMORRHAGE URINARY TRACT,1
BR,HAEMORRHAGIC DISORDER,1
BR,HAEMORRHAGIC NECROTIC PANCREATITIS,1
BR,HAIR COLOUR CHANGES,1
BR,HAND FRACTURE,1
BR,HEAD AND NECK CANCER,1
BR,HEART RATE ABNORMAL,1
BR,HEART VALVE CALCIFICATION,1
BR,HEART VALVE REPLACEMENT,1
BR,HELICOBACTER INFECTION,1
BR,HEPATIC CIRRHOSIS,1
BR,HEPATIC CYST,1
BR,HEPATIC ENCEPHALOPATHY,1
BR,HEPATIC ENZYME INCREASED,1
BR,HEPATIC FUNCTION ABNORMAL,1
BR,HEPATOMEGALY,1
BR,HERPES OPHTHALMIC,1
BR,HERPES SIMPLEX,1
BR,HIGH DENSITY LIPOPROTEIN INCREASED,1
BR,HOSPITALISATION,1
BR,HOUSE DUST ALLERGY,1
BR,HUMERUS FRACTURE,1
BR,HUNGER,1
BR,HYDROCEPHALUS,1
BR,HYPERAESTHESIA,1
BR,HYPERMETROPIA,1
BR,HYPERTHYROIDISM,1
BR,HYPERTRIGLYCERIDAEMIA,1
BR,HYPERVITAMINOSIS,1
BR,HYPOVOLAEMIC SHOCK,1
BR,HYPOXIA,1
BR,ILEUS,1
BR,IMMUNE-MEDIATED NECROTISING MYOPATHY,1
BR,IMPAIRED REASONING,1
BR,IMPATIENCE,1
BR,INCISION SITE INFECTION,1
BR,INCOHERENT,1
BR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
BR,INCREASED APPETITE,1
BR,INCREASED UPPER AIRWAY SECRETION,1
BR,INJECTION SITE DISCOLOURATION,1
BR,INJECTION SITE HAEMATOMA,1
BR,INJECTION SITE HYPERSENSITIVITY,1
BR,INJECTION SITE INJURY,1
BR,INJECTION SITE WARMTH,1
BR,INTENTIONAL DRUG MISUSE,1
BR,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
BR,INTERNATIONAL NORMALISED RATIO FLUCTUATION,1
BR,INTERVERTEBRAL DISC INJURY,1
BR,INTESTINAL CYST,1
BR,INTESTINAL FISTULA,1
BR,INTESTINAL OBSTRUCTION,1
BR,INTESTINAL POLYP,1
BR,IRON DEFICIENCY,1
BR,IRON DEFICIENCY ANAEMIA,1
BR,IRREGULAR SLEEP PHASE,1
BR,ISCHAEMIC CARDIOMYOPATHY,1
BR,JOINT ARTHROPLASTY,1
BR,JOINT EFFUSION,1
BR,JOINT RANGE OF MOTION DECREASED,1
BR,JOINT STIFFNESS,1
BR,JUDGEMENT IMPAIRED,1
BR,KNEE ARTHROPLASTY,1
BR,KYPHOSIS,1
BR,LABORATORY TEST ABNORMAL,1
BR,LACERATION,1
BR,LACRIMAL STRUCTURE INJURY,1
BR,LACRIMATION DECREASED,1
BR,LARYNGEAL OEDEMA,1
BR,LAZINESS,1
BR,LENTICULAR OPACITIES,1
BR,LIGAMENT RUPTURE,1
BR,LIGAMENT SPRAIN,1
BR,LIMB DEFORMITY,1
BR,LIMB OPERATION,1
BR,LIP AND/OR ORAL CAVITY CANCER,1
BR,LIP DISORDER,1
BR,LIP EXFOLIATION,1
BR,LIPODYSTROPHY ACQUIRED,1
BR,LIPOMA,1
BR,LIVER TRANSPLANT,1
BR,LOSS OF CONSCIOUSNESS,1
BR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
BR,LYMPH NODE PAIN,1
BR,LYMPHADENOPATHY,1
BR,LYMPHATIC DISORDER,1
BR,MALIGNANT NEOPLASM PROGRESSION,1
BR,MENINGIOMA,1
BR,MESENTERIC VASCULAR OCCLUSION,1
BR,METASTASES TO LUNG,1
BR,METASTASES TO PELVIS,1
BR,METASTASES TO URINARY TRACT,1
BR,METASTATIC RENAL CELL CARCINOMA,1
BR,MICTURITION DISORDER,1
BR,MICTURITION URGENCY,1
BR,MILIARIA,1
BR,MITRAL VALVE INCOMPETENCE,1
BR,MITRAL VALVE PROLAPSE,1
BR,MITRAL VALVE STENOSIS,1
BR,MONOPARESIS,1
BR,MONOPLEGIA,1
BR,MOOD SWINGS,1
BR,MOUTH HAEMORRHAGE,1
BR,MOUTH INJURY,1
BR,MOUTH SWELLING,1
BR,MULTI-ORGAN DISORDER,1
BR,MUSCLE FATIGUE,1
BR,MUSCLE HAEMORRHAGE,1
BR,MYCOTIC ALLERGY,1
BR,MYDRIASIS,1
BR,MYELITIS,1
BR,MYELOPATHY,1
BR,MYOPATHY,1
BR,NARROW ANTERIOR CHAMBER ANGLE,1
BR,NASAL CONGESTION,1
BR,NECK SURGERY,1
BR,NEOPLASM PROGRESSION,1
BR,NEOPLASM RECURRENCE,1
BR,NEPHROPATHY,1
BR,NERVE ROOT COMPRESSION,1
BR,NIGHT SWEATS,1
BR,NOCTURIA,1
BR,NOCTURNAL DYSPNOEA,1
BR,NORMAL NEWBORN,1
BR,OBESITY SURGERY,1
BR,OCULAR HYPERAEMIA,1
BR,OEDEMA,1
BR,OESOPHAGEAL CARCINOMA,1
BR,OESOPHAGEAL HAEMORRHAGE,1
BR,OESOPHAGEAL SPASM,1
BR,OPPORTUNISTIC INFECTION,1
BR,OPTIC NERVE INJURY,1
BR,ORAL CANDIDIASIS,1
BR,ORAL PAIN,1
BR,ORGAN FAILURE,1
BR,ORTHOSTATIC HYPOTENSION,1
BR,OVARIAN CANCER,1
BR,OVARIAN ENLARGEMENT,1
BR,PALLOR,1
BR,PANCREATIC CARCINOMA,1
BR,PANCREATIC CYST,1
BR,PANCREATIC ENZYMES INCREASED,1
BR,PANCREATITIS ACUTE,1
BR,PARAPLEGIA,1
BR,PAROSMIA,1
BR,PAROXYSMAL ARRHYTHMIA,1
BR,PATHOLOGICAL FRACTURE,1
BR,PATIENT-DEVICE INCOMPATIBILITY,1
BR,PELVIC FRACTURE,1
BR,PELVIC PAIN,1
BR,PERIARTHRITIS,1
BR,PERICARDIAL EFFUSION,1
BR,PERIPHERAL ARTERY OCCLUSION,1
BR,PERIPHERAL ARTERY STENOSIS,1
BR,PERIPHERAL ARTERY STENT INSERTION,1
BR,PERIPHERAL NERVE INJURY,1
BR,PERITONEAL DIALYSIS COMPLICATION,1
BR,PERITONITIS,1
BR,PETECHIAE,1
BR,PETIT MAL EPILEPSY,1
BR,PHANTOM PAIN,1
BR,PHARYNGEAL INFLAMMATION,1
BR,PHARYNGEAL OEDEMA,1
BR,PIGMENTATION DISORDER,1
BR,PITUITARY TUMOUR,1
BR,PLASTIC SURGERY,1
BR,PLATELET COUNT INCREASED,1
BR,PNEUMONIA ASPIRATION,1
BR,PNEUMOTHORAX,1
BR,POLYARTHRITIS,1
BR,POLYCYTHAEMIA,1
BR,POLYGLANDULAR DISORDER,1
BR,POLYMYOSITIS,1
BR,POLYURIA,1
BR,POOR VENOUS ACCESS,1
BR,POST PROCEDURAL HAEMORRHAGE,1
BR,POST PROCEDURAL INFECTION,1
BR,POTENTIATING DRUG INTERACTION,1
BR,PRE-EXISTING CONDITION IMPROVED,1
BR,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,1
BR,PRESYNCOPE,1
BR,PROCEDURAL HAEMORRHAGE,1
BR,PRODUCT BLISTER PACKAGING ISSUE,1
BR,PRODUCT COLOUR ISSUE,1
BR,PRODUCT DROPPER ISSUE,1
BR,PRODUCT PACKAGE ASSOCIATED INJURY,1
BR,PRODUCT PACKAGING ISSUE,1
BR,PRODUCT TASTE ABNORMAL,1
BR,PROSTATIC OBSTRUCTION,1
BR,PROSTATIC OPERATION,1
BR,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
BR,PROSTATOMEGALY,1
BR,PROSTHESIS IMPLANTATION,1
BR,PROSTHESIS USER,1
BR,PROTEIN URINE PRESENT,1
BR,PROTEINURIA,1
BR,PUBIS FRACTURE,1
BR,PULMONARY INFARCTION,1
BR,PULMONARY SEPSIS,1
BR,PULPITIS DENTAL,1
CA,FATIGUE,253
CA,DYSPNOEA,204
CA,DIARRHOEA,188
CA,PAIN,184
CA,DRUG INEFFECTIVE,181
CA,FALL,179
CA,NAUSEA,176
CA,WEIGHT DECREASED,172
CA,ASTHENIA,167
CA,ARTHRALGIA,165
CA,PNEUMONIA,157
CA,BLOOD PRESSURE INCREASED,152
CA,PAIN IN EXTREMITY,151
CA,MALAISE,150
CA,COUGH,139
CA,DIZZINESS,131
CA,HEADACHE,130
CA,NASOPHARYNGITIS,128
CA,DECREASED APPETITE,116
CA,DEATH,114
CA,MYOCARDIAL INFARCTION,113
CA,VOMITING,105
CA,WEIGHT INCREASED,103
CA,PYREXIA,102
CA,HYPOTENSION,101
CA,HAEMOGLOBIN DECREASED,99
CA,ABDOMINAL PAIN,88
CA,BACK PAIN,88
CA,PERIPHERAL SWELLING,83
CA,CONFUSIONAL STATE,78
CA,HYPERTENSION,77
CA,MYALGIA,77
CA,ANAEMIA,76
CA,URINARY TRACT INFECTION,76
CA,INFUSION RELATED REACTION,74
CA,CHEST PAIN,73
CA,RHEUMATOID ARTHRITIS,73
CA,GAIT DISTURBANCE,72
CA,ABDOMINAL DISCOMFORT,68
CA,INSOMNIA,67
CA,HEART RATE INCREASED,63
CA,MUSCLE SPASMS,62
CA,JOINT SWELLING,59
CA,RASH,59
CA,INFLUENZA,58
CA,PRURITUS,58
CA,BLOOD CREATININE INCREASED,57
CA,BLOOD GLUCOSE INCREASED,57
CA,CONSTIPATION,57
CA,DEHYDRATION,57
CA,OXYGEN SATURATION DECREASED,57
CA,BLOOD PRESSURE SYSTOLIC INCREASED,56
CA,OEDEMA PERIPHERAL,56
CA,CEREBROVASCULAR ACCIDENT,54
CA,CONTUSION,54
CA,MUSCULAR WEAKNESS,54
CA,BRONCHITIS,53
CA,INFECTION,53
CA,ANXIETY,52
CA,MUSCULOSKELETAL PAIN,49
CA,MUSCULOSKELETAL STIFFNESS,49
CA,GENERAL PHYSICAL HEALTH DETERIORATION,48
CA,ATRIAL FIBRILLATION,47
CA,CHILLS,47
CA,HEART RATE DECREASED,47
CA,HYPOAESTHESIA,46
CA,BODY TEMPERATURE DECREASED,45
CA,CONDITION AGGRAVATED,45
CA,PARAESTHESIA,45
CA,TREMOR,45
CA,INJECTION SITE PAIN,43
CA,OROPHARYNGEAL PAIN,43
CA,ABDOMINAL PAIN UPPER,42
CA,PRODUCTIVE COUGH,42
CA,SOMNOLENCE,42
CA,ASTHMA,41
CA,PRODUCT SUBSTITUTION ISSUE,41
CA,CARDIAC FAILURE CONGESTIVE,40
CA,ERYTHEMA,40
CA,HAEMATOCHEZIA,40
CA,HYPERHIDROSIS,40
CA,ABDOMINAL DISTENSION,39
CA,BLOOD PRESSURE DIASTOLIC DECREASED,39
CA,DEPRESSION,39
CA,RENAL FAILURE,39
CA,THROMBOSIS,39
CA,LOSS OF CONSCIOUSNESS,38
CA,CHEST DISCOMFORT,37
CA,PLATELET COUNT DECREASED,37
CA,DIABETES MELLITUS,36
CA,OSTEOARTHRITIS,36
CA,PLEURAL EFFUSION,36
CA,CATARACT,35
CA,FEELING ABNORMAL,35
CA,ARTHROPATHY,34
CA,SINUSITIS,34
CA,SYNCOPE,34
CA,BLOOD PRESSURE DECREASED,32
CA,HEPATIC ENZYME INCREASED,32
CA,MALIGNANT NEOPLASM PROGRESSION,32
CA,ACUTE KIDNEY INJURY,31
CA,ALOPECIA,31
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,31
CA,GASTROINTESTINAL HAEMORRHAGE,31
CA,PULMONARY OEDEMA,31
CA,RHINORRHOEA,31
CA,TACHYCARDIA,31
CA,DYSPHONIA,30
CA,HYPERSENSITIVITY,30
CA,NASAL CONGESTION,30
CA,NEOPLASM MALIGNANT,30
CA,WHEEZING,30
CA,BALANCE DISORDER,29
CA,HOT FLUSH,29
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,29
CA,INTERNATIONAL NORMALISED RATIO INCREASED,29
CA,LOWER RESPIRATORY TRACT INFECTION,29
CA,RECTAL HAEMORRHAGE,29
CA,SWELLING,29
CA,DYSPEPSIA,28
CA,DYSPHAGIA,28
CA,DYSPNOEA EXERTIONAL,28
CA,HERPES ZOSTER,28
CA,LUNG DISORDER,28
CA,BLOOD PRESSURE FLUCTUATION,27
CA,WOUND,27
CA,ARTHRITIS,26
CA,MOBILITY DECREASED,26
CA,NEPHROLITHIASIS,26
CA,PRODUCT USE ISSUE,26
CA,RESPIRATORY RATE INCREASED,26
CA,WHITE BLOOD CELL COUNT INCREASED,26
CA,AMNESIA,25
CA,DRUG INTOLERANCE,25
CA,PALPITATIONS,25
CA,SEPSIS,25
CA,TRANSIENT ISCHAEMIC ATTACK,25
CA,BLOOD CHOLESTEROL INCREASED,24
CA,DIABETIC KETOACIDOSIS,24
CA,LIMB INJURY,24
CA,OEDEMA,24
CA,POLLAKIURIA,24
CA,PULMONARY EMBOLISM,24
CA,STRESS,24
CA,CARDIAC DISORDER,23
CA,CELLULITIS,23
CA,DRY MOUTH,23
CA,FLUSHING,23
CA,HAEMORRHAGE,23
CA,HEART RATE IRREGULAR,23
CA,HIP FRACTURE,23
CA,HYPERGLYCAEMIA,23
CA,LUNG INFECTION,23
CA,TOXICITY TO VARIOUS AGENTS,23
CA,VISUAL IMPAIRMENT,23
CA,AGITATION,22
CA,BURNING SENSATION,22
CA,DRY SKIN,22
CA,FEELING HOT,22
CA,FLUID RETENTION,22
CA,TYPE 2 DIABETES MELLITUS,22
CA,URTICARIA,22
CA,WHITE BLOOD CELL COUNT DECREASED,22
CA,ABASIA,21
CA,ALANINE AMINOTRANSFERASE INCREASED,21
CA,ARRHYTHMIA,21
CA,RENAL IMPAIRMENT,21
CA,SLEEP APNOEA SYNDROME,21
CA,DELIRIUM,20
CA,DYSARTHRIA,20
CA,FLATULENCE,20
CA,HYPOGLYCAEMIA,20
CA,MEMORY IMPAIRMENT,20
CA,PALLOR,20
CA,PSORIASIS,20
CA,BLOOD GLUCOSE DECREASED,19
CA,BURSITIS,19
CA,DISCOMFORT,19
CA,DIVERTICULITIS,19
CA,EPISTAXIS,19
CA,INFLAMMATION,19
CA,KIDNEY INFECTION,19
CA,PULMONARY MASS,19
CA,C-REACTIVE PROTEIN ABNORMAL,18
CA,CARDIAC ARREST,18
CA,GASTRIC DISORDER,18
CA,HYPOPHAGIA,18
CA,LOCALISED INFECTION,18
CA,NIGHT SWEATS,18
CA,SPUTUM DISCOLOURED,18
CA,VISION BLURRED,18
CA,APHASIA,17
CA,CARDIAC FAILURE,17
CA,CYSTITIS,17
CA,DYSGEUSIA,17
CA,FREQUENT BOWEL MOVEMENTS,17
CA,GASTROOESOPHAGEAL REFLUX DISEASE,17
CA,HEAD DISCOMFORT,17
CA,HEAD INJURY,17
CA,JOINT STIFFNESS,17
CA,MENTAL DISORDER,17
CA,PANCREATITIS,17
CA,RED BLOOD CELL COUNT DECREASED,17
CA,SYNOVITIS,17
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,17
CA,ASPARTATE AMINOTRANSFERASE INCREASED,16
CA,CROHN^S DISEASE,16
CA,DRUG DOSE OMISSION,16
CA,DRUG EFFECT DECREASED,16
CA,DYSURIA,16
CA,INFLUENZA LIKE ILLNESS,16
CA,LUNG NEOPLASM MALIGNANT,16
CA,MUSCLE STRAIN,16
CA,NECK PAIN,16
CA,RENAL PAIN,16
CA,RHABDOMYOLYSIS,16
CA,SEIZURE,16
CA,THROAT IRRITATION,16
CA,COMA,15
CA,DEEP VEIN THROMBOSIS,15
CA,DRUG HYPERSENSITIVITY,15
CA,DYSSTASIA,15
CA,GASTROINTESTINAL DISORDER,15
CA,HEPATIC STEATOSIS,15
CA,HOSPITALISATION,15
CA,INTENTIONAL PRODUCT MISUSE,15
CA,LIGAMENT SPRAIN,15
CA,LOCAL SWELLING,15
CA,NEEDLE ISSUE,15
CA,RIB FRACTURE,15
CA,SLEEP DISORDER,15
CA,THERAPEUTIC RESPONSE DECREASED,15
CA,ACUTE MYOCARDIAL INFARCTION,14
CA,BLOOD POTASSIUM DECREASED,14
CA,CHOLELITHIASIS,14
CA,CHROMATURIA,14
CA,HAEMATURIA,14
CA,HEMIPARESIS,14
CA,IMPAIRED WORK ABILITY,14
CA,INJECTION SITE ERYTHEMA,14
CA,INJECTION SITE MASS,14
CA,MENTAL STATUS CHANGES,14
CA,NEUTROPENIA,14
CA,PITUITARY TUMOUR BENIGN,14
CA,RESPIRATORY FAILURE,14
CA,THYROID DISORDER,14
CA,ANGINA PECTORIS,13
CA,BLOOD POTASSIUM INCREASED,13
CA,FORCED EXPIRATORY VOLUME DECREASED,13
CA,HEPATOTOXICITY,13
CA,HYPERSOMNIA,13
CA,INCREASED APPETITE,13
CA,JOINT RANGE OF MOTION DECREASED,13
CA,LIMB DISCOMFORT,13
CA,MIGRAINE,13
CA,PULMONARY FIBROSIS,13
CA,RASH ERYTHEMATOUS,13
CA,SINUS CONGESTION,13
CA,SPINAL FRACTURE,13
CA,THERAPY NON-RESPONDER,13
CA,TREATMENT FAILURE,13
CA,TREATMENT NONCOMPLIANCE,13
CA,UPPER RESPIRATORY TRACT INFECTION,13
CA,BASAL CELL CARCINOMA,12
CA,BLISTER,12
CA,BLOOD PRESSURE DIASTOLIC INCREASED,12
CA,CLOSTRIDIUM DIFFICILE INFECTION,12
CA,COMA SCALE ABNORMAL,12
CA,DEPRESSED LEVEL OF CONSCIOUSNESS,12
CA,DISEASE PROGRESSION,12
CA,FAECES DISCOLOURED,12
CA,FEMUR FRACTURE,12
CA,FUNGAL INFECTION,12
CA,GROWTH HORMONE DEFICIENCY,12
CA,HERNIA,12
CA,HYPERKALAEMIA,12
CA,IMMUNE-MEDIATED NECROTISING MYOPATHY,12
CA,INJECTION SITE SWELLING,12
CA,JAUNDICE,12
CA,LETHARGY,12
CA,OBESITY,12
CA,OBSTRUCTIVE AIRWAYS DISORDER,12
CA,OCULAR HYPERAEMIA,12
CA,POOR VENOUS ACCESS,12
CA,PRESYNCOPE,12
CA,ROAD TRAFFIC ACCIDENT,12
CA,SKIN ULCER,12
CA,SWELLING FACE,12
CA,TOOTH DISORDER,12
CA,ARTERIOVENOUS FISTULA OCCLUSION,11
CA,BLOOD IRON DECREASED,11
CA,BONE PAIN,11
CA,BRADYCARDIA,11
CA,BREAST CANCER,11
CA,COLITIS ULCERATIVE,11
CA,DEPRESSED MOOD,11
CA,DIABETES MELLITUS INADEQUATE CONTROL,11
CA,DISORIENTATION,11
CA,DYSKINESIA,11
CA,EATING DISORDER,11
CA,GASTROINTESTINAL TOXICITY,11
CA,HAEMATEMESIS,11
CA,HAEMATOCRIT DECREASED,11
CA,HALLUCINATION,11
CA,HYPERCHOLESTEROLAEMIA,11
CA,INTESTINAL OBSTRUCTION,11
CA,JOINT INJURY,11
CA,LIVER DISORDER,11
CA,LYMPHOMA,11
CA,MASS,11
CA,MELAENA,11
CA,MUSCULOSKELETAL DISCOMFORT,11
CA,NEOPLASM,11
CA,OSTEOPOROSIS,11
CA,PAIN IN JAW,11
CA,PULMONARY FUNCTION TEST DECREASED,11
CA,PULMONARY TOXICITY,11
CA,RESTRICTIVE PULMONARY DISEASE,11
CA,SCIATICA,11
CA,SUICIDAL IDEATION,11
CA,TOOTH FRACTURE,11
CA,TOOTHACHE,11
CA,URINARY INCONTINENCE,11
CA,VERTIGO,11
CA,ACUTE CORONARY SYNDROME,10
CA,AORTIC ANEURYSM,10
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,10
CA,BLOOD CREATINE PHOSPHOKINASE INCREASED,10
CA,BLOOD MAGNESIUM DECREASED,10
CA,BLOOD SODIUM DECREASED,10
CA,BLOOD URINE PRESENT,10
CA,BLUE TOE SYNDROME,10
CA,BREAST MASS,10
CA,CONVULSION,10
CA,DEMENTIA,10
CA,EAR INFECTION,10
CA,EYE HAEMORRHAGE,10
CA,FEELING COLD,10
CA,HAEMOPTYSIS,10
CA,INJECTION SITE BRUISING,10
CA,ISCHAEMIC STROKE,10
CA,LACERATION,10
CA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,10
CA,MICTURITION URGENCY,10
CA,RALES,10
CA,RENAL FAILURE ACUTE,10
CA,RESPIRATORY DISTRESS,10
CA,RESPIRATORY TRACT CONGESTION,10
CA,SPEECH DISORDER,10
CA,SWOLLEN TONGUE,10
CA,TOOTH ABSCESS,10
CA,UNDERDOSE,10
CA,ABDOMINAL PAIN LOWER,9
CA,AGEUSIA,9
CA,ANAPHYLACTIC REACTION,9
CA,ATELECTASIS,9
CA,BLOOD GLUCOSE ABNORMAL,9
CA,CARPAL TUNNEL SYNDROME,9
CA,CORONARY ARTERY OCCLUSION,9
CA,CYST,9
CA,DRUG EFFECT INCOMPLETE,9
CA,EJECTION FRACTION DECREASED,9
CA,EYE DISORDER,9
CA,EYE PAIN,9
CA,FOOT DEFORMITY,9
CA,HAEMATOMA,9
CA,HAEMORRHOIDS,9
CA,HEMIPLEGIA,9
CA,HYPOTHYROIDISM,9
CA,ILL-DEFINED DISORDER,9
CA,INCORRECT DOSE ADMINISTERED,9
CA,INJECTION SITE HAEMORRHAGE,9
CA,INJECTION SITE REACTION,9
CA,KNEE ARTHROPLASTY,9
CA,NODULE,9
CA,ORAL HERPES,9
CA,PERIPHERAL VENOUS DISEASE,9
CA,PNEUMONITIS,9
CA,POOR QUALITY SLEEP,9
CA,PULMONARY CONGESTION,9
CA,RASH MACULO-PAPULAR,9
CA,RESPIRATORY DISORDER,9
CA,SCAR,9
CA,SECOND PRIMARY MALIGNANCY,9
CA,SINUS TACHYCARDIA,9
CA,SKIN DISORDER,9
CA,THROMBOCYTOPENIA,9
CA,TOOTH INFECTION,9
CA,VIRAL INFECTION,9
CA,ACNE,8
CA,ANGINA UNSTABLE,8
CA,ATYPICAL FEMUR FRACTURE,8
CA,BACTERIAL INFECTION,8
CA,BLINDNESS,8
CA,BLOOD BILIRUBIN INCREASED,8
CA,BLOOD CREATININE ABNORMAL,8
CA,CHOKING,8
CA,COLON CANCER,8
CA,EAR PAIN,8
CA,EMPHYSEMA,8
CA,FIBROMYALGIA,8
CA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,8
CA,GASTRITIS,8
CA,GASTROENTERITIS,8
CA,GOUT,8
CA,GROIN PAIN,8
CA,HEPATIC CIRRHOSIS,8
CA,IMPAIRED HEALING,8
CA,INJECTION SITE EXTRAVASATION,8
CA,INTERVERTEBRAL DISC PROTRUSION,8
CA,IRRITABILITY,8
CA,LEUKOPENIA,8
CA,LIP DRY,8
CA,LIP SWELLING,8
CA,LYMPHOCYTE COUNT DECREASED,8
CA,MOVEMENT DISORDER,8
CA,MUSCULOSKELETAL CHEST PAIN,8
CA,MUSCULOSKELETAL DISORDER,8
CA,NEUTROPHIL COUNT DECREASED,8
CA,OVERDOSE,8
CA,PANCREATIC CARCINOMA,8
CA,PANCYTOPENIA,8
CA,PHOTOSENSITIVITY REACTION,8
CA,PROCTALGIA,8
CA,PRURITUS GENERALISED,8
CA,RASH GENERALISED,8
CA,RED CELL DISTRIBUTION WIDTH INCREASED,8
CA,SENSORY LOSS,8
CA,ULCER,8
CA,VISUAL ACUITY REDUCED,8
CA,WOUND INFECTION,8
CA,WOUND SECRETION,8
CA,ABSCESS,7
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,7
CA,AFFECT LABILITY,7
CA,ANEURYSM,7
CA,AORTIC ARTERIOSCLEROSIS,7
CA,ARTERIAL OCCLUSIVE DISEASE,7
CA,BONE DENSITY DECREASED,7
CA,BRAIN NEOPLASM,7
CA,BRONCHOSPASM,7
CA,CARDIAC VALVE DISEASE,7
CA,CARDIOVASCULAR DISORDER,7
CA,CHRONIC KIDNEY DISEASE,7
CA,COAGULOPATHY,7
CA,CREPITATIONS,7
CA,DEVICE RELATED INFECTION,7
CA,DIVERTICULUM,7
CA,DYSLIPIDAEMIA,7
CA,ELECTROCARDIOGRAM QT PROLONGED,7
CA,ERUCTATION,7
CA,EYE SWELLING,7
CA,FURUNCLE,7
CA,GASTRIC INFECTION,7
CA,GINGIVAL BLEEDING,7
CA,GLOMERULAR FILTRATION RATE DECREASED,7
CA,HAND FRACTURE,7
CA,HEPATIC ENZYME ABNORMAL,7
CA,HIATUS HERNIA,7
CA,HYPERLIPIDAEMIA,7
CA,HYPOKALAEMIA,7
CA,HYPONATRAEMIA,7
CA,INTERVERTEBRAL DISC DEGENERATION,7
CA,LARGE INTESTINE POLYP,7
CA,LIVER FUNCTION TEST INCREASED,7
CA,LOWER GASTROINTESTINAL HAEMORRHAGE,7
CA,MALIGNANT MELANOMA,7
CA,METASTASES TO BONE,7
CA,MIDDLE INSOMNIA,7
CA,MOOD SWINGS,7
CA,MYELODYSPLASTIC SYNDROME,7
CA,NEOPLASM PROGRESSION,7
CA,NERVOUSNESS,7
CA,NEURALGIA,7
CA,NEUROPATHY PERIPHERAL,7
CA,ODYNOPHAGIA,7
CA,PANCREATIC CYST,7
CA,PHARYNGEAL OEDEMA,7
CA,POST PROCEDURAL COMPLICATION,7
CA,POST PROCEDURAL INFECTION,7
CA,PROSTATE CANCER,7
CA,PULMONARY FUNCTION TEST ABNORMAL,7
CA,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,7
CA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,7
CA,SEPTIC SHOCK,7
CA,SKIN DISCOLOURATION,7
CA,SMALL INTESTINAL OBSTRUCTION,7
CA,SPLENOMEGALY,7
CA,SQUAMOUS CELL CARCINOMA,7
CA,STOMATITIS,7
CA,THROAT TIGHTNESS,7
CA,TRANSFUSION,7
CA,UMBILICAL HERNIA,7
CA,URINARY RETENTION,7
CA,WRIST FRACTURE,7
CA,ACTINIC KERATOSIS,6
CA,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,6
CA,AGGRESSION,6
CA,ANKLE FRACTURE,6
CA,APHONIA,6
CA,ARTERIOSCLEROSIS CORONARY ARTERY,6
CA,ARTHRITIS INFECTIVE,6
CA,ASCITES,6
CA,ATRIOVENTRICULAR BLOCK,6
CA,ATRIOVENTRICULAR BLOCK COMPLETE,6
CA,BACK DISORDER,6
CA,BLADDER CANCER,6
CA,BLOOD GROWTH HORMONE INCREASED,6
CA,BLOOD LACTATE DEHYDROGENASE INCREASED,6
CA,BLOOD UREA INCREASED,6
CA,BODY TEMPERATURE INCREASED,6
CA,BONE DISORDER,6
CA,BONE MARROW FAILURE,6
CA,BREATH SOUNDS ABNORMAL,6
CA,COGNITIVE DISORDER,6
CA,COLD SWEAT,6
CA,CONCOMITANT DISEASE AGGRAVATED,6
CA,CORONARY ARTERY DISEASE,6
CA,DEVICE OCCLUSION,6
CA,DIARRHOEA HAEMORRHAGIC,6
CA,DRUG-INDUCED LIVER INJURY,6
CA,DRY THROAT,6
CA,ECZEMA,6
CA,FAECES HARD,6
CA,FEBRILE NEUTROPENIA,6
CA,FLANK PAIN,6
CA,GANGRENE,6
CA,GLAUCOMA,6
CA,HAEMOGLOBIN ABNORMAL,6
CA,HEPATIC CANCER,6
CA,HUNGER,6
CA,HYPERAESTHESIA,6
CA,HYPOKINESIA,6
CA,IRRITABLE BOWEL SYNDROME,6
CA,LACRIMATION INCREASED,6
CA,LIPASE INCREASED,6
CA,LYMPHADENOPATHY,6
CA,MACULAR DEGENERATION,6
CA,METASTASES TO LIVER,6
CA,MOUTH HAEMORRHAGE,6
CA,MUSCLE SPASTICITY,6
CA,NERVE COMPRESSION,6
CA,NOCTURIA,6
CA,ORTHOSTATIC HYPOTENSION,6
CA,OSTEOMYELITIS,6
CA,PERICARDIAL EFFUSION,6
CA,PERICARDITIS,6
CA,PERIPHERAL ISCHAEMIA,6
CA,PHLEBITIS,6
CA,PHOTOPHOBIA,6
CA,PLASMA CELL MYELOMA,6
CA,PNEUMONIA ASPIRATION,6
CA,POLYP,6
CA,POSTOPERATIVE WOUND INFECTION,6
CA,PRODUCT QUALITY ISSUE,6
CA,PRODUCT USE IN UNAPPROVED INDICATION,6
CA,RENAL CYST,6
CA,RESPIRATORY TRACT INFECTION,6
CA,RESTLESSNESS,6
CA,SECRETION DISCHARGE,6
CA,SKIN CANCER,6
CA,SKIN FISSURES,6
CA,SLUGGISHNESS,6
CA,SPINAL PAIN,6
CA,SPLEEN DISORDER,6
CA,SUBDURAL HAEMATOMA,6
CA,SUICIDE ATTEMPT,6
CA,TEMPERATURE INTOLERANCE,6
CA,UNEVALUABLE EVENT,6
CA,UNRESPONSIVE TO STIMULI,6
CA,VAGINAL HAEMORRHAGE,6
CA,VASCULITIS,6
CA,WEIGHT FLUCTUATION,6
CA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,6
CA,ADVERSE EVENT,5
CA,BLADDER DISORDER,5
CA,BLOOD COUNT ABNORMAL,5
CA,BLOOD DISORDER,5
CA,BLOOD TEST ABNORMAL,5
CA,BRONCHIAL HYPERREACTIVITY,5
CA,C-REACTIVE PROTEIN INCREASED,5
CA,CALCIUM DEFICIENCY,5
CA,CHOLECYSTITIS,5
CA,COLON ADENOMA,5
CA,CREATININE RENAL CLEARANCE DECREASED,5
CA,CRYING,5
CA,DECUBITUS ULCER,5
CA,DEMENTIA ALZHEIMER^S TYPE,5
CA,DIVERTICULUM INTESTINAL,5
CA,DRY EYE,5
CA,DUODENAL ULCER,5
CA,ENCEPHALOPATHY,5
CA,EYE IRRITATION,5
CA,EYELID DISORDER,5
CA,FACIAL PARALYSIS,5
CA,FAECES PALE,5
CA,GALLBLADDER DISORDER,5
CA,GYNAECOMASTIA,5
CA,HEPATIC PAIN,5
CA,HEPATITIS,5
CA,HYPERKERATOSIS,5
CA,HYPERVENTILATION,5
CA,HYPOAESTHESIA ORAL,5
CA,INCORRECT PRODUCT STORAGE,5
CA,INJECTION SITE PRURITUS,5
CA,INTESTINAL PERFORATION,5
CA,INTESTINAL POLYP,5
CA,IRITIS,5
CA,LIVER FUNCTION TEST ABNORMAL,5
CA,LOW DENSITY LIPOPROTEIN INCREASED,5
CA,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,5
CA,MOUTH ULCERATION,5
CA,MYOCARDIAL ISCHAEMIA,5
CA,NEUROENDOCRINE TUMOUR,5
CA,NEUTROPHIL COUNT INCREASED,5
CA,NIGHTMARE,5
CA,ORAL DISORDER,5
CA,PANCREATIC DISORDER,5
CA,PANCREATIC MASS,5
CA,PANIC ATTACK,5
CA,PERIPHERAL COLDNESS,5
CA,PERSONALITY DISORDER,5
CA,PNEUMOTHORAX,5
CA,POST PROCEDURAL HAEMORRHAGE,5
CA,PROSTATE CANCER METASTATIC,5
CA,PSYCHOMOTOR HYPERACTIVITY,5
CA,QUALITY OF LIFE DECREASED,5
CA,RASH MACULAR,5
CA,RASH PRURITIC,5
CA,RENAL DISORDER,5
CA,ROTATOR CUFF SYNDROME,5
CA,SCAB,5
CA,SCLERODERMA,5
CA,SCRATCH,5
CA,SINUS DISORDER,5
CA,SKIN ABRASION,5
CA,SKIN LESION,5
CA,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,5
CA,SQUAMOUS CELL CARCINOMA OF SKIN,5
CA,SUDDEN DEATH,5
CA,SUNBURN,5
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,5
CA,THYROID FUNCTION TEST ABNORMAL,5
CA,TINNITUS,5
CA,TYPE 1 DIABETES MELLITUS,5
CA,VARICOSE VEIN,5
CA,WALKING AID USER,5
CA,ABDOMINAL ABSCESS,4
CA,ABNORMAL BEHAVIOUR,4
CA,ACCIDENT,4
CA,ACCIDENTAL OVERDOSE,4
CA,ACIDOSIS,4
CA,ADVERSE DRUG REACTION,4
CA,ANGIOEDEMA,4
CA,ANTIPSYCHOTIC DRUG LEVEL INCREASED,4
CA,AORTIC VALVE CALCIFICATION,4
CA,APHTHOUS ULCER,4
CA,ARTERIOSCLEROSIS,4
CA,BLADDER TRANSITIONAL CELL CARCINOMA,4
CA,BLOOD ALBUMIN DECREASED,4
CA,BLOOD CALCIUM DECREASED,4
CA,BLOOD CALCIUM INCREASED,4
CA,BLOOD PRESSURE ABNORMAL,4
CA,BLOOD PRESSURE SYSTOLIC DECREASED,4
CA,BRONCHIECTASIS,4
CA,CARDIAC MURMUR,4
CA,CARDIOMEGALY,4
CA,CATARACT OPERATION,4
CA,CENTRAL OBESITY,4
CA,CEREBRAL HAEMORRHAGE,4
CA,COLITIS,4
CA,COMPRESSION FRACTURE,4
CA,COORDINATION ABNORMAL,4
CA,DENTAL CARIES,4
CA,DIVERTICULUM INTESTINAL HAEMORRHAGIC,4
CA,DRUG ADMINISTRATION ERROR,4
CA,DRUG DEPENDENCE,4
CA,DRUG LEVEL INCREASED,4
CA,DUODENITIS,4
CA,EAR CONGESTION,4
CA,ELECTROLYTE IMBALANCE,4
CA,EMBOLIC STROKE,4
CA,ENDOTRACHEAL INTUBATION,4
CA,EOSINOPHILIA,4
CA,EYE INFECTION,4
CA,EYE PRURITUS,4
CA,FACE OEDEMA,4
CA,FAECAL INCONTINENCE,4
CA,FAECES SOFT,4
CA,FEEDING DISORDER,4
CA,FLUID INTAKE REDUCED,4
CA,FOOT FRACTURE,4
CA,FULL BLOOD COUNT DECREASED,4
CA,FUNGAL SKIN INFECTION,4
CA,GAIT INABILITY,4
CA,GASTROINTESTINAL ULCER,4
CA,GENERALISED OEDEMA,4
CA,GLYCOSYLATED HAEMOGLOBIN INCREASED,4
CA,HAEMORRHAGE INTRACRANIAL,4
CA,HAIR TEXTURE ABNORMAL,4
CA,HAND DEFORMITY,4
CA,HELICOBACTER INFECTION,4
CA,HEPATIC NEOPLASM,4
CA,HEPATOMEGALY,4
CA,HICCUPS,4
CA,HYPERBILIRUBINAEMIA,4
CA,HYPERSENSITIVITY VASCULITIS,4
CA,HYPERTRIGLYCERIDAEMIA,4
CA,HYPOACUSIS,4
CA,HYPOVENTILATION,4
CA,ILEUS,4
CA,INFARCTION,4
CA,INFLAMMATORY BOWEL DISEASE,4
CA,INTENTIONAL PRODUCT USE ISSUE,4
CA,INTERNATIONAL NORMALISED RATIO DECREASED,4
CA,JOINT EFFUSION,4
CA,LABYRINTHITIS,4
CA,LIVER ABSCESS,4
CA,LIVER INJURY,4
CA,LYMPHOEDEMA,4
CA,MEAN CELL HAEMOGLOBIN INCREASED,4
CA,MEDICATION ERROR,4
CA,METABOLIC ACIDOSIS,4
CA,MIDDLE EAR EFFUSION,4
CA,MITRAL VALVE INCOMPETENCE,4
CA,MOUTH SWELLING,4
CA,MUSCLE ATROPHY,4
CA,MUSCLE RUPTURE,4
CA,MUSCLE TIGHTNESS,4
CA,MYOCLONUS,4
CA,NASAL DISORDER,4
CA,NERVOUS SYSTEM DISORDER,4
CA,NEUROLEPTIC MALIGNANT SYNDROME,4
CA,OESOPHAGEAL CARCINOMA,4
CA,ORAL CANDIDIASIS,4
CA,ORAL PAIN,4
CA,OSTEONECROSIS OF JAW,4
CA,OSTEOPENIA,4
CA,PACKED RED BLOOD CELL TRANSFUSION,4
CA,PAINFUL RESPIRATION,4
CA,PANCREATITIS ACUTE,4
CA,PARALYSIS,4
CA,PARKINSON^S DISEASE,4
CA,PELVIC FRACTURE,4
CA,PERIPHERAL VASCULAR DISORDER,4
CA,PHARYNGITIS,4
CA,PILOERECTION,4
CA,POLYDIPSIA,4
CA,POLYPECTOMY,4
CA,POLYURIA,4
CA,PROCEDURAL PAIN,4
CA,PROSTATIC SPECIFIC ANTIGEN INCREASED,4
CA,PROTEINURIA,4
CA,PSORIATIC ARTHROPATHY,4
CA,RASH PAPULAR,4
CA,RED BLOOD CELL COUNT INCREASED,4
CA,RENAL MASS,4
CA,RESPIRATORY DEPRESSION,4
CA,SEASONAL ALLERGY,4
CA,SENSORY DISTURBANCE,4
CA,SKIN ATROPHY,4
CA,SKIN EXFOLIATION,4
CA,SKIN PLAQUE,4
CA,SKIN REACTION,4
CA,SKIN SENSITISATION,4
CA,SPINAL COMPRESSION FRACTURE,4
CA,SPINAL OSTEOARTHRITIS,4
CA,STAPHYLOCOCCAL INFECTION,4
CA,SURGERY,4
CA,SYNOVIAL CYST,4
CA,TENDERNESS,4
CA,TENDON RUPTURE,4
CA,THIRST,4
CA,TOXIC EPIDERMAL NECROLYSIS,4
CA,UPPER GASTROINTESTINAL HAEMORRHAGE,4
CA,UPPER LIMB FRACTURE,4
CA,URINARY TRACT OBSTRUCTION,4
CA,URINE ODOUR ABNORMAL,4
CA,VIITH NERVE PARALYSIS,4
CA,WOUND DRAINAGE,4
CA,ABDOMINAL HERNIA,3
CA,ADENOCARCINOMA OF COLON,3
CA,ADRENAL INSUFFICIENCY,3
CA,ANGER,3
CA,ANGIOPATHY,3
CA,ANION GAP INCREASED,3
CA,ANORECTAL DISCOMFORT,3
CA,ANOSMIA,3
CA,AORTIC CALCIFICATION,3
CA,AORTIC STENOSIS,3
CA,APLASIA PURE RED CELL,3
CA,APLASTIC ANAEMIA,3
CA,ARTHRITIS BACTERIAL,3
CA,ARTHROPOD BITE,3
CA,ASPHYXIA,3
CA,ASPIRATION,3
CA,ATAXIA,3
CA,ATRIAL FLUTTER,3
CA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,3
CA,AZOTAEMIA,3
CA,BENIGN NEOPLASM,3
CA,BENIGN PROSTATIC HYPERPLASIA,3
CA,BILIRUBIN CONJUGATED INCREASED,3
CA,BIPOLAR DISORDER,3
CA,BLOOD BILIRUBIN UNCONJUGATED INCREASED,3
CA,BLOOD CHOLESTEROL ABNORMAL,3
CA,BLOOD GLUCOSE FLUCTUATION,3
CA,BLOOD PRESSURE SYSTOLIC ABNORMAL,3
CA,BODY HEIGHT DECREASED,3
CA,BONE LOSS,3
CA,BREAST NEOPLASM,3
CA,BRONCHITIS CHRONIC,3
CA,BUNDLE BRANCH BLOCK LEFT,3
CA,CANDIDA INFECTION,3
CA,CARDIAC OPERATION,3
CA,CATHETER SITE PAIN,3
CA,CEREBRAL INFARCTION,3
CA,CERVICAL VERTEBRAL FRACTURE,3
CA,CERVIX NEOPLASM,3
CA,CHEST X-RAY ABNORMAL,3
CA,CHOKING SENSATION,3
CA,CHRONIC SINUSITIS,3
CA,CIRCULATORY COLLAPSE,3
CA,CLOSTRIDIUM DIFFICILE COLITIS,3
CA,COLITIS ISCHAEMIC,3
CA,COMPLICATION ASSOCIATED WITH DEVICE,3
CA,CONJUNCTIVITIS,3
CA,CONTRAINDICATED PRODUCT ADMINISTERED,3
CA,CORONARY ARTERIAL STENT INSERTION,3
CA,CORONARY ARTERY BYPASS,3
CA,CUSHINGOID,3
CA,DEAFNESS BILATERAL,3
CA,DECREASED ACTIVITY,3
CA,DERMATITIS CONTACT,3
CA,DISTURBANCE IN ATTENTION,3
CA,DIZZINESS POSTURAL,3
CA,DRUG TOLERANCE INCREASED,3
CA,DRUG WITHDRAWAL SYNDROME,3
CA,EAR DISCOMFORT,3
CA,EAR DISORDER,3
CA,EAR PRURITUS,3
CA,EMOTIONAL DISTRESS,3
CA,ENANTHEMA,3
CA,EROSIVE DUODENITIS,3
CA,ERYTHROBLAST COUNT,3
CA,ESCHERICHIA INFECTION,3
CA,EXCORIATION,3
CA,EXOSTOSIS,3
CA,EYE DISCHARGE,3
CA,FEELING OF BODY TEMPERATURE CHANGE,3
CA,FISTULA,3
CA,FLUID OVERLOAD,3
CA,FORCED VITAL CAPACITY DECREASED,3
CA,FRUSTRATION TOLERANCE DECREASED,3
CA,GASTRIC DILATATION,3
CA,GASTRIC HAEMORRHAGE,3
CA,GASTRIC POLYPS,3
CA,GASTRIC ULCER,3
CA,GASTROENTERITIS VIRAL,3
CA,GASTROINTESTINAL NEOPLASM,3
CA,GASTROINTESTINAL PAIN,3
CA,GASTROINTESTINAL WALL THICKENING,3
CA,GINGIVITIS,3
CA,GRANULOCYTOPENIA,3
CA,HAEMARTHROSIS,3
CA,HALLUCINATION_ AUDITORY,3
CA,HALLUCINATION_ VISUAL,3
CA,HANGOVER,3
CA,HEART RATE ABNORMAL,3
CA,HEPATIC LESION,3
CA,HEPATIC MASS,3
CA,HEPATITIS ACUTE,3
CA,HUMERUS FRACTURE,3
CA,HYPERADRENALISM,3
CA,HYPOMAGNESAEMIA,3
CA,HYPOXIA,3
CA,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,3
CA,INCREASED BRONCHIAL SECRETION,3
CA,INFECTED BITE,3
CA,INJECTION SITE DISCOLOURATION,3
CA,INJECTION SITE INDURATION,3
CA,INJECTION SITE WARMTH,3
CA,INJURY,3
CA,INTERMITTENT CLAUDICATION,3
CA,INTESTINAL HAEMORRHAGE,3
CA,INTESTINAL RESECTION,3
CA,INTRA-ABDOMINAL HAEMORRHAGE,3
CA,INTRACRANIAL ANEURYSM,3
CA,ISCHAEMIC HEPATITIS,3
CA,LARGE INTESTINE PERFORATION,3
CA,LARYNGEAL CANCER,3
CA,LEUKOCYTOSIS,3
CA,LOOSE TOOTH,3
CA,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV,3
CA,LUNG INFILTRATION,3
CA,LUNG NEOPLASM,3
CA,LYMPHADENOPATHY MEDIASTINAL,3
CA,LYMPHOPENIA,3
CA,MEAN CELL VOLUME INCREASED,3
CA,MENTAL IMPAIRMENT,3
CA,METABOLIC ENCEPHALOPATHY,3
CA,METASTASES TO CENTRAL NERVOUS SYSTEM,3
CA,METASTASES TO LUNG,3
CA,METASTATIC NEOPLASM,3
CA,MONOCYTE COUNT INCREASED,3
CA,MULTI-ORGAN FAILURE,3
CA,MULTIPLE SCLEROSIS RELAPSE,3
CA,MYOPATHY,3
CA,NAIL DISCOLOURATION,3
CA,NASAL POLYPS,3
CA,NERVE INJURY,3
CA,NO THERAPEUTIC RESPONSE,3
CA,NON-ALCOHOLIC STEATOHEPATITIS,3
CA,NON-HODGKIN^S LYMPHOMA,3
CA,OCCULT BLOOD,3
CA,OCCULT BLOOD POSITIVE,3
CA,OCULAR DISCOMFORT,3
CA,OCULAR ICTERUS,3
CA,ORTHOPNOEA,3
CA,OVARIAN CYST,3
CA,OVARIAN CYST RUPTURED,3
CA,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,3
CA,PANCREATIC CARCINOMA METASTATIC,3
CA,PARAPROTEINAEMIA,3
CA,PATELLA FRACTURE,3
CA,PEMPHIGOID,3
CA,PERSONALITY CHANGE,3
CA,PETECHIAE,3
CA,PLATELET COUNT INCREASED,3
CA,PNEUMOCOCCAL INFECTION,3
CA,POLYCYTHAEMIA,3
CA,PRERENAL FAILURE,3
CA,PRESCRIBED UNDERDOSE,3
CA,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
CA,PROSTATIC DISORDER,3
CA,PROTEIN TOTAL DECREASED,3
CA,PROTEIN URINE PRESENT,3
CA,PULMONARY HAEMORRHAGE,3
CA,PULMONARY HYPERTENSION,3
CA,PULMONARY THROMBOSIS,3
CA,PULSE ABSENT,3
CA,PURPURA,3
CA,RENAL CELL CARCINOMA,3
CA,RENAL TUBULAR NECROSIS,3
CA,RESTLESS LEGS SYNDROME,3
CA,RETINAL HAEMORRHAGE,3
CA,RIGHT VENTRICULAR FAILURE,3
CA,SCROTAL SWELLING,3
CA,SJOGREN^S SYNDROME,3
CA,SKIN BURNING SENSATION,3
CA,SKIN MASS,3
CA,SNEEZING,3
CA,SNORING,3
CA,SOFT TISSUE INJURY,3
CA,SOLAR LENTIGO,3
CA,SPINAL COLUMN STENOSIS,3
CA,STAPHYLOCOCCUS TEST POSITIVE,3
CA,STASIS DERMATITIS,3
CA,STENT PLACEMENT,3
CA,STEVENS-JOHNSON SYNDROME,3
CA,STREPTOCOCCAL INFECTION,3
CA,SUBSTANCE ABUSE,3
CA,TENDON DISORDER,3
CA,TENDON PAIN,3
CA,TENDONITIS,3
CA,TERMINAL STATE,3
CA,THERAPY CESSATION,3
CA,THINKING ABNORMAL,3
CA,THYROID NEOPLASM,3
CA,TOBACCO ABUSE,3
CA,TRANSURETHRAL PROSTATECTOMY,3
CA,TUBULOINTERSTITIAL NEPHRITIS,3
CA,URINARY TRACT DISORDER,3
CA,URINE ABNORMALITY,3
CA,URINE ANALYSIS ABNORMAL,3
CA,URINE OUTPUT DECREASED,3
CA,UROSEPSIS,3
CA,VASCULAR RUPTURE,3
CA,VENTRICULAR TACHYCARDIA,3
CA,VIITH NERVE INJURY,3
CA,VITAMIN D DECREASED,3
CA,VOLVULUS,3
CA,ABDOMINAL INFECTION,2
CA,ABDOMINAL TENDERNESS,2
CA,ABNORMAL FAECES,2
CA,ACARODERMATITIS,2
CA,ACCIDENT AT WORK,2
CA,ACQUIRED DIAPHRAGMATIC EVENTRATION,2
CA,ACUTE MYELOID LEUKAEMIA,2
CA,ACUTE PULMONARY OEDEMA,2
CA,ACUTE RESPIRATORY FAILURE,2
CA,ADENOSQUAMOUS CARCINOMA OF THE CERVIX,2
CA,AGRANULOCYTOSIS,2
CA,AMYLASE DECREASED,2
CA,ANAL FISTULA,2
CA,ANAL HAEMORRHAGE,2
CA,ANAL INCONTINENCE,2
CA,ANGIOPLASTY,2
KY,PANCREATIC CARCINOMA STAGE IV,1
CL,CEREBROVASCULAR ACCIDENT,4
CL,CATARACT,3
CL,DEAFNESS,3
CL,DEATH,3
CL,ARTHROPATHY,2
CL,CHOLELITHIASIS,2
CL,MYOCARDIAL INFARCTION,2
CL,ALOPECIA,1
CL,ARRHYTHMIA,1
CL,BACK PAIN,1
CL,BACTERIAL INFECTION,1
CL,BALANCE DISORDER,1
CL,BLINDNESS,1
CL,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
CL,BREAST CANCER,1
CL,BRONCHITIS,1
CL,CARDIAC DISORDER,1
CL,CARDIOVASCULAR DISORDER,1
CL,CHONDROPATHY,1
CL,CONJUNCTIVITIS,1
CL,DEPRESSION,1
CL,DIVERTICULITIS,1
CL,DIZZINESS,1
CL,DRUG DISPENSING ERROR,1
CL,DRUG INEFFECTIVE,1
CL,EPILEPSY,1
CL,EYE DISCHARGE,1
CL,EYE DISORDER,1
CL,EYELID DISORDER,1
CL,FAECES DISCOLOURED,1
CL,FALL,1
CL,FATIGUE,1
CL,FRACTURE,1
CL,GASTRIC DISORDER,1
CL,GASTRIC ULCER,1
CL,GASTROINTESTINAL INJURY,1
CL,GASTROOESOPHAGEAL REFLUX DISEASE,1
CL,GLAUCOMA,1
CL,HAEMORRHOIDS,1
CL,HEARING AID USER,1
CL,HEARING IMPAIRED,1
CL,HEPATIC CIRRHOSIS,1
CL,HEPATIC NEOPLASM,1
CL,HYPERKALAEMIA,1
CL,HYPOGLYCAEMIA,1
CL,IMMUNE-MEDIATED NECROTISING MYOPATHY,1
CL,INCOHERENT,1
CL,INFARCTION,1
CL,INTRAOCULAR LENS IMPLANT,1
CL,INTRAOCULAR PRESSURE INCREASED,1
CL,LACTIC ACIDOSIS,1
CL,LANGUAGE DISORDER,1
CL,LEG AMPUTATION,1
CL,LIMB DISCOMFORT,1
CL,LOCALISED INFECTION,1
CL,LOSS OF CONSCIOUSNESS,1
CL,LUNG DISORDER,1
CL,MENISCUS INJURY,1
CL,MYALGIA,1
CL,NAUSEA,1
CL,NEURALGIA,1
CL,OSTEOARTHRITIS,1
CL,OVARIAN CANCER,1
CL,OVERDOSE,1
CL,PANCREATITIS,1
CL,PARAESTHESIA,1
CL,PARALYSIS,1
CL,PARESIS,1
CL,PARKINSON^S DISEASE,1
CL,PLATELET COUNT DECREASED,1
CL,POLYARTHRITIS,1
CL,PROSTATE CANCER,1
CL,PROSTATIC DISORDER,1
CL,PULMONARY MASS,1
CL,RECTAL HAEMORRHAGE,1
CL,RESPIRATORY DISORDER,1
CL,SCIATIC NERVE INJURY,1
CL,SCIATICA,1
CL,SJOGREN^S SYNDROME,1
CL,SPINAL CORD DISORDER,1
CL,SPINAL DISORDER,1
CL,STRESS,1
CL,TACHYCARDIA,1
CL,TUBERCULOSIS,1
CL,UPPER RESPIRATORY TRACT INFECTION,1
CL,URINARY TRACT DISORDER,1
CL,VENOUS OCCLUSION,1
CL,VERTIGO,1
CL,VISUAL ACUITY REDUCED,1
CL,VOMITING,1
CL,WEIGHT INCREASED,1
CN,HEPATIC FUNCTION ABNORMAL,68
CN,BLOOD CREATINE PHOSPHOKINASE INCREASED,64
CN,PRURITUS,39
CN,ALANINE AMINOTRANSFERASE INCREASED,35
CN,ASTHENIA,33
CN,RASH,33
CN,CHEST DISCOMFORT,32
CN,DIZZINESS,32
CN,MYALGIA,32
CN,MYOCARDIAL NECROSIS MARKER INCREASED,32
CN,CEREBRAL INFARCTION,30
CN,NAUSEA,30
CN,ASPARTATE AMINOTRANSFERASE INCREASED,29
CN,LIVER INJURY,29
CN,RENAL IMPAIRMENT,28
CN,LIVER FUNCTION TEST ABNORMAL,26
CN,RHABDOMYOLYSIS,26
CN,TRANSAMINASES INCREASED,25
CN,VOMITING,25
CN,DYSPNOEA,23
CN,HEPATIC ENZYME INCREASED,23
CN,PYREXIA,23
CN,BLOOD BILIRUBIN INCREASED,21
CN,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,20
CN,BLOOD PRESSURE INCREASED,19
CN,DRUG-INDUCED LIVER INJURY,18
CN,CONDITION AGGRAVATED,16
CN,MUSCULAR WEAKNESS,16
CN,DECREASED APPETITE,15
CN,JAUNDICE,15
CN,PAIN IN EXTREMITY,15
CN,BLOOD GLUCOSE INCREASED,14
CN,BLOOD LACTATE DEHYDROGENASE INCREASED,14
CN,HYPERTENSION,14
CN,PALPITATIONS,14
CN,HEPATOCELLULAR INJURY,13
CN,ABDOMINAL PAIN,12
CN,CARDIAC FAILURE,12
CN,GAMMA-GLUTAMYLTRANSFERASE INCREASED,12
CN,LIVER DISORDER,12
CN,OEDEMA PERIPHERAL,12
CN,ANGINA UNSTABLE,11
CN,BLOOD CREATININE INCREASED,11
CN,CHEST PAIN,11
CN,DRUG INEFFECTIVE,11
CN,LUNG INFECTION,11
CN,ABDOMINAL DISTENSION,10
CN,ATRIAL FIBRILLATION,10
CN,DIARRHOEA,10
CN,DISCOMFORT,10
CN,FATIGUE,10
CN,MYOGLOBIN BLOOD INCREASED,10
CN,PAIN,10
CN,ANGINA PECTORIS,9
CN,BACK PAIN,9
CN,COUGH,9
CN,MUSCLE ENZYME INCREASED,9
CN,PRODUCTIVE COUGH,9
CN,CARDIOMYOPATHY,8
CN,COMA,8
CN,CORONARY ARTERY DISEASE,8
CN,DEATH,8
CN,DRUG HYPERSENSITIVITY,8
CN,LYMPHOCYTE COUNT DECREASED,8
CN,MYOCARDIAL INFARCTION,8
CN,PLATELET COUNT DECREASED,8
CN,THROMBOSIS,8
CN,ABDOMINAL DISCOMFORT,7
CN,ACUTE MYOCARDIAL INFARCTION,7
CN,BLOOD PRESSURE DECREASED,7
CN,COAGULOPATHY,7
CN,DIABETES MELLITUS,7
CN,ERYTHEMA,7
CN,FACE OEDEMA,7
CN,HAEMOGLOBIN DECREASED,7
CN,HYPERHIDROSIS,7
CN,HYPOAESTHESIA,7
CN,HYPOTENSION,7
CN,NASOPHARYNGITIS,7
CN,SUSPECTED COUNTERFEIT PRODUCT,7
CN,SYNCOPE,7
CN,UPPER GASTROINTESTINAL HAEMORRHAGE,7
CN,VISION BLURRED,7
CN,ANAEMIA,6
CN,ARTERIOSCLEROSIS CORONARY ARTERY,6
CN,ARTHRALGIA,6
CN,CEREBRAL HAEMORRHAGE,6
CN,CORONARY ARTERY OCCLUSION,6
CN,DERMATITIS EXFOLIATIVE,6
CN,DRY SKIN,6
CN,GASTROINTESTINAL HAEMORRHAGE,6
CN,HAEMATURIA,6
CN,HAEMORRHAGE,6
CN,HEADACHE,6
CN,HEPATIC PAIN,6
CN,HYPERLIPIDAEMIA,6
CN,INJECTION SITE HAEMATOMA,6
CN,MALAISE,6
CN,MUSCLE INJURY,6
CN,NEUTROPHIL COUNT INCREASED,6
CN,PERIPHERAL SWELLING,6
CN,THROMBOCYTOPENIA,6
CN,YELLOW SKIN,6
CN,ABDOMINAL PAIN UPPER,5
CN,ACUTE KIDNEY INJURY,5
CN,BLOOD UREA INCREASED,5
CN,CHROMATURIA,5
CN,CORONARY ARTERY STENOSIS,5
CN,DRY MOUTH,5
CN,FLUSHING,5
CN,HAEMATOCHEZIA,5
CN,HEART RATE INCREASED,5
CN,INCISION SITE PAIN,5
CN,KIDNEY TRANSPLANT REJECTION,5
CN,LEUKOPENIA,5
CN,POLLAKIURIA,5
CN,PRODUCT COUNTERFEIT,5
CN,RASH MACULO-PAPULAR,5
CN,URTICARIA,5
CN,VASCULAR PSEUDOANEURYSM,5
CN,WEIGHT DECREASED,5
CN,WHEEZING,5
CN,ABASIA,4
CN,ANGIOEDEMA,4
CN,ASTHMA,4
CN,BLOOD POTASSIUM INCREASED,4
CN,BLOOD URIC ACID INCREASED,4
CN,CHILLS,4
CN,CONFUSIONAL STATE,4
CN,EYELID OEDEMA,4
CN,FAECES DISCOLOURED,4
CN,HAEMOPTYSIS,4
CN,HAEMORRHAGE INTRACRANIAL,4
CN,HAEMORRHAGE SUBCUTANEOUS,4
CN,HYPOGLYCAEMIA,4
CN,INFECTION,4
CN,INSOMNIA,4
CN,LOSS OF CONSCIOUSNESS,4
CN,MEMORY IMPAIRMENT,4
CN,MUSCLE ATROPHY,4
CN,MYOSITIS,4
CN,PNEUMONIA,4
CN,PRODUCT USE IN UNAPPROVED INDICATION,4
CN,RASH GENERALISED,4
CN,RENAL FAILURE,4
CN,SLEEP DISORDER,4
CN,SWELLING FACE,4
CN,TINNITUS,4
CN,WHITE BLOOD CELL COUNT INCREASED,4
CN,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,4
CN,ANAPHYLACTIC REACTION,3
CN,APPETITE DISORDER,3
CN,ARRHYTHMIA,3
CN,BILIRUBIN CONJUGATED INCREASED,3
CN,BLOOD GLUCOSE FLUCTUATION,3
CN,CARDIAC ARREST,3
CN,CATARACT,3
CN,CHOLECYSTITIS ACUTE,3
CN,CHOLESTASIS,3
CN,CHRONIC GASTRITIS,3
CN,CYANOSIS,3
CN,DEAFNESS,3
CN,DEMENTIA,3
CN,DISEASE PROGRESSION,3
CN,DISEASE RECURRENCE,3
CN,DRUG ERUPTION,3
CN,DYSSTASIA,3
CN,ECCHYMOSIS,3
CN,GAIT DISTURBANCE,3
CN,GASTRITIS,3
CN,GASTROINTESTINAL DISORDER,3
CN,GLOMERULONEPHRITIS MEMBRANOUS,3
CN,HAEMATEMESIS,3
CN,HEPATIC CIRRHOSIS,3
CN,HEPATIC FAILURE,3
CN,HEPATIC LESION,3
CN,HYPERSENSITIVITY,3
CN,HYPOKALAEMIA,3
CN,LACUNAR INFARCTION,3
CN,LIMB DISCOMFORT,3
CN,MENTAL DISORDER,3
CN,MUSCLE SPASMS,3
CN,NEPHROTIC SYNDROME,3
CN,OCULAR ICTERUS,3
CN,OLIGURIA,3
CN,PAPULE,3
CN,PARAESTHESIA,3
CN,PERIPHERAL ARTERY OCCLUSION,3
CN,PRODUCT USE ISSUE,3
CN,PRURITUS GENERALISED,3
CN,SHOCK,3
CN,SINUS BRADYCARDIA,3
CN,SOMNOLENCE,3
CN,SPINAL OSTEOARTHRITIS,3
CN,TRANSIENT ISCHAEMIC ATTACK,3
CN,TREMOR,3
CN,URINARY RETENTION,3
CN,URINARY TRACT INFECTION,3
CN,VASCULAR OCCLUSION,3
CN,WHITE BLOOD CELL COUNT DECREASED,3
CN,XANTHOCHROMIA,3
CN,ACUTE CORONARY SYNDROME,2
CN,ALOPECIA,2
CN,ALPHA HYDROXYBUTYRATE DEHYDROGENASE INCREASED,2
CN,AMAUROSIS,2
CN,AMNESIA,2
CN,ANAPHYLACTIC SHOCK,2
CN,AORTIC VALVE THICKENING,2
CN,ARTERIOSCLEROSIS,2
CN,ASCITES,2
CN,ATRIOVENTRICULAR BLOCK COMPLETE,2
CN,BLOOD ALKALINE PHOSPHATASE INCREASED,2
CN,BODY TEMPERATURE INCREASED,2
CN,BRAIN HERNIATION,2
CN,BRAIN STEM HAEMORRHAGE,2
CN,BRONCHITIS,2
CN,BURNING SENSATION,2
CN,CARDIAC ANEURYSM,2
CN,CARDIAC DISORDER,2
CN,CARDIAC FAILURE ACUTE,2
CN,CHOLECYSTITIS,2
CN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
CN,CIRCUMORAL OEDEMA,2
CN,COLD SWEAT,2
CN,COMPLICATIONS OF TRANSPLANTED KIDNEY,2
CN,DIABETIC NEUROPATHY,2
CN,DISSEMINATED INTRAVASCULAR COAGULATION,2
CN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
CN,DUODENAL ULCER,2
CN,DYSARTHRIA,2
CN,DYSBACTERIOSIS,2
CN,DYSPHAGIA,2
CN,DYSPHONIA,2
CN,ECZEMA,2
CN,ELECTROCARDIOGRAM ABNORMAL,2
CN,ELECTROCARDIOGRAM QT PROLONGED,2
CN,ELECTROCARDIOGRAM T WAVE ABNORMAL,2
CN,ERUCTATION,2
CN,ESSENTIAL HYPERTENSION,2
CN,EYE DISORDER,2
CN,FALL,2
CN,FEELING COLD,2
CN,FLATULENCE,2
CN,GASTRIC CANCER,2
CN,GASTRITIS EROSIVE,2
CN,GASTROOESOPHAGEAL REFLUX DISEASE,2
CN,GINGIVAL BLEEDING,2
CN,GLOMERULAR FILTRATION RATE DECREASED,2
CN,GLOMERULONEPHRITIS,2
CN,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
CN,GOUT,2
CN,GRANULOCYTOPENIA,2
CN,HAEMOLYTIC ANAEMIA,2
CN,HAEMORRHOIDS,2
CN,HAEMOTHORAX,2
CN,HALLUCINATION,2
CN,HEAD DISCOMFORT,2
CN,HEART RATE DECREASED,2
CN,HEMIPARESIS,2
CN,HEPATIC ENZYME ABNORMAL,2
CN,HEPATOTOXICITY,2
CN,HYPERGLYCAEMIA,2
CN,HYPERURICAEMIA,2
CN,HYPOAESTHESIA ORAL,2
CN,HYPOGLYCAEMIC COMA,2
CN,HYPONATRAEMIA,2
CN,HYPOXIA,2
CN,IGA NEPHROPATHY,2
CN,ISCHAEMIC CARDIOMYOPATHY,2
CN,JAUNDICE ACHOLURIC,2
CN,LEFT VENTRICULAR FAILURE,2
CN,LOW DENSITY LIPOPROTEIN DECREASED,2
CN,LOW DENSITY LIPOPROTEIN INCREASED,2
CN,MACULE,2
CN,MEDICATION RESIDUE PRESENT,2
CN,MICTURITION URGENCY,2
CN,MITRAL VALVE INCOMPETENCE,2
CN,MOUTH ULCERATION,2
CN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
CN,MUSCLE RIGIDITY,2
CN,MUSCULOSKELETAL PAIN,2
CN,NEPHROPATHY TOXIC,2
CN,ORTHOSTATIC HYPOTENSION,2
CN,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
CN,PRODUCT PHYSICAL ISSUE,2
CN,PROSTATE CANCER,2
CN,PULMONARY EMBOLISM,2
CN,PULMONARY HYPERTENSION,2
CN,PURPURA,2
CN,RED BLOOD CELLS URINE POSITIVE,2
CN,RESPIRATORY ARREST,2
CN,RESPIRATORY FAILURE,2
CN,SINUS ARRHYTHMIA,2
CN,SKIN EXFOLIATION,2
CN,SWELLING,2
CN,TACHYPNOEA,2
CN,THERAPEUTIC RESPONSE UNEXPECTED,2
CN,TONGUE OEDEMA,2
CN,TOXICITY TO VARIOUS AGENTS,2
CN,TRICUSPID VALVE INCOMPETENCE,2
CN,TYPE 2 DIABETES MELLITUS,2
CN,UPPER RESPIRATORY TRACT INFECTION,2
CN,VERTIGO,2
CN,ABDOMINAL PAIN LOWER,1
CN,ABNORMAL BEHAVIOUR,1
CN,ABNORMAL FAECES,1
CN,ACINETOBACTER INFECTION,1
CN,ACNE,1
CN,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
CN,ACUTE LEFT VENTRICULAR FAILURE,1
CN,AGGRESSION,1
CN,AGITATION,1
CN,AGNOSIA,1
CN,AGRANULOCYTOSIS,1
CN,AKATHISIA,1
CN,ALANINE AMINOTRANSFERASE ABNORMAL,1
CN,AMINO ACID LEVEL ABNORMAL,1
CN,AMYLASE INCREASED,1
CN,ANAL FISSURE,1
CN,ANAL PRURITUS,1
CN,ANAPHYLACTOID REACTION,1
CN,ANGLE CLOSURE GLAUCOMA,1
CN,ANOXIA,1
CN,ANTIMITOCHONDRIAL ANTIBODY POSITIVE,1
CN,ANXIETY,1
CN,AORTIC ARTERIOSCLEROSIS,1
CN,APHASIA,1
CN,APHTHOUS ULCER,1
CN,ARTERIAL INSUFFICIENCY,1
CN,ARTERIOSPASM CORONARY,1
CN,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
CN,ATRIOVENTRICULAR BLOCK,1
CN,BENIGN PROSTATIC HYPERPLASIA,1
CN,BILE DUCT CANCER,1
CN,BILIARY DILATATION,1
CN,BILIARY TRACT INFECTION,1
CN,BK VIRUS INFECTION,1
CN,BLOOD BILIRUBIN ABNORMAL,1
CN,BLOOD CHOLESTEROL DECREASED,1
CN,BLOOD CHOLESTEROL INCREASED,1
CN,BLOOD CREATINE INCREASED,1
CN,BLOOD GLUCOSE ABNORMAL,1
CN,BLOOD GLUCOSE DECREASED,1
CN,BLOOD PRESSURE ABNORMAL,1
CN,BLOOD PRESSURE FLUCTUATION,1
CN,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
CN,BLOOD TEST ABNORMAL,1
CN,BLOOD TRIGLYCERIDES INCREASED,1
CN,BLOOD URINE PRESENT,1
CN,BODY TEMPERATURE DECREASED,1
CN,BONE MARROW FAILURE,1
CN,BONE PAIN,1
CN,BRAIN NATRIURETIC PEPTIDE INCREASED,1
CN,BRAIN OEDEMA,1
CN,BREAST ENLARGEMENT,1
CN,BREAST MASS,1
CN,BRONCHITIS CHRONIC,1
CN,CALCULUS URETHRAL,1
CN,CARDIAC DISCOMFORT,1
CN,CARDIAC ENZYMES INCREASED,1
CN,CARDIAC FAILURE CONGESTIVE,1
CN,CARDIAC FLUTTER,1
CN,CARDIAC VALVE DISEASE,1
CN,CARDIOGENIC SHOCK,1
CN,CARDIORENAL SYNDROME,1
CN,CAROTID ARTERIOSCLEROSIS,1
CN,CAROTID ARTERY STENOSIS,1
CN,CAROTID ARTERY STENT INSERTION,1
CN,CEREBRAL ARTERY EMBOLISM,1
CN,CEREBRAL DISORDER,1
CN,CEREBRAL HAEMATOMA,1
CN,CEREBROVASCULAR ACCIDENT,1
CN,CEREBROVASCULAR INSUFFICIENCY,1
CN,CEREBROVASCULAR STENOSIS,1
CN,CHOLELITHIASIS,1
CN,CHRONIC KIDNEY DISEASE,1
CN,CIRCULATORY COLLAPSE,1
CN,COAGULATION TEST ABNORMAL,1
CN,COAGULATION TIME PROLONGED,1
CN,COGNITIVE DISORDER,1
CN,CONJUNCTIVAL OEDEMA,1
CN,CONSTIPATION,1
CN,COUNTERFEIT DRUG ADMINISTERED,1
CN,CRYSTALLURIA,1
CN,CYTOMEGALOVIRUS INFECTION,1
CN,DEAFNESS NEUROSENSORY,1
CN,DEAFNESS TRANSITORY,1
CN,DEHYDRATION,1
CN,DELIRIUM,1
CN,DEPRESSED LEVEL OF CONSCIOUSNESS,1
CN,DERMATITIS,1
CN,DERMATITIS ALLERGIC,1
CN,DERMATITIS ATOPIC,1
CN,DERMATITIS EXFOLIATIVE GENERALISED,1
CN,DIABETIC KETOACIDOSIS,1
CN,DIABETIC NEPHROPATHY,1
CN,DIABETIC VASCULAR DISORDER,1
CN,DIPLOPIA,1
CN,DISTURBANCE IN ATTENTION,1
CN,DIVERTICULUM INTESTINAL,1
CN,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
CN,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
CN,DRUG INTOLERANCE,1
CN,DUODENAL ULCER HAEMORRHAGE,1
CN,DYSKINESIA,1
CN,DYSPEPSIA,1
CN,DYSPNOEA EXERTIONAL,1
CN,EJECTION FRACTION DECREASED,1
CN,ELECTROCARDIOGRAM ST SEGMENT ABNORMAL,1
CN,EMBOLIC STROKE,1
CN,EMBOLISM,1
CN,EMOTIONAL DISORDER,1
CN,EMOTIONAL DISTRESS,1
CN,ENTERITIS,1
CN,ENZYME ABNORMALITY,1
CN,EOSINOPHILIA,1
CN,EPIDIDYMITIS,1
CN,EPIGASTRIC DISCOMFORT,1
CN,EPISTAXIS,1
CN,ERYTHEMA MULTIFORME,1
CN,ERYTHEMA OF EYELID,1
CN,EXTRAOCULAR MUSCLE PARESIS,1
CN,EYE HAEMORRHAGE,1
CN,EYE SWELLING,1
CN,FACIAL PARALYSIS,1
CN,FAECALOMA,1
CN,FEELING ABNORMAL,1
CN,GAIT INABILITY,1
CN,GASTRIC HAEMORRHAGE,1
CN,GASTRIC LAVAGE ABNORMAL,1
CN,GASTRIC ULCER,1
CN,GASTROENTERITIS,1
CN,GASTROINTESTINAL POLYP HAEMORRHAGE,1
CN,GLUCOSE TOLERANCE DECREASED,1
CN,HAEMARTHROSIS,1
CN,HAEMATOMA,1
CN,HAEMOLYSIS,1
CN,HAEMORRHAGIC TRANSFORMATION STROKE,1
CN,HAIR GROWTH ABNORMAL,1
CN,HALO VISION,1
CN,HEART RATE IRREGULAR,1
CN,HEART VALVE INCOMPETENCE,1
CN,HEMIPLEGIA,1
CN,HENOCH-SCHONLEIN PURPURA,1
CN,HEPATIC ATROPHY,1
CN,HEPATIC CONGESTION,1
CN,HEPATIC CYST,1
CN,HEPATITIS CHOLESTATIC,1
CN,HEPATITIS VIRAL,1
CN,HEPATORENAL FAILURE,1
CN,HERPES ZOSTER,1
CN,HIATUS HERNIA,1
CN,HICCUPS,1
CN,HOSPITALISATION,1
CN,HOT FLUSH,1
CN,HYDRONEPHROSIS,1
CN,HYPERCOAGULATION,1
CN,HYPERKALAEMIA,1
CN,HYPERPLASIA,1
CN,HYPERPYREXIA,1
CN,HYPOACUSIS,1
CN,HYPOCHLORAEMIA,1
CN,HYPOCHROMIC ANAEMIA,1
CN,HYPOGLYCAEMIC ENCEPHALOPATHY,1
CN,HYPOTHYROIDISM,1
CN,ILLOGICAL THINKING,1
CN,INAPPROPRIATE AFFECT,1
CN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CN,INCISION SITE HAEMORRHAGE,1
CN,INDIFFERENCE,1
CN,INFLUENZA,1
CN,INFUSION SITE EXTRAVASATION,1
CN,INJECTION SITE ERYTHEMA,1
CN,INJECTION SITE INDURATION,1
CN,INJECTION SITE PRURITUS,1
CN,INJECTION SITE RASH,1
CN,INJECTION SITE SWELLING,1
CN,INTENTIONAL OVERDOSE,1
CN,INTENTIONAL PRODUCT MISUSE,1
CN,INTERSTITIAL LUNG DISEASE,1
CN,INVESTIGATION ABNORMAL,1
CN,ISCHAEMIA,1
CN,ISCHAEMIC STROKE,1
CN,JAUNDICE CHOLESTATIC,1
CN,JOINT ABSCESS,1
CN,JOINT SWELLING,1
CN,JOINT WARMTH,1
CN,JUGULAR VEIN DISTENSION,1
CN,KETOACIDOSIS,1
CN,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
CN,LACRIMATION DISORDER,1
CN,LANGUAGE DISORDER,1
CN,LARGE INTESTINE PERFORATION,1
CN,LARYNGEAL OBSTRUCTION,1
CN,LEFT VENTRICULAR DYSFUNCTION,1
CN,LEFT VENTRICULAR HYPERTROPHY,1
CN,LEUKAEMIA,1
CN,LEUKOCYTURIA,1
CN,LIBIDO DECREASED,1
CN,LIP AND/OR ORAL CAVITY CANCER,1
CN,LIPID METABOLISM DISORDER,1
CN,LIPIDS INCREASED,1
CN,LIVER TENDERNESS,1
CN,LOCALISED INFECTION,1
CN,LUNG NEOPLASM MALIGNANT,1
CN,MALIGNANT FIBROUS HISTIOCYTOMA,1
CN,MANIA,1
CN,MELAENA,1
CN,MENINGIOMA,1
CN,MENORRHAGIA,1
CN,MENTAL STATUS CHANGES,1
CN,METASTASES TO CENTRAL NERVOUS SYSTEM,1
CN,MILIARIA,1
CN,MIXED DEMENTIA,1
CN,MOUTH HAEMORRHAGE,1
CN,MOVEMENT DISORDER,1
CN,MULTI-ORGAN FAILURE,1
CN,MUSCLE CONTRACTIONS INVOLUNTARY,1
CN,MUSCLE FATIGUE,1
CN,MUSCLE HAEMORRHAGE,1
CN,MUSCLE NECROSIS,1
CN,MUSCLE RUPTURE,1
CN,MUSCLE TIGHTNESS,1
CN,MUSCLE TONE DISORDER,1
CN,MUSCLE TWITCHING,1
CN,MYASTHENIA GRAVIS,1
CN,MYASTHENIC SYNDROME,1
CN,MYOCARDIAL BRIDGING,1
CN,MYOCARDIAL ISCHAEMIA,1
CN,MYOCARDIAL RUPTURE,1
CN,MYOCARDITIS,1
CN,MYOGLOBINAEMIA,1
CN,MYOPATHY,1
CN,NEOPLASM,1
CN,NEPHRITIS,1
CN,NEPHROPATHY,1
CN,NERVOUS SYSTEM DISORDER,1
CN,NERVOUSNESS,1
CN,NEUTROPENIA,1
CN,OCCULT BLOOD,1
CN,OCCULT BLOOD POSITIVE,1
CN,OCULAR DISCOMFORT,1
CN,OEDEMA,1
CN,OESOPHAGEAL CARCINOMA,1
CN,OESOPHAGITIS,1
CN,OPEN ANGLE GLAUCOMA,1
CN,OPTIC NERVE SHEATH HAEMORRHAGE,1
CN,ORAL MUCOSAL ERUPTION,1
CN,ORBITAL OEDEMA,1
CN,OROPHARYNGEAL PAIN,1
CN,OROPHARYNGITIS FUNGAL,1
CN,ORTHOPNOEA,1
CN,OSTEOPOROSIS,1
CN,OTITIS MEDIA,1
CN,OVERDOSE,1
CN,OXYGEN SATURATION DECREASED,1
CN,PAIN OF SKIN,1
CN,PANCREATIC CARCINOMA,1
CN,PANCYTOPENIA,1
CN,PARALYSIS,1
CN,PERINEAL PAIN,1
CN,PERIORBITAL OEDEMA,1
CN,PERIPHERAL COLDNESS,1
CN,PERIPHERAL VENOUS DISEASE,1
CN,PETECHIAE,1
CN,PHARYNGEAL HAEMORRHAGE,1
CN,PHARYNGITIS,1
CN,PITYRIASIS,1
CN,PLATELET COUNT INCREASED,1
CN,PLEURAL EFFUSION,1
CN,PLEURITIC PAIN,1
CN,PNEUMONITIS,1
CN,POLYDIPSIA,1
CN,POLYMYOSITIS,1
CN,POLYURIA,1
CN,POTENTIATING DRUG INTERACTION,1
CN,PRESCRIBED UNDERDOSE,1
CN,PRESYNCOPE,1
CN,PROCEDURAL PAIN,1
CN,PRODUCT QUALITY ISSUE,1
CN,PRODUCT TASTE ABNORMAL,1
CN,PROSTATITIS,1
CN,PROTEIN URINE PRESENT,1
CN,PROTEINURIA,1
CN,PROTHROMBIN TIME PROLONGED,1
CN,PSYCHOTIC DISORDER,1
CN,PULMONARY MASS,1
CN,QUADRIPLEGIA,1
CN,RASH PRURITIC,1
CN,RED BLOOD CELL COUNT DECREASED,1
CN,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
CN,REGURGITATION,1
CN,RENAL CYST,1
CN,RENAL DISORDER,1
CN,RENAL FAILURE ACUTE,1
CN,RENAL INJURY,1
CN,RESPIRATORY RATE INCREASED,1
CN,RESTLESSNESS,1
CN,RETINAL HAEMORRHAGE,1
CN,RETROPERITONEAL HAEMATOMA,1
CN,RHYTHM IDIOVENTRICULAR,1
CN,RIGHT VENTRICULAR FAILURE,1
CN,SCAR,1
CN,SCLERITIS,1
CN,SEIZURE,1
CN,SENILE DEMENTIA,1
CN,SENSE OF OPPRESSION,1
CN,SEPSIS,1
CN,SHOCK HAEMORRHAGIC,1
CN,SICK SINUS SYNDROME,1
CN,SINUS TACHYCARDIA,1
CN,SINUSITIS,1
CN,SJOGREN^S SYNDROME,1
CN,SKIN HAEMORRHAGE,1
CN,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,1
CN,SPEECH DISORDER,1
CN,SPUTUM RETENTION,1
CN,STARVATION,1
CN,STENT PLACEMENT,1
CN,STOMATITIS,1
CN,SUBARACHNOID HAEMORRHAGE,1
CN,SUBDURAL HAEMATOMA,1
CN,SUDDEN HEARING LOSS,1
CN,SUICIDAL IDEATION,1
CN,SUICIDE ATTEMPT,1
CN,SUPRAVENTRICULAR TACHYCARDIA,1
CN,SUSPICIOUSNESS,1
CN,SWOLLEN TONGUE,1
CN,SYSTEMIC LUPUS ERYTHEMATOSUS,1
CN,TACHYCARDIA,1
CN,TACITURNITY,1
CN,TEMPERATURE INTOLERANCE,1
CN,TENDON PAIN,1
CN,THIRST,1
CN,THROAT IRRITATION,1
CN,THROMBOCYTOPENIC PURPURA,1
CN,THYROID NEOPLASM,1
CN,TONIC CONVULSION,1
CN,TONSILLITIS,1
CN,TORSADE DE POINTES,1
CN,TOTAL BILE ACIDS INCREASED,1
CN,TROPONIN I INCREASED,1
CN,TROPONIN INCREASED,1
CN,UREA RENAL CLEARANCE DECREASED,1
CN,URINARY INCONTINENCE,1
CN,URINE ANALYSIS ABNORMAL,1
CN,URINE BILIRUBIN INCREASED,1
CN,VENOUS OCCLUSION,1
CN,VENTRICULAR ARRHYTHMIA,1
CN,VENTRICULAR EXTRASYSTOLES,1
CN,VENTRICULAR FAILURE,1
CN,VENTRICULAR FIBRILLATION,1
CN,VISUAL IMPAIRMENT,1
CN,WEIGHT INCREASED,1
CN,WERNICKE^S ENCEPHALOPATHY,1
CN,XEROPHTHALMIA,1
CO,DEATH,10
CO,INFARCTION,5
CO,CARDIAC DISORDER,4
CO,GAIT DISTURBANCE,4
CO,ANGIOPATHY,3
CO,BLOOD PRESSURE INCREASED,3
CO,FATIGUE,3
CO,GASTRITIS,3
CO,HEADACHE,3
CO,MUSCULAR WEAKNESS,3
CO,THROMBOSIS,3
CO,WEIGHT DECREASED,3
CO,ANAEMIA,2
CO,ANGINA PECTORIS,2
CO,ARTHRALGIA,2
CO,ARTHROPATHY,2
CO,ASTHENIA,2
CO,ATRIAL FIBRILLATION,2
CO,CATARACT,2
CO,CEREBRAL THROMBOSIS,2
CO,COUGH,2
CO,CUTANEOUS VASCULITIS,2
CO,DEPRESSED MOOD,2
CO,DIABETES MELLITUS,2
CO,DIARRHOEA,2
CO,DIZZINESS,2
CO,DYSPNOEA,2
CO,EYE DISORDER,2
CO,HYPERTENSION,2
CO,INFLAMMATION,2
CO,MYOCARDIAL INFARCTION,2
CO,OCULAR HYPERAEMIA,2
CO,PYELONEPHRITIS,2
CO,SPEECH DISORDER,2
CO,SPINAL DISORDER,2
CO,ABDOMINAL PAIN UPPER,1
CO,ACCIDENT,1
CO,ANGINA UNSTABLE,1
CO,APHASIA,1
CO,ARRHYTHMIA,1
CO,ARTERIAL OCCLUSIVE DISEASE,1
CO,BALANCE DISORDER,1
CO,BENIGN MUSCLE NEOPLASM,1
CO,BLOOD GLUCOSE ABNORMAL,1
CO,BLOOD GLUCOSE DECREASED,1
CO,BLOOD GLUCOSE INCREASED,1
CO,BLOOD PRESSURE DECREASED,1
CO,CARDIAC ARREST,1
CO,CARDIAC FAILURE,1
CO,CARDIAC FUNCTION TEST ABNORMAL,1
CO,CARDIAC PROCEDURE COMPLICATION,1
CO,CARDIO-RESPIRATORY ARREST,1
CO,CARDIOVASCULAR DISORDER,1
CO,CEREBRAL HAEMORRHAGE,1
CO,CEREBRAL ISCHAEMIA,1
CO,CHEST PAIN,1
CO,COLON NEOPLASM,1
CO,CONSTIPATION,1
CO,CORONARY ARTERY INSUFFICIENCY,1
CO,DEAFNESS,1
CO,DECREASED APPETITE,1
CO,DEVICE DISLOCATION,1
CO,DEVICE OCCLUSION,1
CO,DIABETES MELLITUS INADEQUATE CONTROL,1
CO,DIABETIC COMA,1
CO,DIABETIC COMPLICATION,1
CO,DIARRHOEA HAEMORRHAGIC,1
CO,DRUG INEFFECTIVE,1
CO,DYSPHONIA,1
CO,EPISTAXIS,1
CO,EXERCISE LACK OF,1
CO,EXTRAPYRAMIDAL DISORDER,1
CO,FALL,1
CO,FEEDING DISORDER,1
CO,FEMUR FRACTURE,1
CO,FIBROMYALGIA,1
CO,FRACTURE PAIN,1
CO,GASTRIC ULCER,1
CO,GASTROINTESTINAL CARCINOMA,1
CO,GASTROINTESTINAL FISTULA,1
CO,GENERALISED OEDEMA,1
CO,HEART RATE DECREASED,1
CO,HELICOBACTER INFECTION,1
CO,HERNIA,1
CO,HYPERGLYCAEMIA,1
CO,HYPERSENSITIVITY,1
CO,HYPERSOMNIA,1
CO,HYPOAESTHESIA,1
CO,HYPOTHYROIDISM,1
CO,INCORRECT DOSE ADMINISTERED,1
CO,INFLUENZA,1
CO,INSOMNIA,1
CO,INTERVERTEBRAL DISC DISORDER,1
CO,INTESTINAL CYST,1
CO,LEUKOCYTURIA,1
CO,LYMPHANGITIS,1
CO,MELANOCYTIC NAEVUS,1
CO,MITRAL VALVE DISEASE,1
CO,MOBILITY DECREASED,1
CO,MULTIPLE SCLEROSIS,1
CO,MUSCLE SPASMS,1
CO,NAUSEA,1
CO,NEOPLASM MALIGNANT,1
CO,NUCLEAR MAGNETIC RESONANCE IMAGING,1
CO,OEDEMA PERIPHERAL,1
CO,OSTEOARTHRITIS,1
CO,OSTEOPOROSIS,1
CO,OVARIAN CANCER,1
CO,PAIN,1
CO,PAIN IN EXTREMITY,1
CO,PALPITATIONS,1
CO,PANCREATIC CARCINOMA,1
CO,PAPILLARY THYROID CANCER,1
CO,PARALYSIS,1
CO,PARKINSON^S DISEASE,1
CO,PLATELET COUNT DECREASED,1
CO,PNEUMONITIS,1
CO,POLYMEDICATION,1
CO,POLYMYALGIA RHEUMATICA,1
CO,PROTEINURIA,1
CO,PULMONARY HAEMORRHAGE,1
CO,RENAL FAILURE CHRONIC,1
CO,RESPIRATORY ARREST,1
CO,RESPIRATORY DISORDER,1
CO,SOMNOLENCE,1
CO,SPONDYLOLISTHESIS,1
CO,UPPER LIMB FRACTURE,1
CO,UTERINE LEIOMYOMA,1
CO,VOMITING,1
CR,INFARCTION,7
CR,DEATH,6
CR,CEREBROVASCULAR ACCIDENT,3
CR,MYOCARDIAL INFARCTION,3
CR,ARRHYTHMIA,2
CR,DRUG PRESCRIBING ERROR,2
CR,FALL,2
CR,HIP FRACTURE,2
CR,MALAISE,2
CR,NEOPLASM MALIGNANT,2
CR,ABASIA,1
CR,ANEURYSM,1
CR,APPARENT DEATH,1
CR,ARTHRALGIA,1
CR,BACK PAIN,1
CR,BLOOD PRESSURE INCREASED,1
CR,CARDIAC ANEURYSM,1
CR,CARDIAC VALVE DISEASE,1
CR,CEREBELLAR ISCHAEMIA,1
CR,CERVIX CARCINOMA,1
CR,CHROMATURIA,1
CR,DEAFNESS,1
CR,DEHYDRATION,1
CR,DIABETES MELLITUS,1
CR,DRUG HYPERSENSITIVITY,1
CR,DRUG INEFFECTIVE,1
CR,DYSPNOEA,1
CR,DYSURIA,1
CR,EMBOLISM,1
CR,GAIT DISTURBANCE,1
CR,GASTRIC ULCER,1
CR,GASTRITIS,1
CR,GASTROINTESTINAL DISORDER,1
CR,HEADACHE,1
CR,HYPERHIDROSIS,1
CR,HYPERSENSITIVITY,1
CR,HYPERTENSIVE CRISIS,1
CR,HYPOACUSIS,1
CR,HYPOTENSION,1
CR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CR,INFECTION,1
CR,INTERMITTENT CLAUDICATION,1
CR,IRON DEFICIENCY ANAEMIA,1
CR,LUNG NEOPLASM MALIGNANT,1
CR,MENINGITIS,1
CR,MUSCLE SPASMS,1
CR,MUSCULOSKELETAL PAIN,1
CR,NAUSEA,1
CR,NECK PAIN,1
CR,NEUROPATHY PERIPHERAL,1
CR,PAIN IN EXTREMITY,1
CR,PALPITATIONS,1
CR,PANCREATITIS,1
CR,PLASMA CELL MYELOMA,1
CR,PNEUMONIA,1
CR,PRODUCT USE IN UNAPPROVED INDICATION,1
CR,PRODUCT USE ISSUE,1
CR,PYREXIA,1
CR,RENAL FAILURE,1
CR,TRANSIENT GLOBAL AMNESIA,1
CR,URTICARIA,1
CR,VOMITING,1
CR,WALKING DISABILITY,1
CR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
HR,INTERSTITIAL LUNG DISEASE,7
HR,BLOOD PRESSURE DECREASED,2
HR,CHEST PAIN,2
HR,DIZZINESS,2
HR,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,2
HR,NAUSEA,2
HR,ABDOMINAL PAIN,1
HR,AMYLASE INCREASED,1
HR,ANAEMIA,1
HR,BLOOD GLUCOSE INCREASED,1
HR,ERYTHEMA,1
HR,GAIT DISTURBANCE,1
HR,HEPATIC STEATOSIS,1
HR,HYPOAESTHESIA,1
HR,HYPOTENSION,1
HR,MYALGIA,1
HR,PARAESTHESIA,1
HR,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,1
HR,RENAL FAILURE ACUTE,1
HR,RHABDOMYOLYSIS,1
CY,DEEP VEIN THROMBOSIS,1
CY,EMBOLISM VENOUS,1
CY,HEAD INJURY,1
CY,MYOCARDIAL INFARCTION,1
CY,OCULAR VASCULAR DISORDER,1
CY,ROAD TRAFFIC ACCIDENT,1
CY,SUBDURAL HAEMATOMA,1
CY,VEIN DISORDER,1
CZ,IMMUNE-MEDIATED NECROTISING MYOPATHY,13
CZ,MYOPATHY,2
CZ,POLYMYOSITIS,2
CZ,ACUTE KIDNEY INJURY,1
CZ,ACUTE MYOCARDIAL INFARCTION,1
CZ,ATRIAL FIBRILLATION,1
CZ,BONE PAIN,1
CZ,BRONCHOPLEURAL FISTULA,1
CZ,CARDIOGENIC SHOCK,1
CZ,CELL-MEDIATED IMMUNE DEFICIENCY,1
CZ,CIRCULATORY COLLAPSE,1
CZ,DIARRHOEA,1
CZ,EYE HAEMORRHAGE,1
CZ,HYPOTENSION,1
CZ,INFECTIOUS PLEURAL EFFUSION,1
CZ,INTENTIONAL OVERDOSE,1
CZ,MULTI-ORGAN DISORDER,1
CZ,PAIN IN EXTREMITY,1
CZ,PANCREATITIS ACUTE,1
CZ,PNEUMOTHORAX,1
CZ,RESPIRATORY TRACT INFECTION,1
CZ,RHABDOMYOLYSIS,1
CZ,TUBERCULOUS PLEURISY,1
DK,SEIZURE,4
DK,DIZZINESS,2
DK,EPISTAXIS,2
DK,GAIT DISTURBANCE,2
DK,MEMORY IMPAIRMENT,2
DK,MUSCULAR WEAKNESS,2
DK,MYALGIA,2
DK,PAIN IN EXTREMITY,2
DK,SINUS BRADYCARDIA,2
DK,ACCIDENTAL OVERDOSE,1
DK,ACUTE KIDNEY INJURY,1
DK,ADENOCARCINOMA OF COLON,1
DK,ARRHYTHMIA,1
DK,ARTHRALGIA,1
DK,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
DK,CALCIUM IONISED DECREASED,1
DK,CARDIAC ARREST,1
DK,CEREBRAL INFARCTION,1
DK,DEPRESSED LEVEL OF CONSCIOUSNESS,1
DK,DISCOMFORT,1
DK,DISTURBANCE IN ATTENTION,1
DK,DRUG INEFFECTIVE,1
DK,DYSSTASIA,1
DK,ELECTROCARDIOGRAM QT PROLONGED,1
DK,ERECTILE DYSFUNCTION,1
DK,FINE MOTOR DELAY,1
DK,GENERAL PHYSICAL HEALTH DETERIORATION,1
DK,GINGIVAL BLEEDING,1
DK,HAEMARTHROSIS,1
DK,HAEMATOMA EVACUATION,1
DK,HAEMOGLOBIN DECREASED,1
DK,HAEMORRHAGE,1
DK,HAEMORRHAGIC DIATHESIS,1
DK,HEADACHE,1
DK,HYPONATRAEMIA,1
DK,INCONTINENCE,1
DK,INFUSION SITE HAEMORRHAGE,1
DK,IRON DEFICIENCY ANAEMIA,1
DK,JOINT SWELLING,1
DK,MALAISE,1
DK,METABOLIC ACIDOSIS,1
DK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
DK,MUSCLE ATROPHY,1
DK,MUSCLE SPASMS,1
DK,MUSCULOSKELETAL STIFFNESS,1
DK,PUPILS UNEQUAL,1
DK,RENAL FAILURE,1
DK,RHABDOMYOLYSIS,1
DK,SENSORY DISTURBANCE,1
DK,SEPSIS,1
DK,SHOCK,1
DK,SLEEP DISORDER,1
DK,SPEECH DISORDER,1
DK,SUBARACHNOID HAEMORRHAGE,1
DK,SUBDURAL HAEMORRHAGE,1
DK,TOOTH DISORDER,1
DK,TROPONIN T INCREASED,1
DK,VASCULITIC RASH,1
DM,CARDIAC DISORDER,1
DM,DYSPHAGIA,1
DM,MUSCLE ATROPHY,1
DM,MUSCLE SPASMS,1
DM,MUSCULAR WEAKNESS,1
DM,WALKING DISABILITY,1
DO,BRAIN HYPOXIA,1
DO,DEATH,1
DO,HAEMORRHAGE,1
DO,OVERDOSE,1
DO,PANCREATIC CARCINOMA,1
DO,THROMBOSIS,1
EC,DEATH,12
EC,MYOCARDIAL INFARCTION,10
EC,CEREBROVASCULAR ACCIDENT,6
EC,APHASIA,3
EC,BLOOD PRESSURE INCREASED,2
EC,CARDIAC DISORDER,2
EC,DIABETES MELLITUS,2
EC,DIZZINESS,2
EC,INFARCTION,2
EC,ABASIA,1
EC,ACUTE MYELOID LEUKAEMIA,1
EC,ADENOCARCINOMA PANCREAS,1
EC,AMNESIA,1
EC,AORTIC OCCLUSION,1
EC,ARTERIAL OCCLUSIVE DISEASE,1
EC,ARTHROPATHY,1
EC,ASPHYXIA,1
EC,ATRIAL FIBRILLATION,1
EC,BRAIN NEOPLASM,1
EC,CARDIO-RESPIRATORY ARREST,1
EC,CATARACT,1
EC,CHOLELITHIASIS,1
EC,COMA,1
EC,CONFUSIONAL STATE,1
EC,CONVULSION,1
EC,COORDINATION ABNORMAL,1
EC,DEEP VEIN THROMBOSIS,1
EC,DISORIENTATION,1
EC,DYSARTHRIA,1
EC,ELDERLY,1
EC,EMBOLIC STROKE,1
EC,FALL,1
EC,FATIGUE,1
EC,GAIT DISTURBANCE,1
EC,GASTRIC CANCER,1
EC,GASTRITIS,1
EC,HAEMORRHAGE INTRACRANIAL,1
EC,HEADACHE,1
EC,HEMIPARESIS,1
EC,HEPATIC FAILURE,1
EC,HERPES ZOSTER,1
EC,HYPERCHOLESTEROLAEMIA,1
EC,HYPOKALAEMIC SYNDROME,1
EC,HYPONATRAEMIC SYNDROME,1
EC,LIMB OPERATION,1
EC,LIVER INJURY,1
EC,LOSS OF CONSCIOUSNESS,1
EC,MALIGNANT NEOPLASM PROGRESSION,1
EC,MONOPARESIS,1
EC,MONOPLEGIA,1
EC,MYALGIA,1
EC,NEOPLASM MALIGNANT,1
EC,PARALYSIS,1
EC,PULMONARY VALVE INCOMPETENCE,1
EC,RECTAL HAEMORRHAGE,1
EC,RENAL DISORDER,1
EC,RENAL FAILURE,1
EC,RESPIRATORY FAILURE,1
EC,ROAD TRAFFIC ACCIDENT,1
EC,SEPTIC SHOCK,1
EC,SPEECH DISORDER,1
EC,SPINAL DISORDER,1
EC,SYSTEMIC LUPUS ERYTHEMATOSUS,1
EC,UPPER GASTROINTESTINAL HAEMORRHAGE,1
EC,VASCULAR GRAFT,1
EG,BLOOD BILIRUBIN INCREASED,2
EG,CHEST PAIN,2
EG,JAUNDICE,2
EG,MYOCARDIAL INFARCTION,2
EG,ABDOMINAL PAIN,1
EG,ANAPHYLACTIC SHOCK,1
EG,ANGIOEDEMA,1
EG,BLOOD PRESSURE INCREASED,1
EG,CARDIAC ARREST,1
EG,CARDIOGENIC SHOCK,1
EG,CHEST DISCOMFORT,1
EG,COMA,1
EG,CORONARY ARTERY STENOSIS,1
EG,DRUG EFFECT INCOMPLETE,1
EG,DRUG INEFFECTIVE,1
EG,DYSPNOEA,1
EG,FEELING ABNORMAL,1
EG,HEPATIC CANCER,1
EG,HEPATITIS,1
EG,HYPOTENSION,1
EG,INFLUENZA,1
EG,LIVER FUNCTION TEST INCREASED,1
EG,MYOCARDIAL ISCHAEMIA,1
EG,NAUSEA,1
EG,PARALYSIS,1
EG,PRODUCT QUALITY ISSUE,1
EG,PRURITUS GENITAL,1
EG,SOMNOLENCE,1
EG,SURGICAL FAILURE,1
SV,DEATH,4
SV,CEREBROVASCULAR ACCIDENT,1
SV,HIP FRACTURE,1
EE,CEREBRAL INFARCTION,2
EE,MUSCULAR WEAKNESS,2
EE,THROMBOSIS,2
EE,PROSTATE CANCER,1
EE,WALKING AID USER,1
EE,WOUND,1
FO,RHABDOMYOLYSIS,3
FO,BEDRIDDEN,1
FO,BLOOD ALKALINE PHOSPHATASE INCREASED,1
FO,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
FO,BLOOD LACTATE DEHYDROGENASE INCREASED,1
FO,BRAIN NATRIURETIC PEPTIDE INCREASED,1
FO,HYPOTENSION,1
FO,IMMOBILE,1
FO,LIVER FUNCTION TEST INCREASED,1
FO,MUSCULAR WEAKNESS,1
FO,MYALGIA,1
FO,MYOGLOBIN BLOOD INCREASED,1
FI,PAIN IN EXTREMITY,5
FI,C-REACTIVE PROTEIN INCREASED,4
FI,ABDOMINAL PAIN,3
FI,BACK PAIN,3
FI,BENIGN PROSTATIC HYPERPLASIA,3
FI,BLOOD CREATININE INCREASED,3
FI,DIABETES MELLITUS,3
FI,DYSPNOEA,3
FI,FATIGUE,3
FI,LOSS OF CONTROL OF LEGS,3
FI,OEDEMA PERIPHERAL,3
FI,PANCREATITIS,3
FI,RENAL FAILURE,3
FI,VISUAL ACUITY REDUCED,3
FI,VOMITING,3
FI,ABDOMINAL PAIN UPPER,2
FI,AGITATION,2
FI,AMYLASE INCREASED,2
FI,BLOOD ALBUMIN DECREASED,2
FI,BLOOD FOLATE INCREASED,2
FI,BLOOD GLUCOSE ABNORMAL,2
FI,BLOOD MAGNESIUM DECREASED,2
FI,BLOOD PRESSURE ABNORMAL,2
FI,BLOOD SODIUM INCREASED,2
FI,BLOOD URIC ACID INCREASED,2
FI,CARDIAC DISORDER,2
FI,CARDIAC FAILURE,2
FI,CATATONIA,2
FI,CEREBROVASCULAR ACCIDENT,2
FI,CONFUSIONAL STATE,2
FI,COUGH,2
FI,DELUSION,2
FI,DYSLIPIDAEMIA,2
FI,HAEMOGLOBIN DECREASED,2
FI,HEADACHE,2
FI,HEART RATE DECREASED,2
FI,HYPERSENSITIVITY,2
FI,MEMORY IMPAIRMENT,2
FI,MONOCYTE PERCENTAGE INCREASED,2
FI,MUSCLE SPASMS,2
FI,MYOCARDIAL INFARCTION,2
FI,NAUSEA,2
FI,NEUROLEPTIC MALIGNANT SYNDROME,2
FI,NEUTROPHIL COUNT DECREASED,2
FI,OBESITY,2
FI,PLATELET COUNT DECREASED,2
FI,PYREXIA,2
FI,SCHIZOPHRENIA,2
FI,SEPSIS,2
FI,SERUM FERRITIN INCREASED,2
FI,SINUSITIS,2
FI,SWELLING FACE,2
FI,TACHYCARDIA,2
FI,THYROXINE FREE INCREASED,2
FI,TOOTH LOSS,2
FI,TRANSFERRIN DECREASED,2
FI,WEIGHT DECREASED,2
FI,WEIGHT INCREASED,2
FI,WHITE BLOOD CELL COUNT DECREASED,2
FI,AMNESIA,1
FI,ANAEMIA,1
FI,AORTIC VALVE CALCIFICATION,1
FI,ARTERIOSCLEROSIS CORONARY ARTERY,1
FI,ARTHRALGIA,1
FI,ARTHRITIS,1
FI,ATRIAL FIBRILLATION,1
FI,BACK DISORDER,1
FI,BLADDER PROLAPSE,1
FI,BLOOD CHOLESTEROL INCREASED,1
FI,BLOOD PRESSURE INCREASED,1
FI,BODY TEMPERATURE INCREASED,1
FI,BRONCHITIS,1
FI,CARDIOMEGALY,1
FI,CEREBRAL DISORDER,1
FI,CHEST PAIN,1
FI,CHOLANGITIS,1
FI,COAGULOPATHY,1
FI,CONSTIPATION,1
FI,CYANOPSIA,1
FI,DEPRESSION,1
FI,DIAPHRAGMATIC DISORDER,1
FI,DIARRHOEA,1
FI,DISEASE PROGRESSION,1
FI,DRUG INEFFECTIVE,1
FI,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
FI,DUODENAL PERFORATION,1
FI,DUODENAL STENOSIS,1
FI,DYSKINESIA,1
FI,EMPYEMA,1
FI,ERYSIPELAS,1
FI,ERYTHEMA,1
FI,EXOSTOSIS OF JAW,1
FI,EYE SWELLING,1
FI,FEELING ABNORMAL,1
FI,FEELING HOT,1
FI,GAIT DISTURBANCE,1
FI,GASTROINTESTINAL FISTULA,1
FI,GASTROINTESTINAL HAEMORRHAGE,1
FI,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
FI,HAEMATOCHEZIA,1
FI,HAEMATOMA,1
FI,HAEMOPTYSIS,1
FI,HAEMOTHORAX,1
FI,HEPATIC ENZYME INCREASED,1
FI,HEPATIC NECROSIS,1
FI,HEPATIC STEATOSIS,1
FI,HEPATORENAL SYNDROME,1
FI,HOSPITALISATION,1
FI,HYPERGLYCAEMIA,1
FI,HYPERTENSION,1
FI,HYPONATRAEMIA,1
FI,HYPOTENSION,1
FI,HYPOTHERMIA,1
FI,HYPOTONIA,1
FI,IDIOPATHIC PULMONARY FIBROSIS,1
FI,INFLUENZA LIKE ILLNESS,1
FI,INTERNATIONAL NORMALISED RATIO INCREASED,1
FI,INTERSTITIAL LUNG DISEASE,1
FI,INTESTINAL PERFORATION,1
FI,ISCHAEMIC STROKE,1
FI,JOINT INJURY,1
FI,LUNG DISORDER,1
FI,LYMPH NODE PAIN,1
FI,METABOLIC ACIDOSIS,1
FI,MOBILITY DECREASED,1
FI,MUCOSAL INFLAMMATION,1
FI,MULTI-ORGAN FAILURE,1
FI,MUSCLE RUPTURE,1
FI,MUSCULOSKELETAL PAIN,1
FI,MUSCULOSKELETAL STIFFNESS,1
FI,MYALGIA,1
FI,MYOPATHY,1
FI,NASAL CONGESTION,1
FI,PAIN,1
FI,PANCREATIC CYST,1
FI,PANCREATIC DISORDER,1
FI,PANCREATITIS RELAPSING,1
FI,PNEUMONIA,1
FI,POLYMYALGIA RHEUMATICA,1
FI,POOR QUALITY SLEEP,1
FI,PRURITUS,1
FI,PRURITUS GENERALISED,1
FI,PULMONARY CONGESTION,1
FI,PULMONARY EMBOLISM,1
FI,PULMONARY FIBROSIS,1
FI,PULMONARY FUNCTION TEST DECREASED,1
FI,RALES,1
FI,RASH,1
FI,RENAL DISORDER,1
FI,RETINAL VASCULAR DISORDER,1
FI,RETROPERITONEAL ABSCESS,1
FI,RHABDOMYOLYSIS,1
FI,RHINITIS,1
FI,RHINITIS ALLERGIC,1
FI,SKIN MASS,1
FI,SKIN ULCER,1
FI,SLEEP DISORDER,1
FI,SUDDEN DEATH,1
FI,SYNOVIAL RUPTURE,1
FI,TESTICULAR CYST,1
FI,THROMBOSIS,1
FI,THYMUS DISORDER,1
FI,THYROID DISORDER,1
FI,TOXICITY TO VARIOUS AGENTS,1
FI,VERTIGO,1
FI,VISION BLURRED,1
FI,VISUAL FIELD DEFECT,1
FI,WALKING DISABILITY,1
FI,WHEELCHAIR USER,1
FI,WHITE BLOOD CELL COUNT INCREASED,1
FR,RHABDOMYOLYSIS,10
FR,FALL,9
FR,THROMBOCYTOPENIA,9
FR,ACUTE KIDNEY INJURY,8
FR,INTERSTITIAL LUNG DISEASE,8
FR,ANGIOEDEMA,6
FR,MYALGIA,6
FR,DIARRHOEA,5
FR,DYSPNOEA,5
FR,HEPATOCELLULAR INJURY,5
FR,HYPOKALAEMIA,5
FR,CHOLESTASIS,4
FR,DEATH,4
FR,DEHYDRATION,4
FR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,4
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,4
FR,HYPERKALAEMIA,4
FR,PRURITUS,4
FR,RENAL FAILURE,4
FR,ACUTE CORONARY SYNDROME,3
FR,ALANINE AMINOTRANSFERASE INCREASED,3
FR,ASPARTATE AMINOTRANSFERASE INCREASED,3
FR,CHEST PAIN,3
FR,HEPATIC ENZYME INCREASED,3
FR,HYPONATRAEMIA,3
FR,HYPOVOLAEMIC SHOCK,3
FR,INTENTIONAL OVERDOSE,3
FR,MALAISE,3
FR,OEDEMA PERIPHERAL,3
FR,PAIN IN EXTREMITY,3
FR,PANCREATITIS ACUTE,3
FR,PANCYTOPENIA,3
FR,PROSTATE CANCER,3
FR,RENAL FAILURE ACUTE,3
FR,SOMNOLENCE,3
FR,TOXICITY TO VARIOUS AGENTS,3
FR,ACUTE PULMONARY OEDEMA,2
FR,ACUTE RESPIRATORY DISTRESS SYNDROME,2
FR,ASTHENIA,2
FR,BLOOD ALKALINE PHOSPHATASE INCREASED,2
FR,CARDIAC FAILURE,2
FR,CARDIO-RESPIRATORY ARREST,2
FR,CARDIOMYOPATHY,2
FR,CELL DEATH,2
FR,CEREBRAL HAEMORRHAGE,2
FR,CONFUSIONAL STATE,2
FR,DEEP VEIN THROMBOSIS,2
FR,DYSPHONIA,2
FR,ELECTROCARDIOGRAM QT PROLONGED,2
FR,IMMUNE-MEDIATED NECROTISING MYOPATHY,2
FR,INSOMNIA,2
FR,INTENTIONAL PRODUCT MISUSE,2
FR,INTERNATIONAL NORMALISED RATIO INCREASED,2
FR,LACTIC ACIDOSIS,2
FR,LEUKOPENIA,2
FR,LOSS OF CONSCIOUSNESS,2
FR,MULTI-ORGAN FAILURE,2
FR,ORGANISING PNEUMONIA,2
FR,OVERDOSE,2
FR,PARAESTHESIA,2
FR,PHLEBITIS,2
FR,PLEURISY,2
FR,PULMONARY EMBOLISM,2
FR,PURPURA,2
FR,RASH,2
FR,RASH MACULO-PAPULAR,2
FR,RESPIRATORY DISTRESS,2
FR,SEPSIS,2
FR,SEPTIC SHOCK,2
FR,TACHYCARDIA PAROXYSMAL,2
FR,TRANSAMINASES INCREASED,2
FR,VERTIGO,2
FR,ABDOMINAL PAIN UPPER,1
FR,ANAPHYLACTIC SHOCK,1
FR,ANAPHYLACTOID SHOCK,1
FR,ANXIETY,1
FR,ARRHYTHMIA,1
FR,ATRIAL FIBRILLATION,1
FR,ATRIAL FLUTTER,1
FR,ATRIAL TACHYCARDIA,1
FR,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
FR,BALANCE DISORDER,1
FR,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
FR,BLOOD PRESSURE INCREASED,1
FR,BLOOD THYROID STIMULATING HORMONE DECREASED,1
FR,BODY TEMPERATURE DECREASED,1
FR,BRAIN OEDEMA,1
FR,BUNDLE BRANCH BLOCK LEFT,1
FR,CARDIAC AMYLOIDOSIS,1
FR,CARDIAC ARREST,1
FR,CARDIOGENIC SHOCK,1
FR,CEREBRAL HAEMATOMA,1
FR,CEREBRAL ISCHAEMIA,1
FR,CHILLS,1
FR,CHOLELITHIASIS,1
FR,CHROMATURIA,1
FR,CIRCULATORY COLLAPSE,1
FR,CIRRHOSIS ALCOHOLIC,1
FR,CONDITION AGGRAVATED,1
FR,CONGESTIVE CARDIOMYOPATHY,1
FR,CONVULSION,1
FR,CORNEAL LIGHT REFLEX TEST ABNORMAL,1
FR,CORONARY ARTERY THROMBOSIS,1
FR,COUGH,1
FR,CYANOSIS,1
FR,CYSTITIS,1
FR,DECREASED APPETITE,1
FR,DELIRIUM,1
FR,DIARRHOEA INFECTIOUS,1
FR,DIZZINESS,1
FR,DRUG INEFFECTIVE,1
FR,DYSPHAGIA,1
FR,DYSSTASIA,1
FR,DYSURIA,1
FR,ECCHYMOSIS,1
FR,ELECTROCARDIOGRAM ABNORMAL,1
FR,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
FR,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
FR,ENDOCARDITIS STAPHYLOCOCCAL,1
FR,EOSINOPHILIA,1
FR,EPILEPSY,1
FR,ERYTHEMA,1
FR,FACIAL BONES FRACTURE,1
FR,FATIGUE,1
FR,GAIT DISTURBANCE,1
FR,GASTRIC ULCER HAEMORRHAGE,1
FR,GASTRODUODENAL ULCER,1
FR,GASTROINTESTINAL DISORDER,1
FR,GASTROINTESTINAL HAEMORRHAGE,1
FR,GENERAL PHYSICAL HEALTH DETERIORATION,1
FR,HAEMATURIA,1
FR,HAEMOGLOBIN DECREASED,1
FR,HAEMOLYTIC ANAEMIA,1
FR,HAEMORRHAGIC ANAEMIA,1
FR,HALLUCINATION,1
FR,HALLUCINATION_ AUDITORY,1
FR,HALLUCINATION_ VISUAL,1
FR,HEAD INJURY,1
FR,HEMIPARESIS,1
FR,HEPATIC STEATOSIS,1
FR,HOT FLUSH,1
FR,HYPERCALCAEMIA,1
FR,HYPERSENSITIVITY VASCULITIS,1
FR,HYPERTHERMIA,1
FR,HYPERVENTILATION,1
FR,HYPOCALCAEMIA,1
FR,HYPOGLYCAEMIA,1
FR,HYPOTENSION,1
FR,HYPOTHERMIA,1
FR,HYPOTHYROIDISM,1
FR,HYPOVENTILATION,1
FR,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
FR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
FR,IMPAIRED HEALING,1
FR,INFECTIVE MYOSITIS,1
FR,INFUSION RELATED REACTION,1
FR,INVASIVE DUCTAL BREAST CARCINOMA,1
FR,ISCHAEMIC STROKE,1
FR,JUGULAR VEIN THROMBOSIS,1
FR,LARYNGEAL DISCOMFORT,1
FR,LARYNGEAL DYSPNOEA,1
FR,LUMBAR SPINAL STENOSIS,1
FR,LUNG DISORDER,1
FR,LUNG INFECTION,1
FR,LYMPHADENOPATHY,1
FR,LYMPHOPENIA,1
FR,MACROCYTOSIS,1
FR,MICROCYTIC ANAEMIA,1
FR,MONARTHRITIS,1
FR,MOTOR DYSFUNCTION,1
FR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
FR,MUSCULAR WEAKNESS,1
FR,MYDRIASIS,1
FR,MYELODYSPLASTIC SYNDROME,1
FR,NAUSEA,1
FR,NECROSIS,1
FR,NECROTISING MYOSITIS,1
FR,NEOPLASM MALIGNANT,1
FR,NEPHROLITHIASIS,1
FR,NEUTROPENIA,1
FR,NIGHT SWEATS,1
FR,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
FR,NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL ABNORMAL,1
FR,OLIGURIA,1
FR,OPHTHALMIC HERPES ZOSTER,1
FR,ORAL LICHEN PLANUS,1
FR,ORTHOSTATIC HYPOTENSION,1
FR,OSTEOARTHRITIS,1
FR,PACKED RED BLOOD CELL TRANSFUSION,1
FR,PALLOR,1
FR,PANCREATIC NEOPLASM,1
FR,PAPILLOEDEMA,1
FR,PARAPARESIS,1
FR,PASTEURELLA INFECTION,1
FR,PEMPHIGOID,1
FR,PETECHIAE,1
FR,PHOTOSENSITIVITY REACTION,1
FR,PNEUMONIA,1
FR,POLYCYTHAEMIA,1
FR,POLYURIA,1
FR,POST PROCEDURAL INFECTION,1
FR,PROCEDURAL HAEMORRHAGE,1
FR,PROTHROMBIN TIME RATIO DECREASED,1
FR,PSEUDOMONAL SEPSIS,1
FR,PSORIASIS,1
FR,PUPILS UNEQUAL,1
FR,PYELONEPHRITIS ACUTE,1
FR,RASH GENERALISED,1
FR,RENAL IMPAIRMENT,1
FR,RENAL PAIN,1
FR,RENAL TUBULAR DISORDER,1
FR,RENAL TUBULAR NECROSIS,1
FR,RESPIRATORY FAILURE,1
FR,RESPIRATORY TRACT INFECTION VIRAL,1
FR,SALIVARY HYPERSECRETION,1
FR,SHOCK,1
FR,SKELETAL INJURY,1
FR,SPLENOMEGALY,1
FR,SQUAMOUS CELL CARCINOMA,1
FR,SUBDURAL HAEMATOMA,1
FR,SUBDURAL HAEMORRHAGE,1
FR,SUFFOCATION FEELING,1
FR,SUICIDE ATTEMPT,1
FR,SUPERINFECTION,1
FR,SYNCOPE,1
FR,SYSTEMIC LUPUS ERYTHEMATOSUS,1
FR,TACHYCARDIA,1
FR,TENDON PAIN,1
FR,TENDONITIS,1
FR,THROMBOSIS IN DEVICE,1
FR,TONGUE OEDEMA,1
FR,TOXIC ENCEPHALOPATHY,1
FR,TOXIC SKIN ERUPTION,1
FR,TRANSIENT ISCHAEMIC ATTACK,1
FR,TREMOR,1
FR,TYPE I HYPERSENSITIVITY,1
FR,URTICARIA,1
FR,VENTRICULAR EXTRASYSTOLES,1
FR,VENTRICULAR TACHYCARDIA,1
FR,VISUAL ACUITY REDUCED,1
FR,VITAMIN B12 DEFICIENCY,1
FR,VITREOUS HAEMORRHAGE,1
FR,VOGT-KOYANAGI-HARADA SYNDROME,1
FR,VOMITING,1
DE,MYALGIA,18
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,9
DE,ANGINA PECTORIS,8
DE,DYSPNOEA,8
DE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,7
DE,MYOPATHY,6
DE,ARTHRALGIA,5
DE,DEPRESSION,4
DE,DIARRHOEA,4
DE,DIZZINESS,4
DE,MUSCLE SPASMS,4
DE,MUSCULAR WEAKNESS,4
DE,MUSCULOSKELETAL DISCOMFORT,4
DE,PARAESTHESIA,4
DE,POLYNEUROPATHY,4
DE,ABASIA,3
DE,GENERAL PHYSICAL HEALTH DETERIORATION,3
DE,HEPATIC ENZYME INCREASED,3
DE,HYPOAESTHESIA,3
DE,MALAISE,3
DE,NAUSEA,3
DE,TENDON RUPTURE,3
DE,TRANSAMINASES INCREASED,3
DE,ABDOMINAL DISTENSION,2
DE,ABDOMINAL PAIN,2
DE,ACUTE HEPATIC FAILURE,2
DE,ASPARTATE AMINOTRANSFERASE INCREASED,2
DE,BACK PAIN,2
DE,C-REACTIVE PROTEIN INCREASED,2
DE,CONDITION AGGRAVATED,2
DE,DEHYDRATION,2
DE,GASTROINTESTINAL DISORDER,2
DE,GLYCOGEN STORAGE DISEASE TYPE V,2
DE,HEADACHE,2
DE,IMPAIRED HEALING,2
DE,LIVER FUNCTION TEST ABNORMAL,2
DE,LIVER INJURY,2
DE,MUSCLE DISORDER,2
DE,NEUROPATHY PERIPHERAL,2
DE,PALPITATIONS,2
DE,RHABDOMYOLYSIS,2
DE,SLEEP DISORDER,2
DE,TENDON PAIN,2
DE,ABDOMINAL PAIN UPPER,1
DE,ABNORMAL LOSS OF WEIGHT,1
DE,ACTINIC KERATOSIS,1
DE,ALANINE AMINOTRANSFERASE INCREASED,1
DE,ALVEOLITIS,1
DE,AMNESIA,1
DE,ANAEMIA,1
DE,ANTICONVULSANT DRUG LEVEL DECREASED,1
DE,APATHY,1
DE,APHASIA,1
DE,ASTHENIA,1
DE,ATRIAL FIBRILLATION,1
DE,ATYPICAL PNEUMONIA,1
DE,AUTOIMMUNE HEPATITIS,1
DE,BALANCE DISORDER,1
DE,BASAL CELL CARCINOMA,1
DE,BILIARY CIRRHOSIS PRIMARY,1
DE,BLOOD CREATINE INCREASED,1
DE,BLOOD GLUCOSE INCREASED,1
DE,BLOOD PRESSURE FLUCTUATION,1
DE,BLOOD PRESSURE INCREASED,1
DE,BONE PAIN,1
DE,BRADYCARDIA,1
DE,CARDIAC DISCOMFORT,1
DE,CAROTID ARTERY STENOSIS,1
DE,CEREBRAL HAEMORRHAGE,1
DE,CEREBROVASCULAR ACCIDENT,1
DE,CHEST PAIN,1
DE,CHOLANGIOLITIS,1
DE,CHOLESTASIS,1
DE,CHROMATURIA,1
DE,CHRONIC HEPATITIS,1
DE,COGNITIVE DISORDER,1
DE,COMPULSIONS,1
DE,CONSTIPATION,1
DE,CONVULSION,1
DE,DEAFNESS UNILATERAL,1
DE,DEATH,1
DE,DECREASED APPETITE,1
DE,DELIRIUM,1
DE,DERMATOMYOSITIS,1
DE,DIABETES MELLITUS,1
DE,DIVERTICULITIS,1
DE,DIZZINESS POSTURAL,1
DE,DRUG INTOLERANCE,1
DE,DRUG-INDUCED LIVER INJURY,1
DE,DYSARTHRIA,1
DE,DYSPEPSIA,1
DE,DYSPNOEA AT REST,1
DE,EAR DISORDER,1
DE,ERYTHROSIS,1
DE,FAECES PALE,1
DE,FATIGUE,1
DE,FEELING ABNORMAL,1
DE,GAIT DISTURBANCE,1
DE,GENERALISED TONIC-CLONIC SEIZURE,1
DE,HAEMOLYSIS,1
DE,HEAD DISCOMFORT,1
DE,HEARING IMPAIRED,1
DE,HEMIPARESIS,1
DE,HEPATIC CIRRHOSIS,1
DE,HEPATIC FIBROSIS,1
DE,HEPATIC NECROSIS,1
DE,HEPATITIS ACUTE,1
DE,HYPERHIDROSIS,1
DE,HYPERSENSITIVITY VASCULITIS,1
DE,IMMUNE-MEDIATED NECROTISING MYOPATHY,1
DE,IMPAIRED DRIVING ABILITY,1
DE,INFLUENZA LIKE ILLNESS,1
DE,INTERNATIONAL NORMALISED RATIO FLUCTUATION,1
DE,INTERSTITIAL LUNG DISEASE,1
DE,INTESTINAL OBSTRUCTION,1
DE,JAUNDICE,1
DE,JOINT STIFFNESS,1
DE,LIVER DISORDER,1
DE,MEMORY IMPAIRMENT,1
DE,MOOD ALTERED,1
DE,MOVEMENT DISORDER,1
DE,MUSCLE ATROPHY,1
DE,MUSCLE CONTRACTURE,1
DE,MUSCLE RUPTURE,1
DE,MYOGLOBIN BLOOD INCREASED,1
DE,NASAL ULCER,1
DE,NEOPLASM PROGRESSION,1
DE,OVERDOSE,1
DE,PAIN,1
DE,PAIN IN EXTREMITY,1
DE,PANCREATIC ENZYMES INCREASED,1
DE,PANCREATITIS,1
DE,PERONEAL NERVE PALSY,1
DE,PRESYNCOPE,1
DE,PRODUCT USE ISSUE,1
DE,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
DE,RASH,1
DE,RAYNAUD^S PHENOMENON,1
DE,RENAL FAILURE ACUTE,1
DE,RHEUMATOID ARTHRITIS,1
DE,SECONDARY AMYLOIDOSIS,1
DE,SKIN ATROPHY,1
DE,SKIN FISSURES,1
DE,SLEEP APNOEA SYNDROME,1
DE,SNORING,1
DE,SOMNOLENCE,1
DE,STATUS EPILEPTICUS,1
DE,SYSTEMIC LUPUS ERYTHEMATOSUS,1
DE,TENDON DISORDER,1
DE,TENDONITIS,1
DE,TESTICULAR ATROPHY,1
DE,TESTICULAR PAIN,1
DE,TRANSIENT GLOBAL AMNESIA,1
DE,TUMOUR MARKER INCREASED,1
DE,VERTIGO,1
DE,VERTIGO POSITIONAL,1
DE,VOMITING,1
DE,WALKING DISABILITY,1
DE,WOUND,1
GR,MYALGIA,12
GR,ASTHENIA,10
GR,DRUG INTOLERANCE,6
GR,DIARRHOEA,5
GR,HAEMATOCRIT DECREASED,5
GR,PAIN,5
GR,BLOOD CREATINE PHOSPHOKINASE INCREASED,4
GR,DRUG INEFFECTIVE,4
GR,ERYTHEMA,4
GR,ILEUS,4
GR,NAUSEA,4
GR,PLATELET COUNT DECREASED,4
GR,ABDOMINAL PAIN,3
GR,ACUTE MYELOMONOCYTIC LEUKAEMIA,3
GR,ALANINE AMINOTRANSFERASE INCREASED,3
GR,ARRHYTHMIA,3
GR,ARTHRITIS,3
GR,BLOOD GLUCOSE INCREASED,3
GR,CARDIAC DISORDER,3
GR,CHOLESTASIS,3
GR,DYSPNOEA,3
GR,FALL,3
GR,HAEMATOMA,3
GR,HYPOTENSION,3
GR,INTENTIONAL PRODUCT MISUSE,3
GR,MUSCULAR WEAKNESS,3
GR,OEDEMA,3
GR,PAIN IN EXTREMITY,3
GR,PANCYTOPENIA,3
GR,PRURITUS,3
GR,RHABDOMYOLYSIS,3
GR,SYNCOPE,3
GR,URINARY TRACT INFECTION,3
GR,VOMITING,3
GR,WHITE BLOOD CELL COUNT DECREASED,3
GR,ABDOMINAL DISCOMFORT,2
GR,ABDOMINAL DISTENSION,2
GR,ALOPECIA,2
GR,AMNESIA,2
GR,ANGIOPLASTY,2
GR,ATRIAL FIBRILLATION,2
GR,B-CELL LYMPHOMA,2
GR,BACK DISORDER,2
GR,BACK PAIN,2
GR,BLOOD BILIRUBIN INCREASED,2
GR,BLOOD PRESSURE INCREASED,2
GR,BLOOD THYROID STIMULATING HORMONE INCREASED,2
GR,CHOLECYSTITIS,2
GR,CONDITION AGGRAVATED,2
GR,CONSTIPATION,2
GR,DEATH,2
GR,DIZZINESS,2
GR,FATIGUE,2
GR,FLATULENCE,2
GR,GASTRIC HAEMORRHAGE,2
GR,HAEMATEMESIS,2
GR,HAEMATURIA,2
GR,HEADACHE,2
GR,HEPATIC ENZYME INCREASED,2
GR,HYPERSENSITIVITY,2
GR,LEUKOPENIA,2
GR,LOSS OF CONSCIOUSNESS,2
GR,MUSCULOSKELETAL STIFFNESS,2
GR,MYELODYSPLASTIC SYNDROME,2
GR,MYOCARDIAL INFARCTION,2
GR,MYOSITIS,2
GR,OEDEMA PERIPHERAL,2
GR,PANCREATITIS,2
GR,PSORIASIS,2
GR,SCIATICA,2
GR,TENDONITIS,2
GR,WHEEZING,2
GR,ABASIA,1
GR,ACUTE KIDNEY INJURY,1
GR,AGEUSIA,1
GR,ALBUMIN CSF INCREASED,1
GR,ALPHA-2 MACROGLOBULIN INCREASED,1
GR,ANAEMIA,1
GR,AORTIC ANEURYSM RUPTURE,1
GR,AORTIC DILATATION,1
GR,AORTIC VALVE INCOMPETENCE,1
GR,APNOEA,1
GR,ARTERIAL STENOSIS,1
GR,ARTHRALGIA,1
GR,ASPARTATE AMINOTRANSFERASE INCREASED,1
GR,ATRIAL THROMBOSIS,1
GR,BENIGN PROSTATIC HYPERPLASIA,1
GR,BILIARY TRACT DISORDER,1
GR,BLEPHARITIS,1
GR,BLINDNESS,1
GR,BLISTER,1
GR,BLOOD CREATININE INCREASED,1
GR,BLOOD UREA INCREASED,1
GR,BRAIN NEOPLASM MALIGNANT,1
GR,BRONCHITIS,1
GR,CARCINOID TUMOUR OF THE DUODENUM,1
GR,CARDIAC FAILURE,1
GR,CARDIAC FAILURE ACUTE,1
GR,CARDIAC FLUTTER,1
GR,CARDIOGENIC SHOCK,1
GR,CATARACT,1
GR,CEREBROVASCULAR ACCIDENT,1
GR,CHEST PAIN,1
GR,CHOKING,1
GR,CHRONIC KIDNEY DISEASE,1
GR,CONFUSIONAL STATE,1
GR,CONTUSION,1
GR,COUGH,1
GR,CSF IMMUNOGLOBULIN INCREASED,1
GR,DEPRESSION,1
GR,DERMATITIS,1
GR,DEVICE MATERIAL ISSUE,1
GR,DIARRHOEA HAEMORRHAGIC,1
GR,DISCOMFORT,1
GR,DIVERTICULITIS,1
GR,DIVERTICULUM INTESTINAL,1
GR,DRUG ERUPTION,1
GR,DRUG HYPERSENSITIVITY,1
GR,DRUG-INDUCED LIVER INJURY,1
GR,DRY SKIN,1
GR,DUODENAL ULCER,1
GR,ELECTROLYTE DEPLETION,1
GR,ENZYME LEVEL INCREASED,1
GR,EPILEPSY,1
GR,EXFOLIATIVE RASH,1
GR,EYE DISORDER,1
GR,EYE IRRITATION,1
GR,FACIAL PARESIS,1
GR,FEBRILE NEUTROPENIA,1
GR,FLUSHING,1
GR,FOOD INTERACTION,1
GR,FUCHS^ SYNDROME,1
GR,GAIT DISTURBANCE,1
GR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
GR,GASTROINTESTINAL DISORDER,1
GR,GASTROOESOPHAGEAL REFLUX DISEASE,1
GR,GENERAL PHYSICAL HEALTH DETERIORATION,1
GR,GLOMERULONEPHRITIS,1
GR,GOITRE,1
GR,HAEMATOCHEZIA,1
GR,HAEMOPTYSIS,1
GR,HAEMORRHAGE,1
GR,HELICOBACTER INFECTION,1
GR,HEPATIC FAILURE,1
GR,HEPATOTOXICITY,1
GR,HERPES SIMPLEX,1
GR,HERPES VIRUS INFECTION,1
GR,HERPES ZOSTER,1
GR,HIP ARTHROPLASTY,1
GR,HIP FRACTURE,1
GR,HYPERHIDROSIS,1
GR,HYPERKALAEMIA,1
GR,HYPERTENSION,1
GR,HYPERTRANSAMINASAEMIA,1
GR,HYPOACUSIS,1
GR,HYPOAESTHESIA,1
GR,HYPOAESTHESIA ORAL,1
GR,HYPOGLYCAEMIA,1
GR,HYPOGLYCAEMIC COMA,1
GR,HYPOTHERMIA,1
GR,HYPOTHYROIDISM,1
GR,IDIOPATHIC PULMONARY FIBROSIS,1
GR,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
GR,IMMUNE-MEDIATED NECROTISING MYOPATHY,1
GR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
GR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
GR,INFECTION,1
GR,INFLUENZA LIKE ILLNESS,1
GR,INSOMNIA,1
GR,INTERSTITIAL LUNG DISEASE,1
GR,INTERVERTEBRAL DISC PROTRUSION,1
GR,JOINT DISLOCATION,1
GR,LARGE INTESTINE POLYP,1
GR,LEFT ATRIAL DILATATION,1
GR,LETHARGY,1
GR,LEUKOCYTOSIS,1
GR,LICHEN PLANUS,1
GR,LIP DRY,1
GR,LIP HAEMORRHAGE,1
GR,LIP OEDEMA,1
GR,LIP PAIN,1
GR,LYMPHOCYTOSIS,1
GR,MACULAR DEGENERATION,1
GR,MALAISE,1
GR,MELAENA,1
GR,MENISCUS INJURY,1
GR,MITRAL VALVE INCOMPETENCE,1
GR,MONOCYTOSIS,1
GR,MOTOR DYSFUNCTION,1
GR,MOVEMENT DISORDER,1
GR,MYELODYSPLASTIC SYNDROME TRANSFORMATION,1
GR,MYOPATHY,1
GR,NEPHROTIC SYNDROME,1
GR,NEURALGIA,1
GR,OCCULT BLOOD POSITIVE,1
GR,OROPHARYNGEAL PAIN,1
GR,OSTEONECROSIS OF JAW,1
GR,OVARIAN CYST,1
GR,PANCREATIC MASS,1
GR,PARALYSIS,1
GR,PERIORBITAL OEDEMA,1
GR,PHARYNGEAL OEDEMA,1
GR,PLATELET COUNT INCREASED,1
GR,PNEUMONIA VIRAL,1
GR,POLYNEUROPATHY,1
GR,POLYPECTOMY,1
GR,PRODUCT USE ISSUE,1
GR,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
GR,PROTEIN TOTAL INCREASED,1
GR,PRURITUS GENERALISED,1
GR,PULMONARY HAEMORRHAGE,1
GR,PULMONARY HYPERTENSION,1
GR,PURPURA,1
GR,RASH GENERALISED,1
GR,RASH MACULO-PAPULAR,1
GR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
GR,RENAL FAILURE ACUTE,1
GR,RENAL IMPAIRMENT,1
GR,RESPIRATORY DISORDER,1
GR,RESPIRATORY TRACT INFECTION,1
GR,RESTLESSNESS,1
GR,RHINORRHOEA,1
GR,ROAD TRAFFIC ACCIDENT,1
GR,SERUM FERRITIN DECREASED,1
GR,SKIN HYPERPIGMENTATION,1
GR,SPEECH DISORDER,1
GR,SPINAL PAIN,1
GR,STRESS,1
GR,SUICIDAL IDEATION,1
GR,TACHYCARDIA,1
GR,THROAT IRRITATION,1
GR,THROMBOCYTOPENIA,1
GR,TINNITUS,1
GR,TRANSAMINASES ABNORMAL,1
GR,TRANSAMINASES INCREASED,1
GR,TRANSIENT ISCHAEMIC ATTACK,1
GR,TREMOR,1
GR,UPPER GASTROINTESTINAL HAEMORRHAGE,1
GR,URTICARIA,1
GR,VENTRICULAR HYPERTROPHY,1
GR,VERTIGO,1
GR,VIRAL INFECTION,1
GR,VISUAL ACUITY REDUCED,1
GR,VULVOVAGINITIS TRICHOMONAL,1
GR,WEIGHT DECREASED,1
GR,WEIGHT INCREASED,1
GR,WHITE BLOOD CELL COUNT INCREASED,1
GT,PAIN,2
GT,ACNE,1
GT,ALANINE AMINOTRANSFERASE INCREASED,1
GT,ANXIETY,1
GT,ASPARTATE AMINOTRANSFERASE INCREASED,1
GT,ASTHENIA,1
GT,BONE DISORDER,1
GT,BRAIN NATRIURETIC PEPTIDE INCREASED,1
GT,BURNING SENSATION,1
GT,CARDIAC FIBRILLATION,1
GT,CEREBROVASCULAR ACCIDENT,1
GT,CHEST DISCOMFORT,1
GT,COGNITIVE DISORDER,1
GT,CONFUSIONAL STATE,1
GT,CONSTIPATION,1
GT,COUGH,1
GT,DEATH,1
GT,DENGUE FEVER,1
GT,DEPRESSION,1
GT,DIZZINESS,1
GT,DYSPNOEA,1
GT,DYSURIA,1
GT,EJECTION FRACTION DECREASED,1
GT,FATIGUE,1
GT,FEELING HOT,1
GT,GASTROINTESTINAL DISORDER,1
GT,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
GT,HEADACHE,1
GT,HYPOAESTHESIA,1
GT,INSOMNIA,1
GT,LIVER FUNCTION TEST ABNORMAL,1
GT,LUNG DISORDER,1
GT,LYMPHOCYTE COUNT DECREASED,1
GT,MEMORY IMPAIRMENT,1
GT,MULTIPLE SCLEROSIS RELAPSE,1
GT,MUSCULAR WEAKNESS,1
GT,MUSCULOSKELETAL PAIN,1
GT,NERVOUS SYSTEM DISORDER,1
GT,PARAESTHESIA,1
GT,PELVIC PAIN,1
GT,PERIPHERAL SWELLING,1
GT,RETINAL DETACHMENT,1
GT,THROAT TIGHTNESS,1
GT,VISUAL ACUITY REDUCED,1
HN,DEATH,6
HN,CEREBROVASCULAR ACCIDENT,2
HN,ABASIA,1
HN,ANEURYSM,1
HN,APPENDICITIS,1
HN,BALANCE DISORDER,1
HN,BLOOD CHOLESTEROL DECREASED,1
HN,CARDIAC DISORDER,1
HN,CARDIAC FAILURE CHRONIC,1
HN,CARDIO-RESPIRATORY ARREST,1
HN,DIZZINESS,1
HN,DYSPNOEA EXERTIONAL,1
HN,FALL,1
HN,FATIGUE,1
HN,GENERALISED OEDEMA,1
HN,GLUCOSE TOLERANCE IMPAIRED,1
HN,GOITRE,1
HN,HYPOTHYROIDISM,1
HN,LIMB DISCOMFORT,1
HN,LIVER DISORDER,1
HN,MENTAL DISORDER,1
HN,MUSCULAR WEAKNESS,1
HN,MYOCARDIAL INFARCTION,1
HN,NONSPECIFIC REACTION,1
HN,OEDEMA PERIPHERAL,1
HN,ORTHOPNOEA,1
HN,SCIATICA,1
HN,SEPTIC SHOCK,1
HN,WEIGHT INCREASED,1
HK,DEATH,73
HK,CARDIAC DISORDER,4
HK,APLASIA PURE RED CELL,2
HK,DIZZINESS,2
HK,ABDOMINAL DISTENSION,1
HK,ACOUSTIC NEUROMA,1
HK,ANGIOPATHY,1
HK,ARTHRALGIA,1
HK,ARTHRITIS,1
HK,BLOOD GLUCOSE DECREASED,1
HK,CARDIAC FAILURE,1
HK,CARDIOVASCULAR DISORDER,1
HK,CONSTIPATION,1
HK,DEAFNESS,1
HK,DIABETES MELLITUS,1
HK,FATIGUE,1
HK,HAEMORRHOIDAL HAEMORRHAGE,1
HK,HERPES ZOSTER,1
HK,HYPOAESTHESIA,1
HK,INSOMNIA,1
HK,LOW DENSITY LIPOPROTEIN INCREASED,1
HK,MUSCULOSKELETAL STIFFNESS,1
HK,MYOPATHY,1
HK,NAUSEA,1
HK,OSTEOPOROSIS,1
HK,PAIN IN EXTREMITY,1
HK,PRURITUS,1
HK,RENAL IMPAIRMENT,1
HK,RHEUMATOID ARTHRITIS,1
HK,SKIN DISCOLOURATION,1
HK,SUDDEN DEATH,1
HU,DEATH,4
HU,DYSPNOEA,4
HU,MALAISE,2
HU,ABDOMINAL PAIN UPPER,1
HU,BREAST CANCER,1
HU,DIZZINESS,1
HU,HAEMORRHAGIC STROKE,1
HU,HEADACHE,1
HU,HEPATIC ENZYME INCREASED,1
HU,HYPERGLYCAEMIA,1
HU,HYPERTENSION,1
HU,IMMUNE-MEDIATED NECROTISING MYOPATHY,1
HU,LISTLESS,1
HU,LYMPHADENOPATHY MEDIASTINAL,1
HU,MALIGNANT NEOPLASM PROGRESSION,1
HU,MALIGNANT PLEURAL EFFUSION,1
HU,MUCOSAL INFLAMMATION,1
HU,MYOSITIS,1
HU,OEDEMA PERIPHERAL,1
HU,ORTHOSTATIC HYPOTENSION,1
HU,PANCREATIC CARCINOMA METASTATIC,1
HU,RENAL FAILURE ACUTE,1
HU,RENAL IMPAIRMENT,1
HU,RHABDOMYOLYSIS,1
HU,TREATMENT NONCOMPLIANCE,1
IS,JAUNDICE,4
IS,DRUG-INDUCED LIVER INJURY,2
IS,CHROMATURIA,1
IS,HEPATIC ENZYME INCREASED,1
IS,HEPATITIS ACUTE,1
IN,RHABDOMYOLYSIS,6
IN,TUBULOINTERSTITIAL NEPHRITIS,2
IN,ACUTE KIDNEY INJURY,1
IN,ANGINA PECTORIS,1
IN,ASTHENIA,1
IN,ATRIAL FIBRILLATION,1
IN,CELLULITIS,1
IN,CHEST PAIN,1
IN,COMPARTMENT SYNDROME,1
IN,CONDITION AGGRAVATED,1
IN,CONSTIPATION,1
IN,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IN,DIABETIC NEPHROPATHY,1
IN,DIZZINESS,1
IN,DYSPNOEA EXERTIONAL,1
IN,GAIT DISTURBANCE,1
IN,HAEMODIALYSIS,1
IN,HEMIPARESIS,1
IN,HYPERTENSION,1
IN,HYPOKALAEMIA,1
IN,HYPOTHYROIDISM,1
IN,INTERCAPILLARY GLOMERULOSCLEROSIS,1
IN,KIDNEY FIBROSIS,1
IN,MUSCLE NECROSIS,1
IN,MUSCLE RIGIDITY,1
IN,MUSCLE TIGHTNESS,1
IN,MYOGLOBINURIA,1
IN,MYOSITIS,1
IN,OEDEMA,1
IN,OEDEMA PERIPHERAL,1
IN,OLIGURIA,1
IN,PAIN,1
IN,PAIN IN EXTREMITY,1
IN,PERONEAL NERVE PALSY,1
IN,PSORIASIS,1
IN,PULMONARY HYPERTENSION,1
IN,RENAL ARTERY ARTERIOSCLEROSIS,1
IN,RENAL FAILURE ACUTE,1
IN,RENAL TUBULAR ATROPHY,1
IN,RENAL TUBULAR DISORDER,1
IN,SLEEP APNOEA SYNDROME,1
IN,TACHYCARDIA,1
IN,TACHYPNOEA,1
IN,TRANSPLANT REJECTION,1
ID,ABASIA,1
ID,ASTHENIA,1
ID,BRADYCARDIA,1
ID,CHEST DISCOMFORT,1
ID,CHEST PAIN,1
ID,DIARRHOEA,1
ID,DYSPNOEA,1
ID,FALL,1
ID,HYPERHIDROSIS,1
ID,NAUSEA,1
ID,PAIN,1
ID,PNEUMONIA,1
ID,SEPSIS,1
ID,THROMBOCYTOPENIA,1
ID,URINARY RETENTION,1
ID,VENTRICULAR TACHYCARDIA,1
ID,VOMITING,1
IR,HAEMOLYTIC ANAEMIA,1
IR,OEDEMA PERIPHERAL,1
IE,DEATH,30
IE,FALL,15
IE,LOWER RESPIRATORY TRACT INFECTION,15
IE,DIARRHOEA,14
IE,DYSPNOEA,12
IE,FATIGUE,11
IE,MALAISE,11
IE,DIZZINESS,10
IE,NAUSEA,10
IE,ASTHENIA,8
IE,COUGH,8
IE,PRODUCT USE ISSUE,8
IE,CHEST PAIN,7
IE,PAIN,7
IE,PAIN IN EXTREMITY,7
IE,VOMITING,7
IE,ARTHRALGIA,6
IE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,6
IE,CONFUSIONAL STATE,6
IE,PARAESTHESIA,6
IE,RASH,6
IE,WEIGHT DECREASED,6
IE,ABDOMINAL PAIN,5
IE,BACK PAIN,5
IE,BLOOD GLUCOSE INCREASED,5
IE,HEADACHE,5
IE,HYPOAESTHESIA,5
IE,MUSCULOSKELETAL PAIN,5
IE,MUSCULOSKELETAL STIFFNESS,5
IE,PALPITATIONS,5
IE,SEPSIS,5
IE,C-REACTIVE PROTEIN INCREASED,4
IE,CARDIAC FAILURE,4
IE,DIABETES MELLITUS,4
IE,DRUG INEFFECTIVE,4
IE,DYSPHAGIA,4
IE,ERYTHEMA,4
IE,INFECTION,4
IE,INSOMNIA,4
IE,LETHARGY,4
IE,PLATELET COUNT DECREASED,4
IE,PNEUMONIA,4
IE,PRURITUS,4
IE,RENAL IMPAIRMENT,4
IE,SWELLING,4
IE,SYNCOPE,4
IE,WHEEZING,4
IE,WHITE BLOOD CELL COUNT DECREASED,4
IE,WHITE BLOOD CELL COUNT INCREASED,4
IE,ABDOMINAL DISTENSION,3
IE,ABDOMINAL PAIN UPPER,3
IE,ACUTE MYOCARDIAL INFARCTION,3
IE,AMNESIA,3
IE,ATRIAL FIBRILLATION,3
IE,CHEST DISCOMFORT,3
IE,CHOKING,3
IE,CORONARY ARTERY DISEASE,3
IE,DEHYDRATION,3
IE,DYSKINESIA,3
IE,GASTROINTESTINAL HAEMORRHAGE,3
IE,HAEMOGLOBIN DECREASED,3
IE,HEAD INJURY,3
IE,HIP FRACTURE,3
IE,HYPERHIDROSIS,3
IE,HYPERSENSITIVITY,3
IE,HYPOTENSION,3
IE,INFLUENZA,3
IE,JAUNDICE,3
IE,KIDNEY INFECTION,3
IE,LUNG NEOPLASM MALIGNANT,3
IE,MOBILITY DECREASED,3
IE,MYALGIA,3
IE,MYOCARDIAL INFARCTION,3
IE,NEUTROPHIL COUNT INCREASED,3
IE,OEDEMA PERIPHERAL,3
IE,PARKINSON^S DISEASE,3
IE,PRODUCTIVE COUGH,3
IE,RENAL FAILURE ACUTE,3
IE,RESPIRATORY TRACT INFECTION,3
IE,RHABDOMYOLYSIS,3
IE,RHEUMATOID ARTHRITIS,3
IE,SOMNOLENCE,3
IE,SWELLING FACE,3
IE,TRANSIENT ISCHAEMIC ATTACK,3
IE,TREMOR,3
IE,UNRESPONSIVE TO STIMULI,3
IE,ABDOMINAL DISCOMFORT,2
IE,ABDOMINAL PAIN LOWER,2
IE,ACUTE HEPATIC FAILURE,2
IE,ACUTE KIDNEY INJURY,2
IE,ALANINE AMINOTRANSFERASE INCREASED,2
IE,ANAEMIA,2
IE,ANAPHYLACTIC REACTION,2
IE,ANXIETY,2
IE,AORTIC ANEURYSM,2
IE,ARTERIOSCLEROSIS CORONARY ARTERY,2
IE,BLOOD ALKALINE PHOSPHATASE INCREASED,2
IE,BLOOD UREA INCREASED,2
IE,BURNING SENSATION,2
IE,CELLULITIS,2
IE,CHRONIC LYMPHOCYTIC LEUKAEMIA,2
IE,COGNITIVE DISORDER,2
IE,CONSTIPATION,2
IE,DECREASED APPETITE,2
IE,DELIRIUM,2
IE,DEPRESSED MOOD,2
IE,DIET NONCOMPLIANCE,2
IE,DRUG PRESCRIBING ERROR,2
IE,DYSPEPSIA,2
IE,DYSPHEMIA,2
IE,ERECTILE DYSFUNCTION,2
IE,EYE PAIN,2
IE,EYE SWELLING,2
IE,FEELING ABNORMAL,2
IE,FLUSHING,2
IE,GASTRITIS,2
IE,HAEMOGLOBIN ABNORMAL,2
IE,HAEMORRHAGE INTRACRANIAL,2
IE,HALLUCINATION,2
IE,HIATUS HERNIA,2
IE,HOSPITALISATION,2
IE,HUMERUS FRACTURE,2
IE,HYPOGLYCAEMIA,2
IE,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,2
IE,INVESTIGATION,2
IE,LIVER FUNCTION TEST ABNORMAL,2
IE,LUNG DISORDER,2
IE,LYMPHOCYTE COUNT DECREASED,2
IE,MELAENA,2
IE,MUSCLE ATROPHY,2
IE,NASOPHARYNGITIS,2
IE,NIGHTMARE,2
IE,OESOPHAGEAL FOOD IMPACTION,2
IE,ON AND OFF PHENOMENON,2
IE,OROPHARYNGEAL PAIN,2
IE,OSTEONECROSIS OF JAW,2
IE,PANCREATIC CARCINOMA,2
IE,PARALYSIS,2
IE,PSORIASIS,2
IE,PULMONARY FIBROSIS,2
IE,PULMONARY OEDEMA,2
IE,PYREXIA,2
IE,RECTAL HAEMORRHAGE,2
IE,RENAL FAILURE,2
IE,RESTLESSNESS,2
IE,SKIN ULCER,2
IE,URINARY TRACT INFECTION,2
IE,VENTRICULAR TACHYCARDIA,2
IE,VERTIGO,2
IE,ABDOMINAL TENDERNESS,1
IE,ABNORMAL DREAMS,1
IE,ACIDOSIS,1
IE,ACTIVITIES OF DAILY LIVING IMPAIRED,1
IE,ADRENAL INSUFFICIENCY,1
IE,AGITATION,1
IE,ALTERED STATE OF CONSCIOUSNESS,1
IE,ANGINA PECTORIS,1
IE,ANGIOPATHY,1
IE,ANKLE FRACTURE,1
IE,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
IE,ARTHRITIS,1
IE,ASPHYXIA,1
IE,ATRIAL FLUTTER,1
IE,B-CELL LYMPHOMA,1
IE,BALANOPOSTHITIS,1
IE,BASAL CELL CARCINOMA,1
IE,BLISTER,1
IE,BLOOD BILIRUBIN INCREASED,1
IE,BLOOD CALCIUM DECREASED,1
IE,BLOOD CHOLESTEROL INCREASED,1
IE,BLOOD CREATINE INCREASED,1
IE,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
IE,BLOOD CREATININE INCREASED,1
IE,BLOOD FOLATE INCREASED,1
IE,BLOOD IRON ABNORMAL,1
IE,BLOOD LACTATE DEHYDROGENASE INCREASED,1
IE,BLOOD PARATHYROID HORMONE INCREASED,1
IE,BLOOD PRESSURE INCREASED,1
IE,BLOOD PRESSURE SYSTOLIC INCREASED,1
IE,BLOOD PROLACTIN INCREASED,1
IE,BLOOD THYROID STIMULATING HORMONE INCREASED,1
IE,BODY TEMPERATURE INCREASED,1
IE,BRADYKINESIA,1
IE,BRAIN INJURY,1
IE,BRAIN OEDEMA,1
IE,BRONCHIECTASIS,1
IE,BRONCHOPNEUMONIA,1
IE,CARDIAC ARREST,1
IE,CARDIAC DISORDER,1
IE,CARDIAC FAILURE CONGESTIVE,1
IE,CARDIAC VALVE DISEASE,1
IE,CARDIOMEGALY,1
IE,CAROTID SINUS SYNDROME,1
IE,CENTRAL NERVOUS SYSTEM LESION,1
IE,CEREBRAL HAEMORRHAGE,1
IE,CEREBRAL INFARCTION,1
IE,CEREBROVASCULAR ACCIDENT,1
IE,CERVICAL VERTEBRAL FRACTURE,1
IE,CHEST X-RAY ABNORMAL,1
IE,CHOLECYSTITIS ACUTE,1
IE,CHRONIC SINUSITIS,1
IE,COCCYDYNIA,1
IE,COELIAC DISEASE,1
IE,COLITIS,1
IE,COLITIS ISCHAEMIC,1
IE,COLORECTAL CANCER METASTATIC,1
IE,COMA SCALE ABNORMAL,1
IE,COMPRESSION FRACTURE,1
IE,CONDITION AGGRAVATED,1
IE,CONVULSION,1
IE,CORONARY ARTERY OCCLUSION,1
IE,CRANIOCEREBRAL INJURY,1
IE,CREPITATIONS,1
IE,CRYING,1
IE,CYST,1
IE,DEEP VEIN THROMBOSIS,1
IE,DEMENTIA ALZHEIMER^S TYPE,1
IE,DEPENDENCE,1
IE,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IE,DEPRESSION,1
IE,DERMATITIS INFECTED,1
IE,DEVICE DISLOCATION,1
IE,DEVICE ISSUE,1
IE,DEVICE KINK,1
IE,DISTURBANCE IN ATTENTION,1
IE,DRUG INTOLERANCE,1
IE,DRUG WITHDRAWAL SYNDROME,1
IE,DRUG-DISEASE INTERACTION,1
IE,DRY MOUTH,1
IE,DRY SKIN,1
IE,DYSURIA,1
IE,EAR SWELLING,1
IE,ELECTROCARDIOGRAM QT PROLONGED,1
IE,ENTEROCOCCAL INFECTION,1
IE,EOSINOPHIL COUNT INCREASED,1
IE,FACIAL PAIN,1
IE,FAECAL INCONTINENCE,1
IE,FAECES DISCOLOURED,1
IE,FEAR OF INJECTION,1
IE,FEELING COLD,1
IE,FEMUR FRACTURE,1
IE,FLUID RETENTION,1
IE,FRACTURE DISPLACEMENT,1
IE,FREQUENT BOWEL MOVEMENTS,1
IE,FUNGAL INFECTION,1
IE,GAIT DISTURBANCE,1
IE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
IE,GASTRIC HAEMORRHAGE,1
IE,GASTRIC ULCER,1
IE,GASTROINTESTINAL CANCER METASTATIC,1
IE,GASTROINTESTINAL CARCINOMA,1
IE,GASTROOESOPHAGEAL REFLUX DISEASE,1
IE,GLIOBLASTOMA MULTIFORME,1
IE,GLOMERULAR FILTRATION RATE DECREASED,1
IE,GLUCOSE TOLERANCE IMPAIRED,1
IE,GRAND MAL CONVULSION,1
IE,GROIN PAIN,1
IE,HAEMATOCRIT DECREASED,1
IE,HAEMOPTYSIS,1
IE,HAEMORRHAGE,1
IE,HAEMORRHAGIC STROKE,1
IE,HEART RATE DECREASED,1
IE,HEART RATE INCREASED,1
IE,HEART RATE IRREGULAR,1
IE,HEPATIC ENZYME INCREASED,1
IE,HEPATORENAL SYNDROME,1
IE,HERPES ZOSTER,1
IE,HERPES ZOSTER OTICUS,1
IE,HYPERCALCAEMIA,1
IE,HYPERTENSION,1
IE,HYPERTENSIVE CARDIOMYOPATHY,1
IE,HYPOKALAEMIA,1
IE,HYPONATRAEMIA,1
IE,HYPOPHYSITIS,1
IE,HYPOPITUITARISM,1
IE,HYPOVOLAEMIA,1
IE,HYPOXIA,1
IE,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
IE,IMMUNE-MEDIATED NECROTISING MYOPATHY,1
IE,IMPAIRED HEALING,1
IE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IE,INJECTION SITE ERYTHEMA,1
IE,INJECTION SITE PAIN,1
IE,INJECTION SITE SWELLING,1
IE,INTERNAL HAEMORRHAGE,1
IE,INTERNATIONAL NORMALISED RATIO INCREASED,1
IE,INTERVERTEBRAL DISC DISORDER,1
IE,INTERVERTEBRAL DISC DISPLACEMENT,1
IE,INTESTINAL RESECTION,1
IE,IRON DEFICIENCY ANAEMIA,1
IE,ISCHAEMIC CARDIOMYOPATHY,1
IE,JAUNDICE CHOLESTATIC,1
IE,JOINT DISLOCATION,1
IE,KNEE OPERATION,1
IE,LACERATION,1
IE,LEFT VENTRICULAR DYSFUNCTION,1
IE,LICHENOID KERATOSIS,1
IE,LIMB DISCOMFORT,1
IE,LOCAL SWELLING,1
IE,LOSS OF CONSCIOUSNESS,1
IE,LOWER RESPIRATORY TRACT INFECTION FUNGAL,1
IE,LUNG INFECTION,1
IE,LYMPHADENOPATHY,1
IE,LYMPHADENOPATHY MEDIASTINAL,1
IE,LYMPHOEDEMA,1
IE,MALIGNANT NEOPLASM PROGRESSION,1
IE,MEAN CELL HAEMOGLOBIN DECREASED,1
IE,MEAN CELL VOLUME DECREASED,1
IE,MEAN CELL VOLUME INCREASED,1
IE,MEMORY IMPAIRMENT,1
IE,METASTASES TO ADRENALS,1
IE,METASTASES TO BONE,1
IE,METASTASES TO LIVER,1
IE,METASTASES TO LYMPH NODES,1
IE,METASTATIC NEOPLASM,1
IE,METASTATIC RENAL CELL CARCINOMA,1
IE,MITRAL VALVE INCOMPETENCE,1
IE,MONOCYTE COUNT INCREASED,1
IE,MOVEMENT DISORDER,1
IE,MULTI-ORGAN FAILURE,1
IE,MULTIPLE SCLEROSIS,1
IE,MUSCLE RUPTURE,1
IE,MUSCLE STRAIN,1
IE,MUSCLE TWITCHING,1
IE,MUSCULAR WEAKNESS,1
IE,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
IE,MYOCARDIAL ISCHAEMIA,1
IE,MYOPATHY,1
IE,NAIL DISCOLOURATION,1
IE,NASAL CONGESTION,1
IE,NECK MASS,1
IE,NECK PAIN,1
IE,NECROTISING FASCIITIS,1
IE,NEOPLASM MALIGNANT,1
IE,NEPHROLITHIASIS,1
IE,NEURALGIA,1
IE,NEUROMYOTONIA,1
IE,NEUROPATHY PERIPHERAL,1
IE,NEUTROPENIA,1
IE,NIGHT SWEATS,1
IE,NOCTURIA,1
IE,OBSTRUCTION,1
IE,OCULAR HYPERAEMIA,1
IE,ONYCHOLYSIS,1
IE,ONYCHOMADESIS,1
IE,OPTIC NEURITIS,1
IE,ORAL DISORDER,1
IE,ORAL INFECTION,1
IE,OSTEITIS,1
IE,PAIN IN JAW,1
IE,PAINFUL RESPIRATION,1
IE,PANCREATIC CARCINOMA METASTATIC,1
IE,PANCREATITIS,1
IE,PELVIC FRACTURE,1
IE,PERIPHERAL SWELLING,1
IE,PHOTOPHOBIA,1
IE,PLANTAR FASCIITIS,1
IE,PNEUMONIA ASPIRATION,1
IE,PNEUMONIA VIRAL,1
IE,POLLAKIURIA,1
IE,POOR QUALITY SLEEP,1
IE,POSTOPERATIVE WOUND INFECTION,1
IE,PRESYNCOPE,1
IE,PRODUCT SUBSTITUTION ISSUE,1
IE,PRODUCT USE IN UNAPPROVED INDICATION,1
IE,PROGRESSIVE MULTIPLE SCLEROSIS,1
IE,PROSTATE CANCER,1
IE,PROSTATOMEGALY,1
IE,PROTEIN URINE PRESENT,1
IE,PSORIATIC ARTHROPATHY,1
IE,PULMONARY EMBOLISM,1
IE,PULMONARY HYPERTENSION,1
IE,PULMONARY MASS,1
IE,PULMONARY SEPSIS,1
IE,PUPIL FIXED,1
IE,RALES,1
IE,RED BLOOD CELL COUNT DECREASED,1
IE,RED CELL DISTRIBUTION WIDTH INCREASED,1
IE,RENAL CANCER STAGE III,1
IE,RENAL DISORDER,1
IE,RESPIRATORY ARREST,1
IE,RHEUMATOID FACTOR INCREASED,1
IE,RHEUMATOID NODULE,1
IE,RHINORRHOEA,1
IE,RIB FRACTURE,1
IE,SCAB,1
IE,SCHIZOPHRENIA,1
IE,SCROTAL SWELLING,1
IE,SERUM FERRITIN INCREASED,1
IE,SINUS TACHYCARDIA,1
IE,SINUSITIS,1
IE,SKIN EXFOLIATION,1
IE,SKIN FISSURES,1
IE,SKIN INFECTION,1
IE,SKIN LESION,1
IE,SKULL FRACTURE,1
IE,SLEEP DISORDER,1
IE,SMALL CELL LUNG CANCER METASTATIC,1
IE,SNEEZING,1
IE,SOFT TISSUE INJURY,1
IE,SPEECH DISORDER,1
IE,SQUAMOUS CELL CARCINOMA,1
IE,STRESS,1
IE,SUBARACHNOID HAEMORRHAGE,1
IE,SUBDURAL HAEMORRHAGE,1
IE,SUDDEN DEATH,1
IE,TACHYCARDIA,1
IE,TERMINAL STATE,1
IE,THERAPEUTIC RESPONSE UNEXPECTED,1
IE,THERAPY NON-RESPONDER,1
IE,THROAT CANCER,1
IE,THROMBOCYTOPENIA,1
IE,TINNITUS,1
IE,TONSILLITIS,1
IE,TOOTH ABSCESS,1
IE,TOOTH EXTRACTION,1
IE,UPPER LIMB FRACTURE,1
IE,UPPER RESPIRATORY TRACT INFECTION,1
IE,URINARY INCONTINENCE,1
IE,URINARY TRACT INFECTION STAPHYLOCOCCAL,1
IE,URTICARIA,1
IE,VARICOSE VEIN,1
IE,VASCULAR COMPRESSION,1
IE,VEIN DISORDER,1
IE,VENOUS OCCLUSION,1
IE,VERTEBRAL OSTEOPHYTE,1
IE,VISION BLURRED,1
IE,VISUAL IMPAIRMENT,1
IE,VITAMIN B12 DECREASED,1
IE,VULVAR EROSION,1
IE,WOUND HAEMORRHAGE,1
IE,YAWNING,1
IL,ASTHENIA,20
IL,DIARRHOEA,11
IL,NAUSEA,9
IL,DYSPNOEA,8
IL,FALL,8
IL,VOMITING,8
IL,CHEST PAIN,7
IL,FATIGUE,7
IL,HEADACHE,7
IL,PNEUMONIA,7
IL,ABDOMINAL PAIN,6
IL,ANAEMIA,6
IL,ATRIAL FIBRILLATION,6
IL,HAEMOGLOBIN DECREASED,6
IL,INTERNATIONAL NORMALISED RATIO INCREASED,6
IL,PYREXIA,6
IL,SYNCOPE,6
IL,THROMBOCYTOPENIA,6
IL,CONFUSIONAL STATE,5
IL,DIZZINESS,5
IL,HYPOGLYCAEMIA,5
IL,MYALGIA,5
IL,MYOCARDIAL INFARCTION,5
IL,RASH,5
IL,RENAL FAILURE,5
IL,ACUTE KIDNEY INJURY,4
IL,CARDIAC FAILURE,4
IL,CEREBROVASCULAR ACCIDENT,4
IL,COUGH,4
IL,DECREASED APPETITE,4
IL,DIABETIC KETOACIDOSIS,4
IL,DRUG INEFFECTIVE,4
IL,FEBRILE NEUTROPENIA,4
IL,HYPERTENSION,4
IL,HYPONATRAEMIA,4
IL,MALAISE,4
IL,NEUTROPENIA,4
IL,PAIN IN EXTREMITY,4
IL,PANCREATIC CARCINOMA,4
IL,RENAL FAILURE ACUTE,4
IL,VISION BLURRED,4
IL,ANGINA UNSTABLE,3
IL,BACK PAIN,3
IL,BLOOD CREATININE INCREASED,3
IL,BLOOD GLUCOSE INCREASED,3
IL,BLOOD PRESSURE INCREASED,3
IL,CHILLS,3
IL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
IL,DEEP VEIN THROMBOSIS,3
IL,DEHYDRATION,3
IL,FEELING ABNORMAL,3
IL,GASTROENTERITIS,3
IL,HEAD INJURY,3
IL,HEPATIC ENZYME INCREASED,3
IL,HEPATIC FAILURE,3
IL,HYPOTENSION,3
IL,INFECTION,3
IL,INFLAMMATION,3
IL,ISCHAEMIC STROKE,3
IL,MONOPLEGIA,3
IL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
IL,MUSCLE SPASMS,3
IL,ORAL PAIN,3
IL,PANCREATIC CARCINOMA METASTATIC,3
IL,PULMONARY EMBOLISM,3
IL,SEPSIS,3
IL,SEPTIC SHOCK,3
IL,SUDDEN HEARING LOSS,3
IL,URINARY RETENTION,3
IL,URINARY TRACT INFECTION,3
IL,ABDOMINAL DISTENSION,2
IL,ABDOMINAL PAIN UPPER,2
IL,ACUTE MYOCARDIAL INFARCTION,2
IL,ALANINE AMINOTRANSFERASE INCREASED,2
IL,AMNESIA,2
IL,ANGINA PECTORIS,2
IL,APHASIA,2
IL,ASPARTATE AMINOTRANSFERASE INCREASED,2
IL,ATRIOVENTRICULAR BLOCK COMPLETE,2
IL,BLOOD PRESSURE DECREASED,2
IL,BLOOD URINE PRESENT,2
IL,BONE PAIN,2
IL,BRADYCARDIA,2
IL,BRONCHITIS,2
IL,BURNING SENSATION,2
IL,CARDIAC ARREST,2
IL,CARDIAC FAILURE CONGESTIVE,2
IL,CATHETERISATION CARDIAC,2
IL,CEREBRAL INFARCTION,2
IL,COAGULATION TIME PROLONGED,2
IL,COGNITIVE DISORDER,2
IL,COLITIS,2
IL,CONSTIPATION,2
IL,CONVULSION,2
IL,CORONARY ARTERY DISEASE,2
IL,DEATH,2
IL,DISEASE PROGRESSION,2
IL,DRY MOUTH,2
IL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
IL,GENERAL PHYSICAL HEALTH DETERIORATION,2
IL,HAEMATEMESIS,2
IL,HAEMATURIA,2
IL,HAEMODIALYSIS,2
IL,HAEMOPTYSIS,2
IL,HYPERCOAGULATION,2
IL,HYPERKALAEMIA,2
IL,HYPERSENSITIVITY,2
IL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
IL,INFLUENZA,2
IL,INTENTIONAL PRODUCT USE ISSUE,2
IL,JAUNDICE,2
IL,LEUKOCYTOSIS,2
IL,LEUKOPENIA,2
IL,LOSS OF CONSCIOUSNESS,2
IL,MALIGNANT NEOPLASM PROGRESSION,2
IL,METABOLIC DISORDER,2
IL,METASTATIC RENAL CELL CARCINOMA,2
IL,MUSCULAR WEAKNESS,2
IL,MYOCARDIAL ISCHAEMIA,2
IL,NASOPHARYNGITIS,2
IL,NEPHROLITHIASIS,2
IL,OEDEMA PERIPHERAL,2
IL,ORAL DISCOMFORT,2
IL,OVARIAN CANCER,2
IL,PALPITATIONS,2
IL,PANCREATITIS,2
IL,PANCREATITIS ACUTE,2
IL,PANCYTOPENIA,2
IL,PNEUMONIA LEGIONELLA,2
IL,PROTHROMBIN TIME PROLONGED,2
IL,RECTAL HAEMORRHAGE,2
IL,RENAL IMPAIRMENT,2
IL,SCOLIOSIS,2
IL,SHOCK,2
IL,SKIN LESION,2
IL,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,2
IL,THROAT IRRITATION,2
IL,THROMBOSIS IN DEVICE,2
IL,TOXICITY TO VARIOUS AGENTS,2
IL,WHITE BLOOD CELL COUNT DECREASED,2
IL,ABDOMINAL PAIN LOWER,1
IL,ABDOMINAL TENDERNESS,1
IL,ACUTE MYELOID LEUKAEMIA,1
IL,ADENOCARCINOMA GASTRIC,1
IL,ADENOCARCINOMA OF COLON,1
IL,ALPHA-1 ANTI-TRYPSIN ABNORMAL,1
IL,ANEURYSM,1
IL,ANGIOEDEMA,1
IL,APLASTIC ANAEMIA,1
IL,ARRHYTHMIA,1
IL,ARTERIOVENOUS GRAFT SITE INFECTION,1
IL,ARTHRALGIA,1
IL,ARTHRITIS,1
IL,ASPHYXIA,1
IL,ASTERIXIS,1
IL,ATRIAL FLUTTER,1
IL,ATRIOVENTRICULAR BLOCK,1
IL,BACTERAEMIA,1
IL,BACTERIAL INFECTION,1
IL,BEDRIDDEN,1
IL,BENIGN PROSTATIC HYPERPLASIA,1
IL,BILIRUBIN CONJUGATED INCREASED,1
IL,BLISTER,1
IL,BLOOD BILIRUBIN INCREASED,1
IL,BLOOD FIBRINOGEN DECREASED,1
IL,BLOOD GLUCOSE DECREASED,1
IL,BLOOD IRON DECREASED,1
IL,BLOOD LACTATE DEHYDROGENASE INCREASED,1
IL,BLOOD LACTIC ACID INCREASED,1
IL,BLOOD PRESSURE DIASTOLIC DECREASED,1
IL,BLOOD SODIUM DECREASED,1
IL,BLOOD SODIUM INCREASED,1
IL,BLOOD TEST ABNORMAL,1
IL,BODY TEMPERATURE INCREASED,1
IL,BONE DISORDER,1
IL,BREAST CANCER,1
IL,BUNDLE BRANCH BLOCK RIGHT,1
IL,C-REACTIVE PROTEIN INCREASED,1
IL,CARDIAC FAILURE CHRONIC,1
IL,CARDIAC OPERATION,1
IL,CARDIAC PACEMAKER INSERTION,1
IL,CARDIAC TAMPONADE,1
IL,CATARACT,1
IL,CELLULITIS,1
IL,CHEST DISCOMFORT,1
IL,CHOLANGITIS,1
IL,CHOLECYSTITIS ACUTE,1
IL,CHOLESTASIS,1
IL,CHROMATURIA,1
IL,CHRONIC KIDNEY DISEASE,1
IL,COAGULOPATHY,1
IL,COLITIS ISCHAEMIC,1
IL,COMA,1
IL,CONCUSSION,1
IL,CONJUNCTIVITIS,1
IL,CORONARY ARTERY OCCLUSION,1
IL,CROHN^S DISEASE,1
IL,CYSTITIS KLEBSIELLA,1
IL,DEAFNESS,1
IL,DELIRIUM,1
IL,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IL,DEPRESSION,1
IL,DERMATITIS,1
IL,DIALYSIS,1
IL,DISCOMFORT,1
IL,DISSEMINATED INTRAVASCULAR COAGULATION,1
IL,DISTURBANCE IN ATTENTION,1
IL,DYSARTHRIA,1
IL,DYSLIPIDAEMIA,1
IL,DYSPHEMIA,1
IL,DYSPHONIA,1
IL,DYSPNOEA EXERTIONAL,1
IL,DYSURIA,1
IL,ELECTROCARDIOGRAM ABNORMAL,1
IL,ELECTROCARDIOGRAM QT PROLONGED,1
IL,ELECTROCARDIOGRAM T WAVE ABNORMAL,1
IL,ELECTROCARDIOGRAM T WAVE INVERSION,1
IL,EMBOLIC STROKE,1
IL,ENDOMETRIAL CANCER METASTATIC,1
IL,EPIDIDYMITIS,1
IL,EPISTAXIS,1
IL,ERYSIPELAS,1
IL,ERYTHEMA,1
IL,FACIAL PARALYSIS,1
IL,FAECES DISCOLOURED,1
IL,FIBROMYALGIA,1
IL,FLUID RETENTION,1
IL,FOOT FRACTURE,1
IL,FREQUENT BOWEL MOVEMENTS,1
IL,FURUNCLE,1
IL,GAIT DISTURBANCE,1
IL,GASTROINTESTINAL FISTULA,1
IL,GASTROINTESTINAL NECROSIS,1
IL,GASTROINTESTINAL OEDEMA,1
IL,GASTROOESOPHAGEAL REFLUX DISEASE,1
IL,GROIN ABSCESS,1
IL,GYNAECOMASTIA,1
IL,HAEMATOCHEZIA,1
IL,HAEMORRHAGE,1
IL,HAEMORRHAGIC STROKE,1
IL,HAEMORRHAGIC TRANSFORMATION STROKE,1
IL,HEAD DISCOMFORT,1
IL,HEART RATE DECREASED,1
IL,HEART RATE INCREASED,1
IL,HEART RATE IRREGULAR,1
IL,HEPATIC ENZYME ABNORMAL,1
IL,HEPATIC FUNCTION ABNORMAL,1
IL,HEPATIC STEATOSIS,1
IL,HEPATITIS,1
IL,HEPATOCELLULAR INJURY,1
IL,HEPATOMEGALY,1
IL,HYDROCEPHALUS,1
IL,HYPERAESTHESIA,1
IL,HYPERBILIRUBINAEMIA,1
IL,HYPERCALCAEMIA,1
IL,HYPERCALCIURIA,1
IL,HYPERGLYCAEMIA,1
IL,HYPERSENSITIVITY VASCULITIS,1
IL,HYPERTHYROIDISM,1
IL,HYPOAESTHESIA,1
IL,HYPOALBUMINAEMIA,1
IL,HYPOVOLAEMIA,1
IL,IDIOPATHIC PULMONARY FIBROSIS,1
IL,ILEAL STENOSIS,1
IL,IMPATIENCE,1
IL,INCORRECT DOSE ADMINISTERED,1
IL,INJECTION SITE ERYTHEMA,1
IL,INJECTION SITE NODULE,1
IL,INJECTION SITE PAIN,1
IL,INJECTION SITE SWELLING,1
IL,INSOMNIA,1
IL,INTENTIONAL PRODUCT MISUSE,1
IL,INTERVERTEBRAL DISC PROTRUSION,1
IL,INTESTINAL OBSTRUCTION,1
IL,INTRAVENTRICULAR HAEMORRHAGE,1
IL,JOINT SWELLING,1
IL,KAPOSI^S SARCOMA,1
IL,LARGE INTESTINAL OBSTRUCTION,1
IL,LEFT VENTRICULAR FAILURE,1
IL,LEIOMYOMA,1
IL,LEUKAEMIA,1
IL,LIP BLISTER,1
IL,LIVER DISORDER,1
IL,LIVER INJURY,1
IL,LOCAL SWELLING,1
IL,LOW DENSITY LIPOPROTEIN DECREASED,1
IL,LUNG INFECTION,1
IL,LYMPHADENOPATHY,1
IL,MALIGNANT MELANOMA,1
IL,MECHANICAL VENTILATION,1
IL,MEDIASTINAL MASS,1
IL,MESENTERIC ARTERY EMBOLISM,1
IL,METABOLIC ACIDOSIS,1
IL,METASTASES TO LUNG,1
IL,METASTASES TO LYMPH NODES,1
IL,METASTATIC MALIGNANT MELANOMA,1
IL,MIGRAINE,1
IL,MITRAL VALVE INCOMPETENCE,1
IL,MONOCLONAL GAMMOPATHY,1
IL,MOOD ALTERED,1
IL,MOTOR DYSFUNCTION,1
IL,MUCOSAL HAEMORRHAGE,1
IL,MUCOSAL INFECTION,1
IL,MUCOSAL INFLAMMATION,1
IL,MULTI-ORGAN FAILURE,1
IL,MUSCLE FATIGUE,1
IL,MUSCULOSKELETAL PAIN,1
IL,MYCOSIS FUNGOIDES,1
IL,MYXOEDEMA COMA,1
IL,NEUROENDOCRINE CARCINOMA OF THE SKIN,1
IL,NON-CARDIAC CHEST PAIN,1
IL,OLIGURIA,1
IL,ONYCHOMYCOSIS,1
IL,OROPHARYNGEAL PAIN,1
IL,OSTEOPOROSIS,1
IL,OVERWEIGHT,1
IL,PAIN OF SKIN,1
IL,PALLOR,1
IL,PAPILLARY THYROID CANCER,1
IL,PARAESTHESIA,1
IL,PARALYSIS,1
IL,PERICARDIAL EFFUSION,1
IL,PERIPHERAL COLDNESS,1
IL,PERIPHERAL EMBOLISM,1
IL,PERIPHERAL SWELLING,1
IL,PLANTAR FASCIITIS,1
IL,PLATELET COUNT DECREASED,1
IL,PLEURAL EFFUSION,1
IL,PNEUMONIA BACTERIAL,1
IL,POLLAKIURIA,1
IL,POLYMYOSITIS,1
IL,POLYP,1
IL,POLYURIA,1
IL,POSTPERICARDIOTOMY SYNDROME,1
IL,PROSTATIC DISORDER,1
IL,PROSTATITIS,1
IL,PROSTATOMEGALY,1
IL,PROTEINURIA,1
IL,PRURITUS,1
IL,PULMONARY CONGESTION,1
IL,PULMONARY HYPERTENSION,1
IL,PULSE ABSENT,1
IL,RENAL CELL CARCINOMA,1
IL,RENAL CYST,1
IL,RENAL INJURY,1
IL,RESPIRATORY DISORDER,1
IL,RESPIRATORY FAILURE,1
IL,RESPIRATORY RATE INCREASED,1
IL,RETINAL DETACHMENT,1
IL,RHABDOMYOLYSIS,1
IL,RHONCHI,1
IL,ROAD TRAFFIC ACCIDENT,1
IL,SCIATICA,1
IL,SECOND PRIMARY MALIGNANCY,1
IL,SENSORY DISTURBANCE,1
IL,SENSORY LOSS,1
IL,SINUS NODE DYSFUNCTION,1
IL,SINUS TACHYCARDIA,1
IL,SKIN HAEMORRHAGE,1
IL,SOMNOLENCE,1
IL,SPEECH DISORDER,1
IL,SPINAL PAIN,1
IL,SPLENECTOMY,1
IL,STAPHYLOCOCCAL INFECTION,1
IL,STENT PLACEMENT,1
IL,STOMA CLOSURE,1
IL,STOMATITIS,1
IL,SUBDURAL HAEMATOMA,1
IL,SUBDURAL HAEMORRHAGE,1
IL,SUICIDAL IDEATION,1
IL,SWELLING FACE,1
IL,TACHYCARDIA,1
IL,THROMBOSIS,1
IL,THYROID NEOPLASM,1
IL,TINNITUS,1
IL,TONGUE HAEMORRHAGE,1
IL,TOOTH LOSS,1
IL,TRANSAMINASES INCREASED,1
IL,TRANSIENT ISCHAEMIC ATTACK,1
IL,TRANSPLANT REJECTION,1
IL,TREMOR,1
IL,TRICUSPID VALVE INCOMPETENCE,1
IL,URINE KETONE BODY PRESENT,1
IL,UROSEPSIS,1
IL,VASCULAR CALCIFICATION,1
IL,VASCULAR STENT OCCLUSION,1
IL,VASCULAR STENT THROMBOSIS,1
IL,VASODILATATION,1
IL,VENTRICULAR FIBRILLATION,1
IL,VENTRICULAR TACHYCARDIA,1
IL,VIRAL INFECTION,1
IL,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
IL,WEIGHT DECREASED,1
IL,WHEEZING,1
IL,WHITE BLOOD CELL COUNT INCREASED,1
IL,YELLOW SKIN,1
IT,RHABDOMYOLYSIS,16
IT,ASTHENIA,10
IT,DYSPNOEA,8
IT,MYALGIA,8
IT,ANAEMIA,7
IT,BLOOD CREATINE PHOSPHOKINASE INCREASED,7
IT,PAIN,6
IT,VOMITING,6
IT,BRADYCARDIA,5
IT,FATIGUE,5
IT,HEADACHE,5
IT,MYOPATHY,5
IT,PRURITUS,5
IT,SYNCOPE,5
IT,CONFUSIONAL STATE,4
IT,ELECTROCARDIOGRAM QT PROLONGED,4
IT,ERYTHEMA,4
IT,FALL,4
IT,LOSS OF CONSCIOUSNESS,4
IT,MUSCLE SPASMS,4
IT,MYOCARDIAL NECROSIS MARKER INCREASED,4
IT,NAUSEA,4
IT,ALANINE AMINOTRANSFERASE INCREASED,3
IT,ARRHYTHMIA,3
IT,ASPARTATE AMINOTRANSFERASE INCREASED,3
IT,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,3
IT,CONDITION AGGRAVATED,3
IT,DIARRHOEA,3
IT,ELECTROCARDIOGRAM T WAVE INVERSION,3
IT,HAEMATOMA,3
IT,HEAD INJURY,3
IT,HEPATITIS ACUTE,3
IT,HYPOGLYCAEMIA,3
IT,HYPOTENSION,3
IT,HYPOTHYROIDISM,3
IT,JAUNDICE,3
IT,MALAISE,3
IT,MYOCARDIAL ISCHAEMIA,3
IT,PYREXIA,3
IT,RENAL FAILURE,3
IT,SOPOR,3
IT,SUICIDE ATTEMPT,3
IT,THROMBOCYTOPENIA,3
IT,TRANSAMINASES INCREASED,3
IT,ABDOMINAL PAIN,2
IT,ABDOMINAL PAIN LOWER,2
IT,ANGIOEDEMA,2
IT,BLOOD BILIRUBIN INCREASED,2
IT,CHOLELITHIASIS,2
IT,DRUG ABUSE,2
IT,FEELING COLD,2
IT,HAEMATURIA,2
IT,HYPERHIDROSIS,2
IT,HYPERTRANSAMINASAEMIA,2
IT,INTENTIONAL SELF-INJURY,2
IT,JAUNDICE CHOLESTATIC,2
IT,LEUKOPENIA,2
IT,MELAENA,2
IT,MULTI-ORGAN FAILURE,2
IT,MUSCLE HAEMORRHAGE,2
IT,MUSCULAR WEAKNESS,2
IT,MYOGLOBIN BLOOD INCREASED,2
IT,OEDEMA PERIPHERAL,2
IT,PANCREATIC CARCINOMA,2
IT,PANCYTOPENIA,2
IT,PELVIC FRACTURE,2
IT,PRURITUS GENERALISED,2
IT,RECTAL HAEMORRHAGE,2
IT,RENAL FAILURE ACUTE,2
IT,TOXICITY TO VARIOUS AGENTS,2
IT,WEIGHT INCREASED,2
IT,ABDOMINAL PAIN UPPER,1
IT,ACUTE KIDNEY INJURY,1
IT,ACUTE RESPIRATORY FAILURE,1
IT,ADVERSE DRUG REACTION,1
IT,AMYOTROPHIC LATERAL SCLEROSIS,1
IT,ANAEMIA MACROCYTIC,1
IT,ANAPHYLACTIC SHOCK,1
IT,ARTHRALGIA,1
IT,ATRIAL FLUTTER,1
IT,ATRIAL THROMBOSIS,1
IT,BLOOD CREATININE INCREASED,1
IT,BLOOD GLUCOSE INCREASED,1
IT,BLOOD LACTATE DEHYDROGENASE INCREASED,1
IT,BLOOD PRESSURE DECREASED,1
IT,CARDIAC ABLATION,1
IT,CARDIAC ARREST,1
IT,CARDIAC FAILURE,1
IT,CARDIOGENIC SHOCK,1
IT,CARDIOVASCULAR DISORDER,1
IT,CEREBRAL HAEMATOMA,1
IT,CEREBROVASCULAR ACCIDENT,1
IT,CHEST DISCOMFORT,1
IT,CHEST PAIN,1
IT,CHOREA,1
IT,CHRONIC GASTRITIS,1
IT,COLD SWEAT,1
IT,CONSCIOUSNESS FLUCTUATING,1
IT,CONSTIPATION,1
IT,CONVULSION,1
IT,COUGH,1
IT,DEHYDRATION,1
IT,DERMATITIS,1
IT,DERMATITIS ALLERGIC,1
IT,DERMATITIS BULLOUS,1
IT,DISCOMFORT,1
IT,DISORIENTATION,1
IT,DISSEMINATED INTRAVASCULAR COAGULATION,1
IT,DIVERTICULAR PERFORATION,1
IT,DIZZINESS,1
IT,DRUG INEFFECTIVE,1
IT,DRUG PRESCRIBING ERROR,1
IT,DRUG-INDUCED LIVER INJURY,1
IT,DUODENAL ULCER,1
IT,DYSURIA,1
IT,ECZEMA,1
IT,EJECTION FRACTION DECREASED,1
IT,EPIGASTRIC DISCOMFORT,1
IT,EPISTAXIS,1
IT,EROSIVE OESOPHAGITIS,1
IT,ERYTHEMA MIGRANS,1
IT,FACE OEDEMA,1
IT,FACIAL PARALYSIS,1
IT,FEBRILE NEUTROPENIA,1
IT,FEELING ABNORMAL,1
IT,FLATULENCE,1
IT,GAIT DISTURBANCE,1
IT,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,1
IT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
IT,GASTRITIS EROSIVE,1
IT,GASTRODUODENAL ULCER,1
IT,GASTROINTESTINAL DISORDER,1
IT,GENERAL PHYSICAL HEALTH DETERIORATION,1
IT,HAEMOCONCENTRATION,1
IT,HAEMOPTYSIS,1
IT,HALLUCINATION,1
IT,HEMIPARESIS,1
IT,HEPATITIS C,1
IT,HEPATOTOXICITY,1
IT,HIATUS HERNIA,1
IT,HYPERCAPNIA,1
IT,HYPERGLYCAEMIA,1
IT,HYPERINSULINAEMIC HYPOGLYCAEMIA,1
IT,HYPERKALAEMIA,1
IT,HYPERPARATHYROIDISM,1
IT,HYPERSENSITIVITY,1
IT,HYPERTENSION,1
IT,HYPERTHERMIA,1
IT,HYPERTHYROIDISM,1
IT,HYPERTONIA,1
IT,HYPOKALAEMIA,1
IT,HYPONATRAEMIA,1
IT,HYPOTONIA,1
IT,IMMUNE-MEDIATED NECROTISING MYOPATHY,1
IT,INFECTION,1
IT,INTERNATIONAL NORMALISED RATIO DECREASED,1
IT,INTERNATIONAL NORMALISED RATIO INCREASED,1
IT,LIVER DISORDER,1
IT,LOCALISED OEDEMA,1
IT,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
IT,LUNG NEOPLASM MALIGNANT,1
IT,MEDICAL DEVICE SITE NECROSIS,1
IT,METABOLIC ACIDOSIS,1
IT,METASTATIC NEOPLASM,1
IT,MIOSIS,1
IT,MONOPARESIS,1
IT,MOUTH HAEMORRHAGE,1
IT,MUSCLE NECROSIS,1
IT,MUSCULOSKELETAL PAIN,1
IT,MYOCARDIAL INFARCTION,1
IT,MYOPATHY TOXIC,1
IT,NECROTISING MYOSITIS,1
IT,NEUTROPENIA,1
IT,OEDEMA,1
IT,OLIGURIA,1
IT,OSTEONECROSIS OF JAW,1
IT,OVERDOSE,1
IT,PAIN IN EXTREMITY,1
IT,PALLOR,1
IT,PANCREATITIS ACUTE,1
IT,PEMPHIGUS,1
IT,PERIPHERAL ISCHAEMIA,1
IT,PERIPHERAL SENSORY NEUROPATHY,1
IT,POLYMYOSITIS,1
IT,POLYURIA,1
IT,PRESCRIBED OVERDOSE,1
IT,PRESYNCOPE,1
IT,PRODUCT USE IN UNAPPROVED INDICATION,1
IT,PRODUCTIVE COUGH,1
IT,PROTEINURIA,1
IT,PSYCHOMOTOR HYPERACTIVITY,1
IT,QUADRIPARESIS,1
IT,RASH,1
IT,RASH ERYTHEMATOUS,1
IT,RASH MACULO-PAPULAR,1
IT,RASH PAPULAR,1
IT,RASH PRURITIC,1
IT,RENAL IMPAIRMENT,1
IT,RENAL INJURY,1
IT,RESPIRATORY ACIDOSIS,1
IT,RESPIRATORY ARREST,1
IT,RESPIRATORY DISORDER,1
IT,RESPIRATORY FAILURE,1
IT,RESPIRATORY FATIGUE,1
IT,RESTLESSNESS,1
IT,RETROPERITONEAL HAEMATOMA,1
IT,SHOCK HAEMORRHAGIC,1
IT,SUBDURAL HAEMORRHAGE,1
IT,SWELLING FACE,1
IT,TENDON INJURY,1
IT,TOXIC EPIDERMAL NECROLYSIS,1
IT,TOXIC SKIN ERUPTION,1
IT,TREATMENT NONCOMPLIANCE,1
IT,TROPONIN INCREASED,1
IT,URINARY INCONTINENCE,1
IT,URINE ABNORMALITY,1
IT,URTICARIA,1
IT,VENTRICULAR ARRHYTHMIA,1
IT,VISION BLURRED,1
IT,VOLUME BLOOD DECREASED,1
JM,COGNITIVE DISORDER,1
JP,INTERSTITIAL LUNG DISEASE,104
JP,CEREBRAL INFARCTION,83
JP,RENAL IMPAIRMENT,82
JP,HEPATIC FUNCTION ABNORMAL,79
JP,PYREXIA,79
JP,ANAEMIA,74
JP,DECREASED APPETITE,74
JP,DIARRHOEA,73
JP,PLATELET COUNT DECREASED,61
JP,RHABDOMYOLYSIS,61
JP,NAUSEA,59
JP,PNEUMONIA,59
JP,DIABETES MELLITUS,57
JP,RASH,57
JP,HYPERTENSION,56
JP,LIVER DISORDER,54
JP,CARDIAC FAILURE,51
JP,WHITE BLOOD CELL COUNT DECREASED,51
JP,BLOOD CREATINE PHOSPHOKINASE INCREASED,49
JP,FALL,48
JP,ALANINE AMINOTRANSFERASE INCREASED,42
JP,ASPARTATE AMINOTRANSFERASE INCREASED,40
JP,DEHYDRATION,40
JP,MALAISE,38
JP,DYSPNOEA,37
JP,VOMITING,35
JP,ALTERED STATE OF CONSCIOUSNESS,33
JP,BLOOD CREATININE INCREASED,33
JP,GAMMA-GLUTAMYLTRANSFERASE INCREASED,32
JP,HAEMOGLOBIN DECREASED,32
JP,LOSS OF CONSCIOUSNESS,32
JP,BACK PAIN,31
JP,DRUG INEFFECTIVE,30
JP,DIZZINESS,29
JP,DRUG ERUPTION,29
JP,NEUTROPHIL COUNT DECREASED,29
JP,C-REACTIVE PROTEIN INCREASED,28
JP,CONSTIPATION,28
JP,SEPSIS,28
JP,BLOOD PRESSURE DECREASED,26
JP,BLOOD UREA INCREASED,26
JP,CONDITION AGGRAVATED,26
JP,HEADACHE,25
JP,HYPOAESTHESIA,25
JP,HYPOGLYCAEMIA,25
JP,RENAL DISORDER,25
JP,BLOOD LACTATE DEHYDROGENASE INCREASED,24
JP,CARDIAC FAILURE CONGESTIVE,24
JP,DEPRESSED LEVEL OF CONSCIOUSNESS,24
JP,MYALGIA,24
JP,BLOOD GLUCOSE INCREASED,23
JP,CEREBRAL HAEMORRHAGE,23
JP,OEDEMA PERIPHERAL,23
JP,PLEURAL EFFUSION,23
JP,BLOOD ALKALINE PHOSPHATASE INCREASED,22
JP,BLOOD PRESSURE INCREASED,22
JP,MALIGNANT NEOPLASM PROGRESSION,22
JP,UPPER RESPIRATORY TRACT INFLAMMATION,22
JP,ABDOMINAL PAIN,21
JP,ACUTE KIDNEY INJURY,21
JP,ANGINA PECTORIS,21
JP,ASTHENIA,21
JP,INSOMNIA,21
JP,NASOPHARYNGITIS,21
JP,PRURITUS,21
JP,DEATH,20
JP,HYPONATRAEMIA,20
JP,WHITE BLOOD CELL COUNT INCREASED,20
JP,DISSEMINATED INTRAVASCULAR COAGULATION,19
JP,GAIT DISTURBANCE,19
JP,HYPERURICAEMIA,19
JP,ARTHRALGIA,18
JP,CELLULITIS,18
JP,COLON CANCER,18
JP,HYPERKALAEMIA,18
JP,IRON DEFICIENCY ANAEMIA,18
JP,MYOCARDIAL INFARCTION,18
JP,PNEUMONIA ASPIRATION,18
JP,RENAL FAILURE,18
JP,RESPIRATORY FAILURE,18
JP,SOMNOLENCE,18
JP,STOMATITIS,18
JP,URINARY TRACT INFECTION,18
JP,CATARACT,17
JP,FEBRILE NEUTROPENIA,17
JP,GASTROENTERITIS,17
JP,HYPERLIPIDAEMIA,17
JP,WEIGHT INCREASED,17
JP,BRONCHITIS,16
JP,DRUG-INDUCED LIVER INJURY,16
JP,ERYTHEMA,16
JP,GLYCOSYLATED HAEMOGLOBIN INCREASED,16
JP,HAEMATURIA,16
JP,INTENTIONAL PRODUCT MISUSE,16
JP,MULTI-ORGAN FAILURE,16
JP,PHARYNGITIS,16
JP,SEPTIC SHOCK,16
JP,EOSINOPHIL COUNT INCREASED,15
JP,GASTRIC CANCER,15
JP,HERPES ZOSTER,15
JP,INTENTIONAL OVERDOSE,15
JP,OEDEMA,15
JP,OSTEONECROSIS OF JAW,15
JP,PANCYTOPENIA,15
JP,URINARY RETENTION,15
JP,COUGH,14
JP,DISEASE PROGRESSION,14
JP,FATIGUE,14
JP,GASTRIC ULCER,14
JP,GASTROINTESTINAL HAEMORRHAGE,14
JP,HYPERGLYCAEMIA,14
JP,HYPOKALAEMIA,14
JP,PAIN,14
JP,PALPITATIONS,14
JP,RENAL FAILURE ACUTE,14
JP,ABDOMINAL PAIN UPPER,13
JP,ACUTE MYOCARDIAL INFARCTION,13
JP,ATRIAL FIBRILLATION,13
JP,BLADDER CANCER,13
JP,FEMUR FRACTURE,13
JP,INTENTIONAL DRUG MISUSE,13
JP,INTESTINAL OBSTRUCTION,13
JP,METASTASES TO LIVER,13
JP,MUSCULAR WEAKNESS,13
JP,PROSTATE CANCER,13
JP,PROTEINURIA,13
JP,TREMOR,13
JP,WEIGHT DECREASED,13
JP,BLOOD POTASSIUM DECREASED,12
JP,EMBOLIC STROKE,12
JP,FEMORAL NECK FRACTURE,12
JP,GASTROOESOPHAGEAL REFLUX DISEASE,12
JP,HAEMORRHAGE SUBCUTANEOUS,12
JP,PERITONITIS,12
JP,PNEUMOCYSTIS JIROVECII PNEUMONIA,12
JP,TOXIC EPIDERMAL NECROLYSIS,12
JP,ABDOMINAL DISCOMFORT,11
JP,ARRHYTHMIA,11
JP,ASTHMA,11
JP,BLOOD CHOLESTEROL INCREASED,11
JP,BLOOD TRIGLYCERIDES INCREASED,11
JP,DIABETES MELLITUS INADEQUATE CONTROL,11
JP,HAEMATOCRIT DECREASED,11
JP,ILEUS,11
JP,LUNG NEOPLASM MALIGNANT,11
JP,MELAENA,11
JP,OVERDOSE,11
JP,RESTLESSNESS,11
JP,SUBDURAL HAEMATOMA,11
JP,THIRST,11
JP,URTICARIA,11
JP,BRADYCARDIA,10
JP,CARDIAC FAILURE ACUTE,10
JP,CARDIO-RESPIRATORY ARREST,10
JP,CORONARY ARTERY STENOSIS,10
JP,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,10
JP,ELECTROCARDIOGRAM QT PROLONGED,10
JP,EPISTAXIS,10
JP,ERYTHEMA MULTIFORME,10
JP,INFLUENZA,10
JP,LUNG DISORDER,10
JP,NEPHROTIC SYNDROME,10
JP,NEUTROPENIA,10
JP,PAIN IN EXTREMITY,10
JP,PANCREATITIS ACUTE,10
JP,PRODUCT USE ISSUE,10
JP,RHEUMATOID ARTHRITIS,10
JP,SUBARACHNOID HAEMORRHAGE,10
JP,BLOOD POTASSIUM INCREASED,9
JP,CARDIAC ARREST,9
JP,CHEST DISCOMFORT,9
JP,CHEST PAIN,9
JP,CHOLECYSTITIS,9
JP,CYTOMEGALOVIRUS INFECTION,9
JP,DELIRIUM,9
JP,DYSPNOEA EXERTIONAL,9
JP,IMMUNE-MEDIATED NECROTISING MYOPATHY,9
JP,LARGE INTESTINE POLYP,9
JP,PULMONARY EMBOLISM,9
JP,RED BLOOD CELL COUNT DECREASED,9
JP,RETINAL HAEMORRHAGE,9
JP,TOXIC ENCEPHALOPATHY,9
JP,VENTRICULAR TACHYCARDIA,9
JP,ALOPECIA,8
JP,BLOOD ALBUMIN DECREASED,8
JP,DEMENTIA,8
JP,DEPRESSION,8
JP,DERMATITIS EXFOLIATIVE,8
JP,DYSPHAGIA,8
JP,ECZEMA,8
JP,ENTEROCOLITIS,8
JP,GASTRITIS,8
JP,GLUCOSE TOLERANCE IMPAIRED,8
JP,HAEMATEMESIS,8
JP,HEART TRANSPLANT REJECTION,8
JP,INFECTION,8
JP,JAUNDICE,8
JP,LYMPHOCYTE COUNT DECREASED,8
JP,MUSCLE SPASMS,8
JP,MUSCULOSKELETAL STIFFNESS,8
JP,NEUROLEPTIC MALIGNANT SYNDROME,8
JP,OSTEOMYELITIS,8
JP,OSTEONECROSIS,8
JP,RHINITIS ALLERGIC,8
JP,SHOCK,8
JP,SYNCOPE,8
JP,SYSTEMIC LUPUS ERYTHEMATOSUS,8
JP,THROMBOCYTOPENIA,8
JP,TOXICITY TO VARIOUS AGENTS,8
JP,ACUTE RESPIRATORY DISTRESS SYNDROME,7
JP,AMYLASE INCREASED,7
JP,BONE MARROW FAILURE,7
JP,CARDIAC FAILURE CHRONIC,7
JP,COLITIS,7
JP,COLITIS MICROSCOPIC,7
JP,COMPRESSION FRACTURE,7
JP,CONVULSION,7
JP,DEEP VEIN THROMBOSIS,7
JP,DRUG EFFECT INCOMPLETE,7
JP,DYSARTHRIA,7
JP,DYSURIA,7
JP,EATING DISORDER,7
JP,EXPOSURE DURING PREGNANCY,7
JP,FACE OEDEMA,7
JP,GENERALISED ERYTHEMA,7
JP,HAEMATOMA,7
JP,HYPOALBUMINAEMIA,7
JP,HYPOTENSION,7
JP,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,7
JP,LARGE INTESTINE PERFORATION,7
JP,LIVER FUNCTION TEST ABNORMAL,7
JP,PROTEIN TOTAL DECREASED,7
JP,SUDDEN DEATH,7
JP,SUDDEN HEARING LOSS,7
JP,TACHYCARDIA,7
JP,TRANSIENT ISCHAEMIC ATTACK,7
JP,TUBULOINTERSTITIAL NEPHRITIS,7
JP,ACUTE CORONARY SYNDROME,6
JP,ANAPHYLACTIC REACTION,6
JP,ANAPHYLACTIC SHOCK,6
JP,ANGINA UNSTABLE,6
JP,AORTIC DISSECTION,6
JP,APLASIA PURE RED CELL,6
JP,ATRIOVENTRICULAR BLOCK COMPLETE,6
JP,ATYPICAL FEMUR FRACTURE,6
JP,BLOOD BILIRUBIN INCREASED,6
JP,BLOOD URIC ACID INCREASED,6
JP,BLOOD URINE PRESENT,6
JP,BREAST CANCER,6
JP,BRONCHOPULMONARY ASPERGILLOSIS,6
JP,CHILLS,6
JP,CHROMATURIA,6
JP,CONTUSION,6
JP,CORONARY ARTERY DISEASE,6
JP,DERMATITIS ACNEIFORM,6
JP,DROWNING,6
JP,DYSGEUSIA,6
JP,DYSLIPIDAEMIA,6
JP,ENTERITIS INFECTIOUS,6
JP,FEELING ABNORMAL,6
JP,FRACTURE,6
JP,GENERAL PHYSICAL HEALTH DETERIORATION,6
JP,HAEMORRHAGE,6
JP,HAEMORRHAGIC DIATHESIS,6
JP,HEPATIC ENZYME INCREASED,6
JP,HYPOCALCAEMIA,6
JP,HYPOTHYROIDISM,6
JP,HYPOXIA,6
JP,INTERNATIONAL NORMALISED RATIO INCREASED,6
JP,LACUNAR INFARCTION,6
JP,LEUKOPENIA,6
JP,METABOLIC ACIDOSIS,6
JP,MONOCYTE COUNT INCREASED,6
JP,MYELODYSPLASTIC SYNDROME,6
JP,OROPHARYNGEAL PAIN,6
JP,OSTEOPOROSIS,6
JP,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,6
JP,POLYMYOSITIS,6
JP,PROTEIN URINE PRESENT,6
JP,PULMONARY OEDEMA,6
JP,ROAD TRAFFIC ACCIDENT,6
JP,SEIZURE,6
JP,UPPER GASTROINTESTINAL HAEMORRHAGE,6
JP,ANURIA,5
JP,ASCITES,5
JP,ATRIOVENTRICULAR BLOCK SECOND DEGREE,5
JP,BLISTER,5
JP,BLOOD CALCIUM DECREASED,5
JP,CHOLECYSTITIS ACUTE,5
JP,CHOLELITHIASIS,5
JP,COLD SWEAT,5
JP,COLITIS ISCHAEMIC,5
JP,CYSTITIS,5
JP,CYTOMEGALOVIRUS ENTEROCOLITIS,5
JP,DERMATOMYOSITIS,5
JP,DIABETIC KETOACIDOSIS,5
JP,DIVERTICULUM INTESTINAL HAEMORRHAGIC,5
JP,DYSLALIA,5
JP,DYSPEPSIA,5
JP,DYSSTASIA,5
JP,EOSINOPHILIA,5
JP,HAEMOPTYSIS,5
JP,HALLUCINATION,5
JP,HEART RATE INCREASED,5
JP,HYPERTRIGLYCERIDAEMIA,5
JP,ILEUS PARALYTIC,5
JP,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
JP,INTENTIONAL PRODUCT USE ISSUE,5
JP,INTESTINAL PERFORATION,5
JP,LOW DENSITY LIPOPROTEIN DECREASED,5
JP,LUNG INFECTION,5
JP,LYMPHADENOPATHY,5
JP,LYMPHOMA,5
JP,MALNUTRITION,5
JP,NEPHROGENIC ANAEMIA,5
JP,NEUTROPHIL COUNT INCREASED,5
JP,OESOPHAGITIS,5
JP,PANCREATIC CARCINOMA,5
JP,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,5
JP,PLEURISY,5
JP,PNEUMONIA BACTERIAL,5
JP,PNEUMOTHORAX,5
JP,PRESCRIBED UNDERDOSE,5
JP,PSYCHIATRIC SYMPTOM,5
JP,RASH GENERALISED,5
JP,RIB FRACTURE,5
JP,SINUSITIS,5
JP,SKIN DISORDER,5
JP,SKIN ULCER,5
JP,SPINAL COMPRESSION FRACTURE,5
JP,STEVENS-JOHNSON SYNDROME,5
JP,SUICIDAL IDEATION,5
JP,SURGERY,5
JP,ABNORMAL BEHAVIOUR,4
JP,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,4
JP,ACUTE PHASE REACTION,4
JP,AGITATION,4
JP,AMNESIA,4
JP,AORTIC ANEURYSM,4
JP,BASOPHIL COUNT INCREASED,4
JP,BILE DUCT CANCER,4
JP,BLOOD BETA-D-GLUCAN INCREASED,4
JP,BLOOD CHOLINESTERASE DECREASED,4
JP,CANCER PAIN,4
JP,CELL MARKER INCREASED,4
JP,CEREBROVASCULAR ACCIDENT,4
JP,CHRONIC KIDNEY DISEASE,4
JP,COLITIS ULCERATIVE,4
JP,COMPUTERISED TOMOGRAM THORAX ABNORMAL,4
JP,CRANIOTOMY,4
JP,DEAFNESS NEUROSENSORY,4
JP,DIFFUSE LARGE B-CELL LYMPHOMA,4
JP,DRUG LEVEL INCREASED,4
JP,DRY SKIN,4
JP,EYELID OEDEMA,4
JP,FAECES DISCOLOURED,4
JP,FAECES SOFT,4
JP,FLUSHING,4
JP,FOETAL DEATH,4
JP,GENERALISED OEDEMA,4
JP,GINGIVAL BLEEDING,4
JP,HAEMATOCHEZIA,4
JP,HAEMOGLOBIN INCREASED,4
JP,HAEMOLYTIC ANAEMIA,4
JP,HELICOBACTER INFECTION,4
JP,HEMIPLEGIA,4
JP,HEPATIC CANCER,4
JP,HEPATIC FAILURE,4
JP,HYPERBILIRUBINAEMIA,4
JP,HYPERCHOLESTEROLAEMIA,4
JP,HYPERHIDROSIS,4
JP,HYPERSENSITIVITY,4
JP,HYPERTHYROIDISM,4
JP,HYPOGLYCAEMIC ENCEPHALOPATHY,4
JP,HYPOGLYCAEMIC UNCONSCIOUSNESS,4
JP,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,4
JP,IMMUNE THROMBOCYTOPENIC PURPURA,4
JP,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,4
JP,INFLAMMATION,4
JP,INTENTIONAL UNDERDOSE,4
JP,INTERNAL HAEMORRHAGE,4
JP,INTERVERTEBRAL DISC PROTRUSION,4
JP,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,4
JP,LACTIC ACIDOSIS,4
JP,LIP SWELLING,4
JP,LOW DENSITY LIPOPROTEIN INCREASED,4
JP,LOWER GASTROINTESTINAL HAEMORRHAGE,4
JP,LOWER RESPIRATORY TRACT INFECTION,4
JP,LUMBAR VERTEBRAL FRACTURE,4
JP,LUPUS NEPHRITIS,4
JP,LYMPHOCYTE PERCENTAGE DECREASED,4
JP,METASTASES TO LUNG,4
JP,MULTIPLE SCLEROSIS RELAPSE,4
JP,MUSCULOSKELETAL PAIN,4
JP,NEUROPATHY PERIPHERAL,4
JP,ORAL MUCOSA EROSION,4
JP,ORAL PAIN,4
JP,OVARIAN CANCER,4
JP,PEMPHIGOID,4
JP,POLLAKIURIA,4
JP,PULMONARY ARTERIAL HYPERTENSION,4
JP,PULMONARY HYPERTENSION,4
JP,PURPURA,4
JP,PYELONEPHRITIS,4
JP,RESPIRATORY DISORDER,4
JP,RETINAL ARTERY OCCLUSION,4
JP,SKIN EXFOLIATION,4
JP,STAPHYLOCOCCAL INFECTION,4
JP,SUICIDE ATTEMPT,4
JP,SUPRAVENTRICULAR EXTRASYSTOLES,4
JP,SYSTEMIC CANDIDA,4
JP,THALAMUS HAEMORRHAGE,4
JP,THROMBOTIC CEREBRAL INFARCTION,4
JP,TINNITUS,4
JP,VENTRICULAR EXTRASYSTOLES,4
JP,VENTRICULAR FIBRILLATION,4
JP,VISUAL FIELD DEFECT,4
JP,VITREOUS HAEMORRHAGE,4
JP,WHEEZING,4
JP,ABDOMINAL DISTENSION,3
JP,ADENOCARCINOMA PANCREAS,3
JP,ADRENAL INSUFFICIENCY,3
JP,AGEUSIA,3
JP,AGRANULOCYTOSIS,3
JP,ANGIOEDEMA,3
JP,ANXIETY,3
JP,AORTIC ANEURYSM RUPTURE,3
JP,APPENDICITIS,3
JP,APPLICATION SITE PRURITUS,3
JP,ARTERIAL DISORDER,3
JP,ARTHRITIS,3
JP,ARTHRITIS BACTERIAL,3
JP,AUTOIMMUNE HAEMOLYTIC ANAEMIA,3
JP,AUTOIMMUNE THYROIDITIS,3
JP,BETA 2 MICROGLOBULIN URINE INCREASED,3
JP,BETA-N-ACETYL-D-GLUCOSAMINIDASE INCREASED,3
JP,BLADDER NEOPLASM,3
JP,BLOOD CHOLESTEROL DECREASED,3
JP,BLOOD SODIUM DECREASED,3
JP,BRAIN OEDEMA,3
JP,BRAIN STEM INFARCTION,3
JP,BRONCHITIS CHRONIC,3
JP,CARDIAC TAMPONADE,3
JP,CENTRAL NERVOUS SYSTEM LYMPHOMA,3
JP,CEREBELLAR HAEMORRHAGE,3
JP,CERVICAL DYSPLASIA,3
JP,CHEST X-RAY ABNORMAL,3
JP,CHOLANGITIS,3
JP,CHOLANGITIS ACUTE,3
JP,CHRONIC GASTRITIS,3
JP,CONCOMITANT DISEASE AGGRAVATED,3
JP,CONCOMITANT DISEASE PROGRESSION,3
JP,CREATININE RENAL CLEARANCE DECREASED,3
JP,CYTOMEGALOVIRUS VIRAEMIA,3
JP,DEAFNESS,3
JP,DELUSION,3
JP,DERMATITIS,3
JP,DERMATITIS CONTACT,3
JP,DERMATOPHYTOSIS OF NAIL,3
JP,DIVERTICULAR PERFORATION,3
JP,DRUG ADMINISTRATION ERROR,3
JP,DYSKINESIA,3
JP,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,3
JP,EMBOLIC CEREBRAL INFARCTION,3
JP,EMPYEMA,3
JP,ENTEROCOLITIS VIRAL,3
JP,EPIGASTRIC DISCOMFORT,3
JP,EPILEPSY,3
JP,EYE SWELLING,3
JP,FACIAL BONES FRACTURE,3
JP,FLUID RETENTION,3
JP,FOLLICULITIS,3
JP,FUNGAL SKIN INFECTION,3
JP,GASTRIC ULCER HAEMORRHAGE,3
JP,GASTRITIS EROSIVE,3
JP,GASTROINTESTINAL NECROSIS,3
JP,GASTROINTESTINAL PERFORATION,3
JP,GLOSSITIS,3
JP,GRANULOCYTOPENIA,3
JP,HAEMORRHAGE INTRACRANIAL,3
JP,HAEMORRHAGIC CEREBRAL INFARCTION,3
JP,HAEMORRHOIDS,3
JP,HALLUCINATION_ VISUAL,3
JP,HEPATIC CIRRHOSIS,3
JP,HEPATIC ENCEPHALOPATHY,3
JP,HEPATOCELLULAR CARCINOMA,3
JP,HEPATOMEGALY,3
JP,HYDROCEPHALUS,3
JP,HYPERCAPNIA,3
JP,HYPERNATRAEMIA,3
JP,HYPERPHOSPHATAEMIA,3
JP,HYPERTHERMIA,3
JP,HYPOPITUITARISM,3
JP,IIIRD NERVE PARALYSIS,3
JP,IMPAIRED HEALING,3
JP,INJURY,3
JP,INSULIN AUTOIMMUNE SYNDROME,3
JP,INTERMITTENT CLAUDICATION,3
JP,IRRITABILITY,3
JP,LEFT VENTRICULAR HYPERTROPHY,3
JP,LYMPHOCYTIC INFILTRATION,3
JP,MATERNAL EXPOSURE DURING PREGNANCY,3
JP,MECHANICAL ILEUS,3
JP,MEDICATION RESIDUE PRESENT,3
JP,MEMORY IMPAIRMENT,3
JP,MENINGITIS,3
JP,METASTASES TO BONE,3
JP,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
JP,MYASTHENIA GRAVIS,3
JP,MYOCARDIAL ISCHAEMIA,3
JP,MYOSITIS,3
JP,NECK PAIN,3
JP,NEOPLASM PROGRESSION,3
JP,NEPHROLITHIASIS,3
JP,NO ADVERSE EVENT,3
JP,NUTRITIONAL CONDITION ABNORMAL,3
JP,OCCULT BLOOD POSITIVE,3
JP,ORGANISING PNEUMONIA,3
JP,OSTEOARTHRITIS,3
JP,OSTEOMALACIA,3
JP,OXYGEN SATURATION DECREASED,3
JP,PAIN IN JAW,3
JP,PALLOR,3
JP,PARKINSON^S DISEASE,3
JP,PAROSMIA,3
JP,PERIPHERAL COLDNESS,3
JP,PERIPHERAL SWELLING,3
JP,PIGMENTATION DISORDER,3
JP,PLATELET COUNT INCREASED,3
JP,PNEUMONIA PNEUMOCOCCAL,3
JP,PNEUMONITIS,3
JP,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,3
JP,POSTRENAL FAILURE,3
JP,PRERENAL FAILURE,3
JP,PROSTATIC SPECIFIC ANTIGEN INCREASED,3
JP,PRURIGO,3
JP,PSEUDOMEMBRANOUS COLITIS,3
JP,PULMONARY CONGESTION,3
JP,PULMONARY HAEMORRHAGE,3
JP,PUTAMEN HAEMORRHAGE,3
JP,RETINAL DETACHMENT,3
JP,RETINOPATHY,3
JP,SCIATICA,3
JP,SHOCK HAEMORRHAGIC,3
JP,SHUNT OCCLUSION,3
JP,SKIN EROSION,3
JP,SMALL INTESTINAL PERFORATION,3
JP,SMALL INTESTINAL ULCER HAEMORRHAGE,3
JP,SMALL INTESTINE ULCER,3
JP,SPEECH DISORDER,3
JP,STAPHYLOCOCCAL SEPSIS,3
JP,STRESS CARDIOMYOPATHY,3
JP,SUBDURAL HAEMORRHAGE,3
JP,SWELLING,3
JP,THERAPEUTIC RESPONSE DECREASED,3
JP,THROMBECTOMY,3
JP,TIBIA FRACTURE,3
JP,TINEA PEDIS,3
JP,TOXIC SKIN ERUPTION,3
JP,TREATMENT NONCOMPLIANCE,3
JP,TYPE 1 DIABETES MELLITUS,3
JP,TYPE 2 DIABETES MELLITUS,3
JP,URINE OUTPUT DECREASED,3
JP,UTERINE DILATION AND EVACUATION,3
JP,VASCULAR PSEUDOANEURYSM,3
JP,VISION BLURRED,3
JP,VISUAL ACUITY REDUCED,3
JP,ABASIA,2
JP,ABDOMINAL PAIN LOWER,2
JP,ABORTION,2
JP,ABORTION MISSED,2
JP,ABSCESS LIMB,2
JP,ABULIA,2
JP,ACCIDENTAL OVERDOSE,2
JP,ACIDOSIS,2
JP,ACNE,2
JP,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,2
JP,ACUTE PRERENAL FAILURE,2
JP,ADENOMA BENIGN,2
JP,ADVERSE EVENT,2
JP,AGGRESSION,2
JP,ALOPECIA TOTALIS,2
JP,ANAEMIA MACROCYTIC,2
JP,ANAL HAEMORRHAGE,2
JP,ANORECTAL DISORDER,2
JP,AORTIC VALVE REPLACEMENT,2
JP,AORTIC VALVE STENOSIS,2
JP,APHTHOUS ULCER,2
JP,APPLICATION SITE ERYTHEMA,2
JP,ARTERIOVENOUS FISTULA,2
JP,ARTHROPATHY,2
JP,ASPHYXIA,2
JP,ATRIAL FLUTTER,2
JP,ATRIOVENTRICULAR BLOCK,2
JP,BACTERIAL TEST POSITIVE,2
JP,BALANCE DISORDER,2
JP,BENIGN PROSTATIC HYPERPLASIA,2
JP,BILE DUCT STONE,2
JP,BLADDER TAMPONADE,2
JP,BLOOD CORTICOTROPHIN DECREASED,2
JP,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,2
JP,BLOOD PARATHYROID HORMONE INCREASED,2
JP,BLOOD PHOSPHORUS DECREASED,2
JP,BLOOD PRESSURE DIASTOLIC DECREASED,2
JP,BLOOD PRESSURE SYSTOLIC DECREASED,2
JP,BOWEN^S DISEASE,2
JP,BRAIN HERNIATION,2
JP,BRAIN NATRIURETIC PEPTIDE INCREASED,2
JP,BRAIN STEM HAEMORRHAGE,2
JP,BRONCHOSPASM,2
JP,BUNDLE BRANCH BLOCK RIGHT,2
JP,CARBOHYDRATE ANTIGEN 19-9 INCREASED,2
JP,CAROTID ARTERY OCCLUSION,2
JP,CAROTID ARTERY STENOSIS,2
JP,CAROTID ARTERY STENT INSERTION,2
JP,CATARACT NUCLEAR,2
JP,CATARACT OPERATION,2
JP,CATHETERISATION CARDIAC,2
JP,CEREBELLAR INFARCTION,2
JP,CEREBRAL ARTERY EMBOLISM,2
JP,CHOROIDAL NEOVASCULARISATION,2
JP,CHRONIC ALLOGRAFT NEPHROPATHY,2
JP,CHRONIC HEPATITIS C,2
JP,CHYLOTHORAX,2
JP,CONJUNCTIVAL HAEMORRHAGE,2
JP,CORNEAL EROSION,2
JP,CORONARY ARTERIAL STENT INSERTION,2
JP,CSF PROTEIN INCREASED,2
JP,CYANOSIS,2
JP,CYSTITIS HAEMORRHAGIC,2
JP,DEMENTIA ALZHEIMER^S TYPE,2
JP,DENTAL CARIES,2
JP,DENTAL FISTULA,2
JP,DERMATITIS BULLOUS,2
JP,DIABETIC NEPHROPATHY,2
JP,DISSEMINATED TUBERCULOSIS,2
JP,DISUSE SYNDROME,2
JP,DIVERTICULITIS,2
JP,DRUG LEVEL DECREASED,2
JP,DRUG PRESCRIBING ERROR,2
JP,DUODENAL ULCER,2
JP,DYSMENORRHOEA,2
JP,DYSPHONIA,2
JP,DYSTONIA,2
JP,EAR PAIN,2
JP,EMERGENCY CARE,2
JP,EMPHYSEMA,2
JP,ENTERITIS,2
JP,EOSINOPHIL COUNT DECREASED,2
JP,EOSINOPHILIC PNEUMONIA,2
JP,EOSINOPHILIC PNEUMONIA ACUTE,2
JP,EPIDIDYMITIS,2
JP,ERYTHROPENIA,2
JP,EYE DISCHARGE,2
JP,EYE HAEMORRHAGE,2
JP,EYE PAIN,2
JP,FACIAL PARALYSIS,2
JP,FANCONI SYNDROME,2
JP,FEEDING DISORDER,2
JP,FEELING COLD,2
JP,FEELING HOT,2
JP,FIBULA FRACTURE,2
JP,FOOT FRACTURE,2
JP,GALLBLADDER POLYP,2
JP,GANGRENE,2
JP,GASTRIC DISORDER,2
JP,GASTRIC HAEMORRHAGE,2
JP,GASTROENTERITIS VIRAL,2
JP,GASTROINTESTINAL DISORDER,2
JP,GASTROINTESTINAL OEDEMA,2
JP,GINGIVAL SWELLING,2
JP,GINGIVITIS,2
JP,GLAUCOMA,2
JP,GLOMERULAR FILTRATION RATE DECREASED,2
JP,GLOMERULONEPHRITIS,2
JP,GLOSSODYNIA,2
JP,GLUCOSE URINE PRESENT,2
JP,HAEMATOCRIT INCREASED,2
JP,HAEMODIALYSIS,2
JP,HAEMODYNAMIC INSTABILITY,2
JP,HAEMORRHAGIC ANAEMIA,2
JP,HAEMORRHOIDAL HAEMORRHAGE,2
JP,HEMIPARESIS,2
JP,HEPATIC CANCER METASTATIC,2
JP,HEPATIC STEATOSIS,2
JP,HEPATITIS ACUTE,2
JP,HOSPITALISATION,2
JP,HOT FLUSH,2
JP,HUMERUS FRACTURE,2
JP,HYDRONEPHROSIS,2
JP,HYPERMAGNESAEMIA,2
JP,HYPERSENSITIVITY VASCULITIS,2
JP,HYPERTROPHIC CARDIOMYOPATHY,2
JP,HYPOGLYCAEMIC COMA,2
JP,HYPOMAGNESAEMIA,2
JP,HYPOPHAGIA,2
JP,HYPOTHERMIA,2
JP,ILEAL ULCER,2
JP,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
JP,INFUSION RELATED REACTION,2
JP,INGUINAL HERNIA,2
JP,INJECTION SITE PAIN,2
JP,INTESTINAL HAEMORRHAGE,2
JP,INTRACRANIAL HAEMATOMA,2
JP,JAUNDICE CHOLESTATIC,2
JP,JOINT ARTHROPLASTY,2
JP,KERATITIS,2
JP,KIDNEY TRANSPLANT REJECTION,2
JP,LACERATION,2
JP,LARGE INTESTINAL ULCER,2
JP,LEUKODERMA,2
JP,LEUKOENCEPHALOPATHY,2
JP,LIP EROSION,2
JP,LIPASE INCREASED,2
JP,LIVER ABSCESS,2
JP,LIVER FUNCTION TEST INCREASED,2
JP,LUMBAR SPINAL STENOSIS,2
JP,LUNG ADENOCARCINOMA,2
JP,LUPUS ENTERITIS,2
JP,LYMPHANGIOSIS CARCINOMATOSA,2
JP,MALIGNANT NEOPLASM OF RENAL PELVIS,2
JP,MANIA,2
JP,MASTITIS,2
JP,MEDIASTINITIS,2
JP,MENORRHAGIA,2
JP,MICROSCOPIC POLYANGIITIS,2
JP,MOUTH HAEMORRHAGE,2
JP,MOVEMENT DISORDER,2
JP,MULTI-ORGAN DISORDER,2
JP,MUSCLE HAEMORRHAGE,2
JP,MYDRIASIS,2
JP,MYOCARDITIS,2
JP,MYOGLOBIN BLOOD INCREASED,2
JP,NEPHROPATHY TOXIC,2
JP,NEUROGENIC BLADDER,2
JP,NEUROSIS,2
JP,NEUTROPHIL PERCENTAGE INCREASED,2
JP,NON-SMALL CELL LUNG CANCER,2
JP,OCULAR HYPERAEMIA,2
JP,OESOPHAGEAL CARCINOMA,2
JP,OLIGURIA,2
JP,ORAL CANDIDIASIS,2
JP,ORAL HERPES,2
JP,OROPHARYNGEAL DISCOMFORT,2
JP,ORTHOSTATIC HYPOTENSION,2
JP,OTITIS MEDIA,2
JP,OTORRHOEA,2
JP,OVARIAN CYST,2
JP,PACKED RED BLOOD CELL TRANSFUSION,2
JP,PANCREATIC FISTULA,2
JP,PANCREATIC NEUROENDOCRINE TUMOUR,2
JP,PANCREATITIS,2
JP,PAPILLARY THYROID CANCER,2
JP,PARKINSONISM,2
JP,PARONYCHIA,2
JP,PERCUTANEOUS CORONARY INTERVENTION,2
JP,PERFORMANCE STATUS DECREASED,2
JP,PERICARDIAL EFFUSION,2
JP,PERICARDIAL HAEMORRHAGE,2
JP,PERSECUTORY DELUSION,2
JP,PHARYNGEAL ERYTHEMA,2
JP,PHARYNGEAL OEDEMA,2
JP,PHOTOSENSITIVITY REACTION,2
JP,PITUITARY-DEPENDENT CUSHING^S SYNDROME,2
JP,PLACENTAL INSUFFICIENCY,2
JP,PLATELET COUNT ABNORMAL,2
JP,PNEUMATOSIS INTESTINALIS,2
JP,PNEUMOTHORAX SPONTANEOUS,2
JP,POLYMYALGIA RHEUMATICA,2
JP,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,2
JP,POLYPECTOMY,2
JP,PORIOMANIA,2
JP,POSTMENOPAUSAL HAEMORRHAGE,2
JP,POSTURE ABNORMAL,2
JP,PRE-ECLAMPSIA,2
JP,PREMATURE LABOUR,2
JP,PRODUCT USE IN UNAPPROVED INDICATION,2
JP,PROSTATITIS,2
JP,PROTEIN URINE,2
JP,PROTHROMBIN TIME PROLONGED,2
JP,PSOAS ABSCESS,2
JP,PUBIS FRACTURE,2
JP,PULMONARY ALVEOLAR HAEMORRHAGE,2
JP,PULMONARY INFARCTION,2
JP,PULMONARY MASS,2
JP,PULMONARY TUBERCULOSIS,2
JP,PURULENCE,2
JP,PUSTULAR PSORIASIS,2
JP,QUALITY OF LIFE DECREASED,2
JP,RASH MACULO-PAPULAR,2
JP,RASH PAPULAR,2
JP,RASH PRURITIC,2
JP,RENAL CELL CARCINOMA,2
JP,RENAL CYST,2
JP,RENAL TUBULAR DISORDER,2
JP,RENOVASCULAR HYPERTENSION,2
JP,RESPIRATORY ARREST,2
JP,RHINITIS,2
JP,RHINORRHOEA,2
JP,RIGHT VENTRICULAR FAILURE,2
JP,SALIVARY HYPERSECRETION,2
JP,SARCOIDOSIS,2
JP,SEASONAL ALLERGY,2
JP,SINUS NODE DYSFUNCTION,2
JP,SINUS TACHYCARDIA,2
JP,SJOGREN^S SYNDROME,2
JP,SKIN INDURATION,2
JP,SKIN PAPILLOMA,2
JP,SKULL FRACTURE,2
JP,SMALL INTESTINAL HAEMORRHAGE,2
JP,SMALL INTESTINAL OBSTRUCTION,2
JP,SNEEZING,2
JP,SPINAL COLUMN STENOSIS,2
JP,SPINAL DEFORMITY,2
JP,STAPHYLOCOCCAL BACTERAEMIA,2
JP,SUBCUTANEOUS HAEMATOMA,2
JP,SWELLING FACE,2
JP,SYNOVIAL CYST,2
JP,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,2
JP,TENOSYNOVITIS,2
JP,THROMBOSIS,2
JP,THROMBOSIS IN DEVICE,2
JP,THROMBOTIC MICROANGIOPATHY,2
JP,TINEA INFECTION,2
JP,TOOTHACHE,2
JP,TRACHEOSTOMY,2
JP,TRANSITIONAL CELL CARCINOMA,2
JP,UNDERDOSE,2
JP,URETERIC CANCER,2
JP,URETEROLITHIASIS,2
JP,URINARY BLADDER HAEMORRHAGE,2
JP,URINARY INCONTINENCE,2
JP,URINE KETONE BODY PRESENT,2
JP,UTERINE HAEMORRHAGE,2
JP,UTERINE LEIOMYOMA,2
JP,VASCULAR CALCIFICATION,2
JP,VASODILATATION,2
JP,VENOUS THROMBOSIS LIMB,2
JP,VERTIGO,2
JP,VIRAL UPPER RESPIRATORY TRACT INFECTION,2
JP,VISUAL IMPAIRMENT,2
JP,WATER INTOXICATION,2
JP,WITHDRAWAL SYNDROME,2
JP,WOUND INFECTION,2
JP,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
JP,ABDOMINAL ABSCESS,1
JP,ABSCESS,1
JP,ABSCESS JAW,1
JP,ABSCESS ORAL,1
JP,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
JP,ACTINIC KERATOSIS,1
JP,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,1
JP,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
JP,ACUTE HEPATIC FAILURE,1
JP,ADENOMYOSIS,1
JP,ADENOVIRAL HAEMORRHAGIC CYSTITIS,1
JP,ADULT T-CELL LYMPHOMA/LEUKAEMIA,1
JP,AGE-RELATED MACULAR DEGENERATION,1
JP,AKATHISIA,1
JP,ALANINE AMINOTRANSFERASE ABNORMAL,1
JP,ALBUMINURIA,1
JP,ALLERGIC COUGH,1
JP,ALLERGIC TRANSFUSION REACTION,1
JP,AMENORRHOEA,1
JP,AMMONIA INCREASED,1
JP,AMYOTROPHIC LATERAL SCLEROSIS,1
JP,ANAL CANCER,1
JP,ANAL PROLAPSE,1
JP,ANAL ULCER,1
JP,ANAPHYLACTOID REACTION,1
JP,ANASTOMOTIC STENOSIS,1
JP,ANGER,1
JP,ANGIOCENTRIC LYMPHOMA,1
JP,ANGIOPLASTY,1
JP,ANGLE CLOSURE GLAUCOMA,1
JP,ANOGENITAL WARTS,1
JP,ANOMALOUS ARRANGEMENT OF PANCREATICOBILIARY DUCT,1
JP,ANTI-GAD ANTIBODY,1
JP,ANTI-INSULIN ANTIBODY,1
JP,ANTI-PLATELET ANTIBODY POSITIVE,1
JP,ANTINUCLEAR ANTIBODY POSITIVE,1
JP,ANTIPHOSPHOLIPID SYNDROME,1
JP,APHAGIA,1
JP,APHASIA,1
JP,APLASTIC ANAEMIA,1
JP,APNOEA,1
JP,APPLICATION SITE CELLULITIS,1
JP,APPLICATION SITE DERMATITIS,1
JP,APPLICATION SITE EXFOLIATION,1
JP,APPLICATION SITE RASH,1
JP,ARTERIAL OCCLUSIVE DISEASE,1
JP,ARTERIAL STENOSIS,1
JP,ARTERIOSCLEROSIS CORONARY ARTERY,1
JP,ARTERY DISSECTION,1
JP,ARTHRITIS FUNGAL,1
JP,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
JP,ASPERGILLOSIS ORAL,1
JP,ATAXIA,1
JP,ATELECTASIS,1
JP,ATYPICAL MYCOBACTERIAL INFECTION,1
JP,AUTOIMMUNE DISORDER,1
JP,AUTOIMMUNE HEPATITIS,1
JP,AUTOIMMUNE MYOCARDITIS,1
JP,AZOTAEMIA,1
JP,BACTERAEMIA,1
JP,BASAL CELL CARCINOMA,1
JP,BASEDOW^S DISEASE,1
JP,BENIGN PANCREATIC NEOPLASM,1
JP,BETA 2 MICROGLOBULIN INCREASED,1
JP,BILE DUCT STENOSIS,1
JP,BILIARY CIRRHOSIS PRIMARY,1
JP,BILIARY DILATATION,1
JP,BIOPSY LIVER ABNORMAL,1
JP,BIPOLAR I DISORDER,1
JP,BLADDER CANCER RECURRENT,1
JP,BLADDER DISORDER,1
JP,BLADDER PAPILLOMA,1
JP,BLADDER TRANSITIONAL CELL CARCINOMA,1
JP,BLAST CELL COUNT INCREASED,1
JP,BLINDNESS,1
JP,BLINDNESS UNILATERAL,1
JP,BLOOD ALKALINE PHOSPHATASE DECREASED,1
JP,BLOOD CALCIUM INCREASED,1
JP,BLOOD CHLORIDE DECREASED,1
JP,BLOOD CORTISOL DECREASED,1
JP,BLOOD CREATINE INCREASED,1
JP,BLOOD CREATINE PHOSPHOKINASE DECREASED,1
JP,BLOOD CREATININE DECREASED,1
JP,BLOOD GASES ABNORMAL,1
JP,BLOOD GLUCOSE ABNORMAL,1
JP,BLOOD GLUCOSE DECREASED,1
JP,BLOOD GLUCOSE FLUCTUATION,1
JP,BLOOD IMMUNOGLOBULIN G DECREASED,1
JP,BLOOD KETONE BODY INCREASED,1
JP,BLOOD LACTIC ACID INCREASED,1
JP,BLOOD MAGNESIUM INCREASED,1
JP,BLOOD PRESSURE ABNORMAL,1
JP,BLOOD PRESSURE FLUCTUATION,1
JP,BLOOD PRESSURE SYSTOLIC INCREASED,1
JP,BLOOD PYRUVIC ACID INCREASED,1
JP,BLOOD THYROID STIMULATING HORMONE DECREASED,1
JP,BLOOD THYROID STIMULATING HORMONE INCREASED,1
JP,BLOOD TRIGLYCERIDES DECREASED,1
JP,BLOOD TRYPSIN INCREASED,1
JP,BLOOD UREA DECREASED,1
JP,BLOOD URINE,1
JP,BODY TEMPERATURE INCREASED,1
JP,BODY TINEA,1
JP,BONE DENSITY DECREASED,1
JP,BONE NEOPLASM,1
JP,BONE PAIN,1
JP,BRAIN CONTUSION,1
JP,BRAIN NEOPLASM,1
JP,BREAST CANCER FEMALE,1
JP,BRONCHIAL DISORDER,1
JP,BRONCHIAL OBSTRUCTION,1
JP,BRONCHIOLITIS,1
JP,BRONCHOPNEUMONIA,1
JP,BRONCHOSTENOSIS,1
JP,BULIMIA NERVOSA,1
JP,BURNING SENSATION,1
JP,BURSITIS,1
JP,CACHEXIA,1
JP,CALCULUS URETERIC,1
JP,CALCULUS URINARY,1
JP,CAMPTOCORMIA,1
JP,CAPILLARY PERMEABILITY INCREASED,1
JP,CARCINOEMBRYONIC ANTIGEN INCREASED,1
JP,CARDIAC ABLATION,1
JP,CARDIAC DISORDER,1
JP,CARDIAC OUTPUT DECREASED,1
JP,CARDIAC PACEMAKER INSERTION,1
JP,CARDIAC SARCOIDOSIS,1
JP,CARDIOACTIVE DRUG LEVEL INCREASED,1
JP,CARDIOLIPIN ANTIBODY POSITIVE,1
JP,CARDIOMEGALY,1
JP,CAROTID ARTERIAL EMBOLUS,1
JP,CAROTID ARTERY THROMBOSIS,1
JP,CAROTID PULSE DECREASED,1
JP,CAUDA EQUINA SYNDROME,1
JP,CELLULITIS PHARYNGEAL,1
JP,CEREBRAL ARTERIOSCLEROSIS,1
JP,CEREBRAL ARTERY OCCLUSION,1
JP,CEREBRAL ARTERY STENOSIS,1
JP,CEREBRAL THROMBOSIS,1
JP,CEREBRAL VENTRICULAR RUPTURE,1
JP,CERVICAL SPINAL STENOSIS,1
JP,CERVICAL VERTEBRAL FRACTURE,1
JP,CERVIX CARCINOMA,1
JP,CHALAZION,1
JP,CHEMOTHERAPY,1
JP,CHOKING,1
JP,CHOLANGIOCARCINOMA,1
JP,CHOLECYSTECTOMY,1
JP,CHOLESTASIS,1
JP,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,1
JP,CHRONIC MYELOID LEUKAEMIA,1
JP,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
JO,MUSCLE RUPTURE,1
JO,PNEUMONITIS,1
KR,PNEUMONIA,15
KR,DIARRHOEA,11
KR,CEREBRAL INFARCTION,9
KR,PYREXIA,9
KR,DYSPNOEA,8
KR,ASTHENIA,7
KR,NAUSEA,7
KR,ACUTE KIDNEY INJURY,5
KR,SEIZURE,5
KR,VOMITING,5
KR,DIZZINESS,4
KR,DYSPEPSIA,4
KR,FALL,4
KR,HYPERGLYCAEMIA,4
KR,MELAENA,4
KR,PLEURAL EFFUSION,4
KR,ACUTE MYOCARDIAL INFARCTION,3
KR,ALANINE AMINOTRANSFERASE INCREASED,3
KR,ATRIAL FIBRILLATION,3
KR,BENIGN PROSTATIC HYPERPLASIA,3
KR,BLOOD PRESSURE DECREASED,3
KR,CARDIAC ARREST,3
KR,CARDIAC FAILURE,3
KR,CEREBRAL HAEMORRHAGE,3
KR,COUGH,3
KR,DEATH,3
KR,DIABETES MELLITUS,3
KR,GASTRIC ULCER,3
KR,HAEMOPTYSIS,3
KR,HYDRONEPHROSIS,3
KR,HYPONATRAEMIA,3
KR,NEUTROPENIA,3
KR,WEIGHT DECREASED,3
KR,ANAL ABSCESS,2
KR,ARTERIOSCLEROSIS,2
KR,ARTHRALGIA,2
KR,ARTHRITIS,2
KR,ARTHRITIS BACTERIAL,2
KR,BLOOD ALKALINE PHOSPHATASE INCREASED,2
KR,BLOOD CREATININE INCREASED,2
KR,CARDIAC FAILURE CONGESTIVE,2
KR,CEREBROVASCULAR ACCIDENT,2
KR,CHEST DISCOMFORT,2
KR,CHEST PAIN,2
KR,DECREASED APPETITE,2
KR,DEHYDRATION,2
KR,FEBRILE NEUTROPENIA,2
KR,FRACTURE,2
KR,GAIT DISTURBANCE,2
KR,GENERALISED OEDEMA,2
KR,HAEMORRHAGE,2
KR,HEADACHE,2
KR,HYPERKALAEMIA,2
KR,HYPOAESTHESIA,2
KR,HYPOPHAGIA,2
KR,ILEUS PARALYTIC,2
KR,INFECTIOUS COLITIS,2
KR,LARGE INTESTINE POLYP,2
KR,LEUKOCYTOSIS,2
KR,LIVER FUNCTION TEST ABNORMAL,2
KR,LUMBAR VERTEBRAL FRACTURE,2
KR,LYMPHOEDEMA,2
KR,MALIGNANT NEOPLASM PROGRESSION,2
KR,MUSCULAR WEAKNESS,2
KR,NEPHROLITHIASIS,2
KR,OEDEMA PERIPHERAL,2
KR,OSTEONECROSIS,2
KR,PAIN,2
KR,PAIN IN EXTREMITY,2
KR,PALPITATIONS,2
KR,PARAESTHESIA,2
KR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
KR,PLATELET COUNT DECREASED,2
KR,PRODUCTIVE COUGH,2
KR,PULMONARY CONGESTION,2
KR,PULMONARY EMBOLISM,2
KR,RENAL IMPAIRMENT,2
KR,RHABDOMYOLYSIS,2
KR,SLEEP DISORDER,2
KR,SOMNOLENCE,2
KR,SUBDURAL HAEMORRHAGE,2
KR,TRANSIENT ISCHAEMIC ATTACK,2
KR,URINARY TRACT INFECTION,2
KR,ABDOMINAL DISCOMFORT,1
KR,ABDOMINAL DISTENSION,1
KR,ABDOMINAL PAIN UPPER,1
KR,ABORTION MISSED,1
KR,ALCOHOLISM,1
KR,AMNESIA,1
KR,ANGINA PECTORIS,1
KR,ANKLE FRACTURE,1
KR,ANXIETY,1
KR,APPENDICITIS,1
KR,ASPARTATE AMINOTRANSFERASE INCREASED,1
KR,ASPHYXIA,1
KR,ASPIRATION PLEURAL CAVITY,1
KR,ATRIAL FLUTTER,1
KR,ATRIOVENTRICULAR BLOCK COMPLETE,1
KR,ATYPICAL PNEUMONIA,1
KR,AZOTAEMIA,1
KR,BACK INJURY,1
KR,BACK PAIN,1
KR,BILE DUCT STONE,1
KR,BIOPSY PROSTATE,1
KR,BLOOD BILIRUBIN INCREASED,1
KR,BLOOD CREATINE INCREASED,1
KR,BLOOD PRESSURE FLUCTUATION,1
KR,BLOOD PRESSURE INCREASED,1
KR,BRONCHIAL HAEMORRHAGE,1
KR,C-REACTIVE PROTEIN INCREASED,1
KR,CARDIAC HYPERTROPHY,1
KR,CARDIOGENIC SHOCK,1
KR,CAROTID ARTERY STENOSIS,1
KR,CATARACT,1
KR,CERVICAL SPINAL STENOSIS,1
KR,CHEST INJURY,1
KR,CHOLANGITIS,1
KR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
KR,COLITIS ISCHAEMIC,1
KR,COLON ADENOMA,1
KR,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
KR,CONDITION AGGRAVATED,1
KR,CONSTIPATION,1
KR,CONTRAINDICATED PRODUCT ADMINISTERED,1
KR,CORONARY ARTERY DISEASE,1
KR,CORONARY ARTERY STENOSIS,1
KR,CYTOMEGALOVIRUS INFECTION,1
KR,DEEP VEIN THROMBOSIS,1
KR,DEMENTIA,1
KR,DEPRESSED MOOD,1
KR,DERMATITIS,1
KR,DERMATITIS BULLOUS,1
KR,DISEASE PROGRESSION,1
KR,DRUG INEFFECTIVE,1
KR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
KR,DRUG-INDUCED LIVER INJURY,1
KR,DYSARTHRIA,1
KR,DYSPHAGIA,1
KR,ELECTROCARDIOGRAM ST-T SEGMENT DEPRESSION,1
KR,ELECTROMYOGRAM ABNORMAL,1
KR,ENDOMETRIAL HYPERPLASIA,1
KR,ENTEROBACTER BACTERAEMIA,1
KR,EPENDYMOMA,1
KR,EPIGASTRIC DISCOMFORT,1
KR,EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE),1
KR,EYE HAEMORRHAGE,1
KR,EYE MOVEMENT DISORDER,1
KR,EYELID PTOSIS,1
KR,FACE INJURY,1
KR,FEMORAL NECK FRACTURE,1
KR,FLATULENCE,1
KR,FOOD CRAVING,1
KR,FOOT FRACTURE,1
KR,FRACTURE TREATMENT,1
KR,FRACTURED COCCYX,1
KR,FRACTURED SACRUM,1
KR,FUNCTIONAL GASTROINTESTINAL DISORDER,1
KR,GASTRIC CANCER,1
KR,GASTRIC HAEMORRHAGE,1
KR,GASTRIC POLYPS,1
KR,GASTRIC ULCER HAEMORRHAGE,1
KR,GASTRITIS,1
KR,GASTROINTESTINAL HAEMORRHAGE,1
KR,GASTROOESOPHAGEAL REFLUX DISEASE,1
KR,GENETIC POLYMORPHISM,1
KR,GINGIVAL BLEEDING,1
KR,GINGIVAL DISORDER,1
KR,GOUT,1
KR,HAEMATEMESIS,1
KR,HAEMATOCHEZIA,1
KR,HAEMATOMA,1
KR,HAEMATURIA,1
KR,HEPATIC ENZYME INCREASED,1
KR,HEPATIC FAILURE,1
KR,HEPATITIS,1
KR,HEPATITIS TOXIC,1
KR,HUMERUS FRACTURE,1
KR,HYPERHIDROSIS,1
KR,HYPERLIPIDAEMIA,1
KR,HYPEROSMOLAR HYPERGLYCAEMIC STATE,1
KR,HYPERTENSIVE CRISIS,1
KR,HYPOALBUMINAEMIA,1
KR,HYPOGLYCAEMIA,1
KR,ILEUS,1
KR,INFLAMMATION,1
KR,INFLUENZA,1
KR,INGUINAL HERNIA,1
KR,INSOMNIA,1
KR,INTELLECTUAL DISABILITY,1
KR,INTERMITTENT CLAUDICATION,1
KR,INTERSTITIAL LUNG DISEASE,1
KR,INTERVERTEBRAL DISC PROTRUSION,1
KR,INTRA-ABDOMINAL HAEMATOMA,1
KR,JOINT SWELLING,1
KR,LIGAMENT DISORDER,1
KR,LIGAMENT RUPTURE,1
KR,LORDOSIS,1
KR,LOSS OF CONSCIOUSNESS,1
KR,LUMBAR SPINAL STENOSIS,1
KR,LUNG INFECTION,1
KR,LUNG NEOPLASM MALIGNANT,1
KR,MENOPAUSE,1
KR,MENTAL IMPAIRMENT,1
KR,METABOLIC ACIDOSIS,1
KR,METABOLIC ENCEPHALOPATHY,1
KR,MONONEURITIS,1
KR,MONOPLEGIA,1
KR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
KR,MUSCLE ATROPHY,1
KR,MUSCLE CONTRACTURE,1
KR,MUSCULOSKELETAL PAIN,1
KR,MUSCULOSKELETAL STIFFNESS,1
KR,MYOCARDIAL ISCHAEMIA,1
KR,MYOPATHY,1
KR,MYOSITIS,1
KR,NASAL DISCOMFORT,1
KR,NASOPHARYNGITIS,1
KR,NEPHROPATHY,1
KR,NEPHROSTOMY,1
KR,NEUTROPENIC COLITIS,1
KR,NOCTURIA,1
KR,OBSTRUCTIVE AIRWAYS DISORDER,1
KR,OEDEMA,1
KR,OESOPHAGEAL FOOD IMPACTION,1
KR,ORAL PAIN,1
KR,ORGANISING PNEUMONIA,1
KR,OROPHARYNGEAL PAIN,1
KR,OSTEOARTHRITIS,1
KR,OSTEOPOROSIS,1
KR,OVARIAN CANCER,1
KR,OXYGEN SATURATION DECREASED,1
KR,PANCREATIC CARCINOMA,1
KR,PANCREATIC CYST RUPTURE,1
KR,PANCREATITIS,1
KR,PARONYCHIA,1
KR,PERICARDIAL HAEMORRHAGE,1
KR,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED,1
KR,PHARYNGEAL INFLAMMATION,1
KR,POLLAKIURIA,1
KR,POLYPECTOMY,1
KR,POLYURIA,1
KR,POST PROCEDURAL HAEMORRHAGE,1
KR,POST PROCEDURAL OEDEMA,1
KR,POST STROKE SEIZURE,1
KR,POSTICTAL STATE,1
KR,POSTOPERATIVE WOUND INFECTION,1
KR,POVERTY OF SPEECH,1
KR,PRESBYACUSIS,1
KR,PRESCRIBED UNDERDOSE,1
KR,PROCTALGIA,1
KR,PROSTATE CANCER,1
KR,PROSTATIC OPERATION,1
KR,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
KR,PRURITUS,1
KR,PULMONARY HAEMORRHAGE,1
KR,PULMONARY HYPERTENSION,1
KR,PULMONARY OEDEMA,1
KR,PULMONARY TUBERCULOSIS,1
KR,RASH,1
KR,RECTAL CANCER,1
KR,RECTAL ULCER,1
KR,REMOVAL OF FOREIGN BODY,1
KR,RENAL ABSCESS,1
KR,RENAL FUNCTION TEST ABNORMAL,1
KR,ROAD TRAFFIC ACCIDENT,1
KR,SEPSIS,1
KR,SHOCK,1
KR,SPINAL COMPRESSION FRACTURE,1
KR,SPINAL CORD COMPRESSION,1
KR,SPINAL CORD NEOPLASM,1
KR,SPUTUM ABNORMAL,1
KR,STAPHYLOCOCCAL INFECTION,1
KR,STOMATITIS,1
KR,SUBCUTANEOUS ABSCESS,1
KR,SURGERY,1
KR,SWELLING FACE,1
KR,SYNCOPE,1
KR,SYSTEMIC IMMUNE ACTIVATION,1
KR,TACHYARRHYTHMIA,1
KR,TENDON RUPTURE,1
KR,THALAMUS HAEMORRHAGE,1
KR,THIRST,1
KR,THROMBOCYTOPENIA,1
KR,THROMBOSIS IN DEVICE,1
KR,TINNITUS,1
KR,TRANSFUSION,1
KR,TUBERCULOSIS,1
KR,TUMOUR EXCISION,1
KR,URINARY INCONTINENCE,1
KR,URTICARIA,1
KR,UTERINE POLYP,1
KR,VASCULAR PARKINSONISM,1
KR,VASCULAR STENT STENOSIS,1
KR,VENTRICULAR FIBRILLATION,1
KR,VERTEBROBASILAR INSUFFICIENCY,1
KR,VERTIGO POSITIONAL,1
KR,WHITE BLOOD CELL COUNT ABNORMAL,1
KR,WHITE MATTER LESION,1
KW,ANAEMIA,4
KW,DRUG INEFFECTIVE,3
KW,RHABDOMYOLYSIS,3
KW,ACUTE KIDNEY INJURY,2
KW,ANURIA,2
KW,COMPLICATIONS OF TRANSPLANTED KIDNEY,2
KW,ABASIA,1
KW,ADVERSE REACTION,1
KW,ARTHRALGIA,1
KW,ASPARTATE AMINOTRANSFERASE INCREASED,1
KW,ASTHENIA,1
KW,BLOOD BILIRUBIN INCREASED,1
KW,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
KW,DEATH,1
KW,DIZZINESS,1
KW,DRUG LEVEL INCREASED,1
KW,FALL,1
KW,FATIGUE,1
KW,FEMUR FRACTURE,1
KW,GAIT DISTURBANCE,1
KW,HAEMOGLOBIN DECREASED,1
KW,HAEMORRHAGIC STROKE,1
KW,HYPOKINESIA,1
KW,JOINT SWELLING,1
KW,KIDNEY FIBROSIS,1
KW,MOTOR DYSFUNCTION,1
KW,MYALGIA,1
KW,MYOCARDIAL INFARCTION,1
KW,MYOCARDIAL ISCHAEMIA,1
KW,PANCREATIC PSEUDOCYST,1
KW,PANCREATITIS NECROTISING,1
KW,RENAL TUBULAR ATROPHY,1
KW,RENAL TUBULAR NECROSIS,1
KW,TOXICITY TO VARIOUS AGENTS,1
KW,TRANSIENT ISCHAEMIC ATTACK,1
LV,GLOMERULAR FILTRATION RATE DECREASED,1
LB,HYPERTENSION,4
LB,CHEST PAIN,3
LB,COUGH,3
LB,DYSPNOEA,3
LB,GLYCOSYLATED HAEMOGLOBIN INCREASED,3
LB,HYPERGLYCAEMIA,3
LB,INFLUENZA,3
LB,ABDOMINAL DISTENSION,2
LB,ABDOMINAL PAIN UPPER,2
LB,ANXIETY,2
LB,BLOOD CREATININE INCREASED,2
LB,BRONCHITIS,2
LB,DRY MOUTH,2
LB,DRY SKIN,2
LB,DYSLIPIDAEMIA,2
LB,FATIGUE,2
LB,FLUID RETENTION,2
LB,HEADACHE,2
LB,HEPATIC CIRRHOSIS,2
LB,HYPOGLYCAEMIA,2
LB,LUNG INFECTION,2
LB,PALPITATIONS,2
LB,PYREXIA,2
LB,RASH,2
LB,URINARY TRACT INFECTION,2
LB,VOMITING,2
LB,WEIGHT DECREASED,2
LB,ADENOIDAL HYPERTROPHY,1
LB,AGGRESSION,1
LB,AGITATION,1
LB,ALOPECIA,1
LB,ANAEMIA,1
LB,ARTERIAL STENOSIS,1
LB,ASTHENIA,1
LB,ASTHMATIC CRISIS,1
LB,BACK PAIN,1
LB,BLOOD GLUCOSE INCREASED,1
LB,BLOOD POTASSIUM INCREASED,1
LB,CALCIFICATION OF MUSCLE,1
LB,CARDIAC DISORDER,1
LB,CARDIAC OPERATION,1
LB,CONDITION AGGRAVATED,1
LB,CORONARY ARTERY STENOSIS,1
LB,CYTOGENETIC ANALYSIS ABNORMAL,1
LB,DEMENTIA ALZHEIMER^S TYPE,1
LB,DEPRESSION,1
LB,DERMATITIS BULLOUS,1
LB,DERMATITIS EXFOLIATIVE,1
LB,DIARRHOEA,1
LB,DIZZINESS,1
LB,DYSPEPSIA,1
LB,EAR DISORDER,1
LB,EAR PAIN,1
LB,EPISTAXIS,1
LB,FACE OEDEMA,1
LB,FUNGAL INFECTION,1
LB,FURUNCLE,1
LB,GASTROINTESTINAL HAEMORRHAGE,1
LB,GENERAL PHYSICAL HEALTH DETERIORATION,1
LB,GLYCOSYLATED HAEMOGLOBIN DECREASED,1
LB,GRANULOMA SKIN,1
LB,HAEMATOCRIT DECREASED,1
LB,HOT FLUSH,1
LB,HYPOACUSIS,1
LB,HYPOTENSION,1
LB,INFECTION,1
LB,INSOMNIA,1
LB,INTERMITTENT CLAUDICATION,1
LB,INTERVERTEBRAL DISC PROTRUSION,1
LB,LYMPHOMA,1
LB,MEDICATION ERROR,1
LB,MULTIPLE SCLEROSIS,1
LB,MUSCULAR WEAKNESS,1
LB,MUSCULOSKELETAL CHEST PAIN,1
LB,MYALGIA,1
LB,MYOCARDIAL INFARCTION,1
LB,NECK PAIN,1
LB,NEPHRECTOMY,1
LB,NEURALGIA,1
LB,NIGHT SWEATS,1
LB,OXYGEN SATURATION DECREASED,1
LB,PAIN,1
LB,PAIN IN EXTREMITY,1
LB,PARAESTHESIA,1
LB,PERICARDIAL EFFUSION,1
LB,PLATELET COUNT INCREASED,1
LB,PNEUMONIA,1
LB,PROCEDURAL PAIN,1
LB,PROSTATE INFECTION,1
LB,PRURITUS,1
LB,PULMONARY OEDEMA,1
LB,RETROPERITONEAL HAEMORRHAGE,1
LB,SINUSITIS,1
LB,SKIN DISORDER,1
LB,SOMNOLENCE,1
LB,STENOSIS,1
LB,TACHYCARDIA,1
LB,THROMBOCYTOPENIA,1
LB,THROMBOCYTOSIS,1
LB,TROPONIN I INCREASED,1
LB,URINARY RETENTION,1
LB,UTERINE LEIOMYOMA,1
LB,VASCULAR CALCIFICATION,1
LB,VISION BLURRED,1
LB,VITAMIN B12 DEFICIENCY,1
LB,VITAMIN D DEFICIENCY,1
LB,WOUND,1
LT,HYPERSENSITIVITY VASCULITIS,1
LU,RHABDOMYOLYSIS,3
LU,DEHYDRATION,2
LU,DYSPNOEA,2
LU,FALL,2
LU,HEPATIC FUNCTION ABNORMAL,2
LU,NEPHROTIC SYNDROME,2
LU,RENAL FAILURE,2
LU,ABASIA,1
LU,ANAEMIA,1
LU,ASTHENIA,1
LU,BLOOD LACTATE DEHYDROGENASE INCREASED,1
LU,BURNING SENSATION,1
LU,CARDIAC DISORDER,1
LU,CEREBROVASCULAR ACCIDENT,1
LU,CHEST PAIN,1
LU,CHOLECYSTITIS,1
LU,CIRRHOSIS ALCOHOLIC,1
LU,COUGH,1
LU,CYANOSIS,1
LU,DEATH,1
LU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
LU,HAEMOGLOBIN DECREASED,1
LU,HYPERNATRAEMIA,1
LU,HYPOTHERMIA,1
LU,HYPOTHYROIDISM,1
LU,KETOACIDOSIS,1
LU,LACUNAR INFARCTION,1
LU,LOW DENSITY LIPOPROTEIN INCREASED,1
LU,OCULAR ICTERUS,1
LU,OEDEMA,1
LU,PAIN IN EXTREMITY,1
LU,PARAESTHESIA,1
LU,RENAL FAILURE ACUTE,1
LU,RESPIRATORY DISORDER,1
LU,SKIN DISCOLOURATION,1
LU,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
LU,THROMBOCYTOPENIA,1
LU,TRANSAMINASES INCREASED,1
LU,TRANSIENT ISCHAEMIC ATTACK,1
LU,URINE ABNORMALITY,1
MY,CEREBROVASCULAR ACCIDENT,2
MY,ABDOMINAL DISCOMFORT,1
MY,ABDOMINAL PAIN,1
MY,ABDOMINAL RIGIDITY,1
MY,BACK PAIN,1
MY,BLOOD PRESSURE FLUCTUATION,1
MY,BLOOD PRESSURE INCREASED,1
MY,BRONCHITIS,1
MY,CARDIAC FAILURE CHRONIC,1
MY,CHOLANGIOCARCINOMA,1
MY,CONSTIPATION,1
MY,CORONARY ARTERY OCCLUSION,1
MY,DEATH,1
MY,DIABETES MELLITUS,1
MY,DIARRHOEA,1
MY,DROOLING,1
MY,DYSARTHRIA,1
MY,ERECTILE DYSFUNCTION,1
MY,FAECES DISCOLOURED,1
MY,FALL,1
MY,FEELING ABNORMAL,1
MY,FLATULENCE,1
MY,HAEMORRHAGE,1
MY,HAEMORRHAGE INTRACRANIAL,1
MY,HEADACHE,1
MY,HYPERLIPIDAEMIA,1
MY,HYPOAESTHESIA,1
MY,INTENTIONAL DRUG MISUSE,1
MY,LOWER LIMB FRACTURE,1
MY,MEMORY IMPAIRMENT,1
MY,MUSCLE INJURY,1
MY,MUSCLE SPASMS,1
MY,MYALGIA,1
MY,MYOSITIS,1
MY,NAUSEA,1
MY,PALPITATIONS,1
MY,PELVIC INFLAMMATORY DISEASE,1
MY,SOMNOLENCE,1
MY,SUICIDAL IDEATION,1
MY,THYROGLOBULIN INCREASED,1
MY,TREMOR,1
MY,UTERINE LEIOMYOMA,1
MY,VASCULAR STENT STENOSIS,1
MY,WEIGHT DECREASED,1
MY,WEIGHT INCREASED,1
MX,CEREBROVASCULAR ACCIDENT,13
MX,DIABETES MELLITUS,12
MX,INFARCTION,12
MX,DEAFNESS,11
MX,DEATH,11
MX,MYOCARDIAL INFARCTION,10
MX,CEREBRAL INFARCTION,9
MX,HYPERTENSION,9
MX,EMBOLISM,8
MX,FALL,8
MX,GAIT DISTURBANCE,8
MX,SPEECH DISORDER,8
MX,BLINDNESS,7
MX,BLOOD PRESSURE INCREASED,7
MX,PAIN IN EXTREMITY,7
MX,APHASIA,6
MX,ARTHRALGIA,6
MX,ABASIA,5
MX,FATIGUE,5
MX,GENERAL PHYSICAL HEALTH DETERIORATION,5
MX,MALAISE,5
MX,MEMORY IMPAIRMENT,5
MX,MOVEMENT DISORDER,5
MX,PAIN,5
MX,PNEUMONIA,5
MX,ASTHENIA,4
MX,BLOOD CHOLESTEROL INCREASED,4
MX,BLOOD GLUCOSE INCREASED,4
MX,DIZZINESS,4
MX,DYSPNOEA,4
MX,GASTRITIS,4
MX,MOBILITY DECREASED,4
MX,ANAEMIA,3
MX,ARTERIAL OCCLUSIVE DISEASE,3
MX,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
MX,CARDIAC FAILURE,3
MX,DEHYDRATION,3
MX,HEADACHE,3
MX,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
MX,OVERWEIGHT,3
MX,PRODUCT USE ISSUE,3
MX,RESPIRATORY FAILURE,3
MX,SENILE DEMENTIA,3
MX,STRESS,3
MX,THROMBOSIS,3
MX,TOXIC NEUROPATHY,3
MX,VISUAL IMPAIRMENT,3
MX,WEIGHT DECREASED,3
MX,ANGINA PECTORIS,2
MX,ARTHROPATHY,2
MX,ATRIAL FIBRILLATION,2
MX,BACK PAIN,2
MX,BENIGN PROSTATIC HYPERPLASIA,2
MX,BLOOD PRESSURE FLUCTUATION,2
MX,BLOOD PRESSURE INADEQUATELY CONTROLLED,2
MX,BLOOD TRIGLYCERIDES INCREASED,2
MX,CARDIAC DISORDER,2
MX,CATARACT,2
MX,COLITIS,2
MX,DEMENTIA ALZHEIMER^S TYPE,2
MX,DEPRESSION,2
MX,DIET REFUSAL,2
MX,DRUG PRESCRIBING ERROR,2
MX,DYSPEPSIA,2
MX,EPISTAXIS,2
MX,FEELING ABNORMAL,2
MX,FLANK PAIN,2
MX,GAIT INABILITY,2
MX,GASTRIC DISORDER,2
MX,HIP FRACTURE,2
MX,HYPERTHYROIDISM,2
MX,HYPOACUSIS,2
MX,HYPOAESTHESIA,2
MX,JOINT INJURY,2
MX,LOSS OF CONSCIOUSNESS,2
MX,MEDICATION ERROR,2
MX,NAUSEA,2
MX,NEPHROLITHIASIS,2
MX,NERVE INJURY,2
MX,PANCREATITIS,2
MX,PROSTATIC DISORDER,2
MX,SPINAL PAIN,2
MX,TENDON RUPTURE,2
MX,THYROID DISORDER,2
MX,VENOUS THROMBOSIS,2
MX,VISUAL ACUITY REDUCED,2
MX,VOMITING,2
MX,WRIST FRACTURE,2
MX,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
MX,ABDOMINAL DISCOMFORT,1
MX,ABDOMINAL DISTENSION,1
MX,ABDOMINAL PAIN,1
MX,ACCIDENT,1
MX,ACCIDENTAL DEATH,1
MX,AGITATION,1
MX,ALOPECIA,1
MX,AMNESIA,1
MX,ANGINA UNSTABLE,1
MX,ANTIPHOSPHOLIPID SYNDROME,1
MX,ANXIETY,1
MX,AORTIC VALVE DISEASE,1
MX,ARRHYTHMIA,1
MX,ARTERIAL DISORDER,1
MX,ASPHYXIA,1
MX,BACK DISORDER,1
MX,BENIGN OVARIAN TUMOUR,1
MX,BLOOD CHOLESTEROL ABNORMAL,1
MX,BLOOD CHOLESTEROL ESTERASE INCREASED,1
MX,BLOOD CREATININE INCREASED,1
MX,BLOOD GLUCOSE DECREASED,1
MX,BLOOD POTASSIUM INCREASED,1
MX,BRAIN INJURY,1
MX,BREAST CANCER,1
MX,BREAST DISORDER,1
MX,BRONCHITIS,1
MX,BURNING SENSATION,1
MX,CARDIAC ARREST,1
MX,CARDIAC FAILURE ACUTE,1
MX,CARDIOPULMONARY FAILURE,1
MX,CARDIOVASCULAR DISORDER,1
MX,CATARACT OPERATION,1
MX,CATARRH,1
MX,CEREBELLAR EMBOLISM,1
MX,CEREBRAL ARTERY EMBOLISM,1
MX,CEREBRAL ATROPHY,1
MX,CEREBRAL HAEMORRHAGE,1
MX,CEREBROVASCULAR DISORDER,1
MX,CEREBROVASCULAR INSUFFICIENCY,1
MX,CERVICAL VERTEBRAL FRACTURE,1
MX,CHEST DISCOMFORT,1
MX,CHONDROPATHY,1
MX,CLAVICLE FRACTURE,1
MX,COGNITIVE DISORDER,1
MX,COMMUNICATION DISORDER,1
MX,CONDITION AGGRAVATED,1
MX,CONGESTIVE CARDIOMYOPATHY,1
MX,COUGH,1
MX,DECREASED APPETITE,1
MX,DEPRESSED LEVEL OF CONSCIOUSNESS,1
MX,DIABETIC COMPLICATION,1
MX,DIABETIC KETOACIDOSIS,1
MX,DIABETIC NEUROPATHY,1
MX,DIARRHOEA,1
MX,DISCOMFORT,1
MX,DISTURBANCE IN ATTENTION,1
MX,DRUG DISPENSING ERROR,1
MX,DRUG INEFFECTIVE,1
MX,DYSLALIA,1
MX,DYSPHAGIA,1
MX,DYSURIA,1
MX,EAR INFECTION,1
MX,ERECTILE DYSFUNCTION,1
MX,ERYTHEMA,1
MX,ESSENTIAL TREMOR,1
MX,EYE DISORDER,1
MX,FACIAL PARALYSIS,1
MX,FEAR,1
MX,FEELING HOT,1
MX,FOOT FRACTURE,1
MX,GANGRENE,1
MX,GINGIVAL ABSCESS,1
MX,GLAUCOMA,1
MX,HAEMOGLOBIN DECREASED,1
MX,HAEMORRHOIDS,1
MX,HEARING IMPAIRED,1
MX,HEART INJURY,1
MX,HEART RATE DECREASED,1
MX,HEART RATE INCREASED,1
MX,HEMIPLEGIA,1
MX,HEPATIC CANCER,1
MX,HEPATIC STEATOSIS,1
MX,HERNIA,1
MX,HERPES VIRUS INFECTION,1
MX,HERPES ZOSTER,1
MX,HIATUS HERNIA,1
MX,HOT FLUSH,1
MX,HUMERUS FRACTURE,1
MX,HYPERGLYCAEMIA,1
MX,HYPERSOMNIA,1
MX,HYPERTENSIVE HEART DISEASE,1
MX,HYPOGLYCAEMIA,1
MX,HYPOKINESIA,1
MX,HYPOTENSION,1
MX,ILEUS PARALYTIC,1
MX,ILL-DEFINED DISORDER,1
MX,IMMUNODEFICIENCY,1
MX,INCORRECT DOSE ADMINISTERED,1
MX,INFECTION,1
MX,INFLAMMATION,1
MX,INTENTIONAL PRODUCT MISUSE,1
MX,INTESTINAL ISCHAEMIA,1
MX,INTESTINAL TRANSIT TIME DECREASED,1
MX,ISCHAEMIC STROKE,1
MX,JOINT DISLOCATION,1
MX,JOINT SWELLING,1
MX,LENS DISLOCATION,1
MX,LIMB DISCOMFORT,1
MX,LOCAL SWELLING,1
MX,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
MX,LOWER LIMB FRACTURE,1
MX,MONOPLEGIA,1
MX,MOTOR DYSFUNCTION,1
MX,MULTIPLE SCLEROSIS,1
MX,MUSCLE RIGIDITY,1
MX,MUSCULOSKELETAL PAIN,1
MX,MUSCULOSKELETAL STIFFNESS,1
MX,MYOCARDIAL ISCHAEMIA,1
MX,MYOPIA,1
MX,NAIL DISORDER,1
MX,NEOPLASM MALIGNANT,1
MX,NERVE DEGENERATION,1
MX,NEURALGIA,1
MX,NIPPLE PAIN,1
MX,NIPPLE SWELLING,1
MX,OESOPHAGEAL DISORDER,1
MX,OVARIAN NEOPLASM,1
MX,PALLOR,1
MX,PALPITATIONS,1
MX,PANCREATIC CARCINOMA,1
MX,PANCREATITIS ACUTE,1
MX,PARALYSIS,1
MX,PERIPHERAL ARTERY ANEURYSM,1
MX,PHOTOPSIA,1
MX,PRESCRIBED OVERDOSE,1
MX,PROCEDURAL PAIN,1
MX,PRODUCT QUALITY ISSUE,1
MX,PRODUCTIVE COUGH,1
MX,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
MX,PROSTATITIS,1
MX,PSEUDOACHALASIA,1
MX,PSYCHOMOTOR HYPERACTIVITY,1
MX,PYREXIA,1
MX,RALES,1
MX,RENAL FAILURE,1
MX,RESPIRATORY ARREST,1
MX,RESPIRATORY DISORDER,1
MX,RHEUMATOID ARTHRITIS,1
MX,SEIZURE,1
MX,SILENT MYOCARDIAL INFARCTION,1
MX,SKIN STRIAE,1
MX,SOMNOLENCE,1
MX,SPINAL DISORDER,1
MX,SPINAL FRACTURE,1
MX,SYNCOPE,1
MX,TIBIA FRACTURE,1
MX,TOXIC NODULAR GOITRE,1
MX,TREMOR,1
MX,TYPE 2 DIABETES MELLITUS,1
MX,UPPER LIMB FRACTURE,1
MX,URINARY INCONTINENCE,1
MX,URINARY TRACT INFECTION,1
MX,UTERINE DISORDER,1
MX,VARICELLA,1
MX,VARICOSE VEIN,1
MX,VENTRICULAR EXTRASYSTOLES,1
MX,VENTRICULAR FAILURE,1
MX,VERTIGO,1
MX,VIITH NERVE PARALYSIS,1
MX,WALKING DISABILITY,1
MX,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
NL,MUSCLE RUPTURE,12
NL,FATIGUE,9
NL,MYALGIA,8
NL,MALAISE,6
NL,CARDIAC DISORDER,5
NL,DEATH,5
NL,DYSPNOEA,5
NL,MOOD SWINGS,5
NL,MUSCLE SPASMS,5
NL,NAUSEA,5
NL,BACK PAIN,4
NL,DIARRHOEA,4
NL,DIZZINESS,4
NL,HEADACHE,4
NL,HYPOAESTHESIA,4
NL,LIVER FUNCTION TEST ABNORMAL,4
NL,PALPITATIONS,4
NL,PNEUMONIA,4
NL,PYREXIA,4
NL,SUICIDAL IDEATION,4
NL,TENDONITIS,4
NL,THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION,4
NL,VISION BLURRED,4
NL,ABDOMINAL DISCOMFORT,3
NL,ABDOMINAL PAIN UPPER,3
NL,AGGRESSION,3
NL,BALANCE DISORDER,3
NL,CARDIAC ARREST,3
NL,CARDIAC FAILURE,3
NL,CHEST PAIN,3
NL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
NL,CONFUSIONAL STATE,3
NL,DECREASED APPETITE,3
NL,HAEMATOMA,3
NL,MYOCARDIAL INFARCTION,3
NL,PRESYNCOPE,3
NL,RENAL IMPAIRMENT,3
NL,RHABDOMYOLYSIS,3
NL,SYNCOPE,3
NL,THROMBOCYTOPENIA,3
NL,VISUAL IMPAIRMENT,3
NL,WEIGHT INCREASED,3
NL,ABDOMINAL PAIN,2
NL,ACUTE KIDNEY INJURY,2
NL,ARTHRALGIA,2
NL,ATRIOVENTRICULAR BLOCK COMPLETE,2
NL,BLINDNESS,2
NL,BRADYCARDIA,2
NL,BREAST CANCER,2
NL,CEREBROVASCULAR ACCIDENT,2
NL,CONSTIPATION,2
NL,COUGH,2
NL,DEPRESSION,2
NL,DIABETES MELLITUS,2
NL,ERECTILE DYSFUNCTION,2
NL,EYE DISORDER,2
NL,FALL,2
NL,FEELING COLD,2
NL,GAIT DISTURBANCE,2
NL,GENERAL PHYSICAL HEALTH DETERIORATION,2
NL,HAEMATOCHEZIA,2
NL,HAEMOGLOBIN DECREASED,2
NL,HYPOMAGNESAEMIA,2
NL,HYPOTENSION,2
NL,INFLUENZA LIKE ILLNESS,2
NL,INSOMNIA,2
NL,INTERNATIONAL NORMALISED RATIO INCREASED,2
NL,JOINT SWELLING,2
NL,LEUKOPENIA,2
NL,MALIGNANT NEOPLASM PROGRESSION,2
NL,MUSCULOSKELETAL DISCOMFORT,2
NL,NEPHROGENIC SYSTEMIC FIBROSIS,2
NL,OEDEMA,2
NL,OEDEMA PERIPHERAL,2
NL,ORTHOSTATIC HYPOTENSION,2
NL,OSTEOARTHRITIS,2
NL,PAIN IN JAW,2
NL,PARAESTHESIA,2
NL,POLYMYALGIA RHEUMATICA,2
NL,PRODUCT SUBSTITUTION ISSUE,2
NL,PROSTATE CANCER METASTATIC,2
NL,PRURITUS,2
NL,RAYNAUD^S PHENOMENON,2
NL,RESPIRATORY FAILURE,2
NL,RETINAL INFARCTION,2
NL,SEIZURE,2
NL,SLEEP DISORDER,2
NL,TERMINAL STATE,2
NL,TINNITUS,2
NL,TREMOR,2
NL,TRISMUS,2
NL,ABASIA,1
NL,ABDOMINAL HERNIA,1
NL,ABDOMINAL INJURY,1
NL,ABDOMINAL PAIN LOWER,1
NL,ABNORMAL LOSS OF WEIGHT,1
NL,ACTIVITIES OF DAILY LIVING IMPAIRED,1
NL,ACUTE MYOCARDIAL INFARCTION,1
NL,ADVERSE DRUG REACTION,1
NL,AGRANULOCYTOSIS,1
NL,AMNESIA,1
NL,AMYOTROPHIC LATERAL SCLEROSIS,1
NL,ANGINA PECTORIS,1
NL,ANGINA UNSTABLE,1
NL,ANGIOPATHY,1
NL,ANGIOPLASTY,1
NL,ANKLE FRACTURE,1
NL,APHONIA,1
NL,ASPARTATE AMINOTRANSFERASE INCREASED,1
NL,ASTHENIA,1
NL,BARRETT^S OESOPHAGUS,1
NL,BLADDER CANCER,1
NL,BLOOD ALKALINE PHOSPHATASE INCREASED,1
NL,BLOOD BLISTER,1
NL,BLOOD CHOLESTEROL INCREASED,1
NL,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
NL,BLOOD GLUCOSE INCREASED,1
NL,BLOOD IRON DECREASED,1
NL,BLOOD PRESSURE INCREASED,1
NL,BONE CONTUSION,1
NL,BONE DISORDER,1
NL,BRAIN NEOPLASM,1
NL,BRONCHIAL DISORDER,1
NL,BRONCHOSPASM,1
NL,BURSITIS,1
NL,CARDIAC TAMPONADE,1
NL,CARPAL TUNNEL SYNDROME,1
NL,CATARACT,1
NL,CHILLS,1
NL,CHOLELITHIASIS,1
NL,CHOLESTASIS,1
NL,CHROMATURIA,1
NL,CLONUS,1
NL,COGNITIVE DISORDER,1
NL,COLON NEOPLASM,1
NL,CONDITION AGGRAVATED,1
NL,CORONARY ARTERY STENOSIS,1
NL,CYTOMEGALOVIRUS INFECTION,1
NL,DEAFNESS,1
NL,DEAFNESS UNILATERAL,1
NL,DEEP VEIN THROMBOSIS,1
NL,DEHYDRATION,1
NL,DEPRESSED MOOD,1
NL,DERMATITIS ALLERGIC,1
NL,DIABETES MELLITUS INADEQUATE CONTROL,1
NL,DIARRHOEA HAEMORRHAGIC,1
NL,DIPLOPIA,1
NL,DISABILITY,1
NL,DISEASE PROGRESSION,1
NL,DISORIENTATION,1
NL,DISTURBANCE IN ATTENTION,1
NL,DIVERTICULITIS,1
NL,DRY EYE,1
NL,DYSPHONIA,1
NL,ELECTROCARDIOGRAM QT PROLONGED,1
NL,EOSINOPHILIA,1
NL,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,1
NL,EPICONDYLITIS,1
NL,EPILEPSY,1
NL,ERECTION INCREASED,1
NL,ERYSIPELAS,1
NL,ESCHERICHIA URINARY TRACT INFECTION,1
NL,EYE PAIN,1
NL,FACE OEDEMA,1
NL,FEBRILE NEUTROPENIA,1
NL,FEELING ABNORMAL,1
NL,FIBROMYALGIA,1
NL,GALLBLADDER POLYP,1
NL,GASTRIC INFECTION,1
NL,GASTRIC ULCER,1
NL,GASTROINTESTINAL TOXICITY,1
NL,GENITAL HAEMORRHAGE,1
NL,GYNAECOMASTIA,1
NL,HAEMATURIA,1
NL,HAEMOPTYSIS,1
NL,HALLUCINATION_ AUDITORY,1
NL,HEPATIC CIRRHOSIS,1
NL,HEPATIC FAILURE,1
NL,HEPATIC FUNCTION ABNORMAL,1
NL,HEPATIC NECROSIS,1
NL,HEPATIC STEATOSIS,1
NL,HERNIA,1
NL,HIGH DENSITY LIPOPROTEIN DECREASED,1
NL,HOT FLUSH,1
NL,HYDRONEPHROSIS,1
NL,HYPERGLYCAEMIA,1
NL,HYPERHIDROSIS,1
NL,HYPERKALAEMIA,1
NL,HYPERLIPIDAEMIA,1
NL,HYPERREFLEXIA,1
NL,HYPERSENSITIVITY,1
NL,HYPERSEXUALITY,1
NL,HYPERTENSION,1
NL,HYPERTHYROIDISM,1
NL,HYPONATRAEMIA,1
NL,HYPOXIA,1
NL,IMMUNE SYSTEM DISORDER,1
NL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
NL,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
NL,INFARCTION,1
NL,INFECTION,1
NL,INJECTION SITE PAIN,1
NL,INTRA-ABDOMINAL HAEMATOMA,1
NL,LABYRINTHITIS,1
NL,LEPTOSPIROSIS,1
NL,LIBIDO DECREASED,1
NL,LIMB DISCOMFORT,1
NL,LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT,1
NL,LYMPHOEDEMA,1
NL,MAJOR DEPRESSION,1
NL,MEDICAL DEVICE COMPLICATION,1
NL,MENINGITIS,1
NL,MENTAL DISORDER,1
NL,METABOLIC ACIDOSIS,1
NL,METASTASES TO LIVER,1
NL,MUSCLE DISORDER,1
NL,MUSCLE RIGIDITY,1
NL,MUSCULAR WEAKNESS,1
NL,NASAL INFLAMMATION,1
NL,NECK PAIN,1
NL,NEOPLASM,1
NL,NEOPLASM PROGRESSION,1
NL,OBESITY,1
NL,OESOPHAGEAL CANCER METASTATIC,1
NL,OESOPHAGEAL CARCINOMA,1
NL,ONYCHOMYCOSIS,1
NL,OPTIC NEURITIS,1
NL,ORAL PAIN,1
NL,ORGANISING PNEUMONIA,1
NL,OSTEITIS,1
NL,PAIN,1
NL,PAIN IN EXTREMITY,1
NL,PANCREATITIS ACUTE,1
NL,PAPILLOEDEMA,1
NL,PATELLA FRACTURE,1
NL,PENILE CURVATURE,1
NL,PERIPHERAL VASCULAR DISORDER,1
NL,PERSONALITY CHANGE,1
NL,PEYRONIE^S DISEASE,1
NL,PHARYNGEAL OEDEMA,1
NL,PITUITARY TUMOUR BENIGN,1
NL,PLEURISY,1
NL,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
NL,POLYNEUROPATHY,1
NL,POSTURE ABNORMAL,1
NL,POTENTIATING DRUG INTERACTION,1
NL,PRODUCT USE IN UNAPPROVED INDICATION,1
NL,PRODUCT USE ISSUE,1
NL,PROSTATE CANCER,1
NL,PROTEIN TOTAL INCREASED,1
NL,PROTEIN URINE,1
NL,PULMONARY ARTERIAL HYPERTENSION,1
NL,PULMONARY EMBOLISM,1
NL,PULMONARY FIBROSIS,1
NL,PYELONEPHRITIS,1
NL,QUALITY OF LIFE DECREASED,1
NL,RASH,1
NL,RECTAL CANCER,1
NL,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
NL,REGURGITATION,1
NL,RENAL DISORDER,1
NL,RENAL FAILURE CHRONIC,1
NL,RESPIRATORY ALKALOSIS,1
NL,RESPIRATORY TRACT INFECTION,1
NL,RETINAL DEGENERATION,1
NL,RETINAL TELANGIECTASIA,1
NL,RHEUMATOID ARTHRITIS,1
NL,SEROTONIN SYNDROME,1
NL,SINUSITIS,1
NL,SKIN EXFOLIATION,1
NL,SOMNOLENCE,1
NL,SPASMODIC DYSPHONIA,1
NL,STENT PLACEMENT,1
NL,STOMATITIS,1
NL,STUPOR,1
NL,SURGERY,1
NL,TEMPORAL ARTERITIS,1
NL,THERAPEUTIC RESPONSE UNEXPECTED,1
NL,THYROID NEOPLASM,1
NL,TONGUE OEDEMA,1
NL,TRANSFERRIN SATURATION DECREASED,1
NL,TRANSIENT ISCHAEMIC ATTACK,1
NL,TUBULOINTERSTITIAL NEPHRITIS,1
NL,TYPE 2 DIABETES MELLITUS,1
NL,ULCER,1
NL,UPPER GASTROINTESTINAL HAEMORRHAGE,1
NL,URETHRAL STENOSIS,1
NL,URINARY RETENTION,1
NL,VASCULITIS,1
NL,VENTRICULAR FIBRILLATION,1
NL,VISUAL EVOKED POTENTIALS ABNORMAL,1
NL,VOMITING,1
NL,WEIGHT DECREASED,1
NL,WHITE BLOOD CELL COUNT INCREASED,1
NZ,IMMUNE-MEDIATED NECROTISING MYOPATHY,5
NZ,NECROTISING MYOSITIS,5
NZ,NAUSEA,3
NZ,AGITATION,2
NZ,FATIGUE,2
NZ,HEADACHE,2
NZ,MYASTHENIA GRAVIS,2
NZ,PAIN,2
NZ,URTICARIA,2
NZ,ACTIVITIES OF DAILY LIVING IMPAIRED,1
NZ,ACUTE MYOCARDIAL INFARCTION,1
NZ,ADENOCARCINOMA OF COLON,1
NZ,AFFECTIVE DISORDER,1
NZ,AGGRESSION,1
NZ,ANGER,1
NZ,ANTINUCLEAR ANTIBODY POSITIVE,1
NZ,ARTHRALGIA,1
NZ,BALANCE DISORDER,1
NZ,BLADDER CANCER,1
NZ,BLINDNESS UNILATERAL,1
NZ,BLOOD GLUCOSE INCREASED,1
NZ,BLOOD PRESSURE INCREASED,1
NZ,BODY TEMPERATURE DECREASED,1
NZ,CARDIAC DISCOMFORT,1
NZ,COLD SWEAT,1
NZ,COLON ADENOMA,1
NZ,CONJUNCTIVITIS,1
NZ,CONSTIPATION,1
NZ,COUGH,1
NZ,DEPRESSION,1
NZ,DIARRHOEA,1
NZ,DIZZINESS,1
NZ,EYE IRRITATION,1
NZ,EYE PRURITUS,1
NZ,FEELING ABNORMAL,1
NZ,GAIT DISTURBANCE,1
NZ,GRANULOMA,1
NZ,HAEMATURIA,1
NZ,HAEMORRHAGE INTRACRANIAL,1
NZ,HEAD DISCOMFORT,1
NZ,HEPATIC ENZYME INCREASED,1
NZ,HEPATITIS VIRAL,1
NZ,HIGH DENSITY LIPOPROTEIN DECREASED,1
NZ,HYPOKINESIA,1
NZ,INFLUENZA LIKE ILLNESS,1
NZ,INTENTIONAL PRODUCT MISUSE,1
NZ,INTERVERTEBRAL DISC SPACE NARROWING,1
NZ,LIMB DISCOMFORT,1
NZ,LOCAL SWELLING,1
NZ,LOSS OF CONSCIOUSNESS,1
NZ,LUMBAR VERTEBRAL FRACTURE,1
NZ,LUNG ADENOCARCINOMA,1
NZ,MALIGNANT LYMPHOID NEOPLASM,1
NZ,MEMORY IMPAIRMENT,1
NZ,MENINGIOMA,1
NZ,MENTAL DISORDER,1
NZ,MIGRAINE,1
NZ,MUSCLE RUPTURE,1
NZ,MUSCULAR WEAKNESS,1
NZ,MUSCULOSKELETAL DISORDER,1
NZ,MYALGIA,1
NZ,MYOCARDIAL INFARCTION,1
NZ,NASOPHARYNGITIS,1
NZ,NECK PAIN,1
NZ,OPTIC NEUROPATHY,1
NZ,PALLOR,1
NZ,PARAESTHESIA,1
NZ,PELVIC FRACTURE,1
NZ,PHOTOPHOBIA,1
NZ,PNEUMONIA,1
NZ,PROSTATOMEGALY,1
NZ,PSYCHIATRIC SYMPTOM,1
NZ,RESPIRATORY DISORDER,1
NZ,ROAD TRAFFIC ACCIDENT,1
NZ,SLEEP DISORDER,1
NZ,SOMNOLENCE,1
NZ,SUBDURAL HAEMATOMA,1
NZ,SURGERY,1
NZ,SWELLING FACE,1
NZ,SYSTEMIC LUPUS ERYTHEMATOSUS,1
NZ,TEARFULNESS,1
NZ,THINKING ABNORMAL,1
NZ,TUBULOINTERSTITIAL NEPHRITIS,1
NZ,TYPE 2 DIABETES MELLITUS,1
NZ,UVEITIS,1
NZ,VISION BLURRED,1
NI,DEATH,3
NG,CYSTITIS HAEMORRHAGIC,1
NG,MEMORY IMPAIRMENT,1
NO,DYSPNOEA,26
NO,MYALGIA,26
NO,GENERAL PHYSICAL HEALTH DETERIORATION,19
NO,DIZZINESS,16
NO,PYREXIA,16
NO,LACTIC ACIDOSIS,15
NO,DEHYDRATION,14
NO,NAUSEA,14
NO,MALAISE,13
NO,POLYNEUROPATHY,13
NO,RENAL FAILURE,13
NO,INTERSTITIAL LUNG DISEASE,12
NO,LISTLESS,12
NO,FATIGUE,11
NO,RHABDOMYOLYSIS,11
NO,ACUTE KIDNEY INJURY,10
NO,DEPRESSION,10
NO,DIARRHOEA,10
NO,FALL,9
NO,HYPOAESTHESIA,9
NO,OSTEONECROSIS OF JAW,9
NO,PNEUMONIA,9
NO,GAIT DISTURBANCE,8
NO,MYOCARDIAL INFARCTION,8
NO,OSTEITIS,8
NO,ASTHENIA,7
NO,CHEST PAIN,7
NO,HEADACHE,7
NO,HYPOXIA,7
NO,PAIN,7
NO,ALANINE AMINOTRANSFERASE INCREASED,6
NO,CARDIAC ARREST,6
NO,COLD SWEAT,6
NO,ECZEMA,6
NO,HERPES ZOSTER,6
NO,HYPOMAGNESAEMIA,6
NO,LOSS OF CONSCIOUSNESS,6
NO,OPHTHALMIC HERPES ZOSTER,6
NO,PAIN IN EXTREMITY,6
NO,PHOTOSENSITIVITY REACTION,6
NO,PULMONARY FIBROSIS,6
NO,ROSACEA,6
NO,SOMNOLENCE,6
NO,TORSADE DE POINTES,6
NO,ULCERATIVE KERATITIS,6
NO,URINARY RETENTION,6
NO,ARTHRALGIA,5
NO,ASPARTATE AMINOTRANSFERASE INCREASED,5
NO,BALANCE DISORDER,5
NO,BENIGN PROSTATIC HYPERPLASIA,5
NO,BODY TEMPERATURE FLUCTUATION,5
NO,BODY TEMPERATURE INCREASED,5
NO,CEREBRAL HAEMORRHAGE,5
NO,CONTUSION,5
NO,DECREASED APPETITE,5
NO,DRY MOUTH,5
NO,DYSPHAGIA,5
NO,FINE MOTOR DELAY,5
NO,MEMORY IMPAIRMENT,5
NO,MYELITIS TRANSVERSE,5
NO,OSTEONECROSIS,5
NO,PERIPHERAL COLDNESS,5
NO,RASH PRURITIC,5
NO,SPINAL CORD INJURY,5
NO,STRESS,5
NO,URINARY TRACT INFECTION,5
NO,VENTRICULAR ARRHYTHMIA,5
NO,VOMITING,5
NO,ABDOMINAL PAIN,4
NO,ANAEMIA,4
NO,BACK PAIN,4
NO,BLOOD CREATININE INCREASED,4
NO,CEREBRAL INFARCTION,4
NO,CHEST DISCOMFORT,4
NO,COUGH,4
NO,DISTURBANCE IN ATTENTION,4
NO,DRUG EFFECT INCOMPLETE,4
NO,DRUG INEFFECTIVE,4
NO,HEPATITIS,4
NO,HYPOGLYCAEMIA,4
NO,HYPONATRAEMIA,4
NO,IMMUNE-MEDIATED NECROTISING MYOPATHY,4
NO,MUSCULOSKELETAL STIFFNESS,4
NO,PALPITATIONS,4
NO,PERONEAL NERVE PALSY,4
NO,PLEURAL EFFUSION,4
NO,RESPIRATORY FAILURE,4
NO,SINUS NODE DYSFUNCTION,4
NO,THROMBOCYTOPENIA,4
NO,TREMOR,4
NO,VISUAL IMPAIRMENT,4
NO,ABDOMINAL PAIN UPPER,3
NO,ANAL FISTULA,3
NO,ANXIETY,3
NO,ATRIAL FIBRILLATION,3
NO,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
NO,BONE MARROW FAILURE,3
NO,C-REACTIVE PROTEIN INCREASED,3
NO,CEREBROVASCULAR ACCIDENT,3
NO,CHILLS,3
NO,CYTOKINE RELEASE SYNDROME,3
NO,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,3
NO,DUODENAL ULCER,3
NO,ERECTILE DYSFUNCTION,3
NO,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
NO,HAEMORRHAGE,3
NO,HEART RATE INCREASED,3
NO,HEPATIC FAILURE,3
NO,HYPERTENSION,3
NO,IMPAIRED QUALITY OF LIFE,3
NO,INCORRECT DOSE ADMINISTERED,3
NO,INFLAMMATION,3
NO,INFLUENZA LIKE ILLNESS,3
NO,MOOD SWINGS,3
NO,MUSCULAR WEAKNESS,3
NO,MYOPATHY,3
NO,NECK PAIN,3
NO,NEUTROPENIA,3
NO,PARAESTHESIA,3
NO,PHOTOPHOBIA,3
NO,QUALITY OF LIFE DECREASED,3
NO,RASH,3
NO,RECTAL HAEMORRHAGE,3
NO,RENAL FAILURE ACUTE,3
NO,SKIN DISORDER,3
NO,SYNCOPE,3
NO,TOXICITY TO VARIOUS AGENTS,3
NO,VISUAL FIELD DEFECT,3
NO,WEIGHT DECREASED,3
NO,ACUTE MYOCARDIAL INFARCTION,2
NO,AMNESIA,2
NO,ARTHRITIS,2
NO,BLADDER CANCER,2
NO,BLOOD BILIRUBIN INCREASED,2
NO,BLOOD PRESSURE INCREASED,2
NO,CHOLECYSTITIS,2
NO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
NO,CLUMSINESS,2
NO,COMMUNICATION DISORDER,2
NO,CONTRAINDICATED PRODUCT ADMINISTERED,2
NO,CYANOSIS,2
NO,DIABETES MELLITUS,2
NO,DIABETIC KETOACIDOSIS,2
NO,DISCOMFORT,2
NO,DRUG ADMINISTRATION ERROR,2
NO,DRUG-INDUCED LIVER INJURY,2
NO,DYSCHEZIA,2
NO,DYSPEPSIA,2
NO,EPISTAXIS,2
NO,ERYTHEMA,2
NO,FEBRILE NEUTROPENIA,2
NO,FEELING HOT,2
NO,HAEMATOMA,2
NO,HAEMOGLOBIN DECREASED,2
NO,HAEMORRHAGE SUBCUTANEOUS,2
NO,HEAD INJURY,2
NO,HEPATIC ENZYME INCREASED,2
NO,HEPATITIS TOXIC,2
NO,HYPERBILIRUBINAEMIA,2
NO,HYPERHIDROSIS,2
NO,HYPERLIPIDAEMIA,2
NO,INHIBITORY DRUG INTERACTION,2
NO,INTERNATIONAL NORMALISED RATIO INCREASED,2
NO,LYME DISEASE,2
NO,MENTAL DISORDER,2
NO,MUSCLE CONTRACTIONS INVOLUNTARY,2
NO,MUSCLE SPASMS,2
NO,MUSCLE STRAIN,2
NO,MYOSITIS,2
NO,NEUTROPHIL COUNT DECREASED,2
NO,NON-CARDIAC CHEST PAIN,2
NO,OVERWEIGHT,2
NO,POLLAKIURIA,2
NO,PRODUCT SUBSTITUTION ISSUE,2
NO,PROTEINURIA,2
NO,PSORIASIS,2
NO,PULMONARY SARCOIDOSIS,2
NO,QUADRIPLEGIA,2
NO,RECTAL ADENOCARCINOMA,2
NO,RENAL IMPAIRMENT,2
NO,SEIZURE,2
NO,SENSORY LOSS,2
NO,SPEECH DISORDER,2
NO,SUFFOCATION FEELING,2
NO,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,2
NO,TACHYCARDIA,2
NO,TENDERNESS,2
NO,TESTICULAR MASS,2
NO,TINNITUS,2
NO,TROPONIN INCREASED,2
NO,UPPER RESPIRATORY TRACT INFECTION,2
NO,URINE OUTPUT INCREASED,2
NO,VISION BLURRED,2
NO,ABDOMINAL DISCOMFORT,1
NO,ABDOMINAL DISTENSION,1
NO,ABNORMAL DREAMS,1
NO,ACCIDENTAL OVERDOSE,1
NO,ACNE,1
NO,ALOPECIA,1
NO,ALTERED STATE OF CONSCIOUSNESS,1
NO,AMENORRHOEA,1
NO,ANAPHYLACTIC REACTION,1
NO,ANAPHYLACTOID REACTION,1
NO,ANGINA UNSTABLE,1
NO,APATHY,1
NO,APPETITE DISORDER,1
NO,ASCITES,1
NO,ASTHMA,1
NO,ATAXIA,1
NO,AUTOIMMUNE HEPATITIS,1
NO,BLINDNESS,1
NO,BLOOD ALKALINE PHOSPHATASE INCREASED,1
NO,BLOOD LACTIC ACID INCREASED,1
NO,BLOOD POTASSIUM DECREASED,1
NO,BLOOD PRESSURE SYSTOLIC DECREASED,1
NO,BLOOD UREA INCREASED,1
NO,BODY TEMPERATURE DECREASED,1
NO,BRADYCARDIA,1
NO,BRONCHOSPASM,1
NO,CARDIAC DISORDER,1
NO,CARDIAC FAILURE,1
NO,CARDIAC FAILURE CONGESTIVE,1
NO,CAROTID ARTERY OCCLUSION,1
NO,CARPAL TUNNEL SYNDROME,1
NO,CHEILITIS,1
NO,CHOLELITHIASIS,1
NO,CHOLESTASIS,1
NO,CHROMATOPSIA,1
NO,CHROMATURIA,1
NO,CHRONIC FATIGUE SYNDROME,1
NO,COGNITIVE DISORDER,1
NO,COLON CANCER,1
NO,CONDITION AGGRAVATED,1
NO,CONFUSIONAL STATE,1
NO,CONJUNCTIVAL HAEMORRHAGE,1
NO,CONJUNCTIVAL IRRITATION,1
NO,CONSTIPATION,1
NO,COOMBS DIRECT TEST POSITIVE,1
NO,CORONARY ARTERY DISEASE,1
NO,CORONARY ARTERY STENOSIS,1
NO,DEAFNESS UNILATERAL,1
NO,DELIRIUM,1
NO,DEPRESSED LEVEL OF CONSCIOUSNESS,1
NO,DEPRESSION SUICIDAL,1
NO,DERMATITIS,1
NO,DEVICE DIFFICULT TO USE,1
NO,DIPLEGIA,1
NO,DIPLOPIA,1
NO,DISORIENTATION,1
NO,DISSOCIATION,1
NO,DOSE CALCULATION ERROR,1
NO,DRUG DEPENDENCE,1
NO,DRUG LEVEL ABOVE THERAPEUTIC,1
NO,DRUG WITHDRAWAL SYNDROME,1
NO,DRY SKIN,1
NO,DRY THROAT,1
NO,DUODENAL ULCER HAEMORRHAGE,1
NO,DYSARTHRIA,1
NO,DYSPNOEA EXERTIONAL,1
NO,EAR DISCOMFORT,1
NO,ELECTROLYTE IMBALANCE,1
NO,EMPHYSEMA,1
NO,EOSINOPHILIA,1
NO,EPILEPSY,1
NO,ERUCTATION,1
NO,ERYTHROPLASIA,1
NO,EWING^S SARCOMA,1
NO,EXTRADURAL HAEMATOMA,1
NO,EYELID PTOSIS,1
NO,FAECAL INCONTINENCE,1
NO,FEELING COLD,1
NO,FEELING DRUNK,1
NO,FLUID OVERLOAD,1
NO,FREQUENT BOWEL MOVEMENTS,1
NO,GASTRIC ULCER,1
NO,GASTRITIS HAEMORRHAGIC,1
NO,GASTROINTESTINAL HAEMORRHAGE,1
NO,GASTROOESOPHAGEAL REFLUX DISEASE,1
NO,GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY,1
NO,GLOMERULAR FILTRATION RATE DECREASED,1
NO,GOUT,1
NO,HAEMATOCHEZIA,1
NO,HAEMODYNAMIC INSTABILITY,1
NO,HAEMORRHAGE INTRACRANIAL,1
NO,HAEMORRHAGIC ANAEMIA,1
NO,HAEMORRHAGIC STROKE,1
NO,HALLUCINATION_ VISUAL,1
NO,HEAD DISCOMFORT,1
NO,HEAD TITUBATION,1
NO,HEMIANOPIA HOMONYMOUS,1
NO,HEMIPARESIS,1
NO,HEPATITIS CHOLESTATIC,1
NO,HEPATITIS FULMINANT,1
NO,HEPATOTOXICITY,1
NO,HOT FLUSH,1
NO,HYPERAEMIA,1
NO,HYPERKALAEMIA,1
NO,HYPERVENTILATION,1
NO,HYPOACUSIS,1
NO,HYPOTENSION,1
NO,IMMUNODEFICIENCY COMMON VARIABLE,1
NO,IMPAIRED GASTRIC EMPTYING,1
NO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
NO,INFLUENZA,1
NO,INFUSION RELATED REACTION,1
NO,INSOMNIA,1
NO,INTRAVASCULAR HAEMOLYSIS,1
NO,IRON DEFICIENCY ANAEMIA,1
NO,IRRITABILITY,1
NO,JAUNDICE,1
NO,JOINT SWELLING,1
NO,LACRIMAL DISORDER,1
NO,LARYNGEAL OEDEMA,1
NO,LARYNGOSPASM,1
NO,LEGIONELLA INFECTION,1
NO,LEUKOPENIA,1
NO,LIGAMENT LAXITY,1
NO,LIVER FUNCTION TEST INCREASED,1
NO,LOWER LIMB FRACTURE,1
NO,LUMBAR SPINAL STENOSIS,1
NO,LUNG DISORDER,1
NO,LUNG INFECTION,1
NO,MALIGNANT MELANOMA IN SITU,1
NO,MELAENA,1
NO,MENTAL IMPAIRMENT,1
NO,METASTASES TO LIVER,1
NO,MIGRAINE,1
NO,MULTI-ORGAN FAILURE,1
NO,MUSCLE DISORDER,1
NO,MUSCLE FATIGUE,1
NO,MUSCLE NECROSIS,1
NO,MUSCLE TIGHTNESS,1
NO,MUSCLE TWITCHING,1
NO,MUSCULOSKELETAL CHEST PAIN,1
NO,MYASTHENIA GRAVIS,1
NO,MYELOPATHY,1
NO,NASAL CONGESTION,1
NO,NASAL DISCOMFORT,1
NO,NECROTISING MYOSITIS,1
NO,NIGHTMARE,1
NO,NO THERAPEUTIC RESPONSE,1
NO,NOCTURIA,1
NO,OLIGURIA,1
NO,OVERDOSE,1
NO,PANCREATITIS HAEMORRHAGIC,1
NO,PANIC REACTION,1
NO,PARESIS,1
NO,PERCUTANEOUS CORONARY INTERVENTION,1
NO,PERICARDIAL EFFUSION,1
NO,PHOBIA,1
NO,PNEUMOCYSTIS JIROVECII INFECTION,1
NO,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
NO,PNEUMONIA BACTERIAL,1
NO,POEMS SYNDROME,1
NO,POLYMYALGIA RHEUMATICA,1
NO,POLYMYOSITIS,1
NO,POST PROCEDURAL HAEMATOMA,1
NO,POST PROCEDURAL HAEMORRHAGE,1
NO,PRESYNCOPE,1
NO,PROCEDURAL HAEMORRHAGE,1
NO,PROCEDURAL PAIN,1
NO,PRODUCT USE IN UNAPPROVED INDICATION,1
NO,PRODUCT USE ISSUE,1
NO,PROTEIN URINE PRESENT,1
NO,PULMONARY CONGESTION,1
NO,PULMONARY EMBOLISM,1
NO,PULMONARY FUNCTION TEST DECREASED,1
NO,PULMONARY TOXICITY,1
NO,PURPURA,1
NO,RASH GENERALISED,1
NO,RASH MACULAR,1
NO,RENAL CYST,1
NO,RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE,1
NO,RESTLESS LEGS SYNDROME,1
NO,RESTLESSNESS,1
NO,RHINORRHOEA,1
NO,SALIVARY GLAND ADENOMA,1
NO,SEDATION,1
NO,SENSORY DISTURBANCE,1
NO,SEROTONIN SYNDROME,1
NO,SINUS TACHYCARDIA,1
NO,SKIN DISCOLOURATION,1
NO,SKIN FISSURES,1
NO,SKIN REACTION,1
NO,SLEEP APNOEA SYNDROME,1
NO,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,1
NO,SMALL INTESTINAL HAEMORRHAGE,1
NO,STEVENS-JOHNSON SYNDROME,1
NO,STOMATITIS,1
NO,SUBARACHNOID HAEMORRHAGE,1
NO,SUBDURAL HAEMATOMA,1
NO,SUDDEN DEATH,1
NO,SUICIDAL IDEATION,1
NO,SUPRAVENTRICULAR TACHYCARDIA,1
NO,SWELLING,1
NO,TACHYPNOEA,1
NO,THIRST,1
NO,THROAT IRRITATION,1
NO,THROMBOCYTOSIS,1
NO,TONIC CONVULSION,1
NO,TOOTH INJURY,1
NO,TRANSAMINASES INCREASED,1
NO,TRANSIENT ISCHAEMIC ATTACK,1
NO,TROPONIN I INCREASED,1
NO,TYPE 2 DIABETES MELLITUS,1
NO,URINARY CASTS PRESENT,1
NO,URINARY INCONTINENCE,1
NO,URINARY TRACT DISORDER,1
NO,URINE OUTPUT DECREASED,1
NO,UROSEPSIS,1
NO,URTICARIA,1
NO,VACCINATION SITE SWELLING,1
NO,VAGINAL CYST,1
NO,VENTRICULAR FIBRILLATION,1
NO,VISUAL ACUITY REDUCED,1
NO,VITAMIN D DEFICIENCY,1
NO,WHEEZING,1
NO,WHITE BLOOD CELL COUNT DECREASED,1
NO,WOUND,1
OM,CHOLECYSTITIS,1
OM,HEPATIC ENZYME INCREASED,1
OM,RASH,1
PK,MYOCARDIAL INFARCTION,4
PK,DEATH,3
PK,ASTHENIA,2
PK,ANGINA PECTORIS,1
PK,ASTHMA,1
PK,BLOOD CHOLESTEROL INCREASED,1
PK,BLOOD GLUCOSE INCREASED,1
PK,CARDIAC DISORDER,1
PK,CHEST PAIN,1
PK,DIABETES MELLITUS,1
PK,FEEDING DISORDER,1
PK,HYPERTENSION,1
PK,LOWER RESPIRATORY TRACT INFECTION,1
PK,LUNG INFECTION,1
PK,LUNG NEOPLASM MALIGNANT,1
PK,MALAISE,1
PK,VEIN DISORDER,1
PA,DEATH,1
PA,ISCHAEMIC STROKE,1
PE,DEATH,43
PE,CEREBROVASCULAR ACCIDENT,13
PE,CARDIAC DISORDER,9
PE,MYOCARDIAL INFARCTION,7
PE,FALL,6
PE,PNEUMONIA,6
PE,MALAISE,5
PE,DEAFNESS,4
PE,INFARCTION,4
PE,NEOPLASM MALIGNANT,4
PE,ANAEMIA,3
PE,ARRHYTHMIA,3
PE,DIABETES MELLITUS,3
PE,GASTRIC INFECTION,3
PE,HAEMORRHAGE,3
PE,HYPERTENSION,3
PE,POISONING,3
PE,ABDOMINAL DISCOMFORT,2
PE,ABDOMINAL PAIN UPPER,2
PE,ANGIOPATHY,2
PE,ARTHROPATHY,2
PE,CATARACT,2
PE,CEREBRAL INFARCTION,2
PE,CEREBRAL ISCHAEMIA,2
PE,GAIT DISTURBANCE,2
PE,GASTRIC ULCER,2
PE,HEADACHE,2
PE,JOINT DISLOCATION,2
PE,MYALGIA,2
PE,VISUAL ACUITY REDUCED,2
PE,ABASIA,1
PE,AMNESIA,1
PE,ANGINA PECTORIS,1
PE,APATHY,1
PE,APHASIA,1
PE,ARTERIAL OCCLUSIVE DISEASE,1
PE,ARTERIOSCLEROSIS,1
PE,ATRIAL FIBRILLATION,1
PE,BLOOD PRESSURE ABNORMAL,1
PE,BLOOD PRESSURE DECREASED,1
PE,BLOOD PRESSURE INCREASED,1
PE,BLOOD URINE PRESENT,1
PE,BLOOD VISCOSITY INCREASED,1
PE,BRONCHIAL DISORDER,1
PE,BURSITIS,1
PE,CARDIAC MURMUR,1
PE,CARDIO-RESPIRATORY ARREST,1
PE,CARTILAGE INJURY,1
PE,CELLULITIS,1
PE,CEREBRAL PALSY,1
PE,CHEST DISCOMFORT,1
PE,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
PE,COLITIS,1
PE,CONVULSION,1
PE,CORONARY ARTERY DISEASE,1
PE,CREST SYNDROME,1
PE,DEMENTIA ALZHEIMER^S TYPE,1
PE,DEPRESSION,1
PE,DIABETIC METABOLIC DECOMPENSATION,1
PE,DIPLEGIA,1
PE,DISEASE PROGRESSION,1
PE,DRUG DEPENDENCE,1
PE,DRUG DOSE OMISSION,1
PE,DRY MOUTH,1
PE,EYE DISORDER,1
PE,FAECES DISCOLOURED,1
PE,FATIGUE,1
PE,FEELING ABNORMAL,1
PE,FOOT AMPUTATION,1
PE,FUNCTIONAL GASTROINTESTINAL DISORDER,1
PE,GASTRIC CANCER,1
PE,GASTRIC DISORDER,1
PE,GASTRITIS,1
PE,GENERAL PHYSICAL HEALTH DETERIORATION,1
PE,GLAUCOMA,1
PE,HAEMOGLOBIN DECREASED,1
PE,HALLUCINATION,1
PE,HEMIPLEGIA,1
PE,HEPATIC FIBROSIS,1
PE,HEPATOMEGALY,1
PE,HIP FRACTURE,1
PE,HYPERSENSITIVITY,1
PE,HYPOAESTHESIA,1
PE,HYPOTHERMIA,1
PE,IMMUNODEFICIENCY,1
PE,IMPATIENCE,1
PE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PE,ISCHAEMIA,1
PE,ISCHAEMIC CARDIOMYOPATHY,1
PE,JOINT INJURY,1
PE,LEG AMPUTATION,1
PE,LEUKAEMIA,1
PE,LIGAMENT RUPTURE,1
PE,LIGAMENT SPRAIN,1
PE,LIP AND/OR ORAL CAVITY CANCER,1
PE,LOW DENSITY LIPOPROTEIN INCREASED,1
PE,MIDDLE EAR ADHESIONS,1
PE,MONOPLEGIA,1
PE,MOOD ALTERED,1
PE,MULTI-ORGAN FAILURE,1
PE,MULTIPLE SCLEROSIS,1
PE,OESOPHAGEAL VARICES HAEMORRHAGE,1
PE,ORAL DISCOMFORT,1
PE,OSTEOARTHRITIS,1
PE,OSTEOPOROSIS,1
PE,OVERDOSE,1
PE,PANCREATIC CARCINOMA,1
PE,PARALYSIS,1
PE,PARKINSON^S DISEASE,1
PE,PHARYNGITIS,1
PE,PROSTATITIS,1
PE,PRURITUS,1
PE,PTERYGIUM,1
PE,PULMONARY OEDEMA,1
PE,RENAL DISORDER,1
PE,RENAL FAILURE,1
PE,RESPIRATORY DISORDER,1
PE,RETINAL DETACHMENT,1
PE,ROAD TRAFFIC ACCIDENT,1
PE,SKIN BURNING SENSATION,1
PE,SPEECH DISORDER,1
PE,SPINAL DISORDER,1
PE,STROKE IN EVOLUTION,1
PE,SURGERY,1
PE,SYNCOPE,1
PE,TENDONITIS,1
PE,THERMAL BURN,1
PE,TINNITUS,1
PE,ULCER,1
PE,UPPER LIMB FRACTURE,1
PE,URINARY TRACT INFECTION,1
PE,VARICOSE VEIN,1
PE,VISION BLURRED,1
PE,VISUAL IMPAIRMENT,1
PE,WEIGHT DECREASED,1
PE,WOUND,1
PE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
PH,DEATH,7
PH,BLOOD GLUCOSE INCREASED,3
PH,CHEST PAIN,3
PH,ANGINA UNSTABLE,2
PH,DYSPNOEA,2
PH,GAIT DISTURBANCE,2
PH,MUSCULAR WEAKNESS,2
PH,MYOCARDIAL INFARCTION,2
PH,NEPHROLITHIASIS,2
PH,PAIN IN EXTREMITY,2
PH,PEPTIC ULCER HAEMORRHAGE,2
PH,PNEUMONIA,2
PH,PYREXIA,2
PH,RHABDOMYOLYSIS,2
PH,ANGIOPLASTY,1
PH,APPENDIX DISORDER,1
PH,ASPARTATE AMINOTRANSFERASE INCREASED,1
PH,ASTHENIA,1
PH,BLOOD CREATINE INCREASED,1
PH,BLOOD CREATININE INCREASED,1
PH,BLOOD GLUCOSE FLUCTUATION,1
PH,BLOOD PRESSURE INCREASED,1
PH,BLOOD URIC ACID DECREASED,1
PH,BLOOD URIC ACID INCREASED,1
PH,CARDIAC ARREST,1
PH,CARDIOGENIC SHOCK,1
PH,CEREBROVASCULAR ACCIDENT,1
PH,CHROMATURIA,1
PH,DEMENTIA ALZHEIMER^S TYPE,1
PH,DIZZINESS,1
PH,DRY SKIN,1
PH,EYE OPERATION,1
PH,EYE SWELLING,1
PH,FAECES DISCOLOURED,1
PH,FLANK PAIN,1
PH,FULL BLOOD COUNT DECREASED,1
PH,GENE MUTATION IDENTIFICATION TEST POSITIVE,1
PH,GUN SHOT WOUND,1
PH,HAEMOCHROMATOSIS,1
PH,HAEMOGLOBIN DECREASED,1
PH,HAEMORRHAGE,1
PH,HYPERSENSITIVITY,1
PH,HYPOAESTHESIA,1
PH,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PH,LIVER DISORDER,1
PH,LOSS OF CONSCIOUSNESS,1
PH,MASS,1
PH,MICTURITION URGENCY,1
PH,MYELITIS,1
PH,NAIL BED BLEEDING,1
PH,NO THERAPEUTIC RESPONSE,1
PH,OEDEMA PERIPHERAL,1
PH,OSTEOARTHRITIS,1
PH,PAIN,1
PH,PERITONEAL DIALYSIS COMPLICATION,1
PH,PERITONITIS BACTERIAL,1
PH,PLATELET COUNT DECREASED,1
PH,POLLAKIURIA,1
PH,POLYP,1
PH,PROSTATITIS,1
PH,RASH,1
PH,RENAL CYST,1
PH,RENAL DISORDER,1
PH,RENAL FAILURE CHRONIC,1
PH,SEPTIC SHOCK,1
PH,SKIN DISCOLOURATION,1
PH,SUDDEN DEATH,1
PH,TRANSIENT ISCHAEMIC ATTACK,1
PH,VIITH NERVE PARALYSIS,1
PH,VOMITING,1
PL,ANGINA PECTORIS,2
PL,DYSPNOEA,2
PL,OVERDOSE,2
PL,SUICIDE ATTEMPT,2
PL,AFFECTIVE DISORDER,1
PL,ALANINE AMINOTRANSFERASE INCREASED,1
PL,ARTERIOSCLEROSIS,1
PL,ASPARTATE AMINOTRANSFERASE INCREASED,1
PL,ASTHENIA,1
PL,ATRIAL FIBRILLATION,1
PL,ATRIOVENTRICULAR BLOCK COMPLETE,1
PL,BLADDER DILATATION,1
PL,BLOOD BILIRUBIN INCREASED,1
PL,BLOOD PRESSURE FLUCTUATION,1
PL,BRADYARRHYTHMIA,1
PL,BUNDLE BRANCH BLOCK LEFT,1
PL,CARDIAC FAILURE,1
PL,CARDIAC FAILURE CHRONIC,1
PL,CAROTID ARTERY OCCLUSION,1
PL,CHEST PAIN,1
PL,CONDITION AGGRAVATED,1
PL,COUGH,1
PL,DEEP VEIN THROMBOSIS,1
PL,DERMATITIS,1
PL,DIARRHOEA,1
PL,DRUG EFFECT INCOMPLETE,1
PL,EPISTAXIS,1
PL,FACIAL ASYMMETRY,1
PL,GASTRIC DISORDER,1
PL,HEPATIC LESION,1
PL,HEPATIC STEATOSIS,1
PL,HEPATOMEGALY,1
PL,IMPAIRED WORK ABILITY,1
PL,INSOMNIA,1
PL,INTENTIONAL OVERDOSE,1
PL,INTENTIONAL PRODUCT MISUSE,1
PL,ISCHAEMIC STROKE,1
PL,LIVER INJURY,1
PL,LOSS OF CONSCIOUSNESS,1
PL,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
PL,MALAISE,1
PL,MALIGNANT NEOPLASM PROGRESSION,1
PL,MUSCULAR WEAKNESS,1
PL,MYOCARDIAL INFARCTION,1
PL,MYOCARDIAL ISCHAEMIA,1
PL,ORTHOPNOEA,1
PL,PALPITATIONS,1
PL,PLEURAL EFFUSION,1
PL,POLYMYOSITIS,1
PL,PRODUCT USE IN UNAPPROVED INDICATION,1
PL,PULMONARY OEDEMA,1
PL,RASH,1
PL,SPEECH DISORDER,1
PL,TINNITUS,1
PL,TOXICITY TO VARIOUS AGENTS,1
PL,TRANSAMINASES INCREASED,1
PL,TRANSIENT ISCHAEMIC ATTACK,1
PL,VENTRICULAR EXTRASYSTOLES,1
PL,VENTRICULAR TACHYCARDIA,1
PL,WEIGHT DECREASED,1
PT,ASTHENIA,3
PT,ASCITES,2
PT,COGNITIVE DISORDER,2
PT,DECREASED APPETITE,2
PT,DIARRHOEA,2
PT,LUPUS-LIKE SYNDROME,2
PT,OEDEMA PERIPHERAL,2
PT,PLEURAL EFFUSION,2
PT,RAYNAUD^S PHENOMENON,2
PT,VISUAL ACUITY REDUCED,2
PT,WEIGHT DECREASED,2
PT,ANOSOGNOSIA,1
PT,ANXIETY,1
PT,BICYTOPENIA,1
PT,BLADDER TRANSITIONAL CELL CARCINOMA,1
PT,BLOOD PRESSURE INCREASED,1
PT,CHEST PAIN,1
PT,DERMATOSIS,1
PT,DIZZINESS,1
PT,DYSLIPIDAEMIA,1
PT,DYSPNOEA,1
PT,DYSURIA,1
PT,EYELID OEDEMA,1
PT,FATIGUE,1
PT,GAIT DISTURBANCE,1
PT,HAEMATURIA,1
PT,HEMIANOPIA HOMONYMOUS,1
PT,HYPERSOMNIA,1
PT,HYPERTENSION,1
PT,INSOMNIA,1
PT,LIVER FUNCTION TEST INCREASED,1
PT,MOVEMENT DISORDER,1
PT,NIGHTMARE,1
PT,NOCTURIA,1
PT,PANCYTOPENIA,1
PT,PEPTIC ULCER,1
PT,PROTEINURIA,1
PT,PULSE ABNORMAL,1
PT,QUADRANTANOPIA,1
PT,RASH MACULO-PAPULAR,1
PT,RASH PRURITIC,1
PT,RHABDOMYOLYSIS,1
PT,SARCOPENIA,1
PT,SPEECH DISORDER,1
PT,SYSTEMIC LUPUS ERYTHEMATOSUS,1
PT,THROMBOPHLEBITIS SUPERFICIAL,1
PT,THROMBOSIS,1
PT,TOXIC SKIN ERUPTION,1
PT,TYPE 2 DIABETES MELLITUS,1
PT,URINARY RETENTION,1
PT,URINE FLOW DECREASED,1
PR,INJECTION SITE PAIN,22
PR,NASOPHARYNGITIS,19
PR,TYPE 2 DIABETES MELLITUS,19
PR,PAIN,16
PR,PAIN IN EXTREMITY,14
PR,ARTHRALGIA,11
PR,FATIGUE,10
PR,HEADACHE,9
PR,HYPERTENSION,9
PR,ASTHMA,6
PR,DIARRHOEA,6
PR,BURNING SENSATION,5
PR,DIZZINESS,5
PR,DRUG INEFFECTIVE,5
PR,GAIT DISTURBANCE,5
PR,MUSCULOSKELETAL PAIN,5
PR,ABDOMINAL PAIN UPPER,4
PR,ASTHENIA,4
PR,BACK PAIN,4
PR,BLOOD GLUCOSE INCREASED,4
PR,BONE PAIN,4
PR,CHEST PAIN,4
PR,DYSPNOEA,4
PR,HYPERSENSITIVITY,4
PR,MALAISE,4
PR,MYALGIA,4
PR,MYOCARDIAL INFARCTION,4
PR,PSORIASIS,4
PR,PYREXIA,4
PR,WEIGHT DECREASED,4
PR,ABDOMINAL DISCOMFORT,3
PR,ABDOMINAL PAIN,3
PR,ABSCESS,3
PR,ANXIETY,3
PR,BRONCHITIS,3
PR,CHILLS,3
PR,COUGH,3
PR,DECREASED APPETITE,3
PR,FIBROMYALGIA,3
PR,INFLAMMATION,3
PR,INJECTION SITE HAEMATOMA,3
PR,INSOMNIA,3
PR,MUSCLE SPASMS,3
PR,WEIGHT INCREASED,3
PR,ARTHRITIS,2
PR,BLOOD PRESSURE INCREASED,2
PR,BURSITIS,2
PR,CARDIAC DISORDER,2
PR,CATARACT,2
PR,CEREBRAL INFARCTION,2
PR,CEREBROVASCULAR ACCIDENT,2
PR,CHIKUNGUNYA VIRUS INFECTION,2
PR,COLITIS ULCERATIVE,2
PR,CONSTIPATION,2
PR,DEPRESSION,2
PR,DISCOMFORT,2
PR,DIVERTICULITIS,2
PR,DRY SKIN,2
PR,DYSPHONIA,2
PR,FALL,2
PR,GALLBLADDER DISORDER,2
PR,GASTRITIS,2
PR,HAEMOGLOBIN DECREASED,2
PR,HEPATIC STEATOSIS,2
PR,HIATUS HERNIA,2
PR,INFECTION,2
PR,INJECTION SITE ERYTHEMA,2
PR,INTERVERTEBRAL DISC PROTRUSION,2
PR,LIMB DISCOMFORT,2
PR,LIMB INJURY,2
PR,NAUSEA,2
PR,PRODUCTIVE COUGH,2
PR,PRURITUS,2
PR,PSORIATIC ARTHROPATHY,2
PR,PULMONARY OEDEMA,2
PR,RESPIRATORY TRACT CONGESTION,2
PR,SINUSITIS,2
PR,SYNCOPE,2
PR,THYROID DISORDER,2
PR,VISUAL IMPAIRMENT,2
PR,ABDOMINAL DISTENSION,1
PR,ACUTE MYOCARDIAL INFARCTION,1
PR,ALANINE AMINOTRANSFERASE INCREASED,1
PR,ALOPECIA,1
PR,ANAL ABSCESS,1
PR,ANORECTAL DISCOMFORT,1
PR,ARTERIAL OCCLUSIVE DISEASE,1
PR,ARTERIAL STENOSIS,1
PR,ARTHROPATHY,1
PR,ASPARTATE AMINOTRANSFERASE INCREASED,1
PR,ASPHYXIA,1
PR,ASPIRATION,1
PR,BACTERIAL INFECTION,1
PR,BLOOD CHOLESTEROL INCREASED,1
PR,BLOOD COUNT ABNORMAL,1
PR,BREAST CANCER,1
PR,BREAST CANCER FEMALE,1
PR,CANDIDA INFECTION,1
PR,CARDIAC FAILURE,1
PR,CARDIAC PACEMAKER REPLACEMENT,1
PR,CARDIO-RESPIRATORY ARREST,1
PR,CAROTID ARTERY DISEASE,1
PR,CEREBRAL HAEMORRHAGE,1
PR,CHEST DISCOMFORT,1
PR,CHRONIC GASTRITIS,1
PR,COLITIS,1
PR,CORONARY ANGIOPLASTY,1
PR,CROHN^S DISEASE,1
PR,CYST,1
PR,DENGUE FEVER,1
PR,DERMOID CYST,1
PR,DEVICE ISSUE,1
PR,DIABETES MELLITUS INADEQUATE CONTROL,1
PR,DISTURBANCE IN ATTENTION,1
PR,DRUG DOSE OMISSION,1
PR,DRUG EFFECT INCOMPLETE,1
PR,DRUG RESISTANCE,1
PR,DRY EYE,1
PR,DYSGEUSIA,1
PR,DYSPHAGIA,1
PR,DYSURIA,1
PR,ENDOTRACHEAL INTUBATION COMPLICATION,1
PR,EYELID PTOSIS,1
PR,FEELING ABNORMAL,1
PR,FEMUR FRACTURE,1
PR,FINGER DEFORMITY,1
PR,FLATULENCE,1
PR,FLUID RETENTION,1
PR,FREQUENT BOWEL MOVEMENTS,1
PR,FUNGAL INFECTION,1
PR,GASTROINTESTINAL INFLAMMATION,1
PR,GASTROINTESTINAL PAIN,1
PR,GASTROOESOPHAGEAL REFLUX DISEASE,1
PR,GENITAL ABSCESS,1
PR,GINGIVAL DISCOMFORT,1
PR,GOITRE,1
PR,HAEMATOCHEZIA,1
PR,HAEMATOMA,1
PR,HEAD INJURY,1
PR,HEPATIC MASS,1
PR,HEPATIC PAIN,1
PR,HIP ARTHROPLASTY,1
PR,HOSPITALISATION,1
PR,HYPOAESTHESIA,1
PR,ILEAL ULCER,1
PR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PR,INJECTION SITE HYPERSENSITIVITY,1
PR,INJECTION SITE HYPOAESTHESIA,1
PR,INJECTION SITE PRURITUS,1
PR,INJECTION SITE RASH,1
PR,INJECTION SITE WARMTH,1
PR,INTRACRANIAL MASS,1
PR,JOINT RANGE OF MOTION DECREASED,1
PR,JOINT SWELLING,1
PR,LARYNGITIS,1
PR,LIGAMENT INJURY,1
PR,LIVER DISORDER,1
PR,MASS,1
PR,MENISCUS INJURY,1
PR,MOBILITY DECREASED,1
PR,MUSCULOSKELETAL DISORDER,1
PR,MUSCULOSKELETAL STIFFNESS,1
PR,NASAL CONGESTION,1
PR,NECK PAIN,1
PR,NERVE COMPRESSION,1
PR,NEUROPATHY PERIPHERAL,1
PR,ODYNOPHAGIA,1
PR,OEDEMA PERIPHERAL,1
PR,ONYCHOMYCOSIS,1
PR,ORAL DISCOMFORT,1
PR,ORAL FUNGAL INFECTION,1
PR,ORAL INFECTION,1
PR,ORAL PAIN,1
PR,OROPHARYNGEAL PAIN,1
PR,OSTEOPOROSIS,1
PR,OVARIAN CYST,1
PR,OVARIAN DISORDER,1
PR,OVARIAN NEOPLASM,1
PR,OVERDOSE,1
PR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
PR,PARAESTHESIA,1
PR,PARKINSON^S DISEASE,1
PR,PERIPHERAL ARTERY OCCLUSION,1
PR,PERIPHERAL SWELLING,1
PR,PLATELET DISORDER,1
PR,PNEUMONIA,1
PR,POLYURIA,1
PR,POST PROCEDURAL COMPLICATION,1
PR,PRODUCT USE IN UNAPPROVED INDICATION,1
PR,PROSTATIC DISORDER,1
PR,PROSTATITIS,1
PR,PROTEINURIA,1
PR,PRURITUS GENERALISED,1
PR,PULMONARY EMBOLISM,1
PR,PUSTULAR PSORIASIS,1
PR,RASH,1
PR,RECTAL HAEMORRHAGE,1
PR,RENAL CANCER,1
PR,RENAL FAILURE,1
PR,RESPIRATORY ARREST,1
PR,RESTLESSNESS,1
PR,RHEUMATOID ARTHRITIS,1
PR,SEIZURE,1
PR,SKIN BURNING SENSATION,1
PR,SKIN DISORDER,1
PR,SKIN EXFOLIATION,1
PR,SKIN HYPERTROPHY,1
PR,SKIN TIGHTNESS,1
PR,SKIN WRINKLING,1
PR,SLEEP APNOEA SYNDROME,1
PR,SPEECH DISORDER,1
PR,SUICIDAL IDEATION,1
PR,SURGERY,1
PR,TACHYCARDIA,1
PR,TEMPERATURE INTOLERANCE,1
PR,THROAT IRRITATION,1
PR,THYROID MASS,1
PR,THYROID NEOPLASM,1
PR,TONGUE DISCOMFORT,1
PR,TYPE 1 DIABETES MELLITUS,1
PR,URINARY TRACT INFECTION,1
PR,URINARY TRACT INFECTION BACTERIAL,1
PR,URINE ABNORMALITY,1
PR,URTICARIA,1
PR,UTERINE DISORDER,1
PR,VENOUS OCCLUSION,1
PR,VERTIGO,1
PR,VIRAL INFECTION,1
PR,VISION BLURRED,1
PR,VOMITING,1
QA,ASPHYXIA,1
QA,MUSCLE SPASMS,1
QA,RHABDOMYOLYSIS,1
QA,UROSEPSIS,1
RO,CARDIAC FAILURE CONGESTIVE,1
RO,SUDDEN CARDIAC DEATH,1
RU,ABDOMINAL ABSCESS,2
RU,BLOOD PRESSURE DECREASED,2
RU,CHOLECYSTITIS,2
RU,ASTHENIA,1
RU,COLON CANCER,1
RU,DISEASE PROGRESSION,1
RU,DIZZINESS,1
RU,ECZEMA,1
RU,EMBOLISM,1
RU,FEELING ABNORMAL,1
RU,HYPERTENSION,1
RU,METASTASES TO LIVER,1
RU,METASTASES TO LUNG,1
RU,NAUSEA,1
RU,PAIN,1
RU,RECTAL CANCER,1
RU,VOMITING,1
SA,PLEURAL EFFUSION,2
SA,RETROPERITONEAL HAEMATOMA,2
SA,ACUTE KIDNEY INJURY,1
SA,ASTHENIA,1
SA,BLOOD TRIGLYCERIDES INCREASED,1
SA,CARDIOMEGALY,1
SA,CARPAL TUNNEL SYNDROME,1
SA,CHEST PAIN,1
SA,DECREASED APPETITE,1
SA,DEPRESSED LEVEL OF CONSCIOUSNESS,1
SA,DISSEMINATED TUBERCULOSIS,1
SA,DIZZINESS,1
SA,DYSPNOEA,1
SA,FATIGUE,1
SA,GASTROENTERITIS SALMONELLA,1
SA,HAEMATOMA,1
SA,HIGH DENSITY LIPOPROTEIN DECREASED,1
SA,HYPERNATRAEMIA,1
SA,HYPOGLYCAEMIA,1
SA,HYPOKALAEMIA,1
SA,HYPOMAGNESAEMIA,1
SA,HYPOPHOSPHATAEMIA,1
SA,HYPOTENSION,1
SA,MONONEURITIS,1
SA,MUSCULAR WEAKNESS,1
SA,NEPHROPATHY TOXIC,1
SA,PSORIASIS,1
SA,PULMONARY OEDEMA,1
SA,PYREXIA,1
SA,SHOCK,1
SA,SUBCUTANEOUS ABSCESS,1
SA,SUDDEN DEATH,1
SA,TRANSPLANT REJECTION,1
SA,TREMOR,1
SA,TUBULOINTERSTITIAL NEPHRITIS,1
SA,VENTRICULAR ASYSTOLE,1
SA,WEIGHT DECREASED,1
RS,ABDOMINAL DISTENSION,1
RS,CEREBRAL ISCHAEMIA,1
RS,CONSTIPATION,1
RS,DELIRIUM,1
RS,FUNCTIONAL GASTROINTESTINAL DISORDER,1
RS,POLYMYOSITIS,1
RS,PYREXIA,1
RS,URINARY RETENTION,1
SG,PAIN,6
SG,PRURITUS,2
SG,RASH,2
SG,ABDOMINAL PAIN UPPER,1
SG,ANGINA PECTORIS,1
SG,ANKLE FRACTURE,1
SG,BALANCE DISORDER,1
SG,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
SG,BURNING SENSATION,1
SG,CONSTIPATION,1
SG,CORONARY ARTERY DISEASE,1
SG,DERMATITIS EXFOLIATIVE,1
SG,DERMATITIS EXFOLIATIVE GENERALISED,1
SG,HAEMORRHAGE INTRACRANIAL,1
SG,HEADACHE,1
SG,HYPERTENSION,1
SG,HYPOAESTHESIA,1
SG,LOCAL SWELLING,1
SG,MUSCULOSKELETAL STIFFNESS,1
SG,MYOCARDIAL INFARCTION,1
SG,MYOSITIS,1
SG,PALPITATIONS,1
SG,RASH ERYTHEMATOUS,1
SG,RASH MACULO-PAPULAR,1
SG,SYNCOPE,1
SG,UPPER LIMB FRACTURE,1
SK,ACUTE HEPATIC FAILURE,1
SK,ACUTE KIDNEY INJURY,1
SK,AORTIC ARTERIOSCLEROSIS,1
SK,APHASIA,1
SK,CARDIAC FAILURE ACUTE,1
SK,EPISTAXIS,1
SK,FACIAL NERVE DISORDER,1
SK,HAEMORRHAGIC STROKE,1
SK,HEMIPARESIS,1
SK,RHABDOMYOLYSIS,1
SI,BRADYCARDIA,3
SI,DIZZINESS,2
SI,SPEECH DISORDER,2
SI,ABNORMAL DREAMS,1
SI,ANGIOEDEMA,1
SI,BLOOD PRESSURE DECREASED,1
SI,CHOKING,1
SI,DISTURBANCE IN ATTENTION,1
SI,DYSARTHRIA,1
SI,DYSPNOEA,1
SI,ENCEPHALITIS,1
SI,FACIAL PARESIS,1
SI,FATIGUE,1
SI,GAIT DISTURBANCE,1
SI,HYPERKALAEMIA,1
SI,HYPERVENTILATION,1
SI,HYPOTENSION,1
SI,HYPOXIA,1
SI,ISCHAEMIC STROKE,1
SI,MALAISE,1
SI,MENTAL DISORDER,1
SI,MOVEMENT DISORDER,1
SI,NERVOUSNESS,1
SI,NIGHT SWEATS,1
SI,PNEUMONIA BACTERIAL,1
SI,PRODUCT USE ISSUE,1
SI,PULSE ABSENT,1
SI,RENAL FAILURE,1
SI,RESUSCITATION,1
SI,SLEEP DISORDER,1
SI,SOMNOLENCE,1
SI,SYNCOPE,1
SI,TONGUE SPASM,1
SI,TREMOR,1
ZA,CARDIAC FAILURE,3
ZA,DEATH,3
ZA,MUSCLE SPASMS,3
ZA,ACUTE MYOCARDIAL INFARCTION,2
ZA,DYSPNOEA,2
ZA,HYPERTENSION,2
ZA,INSOMNIA,2
ZA,PULMONARY OEDEMA,2
ZA,ABDOMINAL PAIN UPPER,1
ZA,ACUTE PULMONARY OEDEMA,1
ZA,ANAEMIA,1
ZA,ANGINA PECTORIS,1
ZA,AORTIC STENOSIS,1
ZA,AORTIC VALVE DISEASE,1
ZA,ASTHMA,1
ZA,BIPOLAR II DISORDER,1
ZA,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
ZA,BRADYCARDIA,1
ZA,BRONCHOSPASM,1
ZA,CARDIAC ARREST,1
ZA,CARDIAC FAILURE CONGESTIVE,1
ZA,CHEST PAIN,1
ZA,COLON CANCER,1
ZA,CONSTIPATION,1
ZA,CORONARY ARTERY DISEASE,1
ZA,COUGH,1
ZA,DEBRIDEMENT,1
ZA,DIASTOLIC DYSFUNCTION,1
ZA,DISEASE PROGRESSION,1
ZA,DIZZINESS,1
ZA,DYSPNOEA PAROXYSMAL NOCTURNAL,1
ZA,DYSURIA,1
ZA,ELECTROCARDIOGRAM Q WAVES,1
ZA,ELECTROCARDIOGRAM T WAVE INVERSION,1
ZA,EPILEPSY,1
ZA,EXPOSURE DURING BREAST FEEDING,1
ZA,EXPOSURE DURING PREGNANCY,1
ZA,FATIGUE,1
ZA,GALLBLADDER DISORDER,1
ZA,GASTROOESOPHAGEAL REFLUX DISEASE,1
ZA,GLOMERULONEPHRITIS,1
ZA,GRAND MAL CONVULSION,1
ZA,HAEMATOMA,1
ZA,HEART TRANSPLANT REJECTION,1
ZA,HEPATIC NEOPLASM,1
ZA,HYPERSENSITIVITY,1
ZA,HYPOGLYCAEMIA,1
ZA,HYPOTENSION,1
ZA,IMMUNE THROMBOCYTOPENIC PURPURA,1
ZA,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
ZA,INTERNATIONAL NORMALISED RATIO INCREASED,1
ZA,IRON DEFICIENCY,1
ZA,JAUNDICE CHOLESTATIC,1
ZA,LEFT VENTRICULAR FAILURE,1
ZA,LIVER DISORDER,1
ZA,MITRAL VALVE INCOMPETENCE,1
ZA,MUSCLE DISORDER,1
ZA,MUSCLE RUPTURE,1
ZA,MYOCARDIAL ISCHAEMIA,1
ZA,NEOPLASM MALIGNANT,1
ZA,NON-CARDIAC CHEST PAIN,1
ZA,OEDEMA PERIPHERAL,1
ZA,ORTHOPNOEA,1
ZA,PNEUMONITIS,1
ZA,PREMATURE BABY,1
ZA,PREMATURE DELIVERY,1
ZA,PURPURA,1
ZA,RENAL FAILURE,1
ZA,RENAL IMPAIRMENT,1
ZA,RESPIRATORY DISTRESS,1
ZA,SHOULDER ARTHROPLASTY,1
ZA,SPINAL DISORDER,1
ZA,SWELLING,1
ZA,THROMBOSIS,1
ZA,TINNITUS,1
ZA,TONGUE BITING,1
ZA,TONIC CLONIC MOVEMENTS,1
ZA,UNEVALUABLE EVENT,1
ZA,URINARY INCONTINENCE,1
ZA,URINARY RETENTION POSTOPERATIVE,1
ZA,VASCULITIS,1
ZA,WEIGHT INCREASED,1
ZA,YELLOW SKIN,1
ES,IMMUNE-MEDIATED NECROTISING MYOPATHY,7
ES,HYPOMAGNESAEMIA,3
ES,PAIN IN EXTREMITY,3
ES,RHABDOMYOLYSIS,3
ES,ACUTE KIDNEY INJURY,2
ES,ANAEMIA,2
ES,ASTHENIA,2
ES,BILE DUCT STONE,2
ES,BLOOD CHOLESTEROL INCREASED,2
ES,CATARACT,2
ES,CONDITION AGGRAVATED,2
ES,CONFUSIONAL STATE,2
ES,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
ES,HEPATITIS CHOLESTATIC,2
ES,HYPOTENSION,2
ES,ISCHAEMIC STROKE,2
ES,LACTIC ACIDOSIS,2
ES,MYALGIA,2
ES,TRANSAMINASES INCREASED,2
ES,ABDOMINAL PAIN,1
ES,ABDOMINAL WALL HAEMATOMA,1
ES,ACIDOSIS,1
ES,ACUTE PULMONARY OEDEMA,1
ES,ADENOCARCINOMA PANCREAS,1
ES,ARTHRALGIA,1
ES,AUTOIMMUNE HEPATITIS,1
ES,BLINDNESS TRANSIENT,1
ES,BLOOD CALCIUM DECREASED,1
ES,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
ES,BLOOD URIC ACID DECREASED,1
ES,CARDIO-RESPIRATORY ARREST,1
ES,CEREBRAL ATROPHY,1
ES,CEREBRAL HAEMATOMA,1
ES,CEREBRAL ISCHAEMIA,1
ES,CHEST PAIN,1
ES,CHEST WALL HAEMATOMA,1
ES,CHOKING SENSATION,1
ES,CHOLESTASIS,1
ES,COMBINED IMMUNODEFICIENCY,1
ES,CONTUSION,1
ES,DEHYDRATION,1
ES,DEPRESSION,1
ES,DIARRHOEA,1
ES,DRUG ADMINISTRATION ERROR,1
ES,DRUG INEFFECTIVE,1
ES,DRUG-INDUCED LIVER INJURY,1
ES,DYSGEUSIA,1
ES,DYSPNOEA,1
ES,ENCEPHALOPATHY,1
ES,ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY,1
ES,FATIGUE,1
ES,FEMUR FRACTURE,1
ES,GYNAECOMASTIA,1
ES,HAEMATOMA,1
ES,HEPATIC STEATOSIS,1
ES,HEPATITIS,1
ES,HEPATOCELLULAR INJURY,1
ES,HEPATOTOXICITY,1
ES,HIP FRACTURE,1
ES,HYPERBILIRUBINAEMIA,1
ES,HYPERSENSITIVITY VASCULITIS,1
ES,HYPERTRIGLYCERIDAEMIA,1
ES,HYPOCOAGULABLE STATE,1
ES,HYPOGLYCAEMIA,1
ES,HYPOTHYROIDISM,1
ES,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
ES,INCORRECT DOSE ADMINISTERED,1
ES,INTENTIONAL OVERDOSE,1
ES,INTERSTITIAL GRANULOMATOUS DERMATITIS,1
ES,MELAENA,1
ES,METABOLIC ACIDOSIS,1
ES,MOVEMENT DISORDER,1
ES,MUSCLE CONTRACTIONS INVOLUNTARY,1
ES,MUSCLE HAEMORRHAGE,1
ES,MUSCLE SPASMS,1
ES,MYOPATHY,1
ES,NECK PAIN,1
ES,PAIN,1
ES,PEMPHIGOID,1
ES,PRESYNCOPE,1
ES,PRURITUS GENERALISED,1
ES,PULMONARY EMBOLISM,1
ES,RECTAL HAEMORRHAGE,1
ES,RENAL IMPAIRMENT,1
ES,RENAL TUBULAR NECROSIS,1
ES,SHOCK,1
ES,SUICIDE ATTEMPT,1
ES,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
ES,TENDON RUPTURE,1
ES,TENDONITIS,1
ES,TOOTH LOSS,1
ES,TREATMENT NONCOMPLIANCE,1
ES,UPPER GASTROINTESTINAL HAEMORRHAGE,1
ES,VISION BLURRED,1
ES,VOMITING,1
LK,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
LK,MYOPATHY,1
SE,FATIGUE,9
SE,DIZZINESS,8
SE,DYSPNOEA,7
SE,DEPRESSION,6
SE,HEADACHE,6
SE,MUSCULAR WEAKNESS,6
SE,NAUSEA,6
SE,PAIN,6
SE,PERIODONTITIS,6
SE,PYREXIA,6
SE,VOMITING,6
SE,ABDOMINAL PAIN,5
SE,CHEST PAIN,5
SE,COUGH,5
SE,MYALGIA,5
SE,PAIN IN EXTREMITY,5
SE,ABDOMINAL DISCOMFORT,4
SE,ARTHRALGIA,4
SE,BALANCE DISORDER,4
SE,CARDIAC DISORDER,4
SE,CEREBROVASCULAR ACCIDENT,4
SE,DIARRHOEA,4
SE,HEPATIC FAILURE,4
SE,LACTOSE INTOLERANCE,4
SE,MALAISE,4
SE,ABDOMINAL PAIN UPPER,3
SE,ANAEMIA,3
SE,ATRIAL FIBRILLATION,3
SE,BLOOD CREATININE INCREASED,3
SE,C-REACTIVE PROTEIN INCREASED,3
SE,CARDIAC FAILURE,3
SE,CONSTIPATION,3
SE,GENERAL PHYSICAL HEALTH DETERIORATION,3
SE,HEARING IMPAIRED,3
SE,HEPATIC ENZYME INCREASED,3
SE,HEPATIC FUNCTION ABNORMAL,3
SE,HYPOTENSION,3
SE,MEMORY IMPAIRMENT,3
SE,MUSCLE ATROPHY,3
SE,RENAL FAILURE,3
SE,RHABDOMYOLYSIS,3
SE,SEPSIS,3
SE,TINNITUS,3
SE,TRANSAMINASES INCREASED,3
SE,WEIGHT DECREASED,3
SE,ANXIETY,2
SE,ASTHENIA,2
SE,BLISTER,2
SE,BREAST CANCER,2
SE,BRONCHITIS,2
SE,CARDIAC FAILURE CONGESTIVE,2
SE,CEREBRAL INFARCTION,2
SE,COGNITIVE DISORDER,2
SE,DYSPHAGIA,2
SE,EYE HAEMORRHAGE,2
SE,FLUSHING,2
SE,HYPERHIDROSIS,2
SE,INSOMNIA,2
SE,JOINT SWELLING,2
SE,MUSCLE SPASMS,2
SE,MUSCULOSKELETAL PAIN,2
SE,MYOCARDIAL INFARCTION,2
SE,NASAL POLYPS,2
SE,NASOPHARYNGITIS,2
SE,PALPITATIONS,2
SE,PERIPHERAL COLDNESS,2
SE,PNEUMONIA,2
SE,PRURITUS,2
SE,RASH,2
SE,RECTAL HAEMORRHAGE,2
SE,RENAL FAILURE ACUTE,2
SE,RESPIRATORY TRACT INFECTION,2
SE,SLEEP DISORDER,2
SE,THROAT IRRITATION,2
SE,TOOTH LOSS,2
SE,URINARY TRACT INFECTION,2
SE,VISUAL IMPAIRMENT,2
SE,ABDOMINAL DISTENSION,1
SE,ABDOMINAL SYMPTOM,1
SE,ABSCESS,1
SE,AGGRESSION,1
SE,AGRANULOCYTOSIS,1
SE,ALOPECIA,1
SE,ALTERED STATE OF CONSCIOUSNESS,1
SE,AMNESIA,1
SE,AMYLOIDOSIS,1
SE,ANGINA PECTORIS,1
SE,ANGIOEDEMA,1
SE,AORTIC VALVE INCOMPETENCE,1
SE,APHAGIA,1
SE,ARTHRITIS,1
SE,ARTHROPATHY,1
SE,BACK PAIN,1
SE,BACTERAEMIA,1
SE,BACTERIURIA,1
SE,BENIGN PROSTATIC HYPERPLASIA,1
SE,BK VIRUS INFECTION,1
SE,BLINDNESS,1
SE,BLINDNESS TRANSIENT,1
SE,BLOOD ALKALINE PHOSPHATASE INCREASED,1
SE,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
SE,BLOOD PRESSURE DECREASED,1
SE,BREAST DISORDER,1
SE,BRONCHIOLITIS,1
SE,BURNING SENSATION,1
SE,CALCIUM DEFICIENCY,1
SE,CARDIAC FIBRILLATION,1
SE,CATARACT,1
SE,CEREBRAL HAEMORRHAGE,1
SE,CHEILITIS,1
SE,CHEST DISCOMFORT,1
SE,CHILLS,1
SE,CHOLELITHIASIS,1
SE,CHOLESTASIS,1
SE,CLOSTRIDIUM DIFFICILE INFECTION,1
SE,COLON CANCER,1
SE,CONDITION AGGRAVATED,1
SE,CONFUSIONAL STATE,1
SE,CONJUNCTIVITIS ALLERGIC,1
SE,CONVULSION,1
SE,COORDINATION ABNORMAL,1
SE,DEAFNESS UNILATERAL,1
SE,DECREASED APPETITE,1
SE,DEHYDRATION,1
SE,DEPRESSED LEVEL OF CONSCIOUSNESS,1
SE,DEPRESSED MOOD,1
SE,DERMATITIS,1
SE,DISEASE PROGRESSION,1
SE,DISTURBANCE IN ATTENTION,1
SE,DIVERTICULITIS,1
SE,DRUG INEFFECTIVE,1
SE,DRY SKIN,1
SE,DYSARTHRIA,1
SE,DYSGEUSIA,1
SE,DYSPEPSIA,1
SE,EAR PAIN,1
SE,EJECTION FRACTION DECREASED,1
SE,EMBOLIC STROKE,1
SE,EOSINOPHILIA,1
SE,ERUCTATION,1
SE,ERYSIPELAS,1
SE,ERYTHEMA,1
SE,EXERCISE LACK OF,1
SE,EYE OEDEMA,1
SE,FAECES DISCOLOURED,1
SE,FALL,1
SE,FEELING ABNORMAL,1
SE,FLATULENCE,1
SE,GAIT DISTURBANCE,1
SE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
SE,GASTRIC ULCER,1
SE,GASTRITIS,1
SE,GASTROOESOPHAGEAL REFLUX DISEASE,1
SE,GENERALISED OEDEMA,1
SE,GROIN PAIN,1
SE,HAEMATOCHEZIA,1
SE,HAEMATOMA,1
SE,HAEMATURIA,1
SE,HAEMOPHILIC ARTHROPATHY,1
SE,HEAD DISCOMFORT,1
SE,HEAD INJURY,1
SE,HEART RATE IRREGULAR,1
SE,HEPATIC PAIN,1
SE,HEPATITIS,1
SE,HIATUS HERNIA,1
SE,HYPOAESTHESIA,1
SE,HYPOGLYCAEMIA,1
SE,HYPONATRAEMIA,1
SE,HYPOTHERMIA,1
SE,IMMUNE-MEDIATED NECROTISING MYOPATHY,1
SE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
SE,INFECTION,1
SE,INFLUENZA LIKE ILLNESS,1
SE,INTERVERTEBRAL DISC PROTRUSION,1
SE,INTRAOCULAR PRESSURE INCREASED,1
SE,IRRITABILITY,1
SE,ISCHAEMIC STROKE,1
SE,JAUNDICE,1
SE,JOINT STIFFNESS,1
SE,KETOACIDOSIS,1
SE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
SE,LARGE INTESTINAL ULCER HAEMORRHAGE,1
SE,LARGE INTESTINE PERFORATION,1
SE,LETHARGY,1
SE,LIVER FUNCTION TEST DECREASED,1
SE,LUNG DISORDER,1
SE,LUNG NEOPLASM MALIGNANT,1
SE,MACULAR FIBROSIS,1
SE,MALIGNANT BREAST LUMP REMOVAL,1
SE,METASTASES TO BONE,1
SE,METASTASES TO THORAX,1
SE,MIGRAINE WITH AURA,1
SE,MOOD ALTERED,1
SE,MOUTH HAEMORRHAGE,1
SE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
SE,MUSCLE RIGIDITY,1
SE,MUSCLE RUPTURE,1
SE,MUSCLE TIGHTNESS,1
SE,MUSCULOSKELETAL STIFFNESS,1
SE,NECK PAIN,1
SE,NECROTISING MYOSITIS,1
SE,NEPHROLITHIASIS,1
SE,NERVE COMPRESSION,1
SE,NERVOUS SYSTEM DISORDER,1
SE,NEUROGENIC BLADDER,1
SE,NEUTROPENIA,1
SE,NIGHTMARE,1
SE,NITRITE URINE PRESENT,1
SE,OMPHALORRHEXIS,1
SE,ORGAN FAILURE,1
SE,ORTHOSTATIC HYPOTENSION,1
SE,OSTEONECROSIS,1
SE,PANCREATITIS,1
SE,PERIPHERAL SWELLING,1
SE,POLYNEUROPATHY,1
SE,POTENTIATING DRUG INTERACTION,1
SE,PRODUCT SUBSTITUTION ISSUE,1
SE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
SE,PROSTATE CANCER METASTATIC,1
SE,PROSTATOMEGALY,1
SE,PRURITUS GENERALISED,1
SE,PTERYGIUM,1
SE,REFLEXES ABNORMAL,1
SE,RENAL HAEMORRHAGE,1
SE,RESTLESSNESS,1
SE,RETCHING,1
SE,RETINAL DETACHMENT,1
SE,RETINAL HAEMORRHAGE,1
SE,RHEUMATOID ARTHRITIS,1
SE,RIB FRACTURE,1
SE,SEXUAL DYSFUNCTION,1
SE,SINUSITIS,1
SE,SKIN ATROPHY,1
SE,SKIN DISCOLOURATION,1
SE,SKIN REACTION,1
SE,SKULL FRACTURE,1
SE,SLUGGISHNESS,1
SE,SOMNOLENCE,1
SE,STRESS CARDIOMYOPATHY,1
SE,SUICIDE ATTEMPT,1
SE,SYNCOPE,1
SE,TENDON DISCOMFORT,1
SE,TENOSYNOVITIS,1
SE,THROMBOTIC CEREBRAL INFARCTION,1
SE,TONGUE DISORDER,1
SE,TONGUE OEDEMA,1
SE,TOXICITY TO VARIOUS AGENTS,1
SE,TRANSIENT ISCHAEMIC ATTACK,1
SE,TREMOR,1
SE,TRIGGER FINGER,1
SE,TROPONIN INCREASED,1
SE,TUBULOINTERSTITIAL NEPHRITIS,1
SE,TUMOUR PAIN,1
SE,UPPER GASTROINTESTINAL HAEMORRHAGE,1
SE,VAGINAL HAEMORRHAGE,1
SE,VENOUS THROMBOSIS LIMB,1
SE,VERTIGO,1
SE,VISION BLURRED,1
SE,VISUAL ACUITY REDUCED,1
SE,VITAMIN D DEFICIENCY,1
SE,WEIGHT INCREASED,1
SE,WHEEZING,1
SE,WHITE BLOOD CELLS URINE POSITIVE,1
CH,TOXICITY TO VARIOUS AGENTS,4
CH,BLOOD ALKALINE PHOSPHATASE INCREASED,3
CH,HEPATITIS CHOLESTATIC,3
CH,IMMUNE-MEDIATED NECROTISING MYOPATHY,3
CH,JAUNDICE,3
CH,MATERNAL EXPOSURE DURING PREGNANCY,3
CH,POTENTIATING DRUG INTERACTION,3
CH,RHABDOMYOLYSIS,3
CH,THROMBOCYTOPENIA,3
CH,ACUTE KIDNEY INJURY,2
CH,ALANINE AMINOTRANSFERASE INCREASED,2
CH,ANAEMIA,2
CH,ANXIETY,2
CH,ATRIAL FIBRILLATION,2
CH,BLOOD BILIRUBIN INCREASED,2
CH,CHILLS,2
CH,CHOLESTASIS,2
CH,CLOSTRIDIUM DIFFICILE COLITIS,2
CH,CONFUSIONAL STATE,2
CH,DECREASED APPETITE,2
CH,DIARRHOEA,2
CH,DRUG-INDUCED LIVER INJURY,2
CH,DYSPNOEA,2
CH,GAIT DISTURBANCE,2
CH,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
CH,GENERAL PHYSICAL HEALTH DETERIORATION,2
CH,HAEMATURIA,2
CH,HALLUCINATION_ VISUAL,2
CH,HEADACHE,2
CH,HEPATIC ENZYME INCREASED,2
CH,HEPATOCELLULAR INJURY,2
CH,HYPONATRAEMIA,2
CH,HYPOTENSION,2
CH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
CH,INTERSTITIAL LUNG DISEASE,2
CH,JAUNDICE CHOLESTATIC,2
CH,LIVER DISORDER,2
CH,MALAISE,2
CH,MELAENA,2
CH,MYALGIA,2
CH,NAUSEA,2
CH,PARAESTHESIA,2
CH,POLYNEUROPATHY,2
CH,PRURITUS,2
CH,RENAL FAILURE,2
CH,TENDON DISORDER,2
CH,TRANSAMINASES INCREASED,2
CH,ABDOMINAL PAIN UPPER,1
CH,ABDOMINAL TENDERNESS,1
CH,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
CH,ACUTE HEPATIC FAILURE,1
CH,AGRANULOCYTOSIS,1
CH,ALOPECIA AREATA,1
CH,ANAPHYLACTOID REACTION,1
CH,ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC,1
CH,ANTINUCLEAR ANTIBODY INCREASED,1
CH,ARTHRALGIA,1
CH,ASCITES,1
CH,ASPARTATE AMINOTRANSFERASE INCREASED,1
CH,ASTHENIA,1
CH,ASTHMA,1
CH,ATRIAL FLUTTER,1
CH,BACTERIAL SEPSIS,1
CH,BALANOPOSTHITIS,1
CH,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
CH,BREAST CANCER METASTATIC,1
CH,C-REACTIVE PROTEIN INCREASED,1
CH,CARDIOGENIC SHOCK,1
CH,CAROTID ARTERY STENOSIS,1
CH,CATHETER SITE HAEMORRHAGE,1
CH,CEREBRAL HAEMORRHAGE,1
CH,CEREBRAL ISCHAEMIA,1
CH,CEREBROVASCULAR ACCIDENT,1
CH,CHOLESTATIC LIVER INJURY,1
CH,CONDITION AGGRAVATED,1
CH,CONGENITAL HAND MALFORMATION,1
CH,CONGENITAL PYELOCALIECTASIS,1
CH,CONTRAINDICATED PRODUCT ADMINISTERED,1
CH,COUGH,1
CH,DELIRIUM,1
CH,DERMATOMYOSITIS,1
CH,DISEASE PROGRESSION,1
CH,DISTURBANCE IN ATTENTION,1
CH,DIVERTICULITIS INTESTINAL HAEMORRHAGIC,1
CH,DRUG ADMINISTRATION ERROR,1
CH,DRUG ERUPTION,1
CH,DRUG INEFFECTIVE,1
CH,DUODENAL ULCER,1
CH,ELECTROCARDIOGRAM QT PROLONGED,1
CH,EPIGASTRIC DISCOMFORT,1
CH,EPISTAXIS,1
CH,FACIAL PARESIS,1
CH,FEELING ABNORMAL,1
CH,GASTROINTESTINAL HAEMORRHAGE,1
CH,GLOMERULONEPHRITIS,1
CH,GLOMERULONEPHRITIS MEMBRANOUS,1
CH,GOUT,1
CH,HAEMANGIOMA OF SKIN,1
CH,HAEMATOMA,1
CH,HAEMOLYSIS,1
CH,HEMIPARESIS,1
CH,HENOCH-SCHONLEIN PURPURA,1
CH,HEPATIC CIRRHOSIS,1
CH,HEPATIC STEATOSIS,1
CH,HEPATITIS,1
CH,HEPATOMEGALY,1
CH,HYPERHIDROSIS,1
CH,HYPERTHYROIDISM,1
CH,HYPOAESTHESIA,1
CH,HYPOKALAEMIA,1
CH,INHIBITORY DRUG INTERACTION,1
CH,INTERNATIONAL NORMALISED RATIO INCREASED,1
CH,IRON DEFICIENCY ANAEMIA,1
CH,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
CH,LIPASE INCREASED,1
CH,LIVER INJURY,1
CH,MEMORY IMPAIRMENT,1
CH,METASTASES TO ABDOMINAL WALL,1
CH,MOUTH INJURY,1
CH,MUSCLE HAEMORRHAGE,1
CH,MYOCLONUS,1
CH,NECK PAIN,1
CH,NERVOUS SYSTEM DISORDER,1
CH,NERVOUSNESS,1
CH,NEUTROPENIA,1
CH,NIGHT SWEATS,1
CH,NODAL ARRHYTHMIA,1
CH,OESOPHAGEAL MOTILITY DISORDER,1
CH,OTITIS MEDIA,1
CH,OVERDOSE,1
CH,PANCYTOPENIA,1
CH,PERIORBITAL HAEMATOMA,1
CH,PHIMOSIS,1
CH,PHOTOPHOBIA,1
CH,PIGMENTATION DISORDER,1
CH,PNEUMONITIS,1
CH,PULMONARY ARTERIAL HYPERTENSION,1
CH,PYREXIA,1
CH,RASH,1
CH,RASH PRURITIC,1
CH,RAYNAUD^S PHENOMENON,1
CH,RENAL FAILURE ACUTE,1
CH,SCLERODACTYLIA,1
CH,SEROTONIN SYNDROME,1
CH,SYSTEMIC SCLEROSIS,1
CH,UPPER GASTROINTESTINAL HAEMORRHAGE,1
CH,UROGENITAL HAEMORRHAGE,1
CH,VENTRICULAR FIBRILLATION,1
CH,VIITH NERVE PARALYSIS,1
CH,VOMITING,1
TW,ACUTE MYOCARDIAL INFARCTION,5
TW,RHABDOMYOLYSIS,5
TW,ACUTE KIDNEY INJURY,4
TW,CORONARY ARTERY DISEASE,4
TW,FATIGUE,4
TW,PAIN IN EXTREMITY,4
TW,URINARY TRACT INFECTION,4
TW,ALANINE AMINOTRANSFERASE INCREASED,3
TW,ALTERED STATE OF CONSCIOUSNESS,3
TW,DIZZINESS,3
TW,DYSPNOEA,3
TW,MUSCULAR WEAKNESS,3
TW,NASOPHARYNGITIS,3
TW,ANGINA UNSTABLE,2
TW,ASPARTATE AMINOTRANSFERASE INCREASED,2
TW,ASTHENIA,2
TW,BLOOD CREATININE INCREASED,2
TW,BLOOD TRIGLYCERIDES INCREASED,2
TW,CEREBRAL HAEMORRHAGE,2
TW,CHROMATURIA,2
TW,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
TW,COUGH,2
TW,DEATH,2
TW,DIABETES MELLITUS,2
TW,FALL,2
TW,HEADACHE,2
TW,HYPERTENSION,2
TW,HYPOTENSION,2
TW,INFLUENZA,2
TW,INTERSTITIAL LUNG DISEASE,2
TW,JAUNDICE,2
TW,LIVER FUNCTION TEST ABNORMAL,2
TW,MYOCARDIAL INFARCTION,2
TW,PNEUMONIA,2
TW,PYREXIA,2
TW,ACCIDENTAL UNDERDOSE,1
TW,ACINETOBACTER INFECTION,1
TW,ACUTE HEPATITIS B,1
TW,AMNESIA,1
TW,ANAL INCONTINENCE,1
TW,ANGINA PECTORIS,1
TW,AORTIC VALVE STENOSIS,1
TW,ARTERIOSCLEROSIS CORONARY ARTERY,1
TW,BLOOD CHOLESTEROL INCREASED,1
TW,BLOOD THYROID STIMULATING HORMONE INCREASED,1
TW,BRADYCARDIA,1
TW,BRAIN OEDEMA,1
TW,BREAST CANCER,1
TW,CANDIDA INFECTION,1
TW,CARCINOMA IN SITU,1
TW,CARDIAC FAILURE CONGESTIVE,1
TW,CATHETERISATION CARDIAC,1
TW,CEREBROVASCULAR ACCIDENT,1
TW,CHEST DISCOMFORT,1
TW,CHOLELITHIASIS,1
TW,COLITIS,1
TW,DECREASED APPETITE,1
TW,DEGENERATIVE AORTIC VALVE DISEASE,1
TW,DEPRESSED LEVEL OF CONSCIOUSNESS,1
TW,DIARRHOEA,1
TW,DISEASE RECURRENCE,1
TW,DIVERTICULITIS,1
TW,DRUG INEFFECTIVE,1
TW,EXERCISE TOLERANCE DECREASED,1
TW,FOOD INTERACTION,1
TW,FUNGAEMIA,1
TW,GASTRIC ULCER,1
TW,GASTROINTESTINAL HAEMORRHAGE,1
TW,GINGIVAL BLEEDING,1
TW,GLOMERULAR FILTRATION RATE DECREASED,1
TW,HAEMOGLOBIN DECREASED,1
TW,HEPATIC STEATOSIS,1
TW,HYPERKALAEMIA,1
TW,HYPERLIPIDAEMIA,1
TW,HYPOGLYCAEMIA,1
TW,HYPOTHYROIDISM,1
TW,HYPOVOLAEMIC SHOCK,1
TW,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
TW,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
TW,LEG AMPUTATION,1
TW,LEUKAEMIA,1
TW,LIVER DISORDER,1
TW,LOWER GASTROINTESTINAL HAEMORRHAGE,1
TW,LUNG CANCER METASTATIC,1
TW,LUNG INFECTION,1
TW,MEDICATION RESIDUE PRESENT,1
TW,MENINGITIS CRYPTOCOCCAL,1
TW,MITRAL VALVE INCOMPETENCE,1
TW,MOUTH ULCERATION,1
TW,MYALGIA,1
TW,MYOCARDIAL ISCHAEMIA,1
TW,NECROTISING FASCIITIS,1
TW,OCULAR ICTERUS,1
TW,OEDEMA PERIPHERAL,1
TW,OLIGURIA,1
TW,PALPITATIONS,1
TW,PARKINSONISM,1
TW,PLATELET COUNT DECREASED,1
TW,PLEURAL EFFUSION,1
TW,PRODUCT QUALITY ISSUE,1
TW,PRODUCTIVE COUGH,1
TW,RENAL FAILURE CHRONIC,1
TW,SEPSIS,1
TW,SEPTIC SHOCK,1
TW,SKIN ABRASION,1
TW,SKIN ULCER,1
TW,SOMNOLENCE,1
TW,SQUAMOUS CELL CARCINOMA,1
TW,STOMA OBSTRUCTION,1
TW,THERAPY CESSATION,1
TW,THROMBOCYTOPENIA,1
TW,TINEA CRURIS,1
TW,TRANSAMINASES INCREASED,1
TW,TRANSITIONAL CELL CARCINOMA,1
TW,TRAUMATIC LUNG INJURY,1
TW,UPPER GASTROINTESTINAL HAEMORRHAGE,1
TW,URINARY INCONTINENCE,1
TW,UROSEPSIS,1
TW,VENTRICULAR DYSFUNCTION,1
TW,VISION BLURRED,1
TW,WEIGHT INCREASED,1
TW,WHITE BLOOD CELL COUNT DECREASED,1
TH,HEPATIC FUNCTION ABNORMAL,2
TH,OEDEMA PERIPHERAL,2
TH,SEPSIS,2
TH,ABASIA,1
TH,ANAEMIA HAEMOLYTIC AUTOIMMUNE,1
TH,ANGINA UNSTABLE,1
TH,AORTIC ANEURYSM,1
TH,AORTIC STENOSIS,1
TH,APLASIA PURE RED CELL,1
TH,ATRIAL FIBRILLATION,1
TH,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
TH,BILE DUCT STONE,1
TH,BLADDER CANCER,1
TH,BLOOD CREATININE INCREASED,1
TH,BLOOD KETONE BODY INCREASED,1
TH,BRONCHIAL DISORDER,1
TH,CATHETER SITE HAEMORRHAGE,1
TH,CEREBROVASCULAR ACCIDENT,1
TH,CHEST PAIN,1
TH,CHOLANGITIS,1
TH,CONSTIPATION,1
TH,DEAFNESS,1
TH,DIABETES MELLITUS,1
TH,DIABETIC KETOACIDOSIS,1
TH,DIARRHOEA,1
TH,DRY SKIN,1
TH,FOLLICULITIS,1
TH,GASTROOESOPHAGEAL REFLUX DISEASE,1
TH,INFECTION,1
TH,PANCREATITIS ACUTE,1
TH,PANCYTOPENIA,1
TH,PARONYCHIA,1
TH,PULMONARY MASS,1
TH,RASH,1
TH,RENAL FAILURE ACUTE,1
TH,SEPTIC SHOCK,1
TH,STOMATITIS,1
TH,SYNCOPE,1
TH,THROMBOCYTOPENIA,1
TH,TRANSAMINASES INCREASED,1
TH,TRANSPLANT REJECTION,1
TH,VOMITING,1
TT,DIABETES MELLITUS,3
TN,ANAEMIA,1
TN,ASTHENIA,1
TN,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
TN,HEADACHE,1
TN,HYPOTENSION,1
TN,MUSCLE SPASMS,1
TN,PIRIFORMIS SYNDROME,1
TR,NAUSEA,6
TR,ASTHENIA,5
TR,FATIGUE,5
TR,TACHYCARDIA,5
TR,AUTOIMMUNE HEPATITIS,4
TR,MYOCARDIAL INFARCTION,4
TR,CHEST PAIN,3
TR,DERMATOMYOSITIS,3
TR,DIZZINESS,3
TR,DYSPNOEA,3
TR,HYPERCALCAEMIA,3
TR,PANCREATITIS ACUTE,3
TR,TRANSIENT ISCHAEMIC ATTACK,3
TR,VEIN DISORDER,3
TR,ABDOMINAL PAIN,2
TR,ACUTE KIDNEY INJURY,2
TR,ANTIPHOSPHOLIPID SYNDROME,2
TR,BLOOD GLUCOSE INCREASED,2
TR,BLOOD PRESSURE DECREASED,2
TR,CONTUSION,2
TR,DECREASED APPETITE,2
TR,DRUG INEFFECTIVE,2
TR,GASTRIC HAEMORRHAGE,2
TR,HEADACHE,2
TR,HYPOAESTHESIA,2
TR,INTESTINAL HAEMORRHAGE,2
TR,MALAISE,2
TR,NEOPLASM,2
TR,PAIN,2
TR,PARAESTHESIA,2
TR,PNEUMONIA,2
TR,PRODUCT USE IN UNAPPROVED INDICATION,2
TR,RENAL IMPAIRMENT,2
TR,RHABDOMYOLYSIS,2
TR,VISION BLURRED,2
TR,VOMITING,2
TR,ABNORMAL DREAMS,1
TR,ACTIVITIES OF DAILY LIVING IMPAIRED,1
TR,ACUTE CORONARY SYNDROME,1
TR,ANAEMIA,1
TR,ANGINA PECTORIS,1
TR,ARRHYTHMIA,1
TR,ARTERIOSCLEROSIS,1
TR,ATAXIA,1
TR,BACK PAIN,1
TR,BLINDNESS,1
TR,BLOOD CREATININE INCREASED,1
TR,BLOOD FOLLICLE STIMULATING HORMONE DECREASED,1
TR,BLOOD LUTEINISING HORMONE DECREASED,1
TR,BLOOD PROLACTIN DECREASED,1
TR,BLOOD TESTOSTERONE DECREASED,1
TR,BLOOD TRIGLYCERIDES INCREASED,1
TR,BLOOD UREA INCREASED,1
TR,BRADYCARDIA,1
TR,BREAST CANCER METASTATIC,1
TR,CARDIAC FAILURE,1
TR,CEREBROVASCULAR DISORDER,1
TR,COGNITIVE DISORDER,1
TR,CONFUSIONAL STATE,1
TR,CORONARY ARTERY DISEASE,1
TR,CORONARY ARTERY STENOSIS,1
TR,CORONARY ARTERY THROMBOSIS,1
TR,CORONARY BYPASS STENOSIS,1
TR,CRYING,1
TR,DEATH,1
TR,DISABILITY,1
TR,DISTURBANCE IN ATTENTION,1
TR,DRUG ADMINISTRATION ERROR,1
TR,DRUG EFFECT INCOMPLETE,1
TR,DRUG INTOLERANCE,1
TR,DYSKINESIA,1
TR,FLATULENCE,1
TR,GAIT DISTURBANCE,1
TR,GANGRENE,1
TR,GENERAL PHYSICAL CONDITION ABNORMAL,1
TR,HAEMATURIA,1
TR,HEPATITIS TOXIC,1
TR,HEPATOTOXICITY,1
TR,HYPERGLYCAEMIA,1
TR,HYPERTENSION,1
TR,INCREASED APPETITE,1
TR,INJECTION SITE MASS,1
TR,INJECTION SITE PAIN,1
TR,INTENTIONAL PRODUCT MISUSE,1
TR,INTRAOCULAR PRESSURE INCREASED,1
TR,ISCHAEMIC STROKE,1
TR,LIBIDO DECREASED,1
TR,MEMORY IMPAIRMENT,1
TR,METASTASES TO BONE,1
TR,MYALGIA,1
TR,NERVOUSNESS,1
TR,NIGHTMARE,1
TR,OVERDOSE,1
TR,PAIN IN EXTREMITY,1
TR,POLYDIPSIA,1
TR,POLYMYALGIA RHEUMATICA,1
TR,POLYURIA,1
TR,PRODUCT QUALITY ISSUE,1
TR,PRODUCT STORAGE ERROR,1
TR,RENAL FAILURE ACUTE,1
TR,RESPIRATORY DISTRESS,1
TR,RESPIRATORY FAILURE,1
TR,ROAD TRAFFIC ACCIDENT,1
TR,SARCOIDOSIS,1
TR,SEPSIS,1
TR,SEXUAL DYSFUNCTION,1
TR,SLEEP DISORDER,1
TR,SOMNOLENCE,1
TR,SUPRAVENTRICULAR TACHYCARDIA,1
TR,TACHYPNOEA,1
TR,UPPER LIMB FRACTURE,1
TR,URINARY TRACT INFECTION,1
TR,URINE OUTPUT DECREASED,1
TR,VERTIGO,1
TR,WEIGHT DECREASED,1
AE,AGGRESSION,1
AE,ANGER,1
AE,ATRIAL FIBRILLATION,1
AE,DIZZINESS,1
AE,DYSPNOEA,1
AE,FATIGUE,1
AE,HAEMORRHAGE,1
AE,HEART RATE IRREGULAR,1
AE,HYPERHIDROSIS,1
AE,HYPOTENSION,1
AE,PALPITATIONS,1
GB,MYALGIA,106
GB,FATIGUE,78
GB,DIZZINESS,47
GB,ACUTE KIDNEY INJURY,46
GB,NAUSEA,45
GB,DYSPNOEA,44
GB,MALAISE,42
GB,ASTHENIA,40
GB,ARTHRALGIA,34
GB,HEADACHE,33
GB,RENAL IMPAIRMENT,33
GB,INSOMNIA,32
GB,DIARRHOEA,31
GB,VOMITING,31
GB,MUSCULAR WEAKNESS,30
GB,PAIN,30
GB,GAIT DISTURBANCE,28
GB,TINNITUS,28
GB,CONFUSIONAL STATE,27
GB,MUSCLE SPASMS,27
GB,GENERAL PHYSICAL HEALTH DETERIORATION,26
GB,SLEEP DISORDER,26
GB,CHEST PAIN,25
GB,CONSTIPATION,23
GB,HYPOTENSION,23
GB,PARAESTHESIA,23
GB,PRURITUS,23
GB,BACK PAIN,22
GB,QUALITY OF LIFE DECREASED,22
GB,SOMNOLENCE,22
GB,PAIN IN EXTREMITY,21
GB,VISION BLURRED,21
GB,COUGH,20
GB,MUSCLE ATROPHY,20
GB,BALANCE DISORDER,18
GB,SYNCOPE,18
GB,ABDOMINAL PAIN UPPER,17
GB,PARALYSIS,17
GB,PSYCHIATRIC SYMPTOM,17
GB,DEPRESSION,16
GB,FALL,15
GB,LETHARGY,15
GB,LIVER FUNCTION TEST ABNORMAL,15
GB,MENTAL DISORDER,15
GB,NIGHTMARE,15
GB,OEDEMA MOUTH,15
GB,RHABDOMYOLYSIS,15
GB,SWELLING FACE,15
GB,ABNORMAL DREAMS,14
GB,CEREBROVASCULAR ACCIDENT,14
GB,DYSPHAGIA,14
GB,LOWER RESPIRATORY TRACT INFECTION,14
GB,MEMORY IMPAIRMENT,14
GB,MUSCLE FATIGUE,14
GB,MUSCLE RIGIDITY,14
GB,NECK PAIN,14
GB,BRADYCARDIA,13
GB,DRUG INTOLERANCE,13
GB,FEELING ABNORMAL,13
GB,HYPONATRAEMIA,13
GB,CONDITION AGGRAVATED,12
GB,DECREASED APPETITE,12
GB,DRUG INEFFECTIVE,12
GB,DYSPEPSIA,12
GB,IMPAIRED WORK ABILITY,12
GB,MYOPATHY,12
GB,OEDEMA PERIPHERAL,12
GB,PYREXIA,12
GB,RASH,12
GB,SEIZURE,12
GB,TRANSIENT ISCHAEMIC ATTACK,12
GB,ADVERSE EVENT,11
GB,AVOIDANT PERSONALITY DISORDER,11
GB,DEAFNESS,11
GB,FRUSTRATION,11
GB,HYPOKALAEMIA,11
GB,HYPOTONIA,11
GB,INTERVERTEBRAL DISC DEGENERATION,11
GB,OCCUPATIONAL PROBLEM ENVIRONMENTAL,11
GB,PRODUCT SUBSTITUTION ISSUE,11
GB,RENAL FAILURE CHRONIC,11
GB,SCREAMING,11
GB,SEXUAL DYSFUNCTION,11
GB,SOCIAL AVOIDANT BEHAVIOUR,11
GB,SOCIAL PROBLEM,11
GB,SWOLLEN TONGUE,11
GB,TENDERNESS,11
GB,WEIGHT DECREASED,11
GB,ABDOMINAL PAIN,10
GB,ABNORMAL WEIGHT GAIN,10
GB,ANAPHYLACTIC REACTION,10
GB,EPISTAXIS,10
GB,ERUCTATION,10
GB,INTRAOCULAR PRESSURE DECREASED,10
GB,LIP SWELLING,10
GB,LOSS OF CONSCIOUSNESS,10
GB,MOBILITY DECREASED,10
GB,OROPHARYNGEAL PAIN,10
GB,POLLAKIURIA,10
GB,SPEECH DISORDER,10
GB,AMNESIA,9
GB,BURNING SENSATION,9
GB,DIABETES MELLITUS,9
GB,EMOTIONAL DISTRESS,9
GB,FLUID OVERLOAD,9
GB,NASOPHARYNGITIS,9
GB,SKIN EXFOLIATION,9
GB,ALOPECIA,8
GB,ANGIOEDEMA,8
GB,BLOOD GLUCOSE INCREASED,8
GB,BLOOD PRESSURE FLUCTUATION,8
GB,DIABETIC KETOACIDOSIS,8
GB,DYSURIA,8
GB,INFLUENZA LIKE ILLNESS,8
GB,LIBIDO INCREASED,8
GB,MYOCARDIAL ISCHAEMIA,8
GB,PALLOR,8
GB,TREMOR,8
GB,VISUAL IMPAIRMENT,8
GB,DRY MOUTH,7
GB,HYPERHIDROSIS,7
GB,HYPOAESTHESIA,7
GB,MICTURITION URGENCY,7
GB,MUSCULOSKELETAL PAIN,7
GB,TENDON PAIN,7
GB,THERAPEUTIC RESPONSE UNEXPECTED,7
GB,THROMBOCYTOPENIA,7
GB,UNRESPONSIVE TO STIMULI,7
GB,URINARY TRACT PAIN,7
GB,ACROPHOBIA,6
GB,BLISTER,6
GB,BLOOD BILIRUBIN INCREASED,6
GB,BLOOD PRESSURE INCREASED,6
GB,CELLULITIS,6
GB,CONTUSION,6
GB,DRUG WITHDRAWAL HEADACHE,6
GB,DRUG-INDUCED LIVER INJURY,6
GB,HYPERSENSITIVITY,6
GB,HYPERSOMNIA,6
GB,NEUROPATHY PERIPHERAL,6
GB,OEDEMA,6
GB,OESOPHAGITIS,6
GB,PERIPHERAL SWELLING,6
GB,PRODUCT QUALITY ISSUE,6
GB,RESPIRATORY FAILURE,6
GB,URINARY RETENTION,6
GB,WITHDRAWAL SYNDROME,6
GB,ABDOMINAL DISTENSION,5
GB,ANGINA PECTORIS,5
GB,ASTHMA,5
GB,ATRIAL FIBRILLATION,5
GB,BONE PAIN,5
GB,CHILLS,5
GB,CIRCULATORY COLLAPSE,5
GB,DISTURBANCE IN ATTENTION,5
GB,DRY EYE,5
GB,DRY THROAT,5
GB,DYSGEUSIA,5
GB,GYNAECOMASTIA,5
GB,HYPERACUSIS,5
GB,HYPERTENSION,5
GB,JOINT STIFFNESS,5
GB,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,5
GB,LIVER DISORDER,5
GB,LOCAL SWELLING,5
GB,MALE SEXUAL DYSFUNCTION,5
GB,MUSCULOSKELETAL STIFFNESS,5
GB,PERSONALITY CHANGE,5
GB,RECTAL HAEMORRHAGE,5
GB,TOXIC EPIDERMAL NECROLYSIS,5
GB,URINE FLOW DECREASED,5
GB,YAWNING,5
GB,ABDOMINAL DISCOMFORT,4
GB,ALANINE AMINOTRANSFERASE INCREASED,4
GB,AMYLASE INCREASED,4
GB,ANXIETY,4
GB,BLOOD CREATININE INCREASED,4
GB,CHROMATURIA,4
GB,DYSPNOEA EXERTIONAL,4
GB,ELECTROCARDIOGRAM QT PROLONGED,4
GB,ERECTILE DYSFUNCTION,4
GB,ERYTHEMA,4
GB,FEELING HOT,4
GB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,4
GB,HALLUCINATION,4
GB,HEMIPARESIS,4
GB,INTERSTITIAL LUNG DISEASE,4
GB,MUSCLE TIGHTNESS,4
GB,MUSCLE TWITCHING,4
GB,MUSCULOSKELETAL CHEST PAIN,4
GB,NEURALGIA,4
GB,PALPITATIONS,4
GB,PRURITUS GENERALISED,4
GB,RASH ERYTHEMATOUS,4
GB,RASH PRURITIC,4
GB,RASH VESICULAR,4
GB,RENAL FAILURE,4
GB,SENSORY DISTURBANCE,4
GB,SINUS BRADYCARDIA,4
GB,SPUTUM DISCOLOURED,4
GB,STRESS,4
GB,SUICIDAL IDEATION,4
GB,SUPRAPUBIC PAIN,4
GB,TONGUE DISCOLOURATION,4
GB,ABNORMAL LOSS OF WEIGHT,3
GB,AORTIC VALVE DISEASE MIXED,3
GB,ARRHYTHMIA,3
GB,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
GB,BLOOD GLUCOSE ABNORMAL,3
GB,BLOOD URINE PRESENT,3
GB,BRAIN OEDEMA,3
GB,C-REACTIVE PROTEIN DECREASED,3
GB,CATHETER SITE CELLULITIS,3
GB,CHEST DISCOMFORT,3
GB,CHOKING,3
GB,CHOLELITHIASIS,3
GB,COGNITIVE DISORDER,3
GB,COMPARTMENT SYNDROME,3
GB,CORONARY ARTERY DISEASE,3
GB,DEAFNESS UNILATERAL,3
GB,DEEP VEIN THROMBOSIS,3
GB,DISEASE PROGRESSION,3
GB,DISORIENTATION,3
GB,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,3
GB,DRY SKIN,3
GB,EPILEPSY,3
GB,FLATULENCE,3
GB,FUNGAL INFECTION,3
GB,GASTRIC ULCER,3
GB,GASTRITIS,3
GB,GASTROOESOPHAGEAL REFLUX DISEASE,3
GB,GROIN PAIN,3
GB,HAEMOGLOBIN DECREASED,3
GB,HEPATIC FUNCTION ABNORMAL,3
GB,HIATUS HERNIA,3
GB,HOT FLUSH,3
GB,ISCHAEMIC STROKE,3
GB,JAUNDICE,3
GB,JOINT SWELLING,3
GB,LABILE BLOOD PRESSURE,3
GB,LIVER INJURY,3
GB,MUSCLE STRAIN,3
GB,NASAL DRYNESS,3
GB,ORTHOSTATIC HYPOTENSION,3
GB,OVERDOSE,3
GB,PANCREATITIS,3
GB,PANCYTOPENIA,3
GB,PHARYNGEAL OEDEMA,3
GB,POLYP,3
GB,PRESYNCOPE,3
GB,PRODUCT SIZE ISSUE,3
GB,RASH MACULAR,3
GB,RASH MACULO-PAPULAR,3
GB,SKIN DISCOLOURATION,3
GB,SKIN MASS,3
GB,STAPHYLOCOCCAL INFECTION,3
GB,STEVENS-JOHNSON SYNDROME,3
GB,TACHYCARDIA,3
GB,TENOTOMY,3
GB,THROAT IRRITATION,3
GB,TONSILLAR ULCER,3
GB,TROPONIN T INCREASED,3
GB,URINARY INCONTINENCE,3
GB,VENTRICULAR TACHYCARDIA,3
GB,VERTIGO,3
GB,VITREOUS DETACHMENT,3
GB,WEIGHT INCREASED,3
GB,ACTINIC KERATOSIS,2
GB,ACTIVITIES OF DAILY LIVING IMPAIRED,2
GB,ACUTE CORONARY SYNDROME,2
GB,AGEUSIA,2
GB,AGGRESSION,2
GB,AKATHISIA,2
GB,ALANINE AMINOTRANSFERASE ABNORMAL,2
GB,ANAEMIA,2
GB,ANGLE CLOSURE GLAUCOMA,2
GB,ARTERIOSCLEROSIS CORONARY ARTERY,2
GB,ARTHRITIS,2
GB,ASCITES,2
GB,ATRIAL FLUTTER,2
GB,AUTOIMMUNE HEPATITIS,2
GB,BINOCULAR EYE MOVEMENT DISORDER,2
GB,BLOOD ALKALINE PHOSPHATASE ABNORMAL,2
GB,C-REACTIVE PROTEIN INCREASED,2
GB,CARDIAC ARREST,2
GB,CARDIAC FAILURE,2
GB,CARDIAC FLUTTER,2
GB,CARDIAC HYPERTROPHY,2
GB,CATARACT,2
GB,CLUSTER HEADACHE,2
GB,COAGULOPATHY,2
GB,CORNEAL ABRASION,2
GB,DEMENTIA,2
GB,DEPRESSED MOOD,2
GB,DERMATITIS,2
GB,DERMATITIS ALLERGIC,2
GB,DUODENAL ULCER PERFORATION,2
GB,EATING DISORDER,2
GB,EOSINOPHIL COUNT INCREASED,2
GB,ERYTHRASMA,2
GB,FAECES DISCOLOURED,2
GB,FUNGAL SKIN INFECTION,2
GB,GASTROINTESTINAL DISORDER,2
GB,GASTROINTESTINAL NECROSIS,2
GB,GASTROINTESTINAL ULCER,2
GB,GENERALISED TONIC-CLONIC SEIZURE,2
GB,HAEMATEMESIS,2
GB,HAEMATURIA,2
GB,HAEMORRHAGE INTRACRANIAL,2
GB,HEART RATE INCREASED,2
GB,HEART RATE IRREGULAR,2
GB,HEPATIC ENCEPHALOPATHY,2
GB,HIV ASSOCIATED NEPHROPATHY,2
GB,HOSPITALISATION,2
GB,HYPERGLYCAEMIA,2
GB,HYPOAESTHESIA ORAL,2
GB,IMMUNOSUPPRESSION,2
GB,INDURATION,2
GB,INTERNATIONAL NORMALISED RATIO INCREASED,2
GB,IRRITABILITY,2
GB,LABORATORY TEST ABNORMAL,2
GB,LIMB DISCOMFORT,2
GB,LIVER FUNCTION TEST INCREASED,2
GB,LOSS OF LIBIDO,2
GB,LUNG INFECTION,2
GB,LYMPHOCYTE COUNT INCREASED,2
GB,MELANOCYTIC NAEVUS,2
GB,METABOLIC ACIDOSIS,2
GB,MILIARIA,2
GB,MOOD SWINGS,2
GB,MOUTH ULCERATION,2
GB,MUSCLE CONTRACTIONS INVOLUNTARY,2
GB,MUSCLE DISORDER,2
GB,MUSCLE INJURY,2
GB,MYOSITIS,2
GB,NASAL INFLAMMATION,2
GB,OEDEMA GENITAL,2
GB,ORAL DISCOMFORT,2
GB,ORCHITIS,2
GB,PAIN OF SKIN,2
GB,PANCREATITIS ACUTE,2
GB,PARAESTHESIA ORAL,2
GB,PEMPHIGOID,2
GB,PLATELET COUNT DECREASED,2
GB,PNEUMOTHORAX,2
GB,POST STROKE SEIZURE,2
GB,PRODUCT TASTE ABNORMAL,2
GB,PRODUCT USE IN UNAPPROVED INDICATION,2
GB,PRODUCT USE ISSUE,2
GB,PSEUDOMONAS INFECTION,2
GB,PSORIASIS,2
GB,PULMONARY EMBOLISM,2
GB,PULMONARY FIBROSIS,2
GB,RASH GENERALISED,2
GB,RETINAL DETACHMENT,2
GB,RETINAL TEAR,2
GB,RHINORRHOEA,2
GB,RIB FRACTURE,2
GB,ROAD TRAFFIC ACCIDENT,2
GB,SEBORRHOEIC DERMATITIS,2
GB,SENSORY LOSS,2
GB,SEPSIS,2
GB,SKIN IRRITATION,2
GB,TENDON DISORDER,2
GB,TESTICULAR PAIN,2
GB,THROMBOSIS,2
GB,TINEA VERSICOLOUR,2
GB,UPPER RESPIRATORY TRACT INFECTION,2
GB,UPPER-AIRWAY COUGH SYNDROME,2
GB,URINARY TRACT DISORDER,2
GB,URINARY TRACT INFECTION,2
GB,URTICARIA,2
GB,UVEITIS,2
GB,WHEEZING,2
GB,WHITE BLOOD CELL COUNT INCREASED,2
GB,WOUND SECRETION,2
GB,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
GB,ABDOMINAL PAIN LOWER,1
GB,ABDOMINAL RIGIDITY,1
GB,ABNORMAL BEHAVIOUR,1
GB,ABORTION SPONTANEOUS,1
GB,ACUTE HEPATIC FAILURE,1
GB,AGITATION,1
GB,ANAL CANCER,1
GB,ANAL SQUAMOUS CELL CARCINOMA,1
GB,ANAPHYLACTIC SHOCK,1
GB,ANIMAL BITE,1
GB,ANKLE FRACTURE,1
GB,ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC,1
GB,ANTINUCLEAR ANTIBODY POSITIVE,1
GB,APATHY,1
GB,APPLICATION SITE RASH,1
GB,ARTERIAL STENOSIS,1
GB,ARTERIAL STENT INSERTION,1
GB,ASPARTATE AMINOTRANSFERASE INCREASED,1
GB,ASTHENOPIA,1
GB,BILE DUCT STONE,1
GB,BILIARY DILATATION,1
GB,BLADDER PAIN,1
GB,BLINDNESS,1
GB,BLOOD CHOLESTEROL INCREASED,1
GB,BLOOD GLUCOSE FLUCTUATION,1
GB,BLOOD PRESSURE DECREASED,1
GB,BLOOD THYROID STIMULATING HORMONE INCREASED,1
GB,BLOOD UREA INCREASED,1
GB,BODY TEMPERATURE INCREASED,1
GB,BREAST CANCER METASTATIC,1
GB,BREAST PAIN,1
GB,BRONCHIAL IRRITATION,1
GB,BRUXISM,1
GB,BULBAR PALSY,1
GB,CALCINOSIS,1
GB,CANDIDA INFECTION,1
GB,CARDIAC DISORDER,1
GB,CARDIAC FAILURE CONGESTIVE,1
GB,CARDIAC FIBRILLATION,1
GB,CARDIO-RESPIRATORY ARREST,1
GB,CEREBRAL HAEMATOMA,1
GB,CEREBRAL HAEMORRHAGE,1
GB,CEREBRAL INFARCTION,1
GB,CHANGE IN SEIZURE PRESENTATION,1
GB,CHOLESTASIS,1
GB,CHRONIC THROAT CLEARING,1
GB,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR,1
GB,CLONIC CONVULSION,1
GB,CLOSTRIDIUM DIFFICILE INFECTION,1
GB,COAGULATION TIME PROLONGED,1
GB,COELIAC DISEASE,1
GB,COLOSTOMY,1
GB,CONTRAINDICATED DRUG ADMINISTERED,1
GB,CONTRAINDICATED PRODUCT ADMINISTERED,1
GB,CONVULSION,1
GB,COORDINATION ABNORMAL,1
GB,CORONARY ARTERY STENOSIS,1
GB,CUTANEOUS VASCULITIS,1
GB,CYANOSIS,1
GB,CYSTITIS NONINFECTIVE,1
GB,DEMENTIA WITH LEWY BODIES,1
GB,DENTAL DISCOMFORT,1
GB,DENTAL OPERATION,1
GB,DEVICE MALFUNCTION,1
GB,DEVICE RELATED INFECTION,1
GB,DIARRHOEA HAEMORRHAGIC,1
GB,DILATATION INTRAHEPATIC DUCT ACQUIRED,1
GB,DIPLEGIA,1
GB,DISABILITY,1
GB,DISCOMFORT,1
GB,DISEASE RECURRENCE,1
GB,DIVERTICULITIS,1
GB,DRUG WITHDRAWAL SYNDROME,1
GB,DUODENAL ULCER,1
GB,DUODENITIS,1
GB,DYSARTHRIA,1
GB,EAR CANAL INJURY,1
GB,EAR INFECTION,1
GB,EAR PAIN,1
GB,EAR SWELLING,1
GB,ECZEMA,1
GB,ELECTROCARDIOGRAM ABNORMAL,1
GB,EMBOLISM,1
GB,EPICONDYLITIS,1
GB,ERYTHEMA MARGINATUM,1
GB,ERYTHEMA NODOSUM,1
GB,EUPHORIC MOOD,1
GB,EXFOLIATIVE RASH,1
GB,EXPIRED DRUG ADMINISTERED,1
GB,EXTRAOCULAR MUSCLE DISORDER,1
GB,EXTRAOCULAR MUSCLE PARESIS,1
GB,EYE HAEMORRHAGE,1
GB,EYE INFECTION,1
GB,EYE SWELLING,1
GB,EYELID OEDEMA,1
GB,EYELID PTOSIS,1
GB,FACIAL PAIN,1
GB,FAECES HARD,1
GB,FEEDING DISORDER,1
GB,FEELING COLD,1
GB,FEELING DRUNK,1
GB,FIBROMYALGIA,1
GB,FIXED ERUPTION,1
GB,FLANK PAIN,1
GB,FOOD INTERACTION,1
GB,FORCED VITAL CAPACITY DECREASED,1
GB,FORMICATION,1
GB,FRACTURE DISPLACEMENT,1
GB,GALLBLADDER DISORDER,1
GB,GANGRENE,1
GB,GASTRIC DISORDER,1
GB,GASTRIC ULCER HAEMORRHAGE,1
GB,GASTRITIS EROSIVE,1
GB,GASTROINTESTINAL HAEMORRHAGE,1
GB,GASTROINTESTINAL MOTILITY DISORDER,1
GB,GASTROINTESTINAL PAIN,1
GB,GENITAL PAIN,1
GB,GENITAL SWELLING,1
GB,GENITAL ULCERATION,1
GB,GINGIVAL BLEEDING,1
GB,GLOMERULAR FILTRATION RATE DECREASED,1
GB,GOUT,1
GB,HAEMATOCHEZIA,1
GB,HAEMATOSPERMIA,1
GB,HAEMORRHAGE,1
GB,HAEMORRHAGIC STROKE,1
GB,HAEMORRHOIDS,1
GB,HALLUCINATION_ VISUAL,1
GB,HEAD INJURY,1
GB,HEPATIC CONGESTION,1
GB,HEPATIC CYST,1
GB,HEPATIC FAILURE,1
GB,HEPATIC PAIN,1
GB,HEPATITIS,1
GB,HEPATITIS ACUTE,1
GB,HEPATITIS VIRAL,1
GB,HEPATOCELLULAR INJURY,1
GB,HUMERUS FRACTURE,1
GB,HUNGER,1
GB,HYPERTROPHIC CARDIOMYOPATHY,1
GB,HYPOACUSIS,1
GB,HYPOCALCAEMIA,1
GB,HYPOMAGNESAEMIA,1
GB,HYPOTHYROIDISM,1
GB,ILEOSTOMY CLOSURE,1
GB,IMMOBILE,1
GB,IMMUNE SYSTEM DISORDER,1
GB,IMMUNE-MEDIATED NECROTISING MYOPATHY,1
GB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
GB,INFLAMMATION,1
GB,INFLAMMATORY MARKER INCREASED,1
GB,INGUINAL HERNIA,1
GB,INNER EAR DISORDER,1
GB,INTENTIONAL PRODUCT MISUSE,1
GB,INTERNAL HAEMORRHAGE,1
GB,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
GB,INTESTINAL ISCHAEMIA,1
GB,INTRA-ABDOMINAL FLUID COLLECTION,1
GB,INTRAOCULAR PRESSURE INCREASED,1
GB,INVASIVE DUCTAL BREAST CARCINOMA,1
GB,JOINT ANKYLOSIS,1
GB,JOINT LOCK,1
GB,LACK OF SPONTANEOUS SPEECH,1
GB,LARGE INTESTINE POLYP,1
GB,LARYNGEAL OEDEMA,1
GB,LARYNGOSPASM,1
GB,LEFT VENTRICULAR DYSFUNCTION,1
GB,LICHEN SCLEROSUS,1
GB,LIGAMENT DISORDER,1
GB,LIGAMENT RUPTURE,1
GB,LIMB DEFORMITY,1
GB,LIP AND/OR ORAL CAVITY CANCER,1
GB,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
GB,LYMPH NODE PAIN,1
GB,LYMPHADENOPATHY,1
GB,MACROGLOSSIA,1
GB,MASTICATION DISORDER,1
GB,MATERNAL EXPOSURE DURING PREGNANCY,1
GB,MEAN CELL VOLUME INCREASED,1
GB,MEGACOLON,1
GB,MELAENA,1
GB,MENTAL FATIGUE,1
GB,MENTAL IMPAIRMENT,1
GB,METASTASES TO CENTRAL NERVOUS SYSTEM,1
GB,METASTASES TO LIVER,1
GB,MIGRAINE,1
GB,MORPHOEA,1
GB,MOTOR NEURONE DISEASE,1
GB,MOUTH SWELLING,1
GB,MOVEMENT DISORDER,1
GB,MUCOSAL INFLAMMATION,1
GB,MUCOSAL ULCERATION,1
GB,MUCOUS MEMBRANE DISORDER,1
GB,MULTI-ORGAN FAILURE,1
GB,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
GB,MULTIPLE SCLEROSIS,1
GB,MUSCLE RUPTURE,1
GB,MUSCULOSKELETAL DISCOMFORT,1
GB,MYOCARDIAL INFARCTION,1
GB,NARCOLEPSY,1
GB,NASAL CONGESTION,1
GB,NECROTISING FASCIITIS,1
GB,NERVE INJURY,1
GB,NERVOUSNESS,1
GB,NEUROLOGICAL DECOMPENSATION,1
GB,NEUROLOGICAL SYMPTOM,1
GB,NEUROMYOPATHY,1
GB,NEUTROPENIC SEPSIS,1
GB,OBSTRUCTIVE AIRWAYS DISORDER,1
GB,OCULAR MYASTHENIA,1
GB,ODYNOPHAGIA,1
GB,ORAL CANDIDIASIS,1
GB,OSTEOARTHRITIS,1
GB,OSTEOMYELITIS,1
GB,OSTEONECROSIS,1
GB,OTITIS MEDIA,1
GB,OVARIAN CANCER,1
GB,OVARIAN CYST,1
GB,OXYGEN SATURATION DECREASED,1
GB,PAIN IN JAW,1
GB,PANCREATITIS NECROTISING,1
GB,PARAMNESIA,1
GB,PARANOIA,1
GB,PELVIC CYST,1
GB,PELVIC FLOOR MUSCLE WEAKNESS,1
GB,PENILE HAEMORRHAGE,1
GB,PENILE PAIN,1
GB,PENILE SIZE REDUCED,1
GB,PENILE ULCERATION,1
GB,PENIS DISORDER,1
GB,PERIARTHRITIS,1
GB,PERIORBITAL OEDEMA,1
GB,PERIPHERAL COLDNESS,1
GB,PERIPHERAL ISCHAEMIA,1
GB,PERONEAL NERVE PALSY,1
GB,PETIT MAL EPILEPSY,1
GB,PHARYNGEAL PARAESTHESIA,1
GB,PHOTOPHOBIA,1
GB,PLANTAR FASCIITIS,1
GB,PLEURAL EFFUSION,1
GB,PLEURITIC PAIN,1
GB,PNEUMONIA,1
GB,PNEUMONITIS,1
GB,POLYMYALGIA RHEUMATICA,1
GB,POLYURIA,1
GB,POOR QUALITY SLEEP,1
GB,POSTOPERATIVE WOUND INFECTION,1
GB,PREMATURE BABY,1
GB,PRIMARY HYPOTHYROIDISM,1
GB,PRODUCT COATING ISSUE,1
GB,PRODUCT USE COMPLAINT,1
GB,PROSTATE CANCER,1
GB,PSYCHOLOGICAL TRAUMA,1
GB,PUBIS FRACTURE,1
GB,PULMONARY HYPERTENSION,1
GB,PULMONARY MYCOSIS,1
GB,PUSTULAR PSORIASIS,1
GB,RASH PAPULAR,1
GB,RENAL CYST,1
GB,RENAL PAIN,1
GB,RENAL TUBULAR NECROSIS,1
GB,RESPIRATORY TRACT HAEMORRHAGE,1
GB,RESTLESSNESS,1
GB,RETCHING,1
GB,RETINAL HAEMORRHAGE,1
GB,RETINOPATHY,1
GB,RETROPERITONEAL HAEMORRHAGE,1
GB,SEIZURE LIKE PHENOMENA,1
GB,SELF-INJURIOUS IDEATION,1
GB,SENSITIVITY OF TEETH,1
GB,SINUS HEADACHE,1
GB,SKIN DISCOMFORT,1
GB,SKIN DISORDER,1
GB,SKIN INFECTION,1
GB,SKIN TEXTURE ABNORMAL,1
GB,SKIN TIGHTNESS,1
GB,SMALL CELL LUNG CANCER METASTATIC,1
GB,SNEEZING,1
GB,SOFT TISSUE DISORDER,1
GB,SPUTUM INCREASED,1
GB,STOMATITIS,1
GB,SUBARACHNOID HAEMORRHAGE,1
GB,SUBDURAL HAEMATOMA,1
GB,SUDDEN HEARING LOSS,1
GB,SWELLING,1
GB,SYSTEMIC SCLEROSIS PULMONARY,1
GB,TACHYPHRENIA,1
GB,TEARFULNESS,1
GB,TENDON INJURY,1
GB,TENDON RUPTURE,1
GB,TENDONITIS,1
GB,THALAMIC INFARCTION,1
GB,THROAT TIGHTNESS,1
GB,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
GB,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
GB,TONIC CLONIC MOVEMENTS,1
GB,TOOTH EXTRACTION,1
GB,TOOTHACHE,1
GB,TORSADE DE POINTES,1
GB,TOXICITY TO VARIOUS AGENTS,1
GB,TRICHORRHEXIS,1
GB,TRISMUS,1
GB,TUBULOINTERSTITIAL NEPHRITIS,1
GB,TYMPANIC MEMBRANE PERFORATION,1
GB,TYPE 2 DIABETES MELLITUS,1
GB,ULTRASOUND SCAN ABNORMAL,1
GB,UMBILICAL HERNIA,1
GB,UPPER GASTROINTESTINAL HAEMORRHAGE,1
GB,URETERIC OBSTRUCTION,1
GB,URETHRAL PAIN,1
GB,VASCULAR OCCLUSION,1
GB,VASCULITIS,1
GB,VULVOVAGINAL CANDIDIASIS,1
GB,VULVOVAGINAL PAIN,1
GB,WALKING AID USER,1
GB,WALKING DISABILITY,1
GB,YELLOW SKIN,1
US,TYPE 2 DIABETES MELLITUS,10096
US,DRUG INEFFECTIVE,3587
US,DRUG HYPERSENSITIVITY,2983
US,FATIGUE,2878
US,NAUSEA,2362
US,DIARRHOEA,2351
US,DYSPNOEA,2101
US,PAIN,2037
US,MYALGIA,1932
US,DIZZINESS,1883
US,PAIN IN EXTREMITY,1870
US,ARTHRALGIA,1778
US,HEADACHE,1773
US,ASTHENIA,1673
US,MALAISE,1667
US,FALL,1589
US,MUSCLE SPASMS,1504
US,MYOCARDIAL INFARCTION,1363
US,WEIGHT DECREASED,1311
US,DEATH,1220
US,RASH,1215
US,PNEUMONIA,1171
US,DRUG DOSE OMISSION,1169
US,VOMITING,1111
US,CEREBROVASCULAR ACCIDENT,1110
US,BACK PAIN,1088
US,CONSTIPATION,1064
US,BLOOD GLUCOSE INCREASED,1042
US,INSOMNIA,1035
US,HYPERTENSION,1031
US,PRURITUS,1014
US,COUGH,995
US,GAIT DISTURBANCE,985
US,GASTROINTESTINAL HAEMORRHAGE,969
US,FEELING ABNORMAL,963
US,DECREASED APPETITE,886
US,ANXIETY,876
US,CHEST PAIN,873
US,WEIGHT INCREASED,851
US,ANAEMIA,835
US,DEPRESSION,824
US,MUSCULAR WEAKNESS,789
US,ABDOMINAL PAIN UPPER,787
US,ABDOMINAL DISCOMFORT,773
US,NEUROPATHY PERIPHERAL,719
US,URINARY TRACT INFECTION,706
US,CARDIAC FAILURE CONGESTIVE,702
US,PERIPHERAL SWELLING,698
US,DIABETES MELLITUS,648
US,ATRIAL FIBRILLATION,638
US,NASOPHARYNGITIS,637
US,HYPOAESTHESIA,634
US,ALOPECIA,629
US,PYREXIA,629
US,HYPOTENSION,624
US,MEMORY IMPAIRMENT,619
US,INJECTION SITE PAIN,599
US,ABDOMINAL PAIN,588
US,PARAESTHESIA,571
US,PRODUCT USE ISSUE,569
US,CONDITION AGGRAVATED,566
US,DEHYDRATION,566
US,SOMNOLENCE,559
US,PRODUCT QUALITY ISSUE,550
US,CARDIAC DISORDER,548
US,BLOOD PRESSURE INCREASED,547
US,BLOOD CHOLESTEROL INCREASED,541
US,TREMOR,532
US,CATARACT,530
US,GASTROOESOPHAGEAL REFLUX DISEASE,523
US,OEDEMA PERIPHERAL,522
US,ARTHRITIS,520
US,CONTUSION,520
US,DYSPEPSIA,513
US,FLUSHING,500
US,VISION BLURRED,500
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,499
US,CONFUSIONAL STATE,480
US,INCORRECT DOSE ADMINISTERED,458
US,MUSCULOSKELETAL PAIN,453
US,INTENTIONAL PRODUCT MISUSE,437
US,EMOTIONAL DISTRESS,434
US,HYPERSENSITIVITY,433
US,ERYTHEMA,430
US,SINUSITIS,426
US,JOINT SWELLING,421
US,EPISTAXIS,419
US,BALANCE DISORDER,416
US,ACUTE KIDNEY INJURY,411
US,BRONCHITIS,409
US,DYSPHAGIA,407
US,RENAL FAILURE,406
US,URTICARIA,406
US,CORONARY ARTERY DISEASE,405
US,HYPERHIDROSIS,387
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,384
US,VISUAL IMPAIRMENT,378
US,DRUG INTOLERANCE,373
US,DRY MOUTH,367
US,HAEMORRHAGE,367
US,DYSGEUSIA,365
US,HAEMOGLOBIN DECREASED,354
US,INFLUENZA,353
US,OROPHARYNGEAL PAIN,346
US,AMNESIA,343
US,LOSS OF CONSCIOUSNESS,342
US,PALPITATIONS,337
US,PSORIASIS,336
US,ABDOMINAL DISTENSION,333
US,ARTHROPATHY,330
US,HEART RATE INCREASED,328
US,OSTEOARTHRITIS,326
US,FLATULENCE,325
US,SEPSIS,324
US,CHEST DISCOMFORT,323
US,THROMBOSIS,314
US,CHILLS,310
US,SYNCOPE,310
US,MUSCULOSKELETAL STIFFNESS,308
US,WHITE BLOOD CELL COUNT DECREASED,307
US,SWELLING,305
US,OSTEOPOROSIS,296
US,TRANSIENT ISCHAEMIC ATTACK,291
US,INFECTION,284
US,PLATELET COUNT DECREASED,282
US,RHEUMATOID ARTHRITIS,281
US,BURNING SENSATION,280
US,HEPATIC ENZYME INCREASED,271
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,271
US,DYSPHONIA,268
US,FLUID RETENTION,265
US,PULMONARY EMBOLISM,265
US,NECK PAIN,261
US,PLEURAL EFFUSION,261
US,DEEP VEIN THROMBOSIS,257
US,DRY SKIN,256
US,DISEASE PROGRESSION,254
US,RENAL DISORDER,253
US,INFLUENZA LIKE ILLNESS,251
US,RECTAL HAEMORRHAGE,251
US,NASAL CONGESTION,246
US,STRESS,244
US,ASTHMA,243
US,CELLULITIS,243
US,BLOOD GLUCOSE DECREASED,240
US,HOT FLUSH,240
US,OEDEMA,240
US,INJECTION SITE ERYTHEMA,238
US,DRUG EFFECT INCOMPLETE,237
US,NERVOUSNESS,230
US,ACUTE MYOCARDIAL INFARCTION,228
US,ADVERSE EVENT,228
US,POLLAKIURIA,226
US,STOMATITIS,226
US,UNEVALUABLE EVENT,226
US,CORONARY ARTERY OCCLUSION,223
US,NEPHROLITHIASIS,222
US,SLEEP DISORDER,220
US,HYPOACUSIS,219
US,INJECTION SITE BRUISING,219
US,RESPIRATORY FAILURE,219
US,THERAPEUTIC RESPONSE UNEXPECTED,219
US,UNDERDOSE,218
US,BONE PAIN,217
US,LIMB DISCOMFORT,216
US,SEIZURE,216
US,BLOOD PRESSURE DECREASED,214
US,HAEMORRHAGIC ANAEMIA,214
US,RHINORRHOEA,214
US,INJURY,212
US,MIGRAINE,211
US,BLOOD CREATININE INCREASED,210
US,UPPER RESPIRATORY TRACT INFECTION,210
US,ABASIA,209
US,FEELING HOT,209
US,HERPES ZOSTER,208
US,DRUG EFFECT DECREASED,205
US,PANCREATITIS,204
US,RASH PRURITIC,198
US,HOSPITALISATION,197
US,RENAL IMPAIRMENT,197
US,INJECTION SITE HAEMORRHAGE,195
US,OVERDOSE,195
US,HAEMATURIA,194
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,194
US,BLISTER,193
US,VERTIGO,192
US,LETHARGY,191
US,LOCAL SWELLING,189
US,THROMBOCYTOPENIA,189
US,UPPER GASTROINTESTINAL HAEMORRHAGE,189
US,CARDIAC ARREST,188
US,HAEMATOCHEZIA,187
US,ACTIVITIES OF DAILY LIVING IMPAIRED,185
US,SKIN DISCOLOURATION,184
US,WHEEZING,184
US,BLOOD TRIGLYCERIDES INCREASED,182
US,MOBILITY DECREASED,180
US,SWELLING FACE,180
US,INCORRECT DRUG ADMINISTRATION DURATION,179
US,PULMONARY OEDEMA,179
US,GASTROINTESTINAL DISORDER,178
US,CARDIAC FAILURE,177
US,CYSTITIS,177
US,DYSURIA,177
US,GASTRIC DISORDER,176
US,BODY HEIGHT DECREASED,175
US,SLEEP APNOEA SYNDROME,175
US,ADVERSE DRUG REACTION,174
US,DYSPNOEA EXERTIONAL,173
US,TINNITUS,172
US,HALLUCINATION,169
US,DIABETIC NEUROPATHY,168
US,INTERVERTEBRAL DISC PROTRUSION,168
US,CEREBRAL HAEMORRHAGE,165
US,BLOOD POTASSIUM DECREASED,164
US,SKIN EXFOLIATION,164
US,THROAT IRRITATION,164
US,ANGINA PECTORIS,163
US,MULTIPLE SCLEROSIS RELAPSE,163
US,BACK DISORDER,161
US,EYE PAIN,161
US,PRODUCT USE IN UNAPPROVED INDICATION,161
US,PLASMA CELL MYELOMA,160
US,PRODUCTIVE COUGH,160
US,IMPAIRED HEALING,159
US,GLAUCOMA,158
US,INTENTIONAL PRODUCT USE ISSUE,158
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,157
US,HYPERGLYCAEMIA,157
US,INJECTION SITE PRURITUS,156
US,VISUAL ACUITY REDUCED,156
US,HEAD INJURY,155
US,RENAL FAILURE ACUTE,155
US,SPEECH DISORDER,155
US,THERAPY CESSATION,155
US,BONE DISORDER,154
US,MUSCLE DISORDER,153
US,DISCOMFORT,152
US,HYPERLIPIDAEMIA,150
US,NO ADVERSE EVENT,150
US,DRUG ADMINISTRATION ERROR,149
US,SUICIDAL IDEATION,149
US,FEMUR FRACTURE,148
US,AGITATION,147
US,COAGULOPATHY,147
US,ARRHYTHMIA,146
US,MALIGNANT NEOPLASM PROGRESSION,146
US,GLUCOSE TOLERANCE IMPAIRED,145
US,LIVER FUNCTION TEST ABNORMAL,145
US,CHROMATURIA,144
US,ROAD TRAFFIC ACCIDENT,143
US,URINARY INCONTINENCE,143
US,BLINDNESS,142
US,GENERAL PHYSICAL HEALTH DETERIORATION,142
US,HAEMOPTYSIS,142
US,HIP FRACTURE,142
US,IRRITABILITY,142
US,LIVER DISORDER,142
US,DEPRESSED MOOD,141
US,DIVERTICULITIS,141
US,HYPOTHYROIDISM,140
US,NEUTROPENIA,140
US,ORAL PAIN,140
US,DEVICE MALFUNCTION,139
US,DYSSTASIA,139
US,GOUT,139
US,RIB FRACTURE,137
US,THERAPEUTIC RESPONSE DECREASED,137
US,EXPIRED PRODUCT ADMINISTERED,136
US,EYE IRRITATION,135
US,HAEMATOMA,135
US,HIATUS HERNIA,135
US,DRY EYE,134
US,OSTEOPENIA,134
US,SURGERY,133
US,DISTURBANCE IN ATTENTION,132
US,LIMB INJURY,132
US,NEOPLASM MALIGNANT,132
US,OXYGEN SATURATION DECREASED,132
US,RASH GENERALISED,131
US,AGEUSIA,129
US,INTERVERTEBRAL DISC DEGENERATION,128
US,LOWER GASTROINTESTINAL HAEMORRHAGE,128
US,CHRONIC KIDNEY DISEASE,127
US,BREAST CANCER,126
US,FOOT FRACTURE,126
US,HEART RATE DECREASED,126
US,VITAMIN D DEFICIENCY,126
US,DRUG WITHDRAWAL SYNDROME,125
US,GASTRITIS,125
US,INTERNAL HAEMORRHAGE,125
US,PAIN IN JAW,125
US,STAPHYLOCOCCAL INFECTION,125
US,TOOTH DISORDER,125
US,HYPOGLYCAEMIA,123
US,MUSCULOSKELETAL DISCOMFORT,123
US,WHITE BLOOD CELL COUNT INCREASED,123
US,BLOOD URINE PRESENT,122
US,HYPOKALAEMIA,122
US,LUNG NEOPLASM MALIGNANT,122
US,COLITIS,121
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,121
US,FIBROMYALGIA,121
US,ROTATOR CUFF SYNDROME,121
US,ACUTE RESPIRATORY FAILURE,120
US,INJECTION SITE SWELLING,120
US,PRODUCT SUBSTITUTION ISSUE,120
US,SPINAL OSTEOARTHRITIS,120
US,TACHYCARDIA,120
US,EYE DISORDER,119
US,HYPERSOMNIA,119
US,SWOLLEN TONGUE,119
US,INJECTION SITE MASS,118
US,MOVEMENT DISORDER,118
US,RESTLESS LEGS SYNDROME,118
US,CHOLELITHIASIS,117
US,HAEMORRHOIDS,117
US,ARTERIAL OCCLUSIVE DISEASE,116
US,COGNITIVE DISORDER,116
US,EYE SWELLING,116
US,LACRIMATION INCREASED,116
US,RED BLOOD CELL COUNT DECREASED,116
US,RHABDOMYOLYSIS,116
US,DEAFNESS,115
US,FULL BLOOD COUNT DECREASED,115
US,JOINT INJURY,115
US,MENTAL STATUS CHANGES,115
US,NIGHT SWEATS,115
US,BLOOD POTASSIUM INCREASED,114
US,HEART RATE IRREGULAR,113
US,HYPOXIA,113
US,UPPER LIMB FRACTURE,112
US,PULMONARY HYPERTENSION,111
US,JOINT STIFFNESS,110
US,BLOOD CREATINE PHOSPHOKINASE INCREASED,109
US,LUNG DISORDER,109
US,NEURALGIA,109
US,DEMENTIA,108
US,DYSARTHRIA,108
US,LACERATION,107
US,HYPONATRAEMIA,106
US,INJECTION SITE REACTION,106
US,OCULAR HYPERAEMIA,106
US,BLOOD TESTOSTERONE DECREASED,105
US,INTENTIONAL DRUG MISUSE,105
US,SINUS DISORDER,105
US,SKIN LESION,105
US,ERECTILE DYSFUNCTION,104
US,FUNGAL INFECTION,104
US,NIGHTMARE,104
US,SKIN ULCER,104
US,PANCYTOPENIA,103
US,FAECES DISCOLOURED,102
US,HEARING IMPAIRED,102
US,INTERNATIONAL NORMALISED RATIO INCREASED,102
US,MULTIPLE SCLEROSIS,102
US,SKIN DISORDER,102
US,TREATMENT NONCOMPLIANCE,102
US,CARPAL TUNNEL SYNDROME,101
US,LOCALISED INFECTION,101
US,MUSCLE ATROPHY,101
US,PRURITUS GENERALISED,101
US,ALANINE AMINOTRANSFERASE INCREASED,100
US,PROSTATE CANCER,100
US,BLOOD PRESSURE ABNORMAL,99
US,FEELING COLD,99
US,LYMPHADENOPATHY,99
US,CONVULSION,98
US,DISORIENTATION,98
US,PANIC ATTACK,98
US,ANKLE FRACTURE,97
US,APHASIA,97
US,GALLBLADDER DISORDER,97
US,RETCHING,97
US,ERUCTATION,96
US,HEPATIC STEATOSIS,96
US,OSTEOMYELITIS,96
US,PULMONARY MASS,96
US,INTESTINAL OBSTRUCTION,95
US,MALABSORPTION,95
US,RASH MACULAR,95
US,CLOSTRIDIUM DIFFICILE INFECTION,94
US,SPINAL COLUMN STENOSIS,94
US,ASPARTATE AMINOTRANSFERASE INCREASED,93
US,BRADYCARDIA,93
US,DRUG PRESCRIBING ERROR,93
US,NERVE INJURY,93
US,POOR QUALITY SLEEP,93
US,DIVERTICULUM,92
US,MENTAL DISORDER,92
US,SUBDURAL HAEMATOMA,92
US,VIRAL INFECTION,92
US,CRYING,91
US,MULTIPLE FRACTURES,91
US,OSTEONECROSIS OF JAW,91
US,PRE-EXISTING CONDITION IMPROVED,91
US,PRESYNCOPE,91
US,TOXICITY TO VARIOUS AGENTS,91
US,CROHN^S DISEASE,90
US,DYSKINESIA,90
US,EYE PRURITUS,90
US,LABORATORY TEST ABNORMAL,90
US,EAR INFECTION,89
US,MUSCULOSKELETAL DISORDER,89
US,SCIATICA,89
US,ARTERIOSCLEROSIS,88
US,DRUG DISPENSING ERROR,88
US,HAEMORRHAGE INTRACRANIAL,88
US,URINARY RETENTION,88
US,HERNIA,87
US,HYPOPHAGIA,87
US,NOCTURIA,87
US,WOUND,87
US,ATELECTASIS,86
US,LOW DENSITY LIPOPROTEIN INCREASED,86
US,LOWER LIMB FRACTURE,86
US,WRIST FRACTURE,86
US,COMPLETED SUICIDE,85
US,INFLAMMATION,85
US,RASH ERYTHEMATOUS,85
US,FEELING JITTERY,84
US,APPLICATION SITE ERYTHEMA,83
US,GASTRIC ULCER,83
US,IRRITABLE BOWEL SYNDROME,83
US,CARDIOVASCULAR DISORDER,82
US,FLUID OVERLOAD,82
US,MUSCULOSKELETAL CHEST PAIN,82
US,ABNORMAL DREAMS,81
US,BLOOD GLUCOSE ABNORMAL,81
US,DIABETIC KETOACIDOSIS,81
US,FREQUENT BOWEL MOVEMENTS,81
US,LIP SWELLING,81
US,PANCREATITIS ACUTE,81
US,CARDIOMYOPATHY,80
US,DEVICE ISSUE,80
US,DIPLOPIA,80
US,EAR PAIN,79
US,THYROID DISORDER,79
US,TOOTHACHE,79
US,BURSITIS,78
US,MACULAR DEGENERATION,78
US,MUSCLE TWITCHING,78
US,PROSTATIC SPECIFIC ANTIGEN INCREASED,78
US,RESPIRATORY TRACT CONGESTION,78
US,SEPTIC SHOCK,78
US,ANAPHYLACTIC REACTION,77
US,CORONARY ARTERY BYPASS,77
US,GLOSSODYNIA,77
US,MEDICATION ERROR,77
US,PERICARDIAL EFFUSION,77
US,STENT PLACEMENT,77
US,CHOKING,76
US,EXOSTOSIS,76
US,HAIR TEXTURE ABNORMAL,76
US,SKIN BURNING SENSATION,76
US,SPINAL FRACTURE,76
US,TENDONITIS,76
US,ABNORMAL BEHAVIOUR,75
US,HAEMATOCRIT DECREASED,75
US,HYPERKALAEMIA,75
US,ISCHAEMIC STROKE,75
US,HAIR COLOUR CHANGES,74
US,MENTAL IMPAIRMENT,74
US,PHARYNGEAL OEDEMA,74
US,PSORIATIC ARTHROPATHY,74
US,RENAL CYST,74
US,SNEEZING,74
US,BLOOD CALCIUM INCREASED,73
US,LEUKOCYTOSIS,73
US,NEOPLASM PROGRESSION,73
US,NERVOUS SYSTEM DISORDER,73
US,ACNE,72
US,HAEMORRHAGIC STROKE,72
US,ARTERIOSCLEROSIS CORONARY ARTERY,71
US,DENTAL CARIES,71
US,MITRAL VALVE INCOMPETENCE,71
US,SEASONAL ALLERGY,71
US,BLOOD CHOLESTEROL ABNORMAL,70
US,GINGIVAL BLEEDING,70
US,SKIN CANCER,70
US,BLOOD COUNT ABNORMAL,69
US,EATING DISORDER,69
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,69
US,MUSCLE STRAIN,69
US,BLOOD SODIUM DECREASED,68
US,BLOOD UREA INCREASED,68
US,EYE HAEMORRHAGE,68
US,INJECTION SITE NODULE,68
US,ANGER,67
US,BLOOD ALKALINE PHOSPHATASE INCREASED,67
US,BLOOD MAGNESIUM DECREASED,67
US,BLOOD PRESSURE FLUCTUATION,67
US,CARDIO-RESPIRATORY ARREST,67
US,FEAR,67
US,INCREASED TENDENCY TO BRUISE,67
US,LUNG INFECTION,67
US,OBESITY,67
US,RESPIRATORY DISORDER,67
US,THROAT TIGHTNESS,67
US,WITHDRAWAL SYNDROME,67
US,ANGINA UNSTABLE,66
US,MIDDLE INSOMNIA,66
US,AGGRESSION,65
US,BACK INJURY,65
US,KIDNEY INFECTION,65
US,NERVE COMPRESSION,65
US,SINUS CONGESTION,65
US,CARDIOMEGALY,64
US,MYOCARDIAL ISCHAEMIA,64
US,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,64
US,VITAMIN D DECREASED,64
US,MYOPATHY,63
US,RASH PAPULAR,63
US,SMALL INTESTINAL OBSTRUCTION,63
US,VAGINAL HAEMORRHAGE,63
US,CANDIDA INFECTION,62
US,GASTROENTERITIS VIRAL,62
US,HEMIPARESIS,62
US,HYPERCHOLESTEROLAEMIA,62
US,KNEE ARTHROPLASTY,62
US,METASTASES TO LIVER,62
US,BASAL CELL CARCINOMA,61
US,CORONARY ARTERIAL STENT INSERTION,61
US,EXTRA DOSE ADMINISTERED,61
US,IRON DEFICIENCY ANAEMIA,61
US,LARGE INTESTINE POLYP,61
US,LARYNGITIS,61
US,NEPHROPATHY,61
US,SENSORY DISTURBANCE,61
US,CLOSTRIDIUM DIFFICILE COLITIS,60
US,DERMATITIS,60
US,ECCHYMOSIS,60
US,EMOTIONAL DISORDER,60
US,PANCREATIC CARCINOMA METASTATIC,60
US,PERIPHERAL VASCULAR DISORDER,60
US,PULMONARY FIBROSIS,60
US,ULCER,60
US,MOOD ALTERED,59
US,MUSCLE TIGHTNESS,59
US,PRESCRIBED OVERDOSE,59
US,RESTLESSNESS,59
US,ASCITES,58
US,CEREBRAL INFARCTION,58
US,HYPOKINESIA,58
US,INCORRECT PRODUCT STORAGE,58
US,METASTASES TO BONE,58
US,MUSCLE INJURY,58
US,RENAL FAILURE CHRONIC,58
US,THIRST,58
US,TOOTH LOSS,58
US,APPLICATION SITE PAIN,57
US,BLADDER CANCER,57
US,ORAL DISCOMFORT,57
US,PRODUCT ADHESION ISSUE,57
US,BLOOD GLUCOSE FLUCTUATION,56
US,DRUG ADMINISTERED AT INAPPROPRIATE SITE,56
US,FEEDING DISORDER,56
US,MASS,56
US,MELAENA,56
US,PANCREATIC CARCINOMA,56
US,PNEUMONIA ASPIRATION,56
US,PRODUCT TASTE ABNORMAL,56
US,TENDERNESS,56
US,TOOTH FRACTURE,56
US,APPLICATION SITE PRURITUS,55
US,BLOOD BILIRUBIN INCREASED,55
US,MENISCUS INJURY,55
US,PRODUCT PHYSICAL ISSUE,55
US,TOOTH INFECTION,55
US,ANHEDONIA,54
US,BLINDNESS UNILATERAL,54
US,MICTURITION URGENCY,54
US,MUSCLE SPASTICITY,54
US,OESOPHAGITIS,54
US,UNRESPONSIVE TO STIMULI,54
US,JOINT RANGE OF MOTION DECREASED,53
US,PRESCRIBED UNDERDOSE,53
US,PULMONARY CONGESTION,53
US,RESPIRATORY DISTRESS,53
US,UPPER-AIRWAY COUGH SYNDROME,53
US,ANGIOEDEMA,52
US,AORTIC ANEURYSM,52
US,CARDIAC VALVE DISEASE,52
US,CAROTID ARTERY OCCLUSION,52
US,COLD SWEAT,52
US,DELIRIUM,52
US,HEAD DISCOMFORT,52
US,ILL-DEFINED DISORDER,52
US,ISCHAEMIC CARDIOMYOPATHY,52
US,LIGAMENT SPRAIN,52
US,MOOD SWINGS,52
US,SCAR,52
US,SPINAL COMPRESSION FRACTURE,52
US,TRANSFUSION,52
US,ACUTE CORONARY SYNDROME,51
US,BLADDER DISORDER,51
US,COMA,51
US,COORDINATION ABNORMAL,51
US,CYST,51
US,HAIR DISORDER,51
US,INTRAOCULAR PRESSURE INCREASED,51
US,LEUKOPENIA,51
US,SPINAL DISORDER,51
US,CARDIAC MURMUR,50
US,DIABETES MELLITUS INADEQUATE CONTROL,50
US,GINGIVAL PAIN,50
US,HAEMATEMESIS,50
US,HYPOMAGNESAEMIA,50
US,ORTHOSTATIC HYPOTENSION,50
US,PALLOR,50
US,SKIN IRRITATION,50
US,SUBARACHNOID HAEMORRHAGE,50
US,VITREOUS FLOATERS,50
US,ATRIOVENTRICULAR BLOCK,49
US,BLOOD CHOLESTEROL DECREASED,49
US,COLITIS ULCERATIVE,49
US,EMPHYSEMA,49
US,ESSENTIAL HYPERTENSION,49
US,FEBRILE NEUTROPENIA,49
US,GROIN PAIN,49
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,49
US,LOW TURNOVER OSTEOPATHY,49
US,PAIN OF SKIN,49
US,TOOTH ABSCESS,49
US,APHONIA,48
US,BLOOD TEST ABNORMAL,48
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,48
US,DEVICE RELATED INFECTION,48
US,ECZEMA,48
US,IMPAIRED GASTRIC EMPTYING,48
US,IMPAIRED WORK ABILITY,48
US,LIBIDO DECREASED,48
US,PARALYSIS,48
US,PROSTATOMEGALY,48
US,PULMONARY ARTERIAL HYPERTENSION,48
US,PULMONARY THROMBOSIS,48
US,SKIN HAEMORRHAGE,48
US,TENDON RUPTURE,48
US,ABDOMINAL PAIN LOWER,47
US,ATRIAL FLUTTER,47
US,BONE LOSS,47
US,DECUBITUS ULCER,47
US,EJECTION FRACTION DECREASED,47
US,IMPAIRED DRIVING ABILITY,47
US,MADAROSIS,47
US,PNEUMONITIS,47
US,SPLENOMEGALY,47
US,ACCIDENTAL OVERDOSE,46
US,ANGIOPATHY,46
US,CARDIAC FLUTTER,46
US,COELIAC DISEASE,46
US,INJECTION SITE RASH,46
US,INJECTION SITE URTICARIA,46
US,LIVER FUNCTION TEST INCREASED,46
US,METASTASES TO LUNG,46
US,ORAL CANDIDIASIS,46
US,PARAESTHESIA ORAL,46
US,POLYP,46
US,SCAB,46
US,TEMPERATURE INTOLERANCE,46
US,THINKING ABNORMAL,46
US,BONE DENSITY DECREASED,45
US,ENCEPHALOPATHY,45
US,END STAGE RENAL DISEASE,45
US,MALNUTRITION,45
US,RENAL CANCER,45
US,TRICUSPID VALVE INCOMPETENCE,45
US,BLOOD IRON DECREASED,44
US,DISABILITY,44
US,LUNG INFILTRATION,44
US,URINE ODOUR ABNORMAL,44
US,VENTRICULAR TACHYCARDIA,44
US,WALKING AID USER,44
US,ABDOMINAL HERNIA,43
US,BACTERIAL INFECTION,43
US,DRY THROAT,43
US,DYSLIPIDAEMIA,43
US,FOOT DEFORMITY,43
US,GAIT INABILITY,43
US,GLOMERULAR FILTRATION RATE DECREASED,43
US,HIP ARTHROPLASTY,43
US,ORAL HERPES,43
US,SEXUAL DYSFUNCTION,43
US,SQUAMOUS CELL CARCINOMA,43
US,ACCIDENT,42
US,EAR DISCOMFORT,42
US,JOINT DISLOCATION,42
US,MEDICATION RESIDUE PRESENT,42
US,PARKINSON^S DISEASE,42
US,PROCEDURAL PAIN,42
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,42
US,WEIGHT FLUCTUATION,42
US,BREAST CANCER FEMALE,41
US,CONCUSSION,41
US,ELECTROLYTE IMBALANCE,41
US,HEPATIC FAILURE,41
US,INTERSTITIAL LUNG DISEASE,41
US,LUMBAR SPINAL STENOSIS,41
US,LYMPHOMA,41
US,MUCOSAL INFLAMMATION,41
US,NEUTROPHIL COUNT DECREASED,41
US,SEDATION,41
US,SENSORY LOSS,41
US,SINUS BRADYCARDIA,41
US,SUPRAVENTRICULAR TACHYCARDIA,41
US,VENTRICULAR EXTRASYSTOLES,41
US,BOWEL MOVEMENT IRREGULARITY,40
US,COLON CANCER,40
US,DEMENTIA ALZHEIMER^S TYPE,40
US,DEVICE FAILURE,40
US,DIALYSIS,40
US,DIVERTICULUM INTESTINAL,40
US,INFUSION RELATED REACTION,40
US,INJECTION SITE EXTRAVASATION,40
US,METABOLIC ACIDOSIS,40
US,MULTIPLE INJURIES,40
US,PELVIC FRACTURE,40
US,POOR QUALITY DRUG ADMINISTERED,40
US,POST PROCEDURAL HAEMORRHAGE,40
US,RESPIRATORY ARREST,40
US,RESPIRATORY TRACT INFECTION,40
US,ULCER HAEMORRHAGE,40
US,AORTIC STENOSIS,39
US,CHOLECYSTECTOMY,39
US,DRUG DEPENDENCE,39
US,EYE INFECTION,39
US,FACIAL PAIN,39
US,HUNGER,39
US,HYPOAESTHESIA ORAL,39
US,NODULE,39
US,POST PROCEDURAL COMPLICATION,39
US,ABNORMAL LOSS OF WEIGHT,38
US,ABSCESS,38
US,CARDIAC PACEMAKER INSERTION,38
US,CENTRAL NERVOUS SYSTEM LESION,38
US,HYPERCALCAEMIA,38
US,INCONTINENCE,38
US,JAUNDICE,38
US,NEPHROGENIC SYSTEMIC FIBROSIS,38
US,PNEUMOTHORAX,38
US,PROTEINURIA,38
US,SKIN FISSURES,38
US,TUBULOINTERSTITIAL NEPHRITIS,38
US,UROSEPSIS,38
US,CARDIOGENIC SHOCK,37
US,CORONARY ARTERY STENOSIS,37
US,DIABETIC RETINOPATHY,37
US,EYELID OEDEMA,37
US,GENERALISED OEDEMA,37
US,GOITRE,37
US,HEPATIC CIRRHOSIS,37
US,INCREASED APPETITE,37
US,INTRAMEDULLARY ROD INSERTION,37
US,LOWER RESPIRATORY TRACT INFECTION,37
US,MULTIPLE ALLERGIES,37
US,MUSCLE FATIGUE,37
US,MYOSITIS,37
US,SYSTEMIC LUPUS ERYTHEMATOSUS,37
US,URINE OUTPUT DECREASED,37
US,ACCIDENTAL EXPOSURE TO PRODUCT,36
US,BREAST PAIN,36
US,DECREASED INTEREST,36
US,ELECTROCARDIOGRAM QT PROLONGED,36
US,EXPIRED DRUG ADMINISTERED,36
US,FRACTURE,36
US,HAIR GROWTH ABNORMAL,36
US,HIGH DENSITY LIPOPROTEIN DECREASED,36
US,INITIAL INSOMNIA,36
US,MALIGNANT MELANOMA,36
US,OPEN REDUCTION OF FRACTURE,36
US,PSYCHOLOGICAL TRAUMA,36
US,RHINITIS ALLERGIC,36
US,SCOLIOSIS,36
US,SYNOVITIS,36
US,TRANSAMINASES INCREASED,36
US,APPARENT DEATH,35
US,BEDRIDDEN,35
US,BLOOD PRESSURE INADEQUATELY CONTROLLED,35
US,CONJUNCTIVITIS,35
US,FACIAL BONES FRACTURE,35
US,GASTRIC ULCER HAEMORRHAGE,35
US,HEMIPLEGIA,35
US,HEPATITIS,35
US,PERIPHERAL COLDNESS,35
US,PHOTOSENSITIVITY REACTION,35
US,WRONG DRUG ADMINISTERED,35
US,BENIGN PROSTATIC HYPERPLASIA,34
US,BLOOD DISORDER,34
US,BRAIN INJURY,34
US,CALCIUM DEFICIENCY,34
US,CARDIAC OPERATION,34
US,CAROTID ARTERY STENOSIS,34
US,DERMATITIS CONTACT,34
US,DISEASE RECURRENCE,34
US,DIZZINESS POSTURAL,34
US,FLANK PAIN,34
US,HAEMORRHOIDAL HAEMORRHAGE,34
US,HAND FRACTURE,34
US,METASTASES TO LYMPH NODES,34
US,MOUTH ULCERATION,34
US,NASAL DISCOMFORT,34
US,NO THERAPEUTIC RESPONSE,34
US,ORAL MUCOSAL BLISTERING,34
US,PRODUCT PACKAGING ISSUE,34
US,PRODUCT SIZE ISSUE,34
US,BLOOD CALCIUM DECREASED,33
US,BLOOD THYROID STIMULATING HORMONE INCREASED,33
US,CATARACT OPERATION,33
US,DECREASED ACTIVITY,33
US,ELECTROCARDIOGRAM ABNORMAL,33
US,FURUNCLE,33
US,GASTRIC HAEMORRHAGE,33
US,HEPATIC ENZYME ABNORMAL,33
US,HYPERKERATOSIS,33
US,INJECTION SITE WARMTH,33
US,JOINT EFFUSION,33
US,MOUTH HAEMORRHAGE,33
US,OESOPHAGEAL DISORDER,33
US,PHOTOPHOBIA,33
US,RENAL PAIN,33
US,TOOTH EXTRACTION,33
US,WOUND INFECTION,33
US,AORTIC VALVE INCOMPETENCE,32
US,APHAGIA,32
US,DEPRESSED LEVEL OF CONSCIOUSNESS,32
US,LEFT VENTRICULAR DYSFUNCTION,32
US,LIVER INJURY,32
US,MUSCLE RUPTURE,32
US,ORTHOPNOEA,32
US,PLATELET COUNT INCREASED,32
US,RETINAL DETACHMENT,32
US,SHOCK HAEMORRHAGIC,32
US,TARDIVE DYSKINESIA,32
US,THYROID CANCER,32
US,AORTIC ARTERIOSCLEROSIS,31
US,CATHETERISATION CARDIAC,31
US,COMPRESSION FRACTURE,31
US,LEFT VENTRICULAR HYPERTROPHY,31
US,LYMPHOEDEMA,31
US,MAJOR DEPRESSION,31
US,PELVIC PAIN,31
US,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,31
US,PERSONALITY CHANGE,31
US,TRIGGER FINGER,31
US,BACTERAEMIA,30
US,BARRETT^S OESOPHAGUS,30
US,BONE LESION,30
US,BREAST MASS,30
US,DEVICE OCCLUSION,30
US,EXPOSED BONE IN JAW,30
US,IMMUNE-MEDIATED NECROTISING MYOPATHY,30
US,INJURY ASSOCIATED WITH DEVICE,30
US,INTERVERTEBRAL DISC DISORDER,30
US,ONYCHOMYCOSIS,30
US,PERONEAL NERVE PALSY,30
US,PHARYNGITIS,30
US,TIBIA FRACTURE,30
US,APPLICATION SITE RASH,29
US,DEFORMITY,29
US,DIVERTICULUM INTESTINAL HAEMORRHAGIC,29
US,HICCUPS,29
US,HYPERTONIC BLADDER,29
US,INTRACRANIAL ANEURYSM,29
US,LYMPHOCYTE COUNT DECREASED,29
US,MYELODYSPLASTIC SYNDROME,29
US,ONYCHOCLASIS,29
US,ORAL DISORDER,29
US,PARANOIA,29
US,SKIN INFECTION,29
US,SPONDYLOLISTHESIS,29
US,SUNBURN,29
US,TENDON DISORDER,29
US,THERAPY NON-RESPONDER,29
US,ANOSMIA,28
US,BLOOD BLISTER,28
US,EXERCISE TOLERANCE DECREASED,28
US,HEART RATE ABNORMAL,28
US,HUMERUS FRACTURE,28
US,IMMUNE SYSTEM DISORDER,28
US,LIGAMENT RUPTURE,28
US,LIPASE INCREASED,28
US,MACULAR OEDEMA,28
US,PHARYNGITIS STREPTOCOCCAL,28
US,POLYURIA,28
US,PROCTALGIA,28
US,QUALITY OF LIFE DECREASED,28
US,SINUS TACHYCARDIA,28
US,SNORING,28
US,SPINAL OPERATION,28
US,STRESS FRACTURE,28
US,VASCULAR GRAFT,28
US,ANEURYSM,27
US,EXTRASYSTOLES,27
US,FAECES SOFT,27
US,FEELING DRUNK,27
US,GASTRITIS EROSIVE,27
US,GYNAECOMASTIA,27
US,HALLUCINATION_ VISUAL,27
US,HYPOVOLAEMIC SHOCK,27
US,JAW DISORDER,27
US,NAIL DISORDER,27
US,ODYNOPHAGIA,27
US,PROTEIN TOTAL DECREASED,27
US,RIGHT VENTRICULAR FAILURE,27
US,TROPONIN INCREASED,27
US,WHEELCHAIR USER,27
US,ADENOCARCINOMA PANCREAS,26
US,ANAL INCONTINENCE,26
US,BRAIN NEOPLASM,26
US,EYE DISCHARGE,26
US,GASTROENTERITIS,26
US,INCREASED UPPER AIRWAY SECRETION,26
US,INJECTION SITE INDURATION,26
US,KNEE OPERATION,26
US,NASAL DRYNESS,26
US,PATHOLOGICAL FRACTURE,26
US,PHOTOPSIA,26
US,PRODUCT ODOUR ABNORMAL,26
US,REACTION TO DRUG EXCIPIENTS,26
US,RENAL INJURY,26
US,RETINOPATHY,26
US,SKIN WARM,26
US,SLUGGISHNESS,26
US,SPINAL PAIN,26
US,TREATMENT FAILURE,26
US,TYPE 1 DIABETES MELLITUS,26
US,WRONG PATIENT RECEIVED MEDICATION,26
US,DEVICE USE ERROR,25
US,DIABETIC FOOT,25
US,FEELING OF BODY TEMPERATURE CHANGE,25
US,FOREIGN BODY,25
US,GASTROINTESTINAL PAIN,25
US,GENERALISED TONIC-CLONIC SEIZURE,25
US,HALLUCINATION_ AUDITORY,25
US,HEPATIC CYST,25
US,HEPATIC FUNCTION ABNORMAL,25
US,ILEUS,25
US,INTENTIONAL OVERDOSE,25
US,LIP DRY,25
US,MULTI-ORGAN FAILURE,25
US,OESOPHAGEAL PAIN,25
US,OSTEOLYSIS,25
US,POOR PERIPHERAL CIRCULATION,25
US,POSTOPERATIVE WOUND INFECTION,25
US,RADIUS FRACTURE,25
US,RHINITIS,25
US,SCRATCH,25
US,SECRETION DISCHARGE,25
US,SINUS HEADACHE,25
US,SKIN ABRASION,25
US,THYROID FUNCTION TEST ABNORMAL,25
US,VITAMIN B12 DEFICIENCY,25
US,WOUND HAEMORRHAGE,25
US,APATHY,24
US,APPLICATION SITE IRRITATION,24
US,BLINDNESS TRANSIENT,24
US,BRONCHOSPASM,24
US,CHRONIC SINUSITIS,24
US,COLITIS ISCHAEMIC,24
US,DELUSION,24
US,DEVICE DISLOCATION,24
US,DIABETIC NEPHROPATHY,24
US,EAR DISORDER,24
US,ENERGY INCREASED,24
US,FAECAL INCONTINENCE,24
US,FISTULA,24
US,IDIOPATHIC PULMONARY FIBROSIS,24
US,INCOHERENT,24
US,JAW FRACTURE,24
US,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,24
US,LIPOMA,24
US,LOW DENSITY LIPOPROTEIN DECREASED,24
US,METASTATIC RENAL CELL CARCINOMA,24
US,NEOPLASM,24
US,OCULAR DISCOMFORT,24
US,OSTEONECROSIS,24
US,OSTEOSCLEROSIS,24
US,PRODUCT LABEL ISSUE,24
US,PRODUCT SOLUBILITY ABNORMAL,24
US,RED BLOOD CELL SEDIMENTATION RATE INCREASED,24
US,RETINAL HAEMORRHAGE,24
US,SKIN ATROPHY,24
US,SPUTUM DISCOLOURED,24
US,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,24
US,VIITH NERVE PARALYSIS,24
US,YELLOW SKIN,24
US,BIPOLAR DISORDER,23
US,BODY TEMPERATURE INCREASED,23
US,CEREBRAL ATROPHY,23
US,CHAPPED LIPS,23
US,CLAVICLE FRACTURE,23
US,FACIAL PARALYSIS,23
US,FOREIGN BODY SENSATION IN EYES,23
US,GASTROINTESTINAL SOUNDS ABNORMAL,23
US,HYDRONEPHROSIS,23
US,HYPERCHLORHYDRIA,23
US,HYPOCALCAEMIA,23
UM,DYSPNOEA,2
UM,ARTHRALGIA,1
UM,BLOOD PRESSURE INCREASED,1
UM,DIARRHOEA,1
UM,DRUG HYPERSENSITIVITY,1
UM,FATIGUE,1
UM,GAIT DISTURBANCE,1
UM,HAEMORRHAGIC DIATHESIS,1
UM,HEART RATE INCREASED,1
UM,INFECTION,1
UM,INJECTION SITE REACTION,1
UM,MYALGIA,1
UM,OXYGEN SATURATION DECREASED,1
UM,PAIN IN EXTREMITY,1
UM,PULMONARY FIBROSIS,1
UM,SKIN DISCOLOURATION,1
UM,STAPHYLOCOCCAL INFECTION,1
UM,VASCULAR PAIN,1
UY,DEEP VEIN THROMBOSIS,1
VE,DEATH,179
VE,MYOCARDIAL INFARCTION,105
VE,RESPIRATORY ARREST,53
VE,CEREBROVASCULAR ACCIDENT,51
VE,CARDIAC ARREST,21
VE,FALL,14
VE,SEPSIS,13
VE,PNEUMONIA,12
VE,DIABETES MELLITUS,11
VE,HYPERTENSION,11
VE,NEOPLASM MALIGNANT,11
VE,CARDIAC DISORDER,10
VE,PULMONARY OEDEMA,8
VE,RESPIRATORY FAILURE,8
VE,EYE DISORDER,7
VE,INFLUENZA,7
VE,LUNG NEOPLASM MALIGNANT,7
VE,RENAL FAILURE,7
VE,BLOOD PRESSURE INCREASED,6
VE,CORONARY ARTERY OCCLUSION,6
VE,DIZZINESS,6
VE,FEMUR FRACTURE,6
VE,MALAISE,6
VE,RENAL DISORDER,6
VE,ROAD TRAFFIC ACCIDENT,6
VE,CARDIO-RESPIRATORY ARREST,5
VE,PAIN,5
VE,PAIN IN EXTREMITY,5
VE,TACHYCARDIA,5
VE,ABDOMINAL PAIN UPPER,4
VE,APHASIA,4
VE,ARRHYTHMIA,4
VE,DIVERTICULITIS,4
VE,GAIT DISTURBANCE,4
VE,HIP FRACTURE,4
VE,HYPOTENSION,4
VE,THROMBOSIS,4
VE,ANKLE FRACTURE,3
VE,ASTHENIA,3
VE,CARDIOVASCULAR DISORDER,3
VE,CEREBRAL INFARCTION,3
VE,CHEST PAIN,3
VE,COLITIS,3
VE,DRUG INEFFECTIVE,3
VE,HAEMOGLOBIN DECREASED,3
VE,HEADACHE,3
VE,INTESTINAL INFARCTION,3
VE,INTESTINAL OBSTRUCTION,3
VE,LIMB DISCOMFORT,3
VE,LIVER DISORDER,3
VE,LOWER LIMB FRACTURE,3
VE,LUNG DISORDER,3
VE,METASTASIS,3
VE,MYALGIA,3
VE,SOMNOLENCE,3
VE,WRIST FRACTURE,3
VE,ABASIA,2
VE,ABDOMINAL PAIN,2
VE,ARTERIAL OCCLUSIVE DISEASE,2
VE,ARTERIOSCLEROSIS,2
VE,ARTHROPATHY,2
VE,BLOOD GLUCOSE ABNORMAL,2
VE,BRONCHOPNEUMONIA,2
VE,CARDIAC VALVE DISEASE,2
VE,CARDIOGENIC SHOCK,2
VE,COLON CANCER,2
VE,CONSTIPATION,2
VE,CORONARY ARTERY DISEASE,2
VE,DEMENTIA ALZHEIMER^S TYPE,2
VE,DEPRESSION,2
VE,DISCOMFORT,2
VE,DYSPNOEA,2
VE,FATIGUE,2
VE,FEEDING DISORDER,2
VE,GALLBLADDER DISORDER,2
VE,GASTRIC CANCER,2
VE,GENERAL PHYSICAL HEALTH DETERIORATION,2
VE,HAEMORRHAGIC STROKE,2
VE,HEPATIC CANCER,2
VE,HEPATIC CIRRHOSIS,2
VE,INFECTION,2
VE,INSOMNIA,2
VE,INTERVERTEBRAL DISC PROTRUSION,2
VE,ISCHAEMIC STROKE,2
VE,LEUKAEMIA,2
VE,METASTASES TO LUNG,2
VE,MULTIPLE FRACTURES,2
VE,MUSCULOSKELETAL PAIN,2
VE,NAUSEA,2
VE,NO ADVERSE EVENT,2
VE,PALPITATIONS,2
VE,PELVIC FRACTURE,2
VE,PERIPHERAL VASCULAR DISORDER,2
VE,PLEURAL EFFUSION,2
VE,POISONING,2
VE,POST PROCEDURAL COMPLICATION,2
VE,PROSTATE CANCER,2
VE,PYREXIA,2
VE,RASH,2
VE,RESPIRATORY DISORDER,2
VE,RESTLESSNESS,2
VE,RHABDOMYOLYSIS,2
VE,ROTATOR CUFF SYNDROME,2
VE,THYROID CYST,2
VE,THYROID NEOPLASM,2
VE,TREMOR,2
VE,URINARY TRACT INFECTION,2
VE,UROSEPSIS,2
VE,WEIGHT DECREASED,2
VE,ABORTION SPONTANEOUS,1
VE,ABSCESS,1
VE,ACCIDENT,1
VE,ACCIDENT AT WORK,1
VE,ACNE,1
VE,ACUTE CORONARY SYNDROME,1
VE,AGITATION,1
VE,AMNESIA,1
VE,ANGINA PECTORIS,1
VE,ANGINA UNSTABLE,1
VE,ANGIOPATHY,1
VE,ANXIETY,1
VE,AORTIC ANEURYSM,1
VE,AORTIC VALVE STENOSIS,1
VE,ARTHRALGIA,1
VE,ASPHYXIA,1
VE,ASPIRATION BRONCHIAL,1
VE,ASTHMA,1
VE,BACK DISORDER,1
VE,BACK PAIN,1
VE,BACTERIAL INFECTION,1
VE,BENIGN PROSTATIC HYPERPLASIA,1
VE,BLADDER NEOPLASM,1
VE,BLEEDING VARICOSE VEIN,1
VE,BLINDNESS,1
VE,BLOOD GLUCOSE FLUCTUATION,1
VE,BLOOD GLUCOSE INCREASED,1
VE,BLOOD PRESSURE ABNORMAL,1
VE,BLOOD PRESSURE DECREASED,1
VE,BONE CYST,1
VE,BRAIN NEOPLASM,1
VE,BREAST ABSCESS,1
VE,BREAST CANCER,1
VE,BRONCHITIS,1
VE,CAESAREAN SECTION,1
VE,CARDIAC FAILURE,1
VE,CAROTID ARTERY OCCLUSION,1
VE,CARPAL TUNNEL SYNDROME,1
VE,CATARACT,1
VE,CELLULITIS,1
VE,CEREBRAL THROMBOSIS,1
VE,CHEST DISCOMFORT,1
VE,CHOLECYSTECTOMY,1
VE,CHOLELITHIASIS,1
VE,CLEAR CELL RENAL CELL CARCINOMA,1
VE,COMA,1
VE,COMPLETED SUICIDE,1
VE,CONJUNCTIVAL DISORDER,1
VE,CONTUSION,1
VE,CONVULSION,1
VE,COUGH,1
VE,DENGUE FEVER,1
VE,DEPRESSED MOOD,1
VE,DEVICE RELATED SEPSIS,1
VE,DIABETIC COMA,1
VE,DIARRHOEA,1
VE,DISORIENTATION,1
VE,DRY EYE,1
VE,DYSPHAGIA,1
VE,DYSPNOEA EXERTIONAL,1
VE,DYSURIA,1
VE,EFFUSION,1
VE,EPILEPSY,1
VE,ERYTHEMA,1
VE,EYE HAEMORRHAGE,1
VE,EYELID PTOSIS,1
VE,FLUID RETENTION,1
VE,GALLBLADDER PAIN,1
VE,GALLBLADDER PERFORATION,1
VE,GASTRIC NEOPLASM,1
VE,GASTRIC ULCER,1
VE,GASTRITIS HAEMORRHAGIC,1
VE,GASTROINTESTINAL DISORDER,1
VE,GASTROINTESTINAL INJURY,1
VE,GASTROOESOPHAGEAL REFLUX DISEASE,1
VE,GENE MUTATION IDENTIFICATION TEST POSITIVE,1
VE,GENERALISED OEDEMA,1
VE,GUILLAIN-BARRE SYNDROME,1
VE,GUN SHOT WOUND,1
VE,HAEMORRHAGE,1
VE,HALLUCINATION,1
VE,HAND FRACTURE,1
VE,HEAD INJURY,1
VE,HEART RATE DECREASED,1
VE,HEART VALVE STENOSIS,1
VE,HELICOBACTER INFECTION,1
VE,HEPATIC RUPTURE,1
VE,HEPATIC STEATOSIS,1
VE,HEPATITIS,1
VE,HYPERAESTHESIA,1
VE,HYPERSENSITIVITY,1
VE,HYPOAESTHESIA,1
VE,HYPOKINESIA,1
VE,ILL-DEFINED DISORDER,1
VE,IMMUNE SYSTEM DISORDER,1
VE,INFARCTION,1
VE,INFECTIOUS PLEURAL EFFUSION,1
VE,INFLAMMATION,1
VE,INGUINAL HERNIA,1
VE,INJURY,1
VE,INTERVERTEBRAL DISC DISORDER,1
VE,INTESTINAL HAEMORRHAGE,1
VE,INTESTINAL SEPSIS,1
VE,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
VE,KERATITIS,1
VE,KIDNEY INFECTION,1
VE,LOCAL SWELLING,1
VE,LOSS OF CONSCIOUSNESS,1
VE,LOWER RESPIRATORY TRACT INFLAMMATION,1
VE,MACULE,1
VE,MALIGNANT NEOPLASM OF PLEURA,1
VE,MEDICAL DEVICE COMPLICATION,1
VE,MENISCAL DEGENERATION,1
VE,METASTASES TO BONE,1
VE,METASTASES TO CENTRAL NERVOUS SYSTEM,1
VE,METASTASES TO LIVER,1
VE,METASTASES TO SPINE,1
VE,MOBILITY DECREASED,1
VE,MONOPARESIS,1
VE,MUSCLE SPASMS,1
VE,MUSCULOSKELETAL DISORDER,1
VE,NECK PAIN,1
VE,NEOPLASM,1
VE,NEOPLASM PROSTATE,1
VE,NEPHROLITHIASIS,1
VE,NON-HODGKIN^S LYMPHOMA,1
VE,OBSTRUCTIVE UROPATHY,1
VE,OEDEMA MOUTH,1
VE,OEDEMA PERIPHERAL,1
VE,OESOPHAGEAL CARCINOMA,1
VE,ORAL DISORDER,1
VE,ORAL PUSTULE,1
VE,OROPHARYNGEAL PAIN,1
VE,OSTEOARTHRITIS,1
VE,OXYGEN SATURATION DECREASED,1
VE,PANCREATIC CARCINOMA,1
VE,PANCREATIC ENLARGEMENT,1
VE,PANCREATIC INJURY,1
VE,PANCREATITIS,1
VE,PARALYSIS,1
VE,PARKINSON^S DISEASE,1
VE,PENIS DISORDER,1
VE,PERIPHERAL COLDNESS,1
VE,PHOTOSENSITIVITY REACTION,1
VE,PLEURAL DISORDER,1
VE,POLLAKIURIA,1
VE,POST PROCEDURAL INFECTION,1
VE,PRODUCT USE ISSUE,1
VE,PROGRESSIVE SUPRANUCLEAR PALSY,1
VE,PROSTATIC DISORDER,1
VE,PRURITUS,1
VE,PULMONARY FIBROSIS,1
VE,PULMONARY HAEMORRHAGE,1
VE,PULMONARY INFARCTION,1
VE,PULMONARY SEPSIS,1
VE,RASH GENERALISED,1
VE,RASH PAPULAR,1
VE,RASH PUSTULAR,1
VE,RECTAL HAEMORRHAGE,1
VE,RESPIRATORY TRACT INFECTION,1
VE,RETINAL HAEMORRHAGE,1
VE,RHINALGIA,1
VE,RHINITIS,1
VE,SEIZURE,1
VE,SEPTIC SHOCK,1
VE,SERUM FERRITIN INCREASED,1
VE,SKELETAL INJURY,1
VE,SKIN EXFOLIATION,1
VE,SKIN ULCER,1
VE,SOFT TISSUE INFECTION,1
VE,SPEECH DISORDER,1
VE,SPINAL FRACTURE,1
VE,SWELLING,1
VE,SYNCOPE,1
VE,SYNOVITIS,1
VE,TENDONITIS,1
VE,THERMAL BURN,1
VE,THINKING ABNORMAL,1
VE,THYROID CANCER,1
VE,THYROID DISORDER,1
VE,TIC,1
VE,TINNITUS,1
VE,TOE AMPUTATION,1
VE,TONSILLAR DISORDER,1
VE,TOOTH FRACTURE,1
VE,TRANSAMINASES INCREASED,1
VE,TRAUMATIC LIVER INJURY,1
VE,TUMOUR INVASION,1
VE,TUMOUR OF AMPULLA OF VATER,1
VE,TUMOUR PERFORATION,1
VE,TYPE 2 DIABETES MELLITUS,1
VE,URINARY BLADDER HAEMORRHAGE,1
VE,URINARY INCONTINENCE,1
VE,UTERINE CANCER,1
VE,UTERINE DISORDER,1
VE,VAGINAL CYST,1
VE,VAGINAL PROLAPSE,1
VE,VARICOSE VEIN,1
VE,VASCULAR ACCESS SITE INFECTION,1
VE,VASCULAR BYPASS DYSFUNCTION,1
VE,VERTIGO,1
VE,VISUAL IMPAIRMENT,1
VE,VOMITING,1
VE,WALKING DISABILITY,1
VN,COAGULOPATHY,2
VN,ABSCESS LIMB,1
VN,ACNE,1
VN,ACUTE KIDNEY INJURY,1
VN,ALOPECIA,1
VN,ALTERED STATE OF CONSCIOUSNESS,1
VN,ANGINA UNSTABLE,1
VN,ARRHYTHMIA,1
VN,BLOOD CREATININE INCREASED,1
VN,CARDIAC FAILURE,1
VN,CARDIO-RESPIRATORY ARREST,1
VN,CEREBRAL INFARCTION,1
VN,COUGH,1
VN,DECREASED APPETITE,1
VN,DYSPNOEA,1
VN,ESCHERICHIA URINARY TRACT INFECTION,1
VN,FATIGUE,1
VN,INFECTION,1
VN,PALLOR,1
VN,PHARYNGEAL HAEMORRHAGE,1
VN,PNEUMONIA,1
VN,PRURITUS,1
VN,PYREXIA,1
VN,SEPSIS,1
VN,SMALL INTESTINAL ULCER HAEMORRHAGE,1
VN,SPUTUM DISCOLOURED,1
VN,TACHYCARDIA,1
VN,UPPER GASTROINTESTINAL HAEMORRHAGE,1
VN,URINARY TRACT INFECTION,1
